As filed with the U.S. Securities and Exchange
Commission on February 21, 2024
Registration No. [ ]
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM F-3
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
Lichen China Limited
(Exact name of registrant as specified in its charter)
Cayman Islands |
|
N/A |
|
Not Applicable |
(State or other
jurisdiction of |
|
(Translation of Registrant’s Name |
|
(I.R.S. Employer |
incorporation or organization) |
|
into English) |
|
Identification No.) |
15th Floor, Xingang Square, Hubin North Road,
Siming District, Xiamen City,
Fujian Province, China,
361013
+86-592-5586999
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY 10168
(212) 947-7200
(Name, address including zip code, and telephone
number, including area code, of agent for service)
Copies to:
William S. Rosenstadt, Esq.
Mengyi “Jason” Ye, Esq.
Yarona L. Yieh, Esq.
Ortoli Rosenstadt LLP
366 Madison Avenue, 3rd Floor
New York, NY 10017
+1-212-588-0022 – telephone
+1-212-826-9307 – facsimile
Approximate date of commencement of proposed sale
to the public: From time to time after the effective date of this registration statement as determined by the registrant.
If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐
If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.
☒
If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant
to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. ☐
If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging growth company ☒
If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities
Act. ☐
† |
The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. |
The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section
8(a), may determine.
The information in this preliminary prospectus
is not complete and may be changed. The securities may not be sold until the registration statement filed with the Securities and Exchange
Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting offers to buy these
securities in any state where the offer or sale is not permitted.
PRELIMINARY PROSPECTUS |
SUBJECT TO COMPLETION |
DATED
FEBRUARY 21, 2024 |
Lichen China Limited
$100,000,000
Class A Ordinary Shares
Share Purchase Contracts
Share Purchase Units
Warrants
Debt Securities
Rights
Units
We may offer, from time to time, in one or more
offerings, Class A ordinary shares, share purchase contracts, share purchase units, warrants, debt securities, rights or units, which
we collectively refer to as the “securities”. The aggregate initial offering price of the securities that we may offer and
sell under this prospectus will not exceed $100,000,000.
We may offer and sell any combination of the securities
described in this prospectus in different series, at times, in amounts, at prices and on terms to be determined at, or prior to, the time
of each offering. This prospectus describes the general terms of these securities and the general manner in which these securities will
be offered. We will provide the specific terms of these securities in supplements to this prospectus. The prospectus supplements will
also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained
in this prospectus. This prospectus may not be used to consummate a sale of securities unless accompanied by the applicable prospectus
supplement. You should read this prospectus and any applicable prospectus supplement before you invest.
We may offer and sell the securities from time
to time at fixed prices, at market prices, or at negotiated prices, to or through underwriters, to other purchasers, through agents, or
through a combination of these methods. If any underwriters are involved in the sale of any securities with respect to which this prospectus
is being delivered, the names of such underwriters and any applicable commissions or discounts will be set forth in a prospectus supplement.
The offering price of such securities and the net proceeds we expect to receive from such sale will also be set forth in a prospectus
supplement. See “Plan of Distribution” elsewhere in this prospectus for a more complete description of the ways in which the
securities may be sold.
Pursuant to General Instruction I.B.5. of Form
F-3, in no event will we sell the securities covered hereby in a public primary offering with a value exceeding more than one-third of
the aggregate market value of our Class A Ordinary Shares in any 12-month period so long as the aggregate market value of our voting and
non-voting common equity held by non-affiliates remains below $75,000,000. During the 12 calendar months prior to and including the date
of this prospectus, we have not offered or sold any securities pursuant to General Instruction I.B.5 of Form F-3.
Our Class A ordinary shares are traded on the
Nasdaq Capital Market under the symbol “LICN.” On February 20, 2024, the closing price of our Class A ordinary shares as reported
by the Nasdaq Capital Market was $1.30. The applicable prospectus supplement will contain information, where applicable, as to other listings,
if any, on the Nasdaq Capital Market or other securities exchange of the securities covered by the prospectus supplement. We may experience
price volatility in our stock. See related risk factors in the “Risk Factors” section of this prospectus and as set forth
in our most recent annual report on Form 20-F.
Unless otherwise specified in an applicable prospectus
supplement, our share purchase contracts, share purchase units, warrants, debt securities, rights and units will not be listed on any
securities or stock exchange or on any automated dealer quotation system.
Investors are cautioned that you are not
buying shares of a China-based operating company but instead are buying shares of a Cayman Islands holding company with operations conducted
by our subsidiaries based in China and that this structure involves unique risks to investors.
This is an offering of the ordinary shares
of the Cayman Islands holding company. We conduct our business through the PRC subsidiaries. You will not and may never have direct ownership
in the operating entity based in China. We do not use a Variable Interest Entity (“VIE”) structure.
Throughout this prospectus, unless the context
indicates otherwise, references to “Lichen China”, “Lichen China Limited”, “we,” “us,”
the “Company,” “our company” refer to Lichen China Limited, a holding company. References to “Subsidiaries,”
“Operating Subsidiaries,” or “PRC subsidiaries” refer to the Lichen China Limited’s subsidiaries established
under the laws of the People’s Republic of China. References to “Group” are to Lichen China Limited and its consolidated
subsidiaries collectively.
Lichen China Limited is a Cayman Islands holding
company and is not a Chinese operating company. As a holding company with no material operations of its own, it conducts all of its operations
and operates its business in China through its PRC subsidiaries. Because of our corporate structure as a Cayman Islands holding company
with operations conducted by our PRC subsidiaries, it involves unique risks to investors. Furthermore, Chinese regulatory authorities
could change the rules and regulations regarding foreign ownership in the industry in which the Company operates, which would likely result
in a material change in our operations and/or a material change in the value of the securities we are registering for sale, including
that it could cause the value of such securities to significantly decline or become worthless. Investors in our ordinary shares should
be aware that they do not directly hold equity interests in the Chinese operating entities, but rather are purchasing equity solely in
Lichen China Limited, our Cayman Islands holding company, which indirectly owns 100% equity interests in the PRC subsidiaries. Our ordinary
shares offered in this offering are shares of our Cayman Islands holding company instead of shares of our subsidiaries in China. See “Risk
Factors — Risks Related to Doing Business in China — The filing, approval or other administration requirements
of the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required in connection
with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be able to complete
the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable.” on page 14.
Investing in our ordinary shares involves a
high degree of risk. Before buying any ordinary shares, you should carefully read the discussion of material risks of investing in our
ordinary shares in “Risk Factors” beginning on page 13 of this prospectus.
The
Chinese government has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy through
regulation and state ownership. Our ability to operate in China may be harmed by changes in its laws and regulations, including those
relating to taxation, environmental regulations, land use rights, property and other matters. The central or local governments of these
jurisdictions may impose new, stricter regulations or interpretations of existing regulations that would require additional expenditures
and efforts on our part to ensure our compliance with such regulations or interpretations. Accordingly, government actions in the future,
including any decision not to continue to support recent economic reforms and to return to a more centrally planned economy or regional
or local variations in the implementation of economic policies, could have a significant effect on economic conditions in China or particular
regions thereof, and could require us to divest ourselves of any interest we then hold in Chinese properties. See “Risk Factors — Risks
Related to Doing Business in China — Uncertainties with respect to the PRC legal system, including uncertainties regarding
the enforcement of laws, and sudden or unexpected changes in laws and regulations in China with little advance notice could adversely
affect us and limit the legal protections available to you and us” on page 13 ,
“Any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and foreign
investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer our Class
A ordinary shares to investors and cause the value of our Class A ordinary shares to significantly decline or be worthless. The M&A
Rules and certain other PRC regulations establish complex procedures for some acquisitions of Chinese companies by foreign investors,
which could make it more difficult for us to pursue growth through acquisitions in China” on page 16, and “We may lose the
ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless
if the Chinese government may exert more oversight and control over offerings that are conducted overseas and/or foreign investment in
China-based issuers” on page 20.
In particular, as substantially all of our operations
are conducted through the PRC subsidiaries, we are subject to certain legal and operational risks associated with our operations in China,
including those changes in the legal, political and economic policies of the Chinese government, the relations between China and the United States,
or Chinese or United States regulations may materially and adversely affect our business, financial condition and results of operations.
PRC laws and regulations governing our current business operations are sometimes vague and uncertain, and therefore, these risks could
result in a material change in our operations and/or the value of our ordinary shares or could significantly limit or completely hinder
our ability to offer or continue to offer securities to investors and cause the value of our ordinary shares to significantly decline
or be worthless. Recently, the PRC government initiated a series of regulatory actions and statements to regulate business operations
in China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over
China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope of cybersecurity
reviews, and expanding the efforts in anti-monopoly enforcement.
As
confirmed by our PRC counsel, Tianyuan Law Firm, we will not be subject
to cybersecurity review with the Cyberspace Administration of China, or the “CAC,” after the Cybersecurity Review Measures
became effective on February 15, 2022, since we currently do not have over one million users’ personal information and do
not anticipate that we will be collecting over one million users’ personal information in the foreseeable future, which we understand
might otherwise subject us to the Cybersecurity Review Measures; we are also not subject to network data security review by the CAC if
the Draft Regulations on the Network Data Security Administration are enacted as proposed, since we currently do not have over one million
users’ personal information and do not collect data that affects or may affect national security and we do not anticipate that
we will be collecting over one million users’ personal information or data that affects or may affect national security in the
foreseeable future, which we understand might otherwise subject us to the Security Administration Draft. See “Risk Factors — Risks
Related to Doing Business in China.”
On February 17, 2023, the China Securities
Regulatory Commission, or the CSRC, announced the Circular on the Administrative Arrangements for Filing of Securities Offering and Listing
by Domestic Companies, or the Circular, and released a set of new regulations which consists of the Trial Administrative Measures of Overseas
Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines. On the same date, the CSRC
also released the Notice on the Arrangements for the Filing Management of Overseas Listing of Domestic Companies, or the Notice. The Trial
Measures came into effect on March 31, 2023. The Trial Measures refine the regulatory system by subjecting both direct and indirect
overseas offering and listing activities to the CSRC filing-based administration. Requirements for filing entities, time points and procedures
are specified. A PRC domestic company that seeks to offer and list securities in overseas markets shall fulfill the filing procedure with
the CSRC per the requirements of the Trial Measures. Where a PRC domestic company seeks to indirectly offer and list securities in overseas
markets, the issuer shall designate a major domestic operating entity, which shall, as the domestic responsible entity, file with the
CSRC. The Trial Measures also lay out requirements for the reporting of material events. Breaches of the Trial Measures, such as
offering and listing securities overseas without fulfilling the filing procedures, shall bear legal liabilities, including a fine between
RMB 1.0 million (approximately $150,000) and RMB 10.0 million (approximately $1.5 million), and the Trial Measures increase
the cost for offenders by enforcing accountability with administrative penalties and incorporating the compliance status of relevant market
participants into the Securities Market Integrity Archives.
According to the Circular, since the date of effectiveness
of the Trial Measures on March 31, 2023, PRC domestic enterprises falling within the scope of filing that have been listed overseas
or met the following circumstances are “existing enterprises”: before the effectiveness of the Trial Measures on March 31,
2023, the application for indirect overseas issuance and listing has been approved by the overseas regulators or overseas stock exchanges
(such as the registration statement has become effective on the U.S. market), it is not required to perform issuance and listing
supervision procedures of the overseas regulators or overseas stock exchanges, and the overseas issuance and listing will be completed
by September 30, 2023. Existing enterprises are not required to file with the CSRC immediately, and filings with the CSRC should
be made as required if they involve refinancings and other filing matters. PRC domestic enterprises that have submitted valid applications
for overseas issuance and listing but have not been approved by overseas regulatory authorities or overseas stock exchanges at the date
of effectiveness of the Trial Measures on March 31, 2023 can reasonably arrange the timing of filing applications with the CSRC and
shall complete the filing with the CSRC before the overseas issuance and listing.
In addition, an overseas-listed company must also
submit the filing with respect to its follow-on offerings, issuance of convertible corporate bonds and exchangeable bonds, and other equivalent
offering activities, within the time frame specified by the Trial Measures. As a result, we will be required to file with the CSRC within
three business days after the completion of the offerings in connection with this registration statement. We will begin the process
of preparing a report and other required materials in connection with the CSRC filing, which will be submitted to the CSRC in due course.
However, if we do not maintain the permissions and approvals of the filing procedure in a timely manner under PRC laws and regulations,
we may be subject to investigations by competent regulators, fines or penalties, ordered to suspend our relevant operations and rectify
any non-compliance, prohibited from engaging in relevant business or conducting any offering, and these risks could result in a material
adverse change in our operations, limit our ability to offer or continue to offer securities to investors, or cause such securities to
significantly decline in value or become worthless. As the Circular and Trial Measures were newly published, there exists uncertainty
with respect to the filing requirements and their implementation. Any failure or perceived failure of us to fully comply with such new
regulatory requirements could significantly limit or completely hinder our ability to offer or continue to offer securities to investors,
cause significant disruption to our business operations, and severely damage our reputation, which could materially and adversely affect
our financial condition and results of operations and could cause the value of our securities to significantly decline or be worthless.
See “Risk Factors — Risks Related to Doing Business in China — The filing, approval or other administration
requirements of the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required
in connection with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be
able to complete the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable” on page 14.
As
of the date of this prospectus, according to our PRC counsel, Tianyuan Law Firm,
although we are required to complete the filing procedure in connection with our offerings under the Trial Measures, no relevant PRC laws
or regulations in effect require that we obtain permission from any PRC authorities to issue securities to foreign investors, and we have
not received any inquiry, notice, warning, sanction, or any regulatory objection to this offering from the CSRC, the CAC, or any other
PRC authorities that have jurisdiction over our operations.
The Standing Committee of the National People’s
Congress, or the SCNPC, or other PRC regulatory authorities may in the future promulgate laws, regulations or implementing rules that
requires our company or any of our subsidiaries to obtain regulatory approval from Chinese authorities before listing in the U.S. In
other words, although the Company has not received any denial to list on the U.S. exchange, our operations could be adversely affected,
directly or indirectly; our ability to offer, or continue to offer, securities to investors would be potentially hindered and the value
of our securities might significantly decline or be worthless, by existing or future laws and regulations relating to its business or
industry or by intervene or interruption by PRC governmental authorities, if we or our subsidiaries (i) do not receive or maintain
such permissions or approvals, (ii) inadvertently conclude that such permissions or approvals are not required, (iii) applicable
laws, regulations, or interpretations change and we are required to obtain such permissions or approvals in the future, or (iv) any
intervention or interruption by PRC governmental with little advance notice. See “Risk Factors — Risks
Related to Doing Business in China” beginning on page 13 this prospectus for a discussion of these legal and operational risks
and information that should be considered before making a decision to purchase our ordinary shares.
In addition, since 2021, the Chinese government
has strengthened its anti-monopoly supervision, mainly in three aspects: (1) establishing the National Anti-Monopoly Bureau; (2) revising
and promulgating anti-monopoly laws and regulations, including: the Anti-Monopoly Law (draft Amendment published on October 23, 2021
for public opinions), the anti-monopoly guidelines for various industries, and the detailed Rules for the Implementation of the Fair Competition
Review System; and (3) expanding the anti-monopoly law enforcement targeting Internet companies and large enterprises. As of the
date of this prospectus, the Chinese government’s recent statements and regulatory actions related to anti-monopoly concerns have
not impacted our ability to conduct business, accept foreign investments, or list on a U.S. or other foreign exchange because neither
the Company nor its PRC subsidiaries engage in monopolistic behaviors that are subject to these statements or regulatory actions.
Pursuant to the Holding Foreign Companies Accountable
Act, or the HFCAA, if the Public Company Accounting Oversight Board, or the PCAOB, is unable to inspect an issuer’s auditors for
three consecutive years, the issuer’s securities are prohibited to trade on a U.S. stock exchange. The PCAOB issued a
Determination Report on December 16, 2021 which found that the PCAOB is unable to inspect or investigate completely registered public
accounting firms headquartered in: (1) mainland China of the People’s Republic of China because of a position taken by one
or more authorities in mainland China; and (2) Hong Kong, a Special Administrative Region and dependency of the PRC, because
of a position taken by one or more authorities in Hong Kong. Furthermore, the PCAOB’s report identified the specific registered
public accounting firms which are subject to these determinations. On June 22, 2021, the U.S. Senate passed the Accelerating
Holding Foreign Companies Accountable Act, and on December 29, 2022, legislation entitled “Consolidated Appropriations Act,
2023” (the “Consolidated Appropriations Act”) was signed into law by President Biden, which contained, among other things,
an identical provision to the Accelerating Holding Foreign Companies Accountable Act and amended the HFCAA by requiring the SEC to prohibit
an issuer’s securities from trading on any U.S stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years
instead of three, thus reducing the time period for triggering the prohibition on trading. On August 26, 2022, the PCAOB announced
that it had signed a Statement of Protocol (the “SOP”) with the China Securities Regulatory Commission and the Ministry of
Finance of China. The SOP, together with two protocol agreements governing inspections and investigations (together, the “SOP Agreement”),
establishes a specific, accountable framework to make possible complete inspections and investigations by the PCAOB of audit firms based
in mainland China and Hong Kong, as required under U.S. law. On December 15, 2022, the PCAOB announced that it was able
to secure complete access to inspect and investigate PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong
completely in 2022. The PCAOB Board vacated its previous 2021 determinations that the PCAOB was unable to inspect or investigate completely
registered public accounting firms headquartered in mainland China and Hong Kong. However, whether the PCAOB will continue to be
able to satisfactorily conduct inspections of PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong
is subject to uncertainties and depends on a number of factors out of our and our auditor’s control. The PCAOB continues to demand
complete access in mainland China and Hong Kong moving forward and is making plans to resume regular inspections in early 2023 and
beyond, as well as to continue pursuing ongoing investigations and initiate new investigations as needed. The PCAOB has also indicated
that it will act immediately to consider the need to issue new determinations with the HFCAA if needed.
Our auditor, Enrome LLP, the independent registered
public accounting firm, as an auditor of companies that are traded publicly in the United States and a firm registered with the PCAOB,
is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess Enrome LLP’s compliance
with applicable professional standards. Enrome LLP is headquartered in Singapore. As of the date of this annual report, Enrome LLP is
not included in the list of PCAOB Identified Firms in the PCAOB Determination Report issued in December 2021. Our auditors, B&V for
the fiscal year ended December 31, 2020 and TPS Thayer for the fiscal year ended December 31, 2021 and 2022, are both based in the U.S.
B&V withdrew its registration from the PCAOB in January 2022. TPS Thayer is headquartered in Sugar Land, Texas, and its registration
with the PCAOB took effect in September 2020 and it is currently subject to PCAOB inspections. See “Risk Factors — Risks
Related to Doing Business in China — The recent joint statement by the SEC and PCAOB, proposed rule changes submitted
by Nasdaq, and the Holding Foreign Companies Accountable Act all call for additional and more stringent criteria to be applied to emerging
market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the
PCAOB. These developments could add uncertainties to our offering” on page 29.
Our management monitors the cash position of each
entity within our organization regularly and prepare budgets on a monthly basis to ensure each entity has the necessary funds to fulfill
its obligation for the foreseeable future and to ensure adequate liquidity. In the event that there is a need for cash or a potential
liquidity issue, it will be reported to our Chief Financial Officer and subject to approval by our board of directors, we will enter into
an intercompany loan for the subsidiary in accordance with the applicable PRC laws and regulations. However, the funds or assets may not
be available to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions
and limitations on the ability of us or our subsidiaries by the PRC government to transfer cash or assets. See “Risk Factors — Risks
Related to Doing Business in China — To the extent cash or assets in the business is in the PRC or Hong Kong or a
PRC or Hong Kong entity, the funds or assets may not be available to fund operations or for other use outside of the PRC or Hong Kong
due to interventions in or the imposition of restrictions and limitations on the ability of us or our subsidiaries by the PRC government
to transfer cash or assets.”
Under existing PRC foreign exchange regulations,
payment of current account items, such as profit distributions and trade and service-related foreign exchange transactions, can be made
in foreign currencies without prior approval from the State Administration of Foreign Exchange, or the SAFE, by complying with certain
procedural requirements. Therefore, our PRC subsidiaries are able to pay dividends in foreign currencies to us without prior approval
from SAFE, subject to the condition that the remittance of such dividends outside of the PRC complies with certain procedures under PRC
foreign exchange regulations, such as the overseas investment registrations by our shareholders or the ultimate shareholders of our corporate
shareholders who are PRC residents. Approval from, or registration with, appropriate government authorities is, however, required where
the RMB is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated
in foreign currencies. The PRC government may also at its discretion restrict access in the future to foreign currencies for current account
transactions. Current PRC regulations permit our PRC subsidiaries to pay dividends to the Company only out of their accumulated profits,
if any, determined in accordance with Chinese accounting standards and regulations. As of the date of this prospectus, there are no restrictions
or limitations imposed by the Hong Kong government on the transfer of capital within, into and out of Hong Kong (including funds
from Hong Kong to the PRC), except for transfer of funds involving money laundering and criminal activities. Cayman Islands law prescribes
that a company may only pay dividends out of its profits or share premium, and that a company may only pay dividends if, immediately following
the date on which the dividend is paid, the company remains able to pay its debts as they fall due in the ordinary course of business.
Other than that, there is no restrictions on Lichen China Limited’s ability to pay dividends to its shareholders. See “Prospectus
Summary — Transfers of Cash to and from Our Subsidiaries,” and “Risk Factors — Risks Related
to Doing Business in China — To the extent cash or assets in the business is in the PRC or Hong Kong or a PRC or
Hong Kong entity, the funds or assets may not be available to fund operations or for other use outside of the PRC or Hong Kong
due to interventions in or the imposition of restrictions and limitations on the ability of us or our subsidiaries by the PRC government
to transfer cash or assets,” “Risk Factors — Risks Related to Doing Business in China — We
are a holding company and we rely on our subsidiaries for funding dividend payments, which are subject to restrictions under PRC laws,”
and “Risk Factors — Risks Related to Doing Business in China — Our PRC subsidiaries are subject
to restrictions on paying dividends or making other payments to us, which may have a material adverse effect on our ability to conduct
our business.”
As a holding company, we may rely on dividends
and other distributions on equity paid by our subsidiaries, including those based in the PRC, for our cash and financing requirements.
If any of our PRC subsidiaries incurs debt on its own behalf in the future, the instruments governing such debt may restrict their ability
to pay dividends to us. Lichen China Limited is permitted under the laws of the Cayman Islands to provide funding to our subsidiaries
incorporated in Hong Kong through loans or capital contributions without restrictions on the amount of the funds. Our subsidiaries
are permitted under the respective laws of Hong Kong to provide funding to Lichen China Limited through dividend distribution without
restrictions on the amount of the funds. There are no restrictions on dividend transfers from Hong Kong to the Cayman Islands. Current
PRC regulations permit Fujian Province Lichen Management and Consulting Company Limited (“Lichen WFOE” or “Lichen Zixun”)
to pay dividends to the Company only out of its accumulated profits, if any, determined in accordance with Chinese accounting standards
and regulations. The transfer of funds among companies are subject to the Provisions of the Supreme People’s Court on Several Issues
Concerning the Application of Law in the Trial of Private Lending Cases (2020 Revision, the “Provisions on Private Lending Cases”),
which was implemented on August 20, 2020 to regulate the financing activities between natural persons, legal persons and unincorporated
organizations. As advised by our PRC counsel, Tianyuan Law Firm, the Provisions on Private Lending Cases does not prohibit using cash
generated from one subsidiary to fund another subsidiary’s operations. We have not been notified of any other restriction which
could limit our PRC subsidiaries’ ability to transfer cash between PRC subsidiaries. During the fiscal years ended December 31,
2020, Lichen Zixun made dividend payments of RMB30 million (approximately $4.3 million) to the then ultimate shareholders of Lichen Zixun,
who are PRC individuals. The Company made no such dividend, distribution or transfer during the fiscal year ended December 31, 2021. As
of the date of this prospectus, except for the previously mentioned dividend payments in fiscal year 2020, neither the Company nor its
subsidiaries have made other transfers, dividends, or distributions to investors and no investors have made transfers, dividends, or distributions
to the Company or its subsidiaries. As of the date of this prospectus, no dividends, distributions or transfers has been made between
Lichen China Limited and any of its subsidiaries. We do not expect to pay any cash dividends in the foreseeable future. Also, as of the
date of this prospectus, no cash generated from one subsidiary is used to fund another subsidiary’s operations and we do not anticipate
any difficulties or limitations on our ability to transfer cash between subsidiaries. See “Prospectus Summary — Transfers
of Cash to and from Our Subsidiaries” on page 7 and “Consolidated Financial Statements” incorporated by reference
into this prospectus.
We are an “emerging growth company”
as defined under federal securities laws and, as such, will be subject to reduced public company reporting requirements. See “Prospectus
Summary — Implications of Being an Emerging Growth Company” and “Prospectus Summary — Implications
of Being a Foreign Private Issuer” on page 5 for additional information.
This prospectus may not be used to offer or
sell our securities unless accompanied by a prospectus supplement. The information contained or incorporated in this prospectus or in
any prospectus supplement is accurate only as of the date of this prospectus, or such prospectus supplement, as applicable, regardless
of the time of delivery of this prospectus or any sale of our securities.
Investing in our securities being offered pursuant
to this prospectus involves a high degree of risk. You should carefully read and consider the ‘‘Risk Factors’’
section of this prospectus, and risk factors set forth in our most recent annual report on Form
20-F, in other reports incorporated herein by reference, and in the applicable prospectus supplement before you make your investment
decision.
Neither the Securities and Exchange Commission,
the Cayman Islands Monetary Authority, nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is ,
2024
TABLE OF CONTENTS
You should rely only on the information contained
or incorporated by reference in this prospectus or any prospectus supplement. We have not authorized any person to provide you with different
or additional information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus
is not an offer to sell securities, and it is not soliciting an offer to buy securities in any jurisdiction where the offer or sale is
not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement, as well as information
we have previously filed with the SEC and incorporated by reference, is accurate as of the date on the front of those documents only.
Our business, financial condition, results of operations and prospects may have changed since those dates.
ABOUT THIS PROSPECTUS
This prospectus is a part of a registration statement
that we have filed with the SEC utilizing a “shelf” registration process. Under this shelf registration process, we may sell
any combination of the securities described in this prospectus in one or more offerings up to an aggregate offering price of $100,000,000.
Each time we sell securities, we will provide
a supplement to this prospectus that contains specific information about the securities being offered and the specific terms of that offering.
The supplement may also add, update or change information contained in this prospectus. If there is any inconsistency between the information
in this prospectus and any prospectus supplement, you should rely on the prospectus supplement.
We may offer and sell securities to, or through,
underwriting syndicates or dealers, through agents or directly to purchasers.
The prospectus supplement for each offering of
securities will describe in detail the plan of distribution for that offering.
In connection with any offering of securities
(unless otherwise specified in a prospectus supplement), the underwriters or agents may over-allot or effect transactions which stabilize
or maintain the market price of the securities offered at a higher level than that which might exist in the open market. Such transactions,
if commenced, may be interrupted or discontinued at any time. See “Plan of Distribution.”
Please carefully read both this prospectus and
any prospectus supplement together with the documents incorporated herein by reference under “Incorporation of Documents by Reference”
and the additional information described below under “Where You Can Get More Information.”
Prospective investors should be aware that the
acquisition of the securities described herein may have tax consequences. You should read the tax discussion contained in the applicable
prospectus supplement and consult your tax advisor with respect to your own particular circumstances.
You should rely only on the information contained
or incorporated by reference in this prospectus and any prospectus supplement. We have not authorized anyone to provide you with different
information. The distribution or possession of this prospectus in or from certain jurisdictions may be restricted by law. This prospectus
is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or
sale is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted
to make such offer or sale. The information contained in this prospectus is accurate only as of the date of this prospectus and any information
incorporated by reference is accurate as of the date of the applicable document incorporated by reference, regardless of the time of delivery
of this prospectus or of any sale of the securities. Our business, financial condition, results of operations and prospects may have changed
since those dates.
COMMONLY USED DEFINED TERMS
Throughout this prospectus, unless the context
indicates otherwise, references to “Lichen China”, “Lichen China Limited”, “we,” “us,”
the “Company,” “our company” refer to Lichen China Limited, a holding company. References to “Subsidiaries,”
“Operating Subsidiaries,” or “PRC subsidiaries” refer to the Lichen China Limited’s subsidiaries established
under the laws of the People’s Republic of China. References to “Group” are to Lichen China Limited and its consolidated
subsidiaries collectively. Unless otherwise indicated, in this prospectus, references to:
| ● | “China”
or the “PRC” are to the People’s Republic of China; |
|
● |
“Class A ordinary shares” are to a class of shares of Lichen China Limited called the “series A ordinary shares” with par value $0.00004 per share; |
|
● |
“Class B ordinary shares” are to a class of shares of Lichen China Limited called the “series B ordinary shares” with par value $0.00004 per share; |
|
● |
“HKD” are to the official currency of Hong Kong; |
|
● |
“Lichen China” or “LICN” are to Lichen China Limited, a Cayman Islands exempted company; |
|
● |
“Legend Consulting BVI” are to Legend Consulting Investments Limited, a British Virgin Islands exempted company and a wholly-owned subsidiary of Lichen China; |
|
● |
“Legend Consulting HK” are to Legend Consulting Limited (HK), a Hong Kong company and a wholly-owned subsidiary of Legend Consulting BVI; |
|
● |
“Lichen WFOE” or “Lichen Zixun” are to Fujian Province Lichen Management and Consulting Company Limited, a wholly foreign-owned company organized under the laws of the PRC and a wholly-owned subsidiary of Legend Consulting HK; |
|
● |
“Lichen Education” are to Xiamen City Legend Education Services Company Limited, a limited liability company organized under the laws of the PRC and a wholly-owned subsidiary of Lichen WFOE; |
|
● |
“RMB” are to Renminbi, or the legal currency of the PRC; |
|
● |
“U.S. dollars,” “$,” and “USD” are to the legal currency of the United States; and |
|
● |
“WFOE” are to wholly foreign-owned enterprise. |
SPECIAL NOTICE REGARDING FORWARD-LOOKING STATEMENTS
This prospectus contains forward-looking statements.
All statements contained in this prospectus other than statements of historical fact, including statements regarding our future results
of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements.
The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based
these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may
affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives,
and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the factors
described under the section titled “Risk Factors” in this prospectus and in the documents incorporated by reference herein
and under a similar heading in any applicable prospectus supplement. Moreover, we operate in a very competitive and rapidly changing environment.
New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors
on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those
contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and
trends discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied
in the forward-looking statements.
You should not rely upon forward-looking statements
as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur.
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results,
levels of activity, performance, or achievements. Except as required by applicable law, we undertake no duty to update any of these forward-looking
statements after the date of this prospectus or to conform these statements to actual results or revised expectations.
PROSPECTUS SUMMARY
Business Overview
Through our PRC subsidiaries, we provide (i) financial
and taxation solution services; (ii) education support services; and (iii) software and maintenance services in the PRC. The connections
and synergies amongst our services are illustrated in the diagram below:
The financial and taxation solution services provided
to our corporate customers mainly comprise financial and taxation related management consultation, internal control management consultation,
annual or regular consultation, and internal training and general consultation.
The education support services provided to our
partnered institutions (“Partnered Institutions”) mainly comprise the provision of marketing, operational and technical support
and the sales of teaching and learning materials.
The software and maintenance services provided
to our corporate customers mainly comprise the sales of financial and taxation analysis software and sales of financial and taxation training
software.
Financial and Taxation Solution Services
We focus on our financial and taxation solution
services to business companies in the PRC. We believe that every company, regardless of its size, should adopt a sound financial and taxation
management system for growth and sustainable development. With such philosophy in mind as a guiding principle, our financial and taxation
solution services are customized based on the specific needs and requirements of individual customers.
Education Support Services
Our
education support services are provided to our Partnered Institutions. As of the date of this prospectus, we collaborate with 23 Partnered
Institutions in 11 provinces or municipalities and 20 cities in the PRC. Partnered
Institutions are education services providers which mainly engage in organization of various seminars, talks and training courses to entrepreneurs,
senior executives as well as financial and taxation executives. From the personal and business networks of our management as well as our
marketing initiatives (being our talks and seminars hosted by the Partnered Institutions), potential customers who wish to set up education
institutions may approach us and initiate discussions with us, with an aim to becoming our Partnered Institutions.
Software and Maintenance Services
Lichen Zixun has been providing financial and
taxation training software and academic affairs management system to our Partnered Institutions as part of our services under the Partnership
Agreements.
Leveraging our understanding of corporate needs
on financial and taxation management and analysis tools in daily operation of our enterprise customers, we began to invest and develop
our first financial and taxation analysis software, namely, Enterprise Financial Intelligence Analysis System V1.0, in 2017 and have commercialized
it for sale to our corporate customers since 2019.
With respect to our Lichen Education Accounting
Practice System V1.0, a financial and taxation training system that was developed in 2014, it is focused on students’ or users’
practice experience by resembling, illustrating and providing practices on various accounting tasks, such as bookkeeping, tax computation,
filing tax returns and issuing valued-added tax invoices in actual business practices. Thereafter, we updated and developed some new training
systems based on Lichen Education Accounting Practice System V1.0. Lichen Education has eight copyrights for financial and taxation training
software to date.
As
of the date of this prospectus, we have not experienced any product recalls, liability claims or material complaints on our software products.
After Sales Services
Our customers who engage us for our financial
and taxation related consultation services may attend courses provided by our Partnered Institutions. Continuous training can enhance
the financial and taxation concepts of our customers and ensure the continuous implementation of the financial and taxation solutions
we provided to them. We also provide general customer care by responding to customer queries as they arise, in order to resolve their
problems on a timely basis.
From time to time, the Partnered Institutions
will also host talks and seminars, conducted by our experienced senior management personnel, internal consultants or external experts,
to which our customers are invited. As for our Partnered Institutions, we provide continuous support to them, including operational and
technical support in school management and operation and trainings to Partnered Institutions’ staff and employees to enhance their
teaching quality. With respect to our software products, we offer software installation, training and after sales technical and maintenance
services, such as telephone, instant communication and remote support services, within one year of purchase for our financial and taxation
training software and financial and taxation analysis software.
Sales and Marketing
We believe brand recognition of “Lichen”
is critical to our ability to attract new customers and retain business collaboration and relationship with our existing clientele, and
our promotion and marketing efforts are designed to enhance our brand awareness and reputations among them. Generally, we attract new
customers with referrals from our Partnered Institutions and personal and business networks of our executives and directors.
In addition, we organize
marketing activities, such as seminars, talks and consultation events with our Partnered Institutions, business federations and business
associations, leveraging our accumulated resources and connections. Through the business relationships with our Partnered Institutions,
we could, on the one hand, provide our education support services to them and, on the other hand, by leveraging their business networks
and their geographical coverage, promote our brand name and services to the participants of these seminars, talks and courses organized
by them. As of the date of this prospectus, we have deployed external experts and internal consultants to participate in and deliver more
than 1,000 talks, courses and seminars organized for their target audience.
Corporate History and Structure
The following diagram illustrates our corporate structure:
Holding Company Structure
Lichen China Limited was incorporated on April
13, 2016 under the laws of the Cayman Islands. As of the date of this prospectus, the authorized share capital of the Company is US$50,000
divided into 1,000,000,000 Class A ordinary shares and 250,000,000 Class B ordinary shares, of which 17,500,000 Class A ordinary shares
and 9,000,000 Class B ordinary shares are issued and outstanding. The Company is a holding company and is currently not actively engaging
in any business. You may never hold equity interests in the operating PRC Subsidiaries. Further, Lichen China Limited controls and receives
the economic benefits of its PRC subsidiaries’ business operation, if any, through equity ownership. We do not use a Variable Interest
Entity (“VIE”) structure.
Our Subsidiaries and
Business Functions
Legend Consulting BVI was incorporated on December
20, 2013 under the laws of the British Virgin Islands with limited liability. Legend Consulting BVI is a wholly owned subsidiary of the
Company. Legend Consulting BVI is a holding company and is currently not actively engaging in any business.
Legend Consulting HK was formed on January 8,
2014 under the laws of Hong Kong. Legend Consulting HK is a wholly owned subsidiary of Legend Consulting BVI. It is a holding company
and is not actively engaging in any business.
Lichen Zixun was established on April 14, 2004
under the laws of the PRC. Lichen Zixun is a wholly owned subsidiary of Legend Consulting HK and is our main operating entity.
Lichen Education was established on July 30, 2014
under the laws of PRC. Lichen Education is a wholly owned subsidiary of Lichen Zixun and is our operating entity.
Summary of Risk Factors
Investing in our Class A ordinary shares involves
a high degree of risk. This summary does not address all of the risks that we face. Please refer to the information contained in and incorporated
by reference under the heading “Risk Factors” on page 13 of this prospectus.
Risks Related to Doing Business in China
Risks related to doing business in China, beginning
on page 13 of this prospectus, include but are not limited to the following:
|
● | “Uncertainties with respect to the PRC legal system,
including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in laws and regulations in China with little
advance notice could adversely affect us and limit the legal protections available to you and us.” See page 13. |
| ● | “The filing, approval or other administration requirements
of the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required in connection
with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be able to complete
the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable.” See page 14. |
| ● | “Any actions by the Chinese government to exert more
oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers could significantly limit
or completely hinder our ability to offer or continue to offer our ordinary shares to investors and cause the value of our ordinary shares
to significantly decline or be worthless. The M&A Rules and certain other PRC regulations establish complex procedures for some acquisitions
of Chinese companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in China.”
See page 16. |
| ● | “There are significant legal and other obstacles to
obtaining information needed for shareholder investigations or litigation outside China or otherwise with respect to foreign entities.”
See page 17. |
| ● | “PRC regulation of loans to, and direct investments
in, PRC entities by offshore holding companies may delay or prevent us from using proceeds from this offering and/or future financing
activities to make loans or additional capital contributions to our PRC operating subsidiaries.” See page 17. |
| ● | “We must remit the offering proceeds to China before
they may be used to benefit our business in China, and this process may take several months to complete.” See page 18. |
| ● | “PRC regulation of loans to and direct investment in
PRC entities by offshore holding companies to PRC entities may delay or prevent us from making loans or additional capital contributions
to our PRC operating subsidiaries.” See page 19. |
| ● | “Adverse changes in political and economic policies
of the PRC government could have a material adverse effect on the overall economic growth of China, which could reduce the demand for
our products and services and materially and adversely affect our competitive position.” See page 19. |
| ● | “We may become subject to a variety of laws and regulations
in the PRC regarding privacy, data security, cybersecurity, and data protection. We may be liable for improper use or appropriation of
personal information provided by our customers.” See page 25. |
| ● | “Trading in our securities may be prohibited under
the HFCAA and as a result an exchange may determine to delist our securities if it is later determined that the PCAOB is unable to inspect
or investigate completely our auditor because of a position taken by an authority in a foreign jurisdiction.” See page 31. |
| ● | “The recent joint statement by the SEC and PCAOB, proposed
rule changes submitted by Nasdaq, and the Holding Foreign Companies Accountable Act all call for additional and more stringent criteria
to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors
who are not inspected by the PCAOB. These developments could add uncertainties to our offering.” See page 29. |
| ● | “The approval of the China Securities Regulatory Commission
may be required in connection with this offering, and, if required, we cannot predict whether we will be able to obtain such approval.”
See page 31. |
| ● | “To
the extent cash or assets in the business is in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may
not be available to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of
restrictions and limitations on the ability of us or our subsidiaries by the PRC government to transfer cash or assets.” See page 24. |
Implications of Being an Emerging Growth Company
We qualify as and elect to be an “emerging
growth company” as defined in the Jumpstart our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take
advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. These provisions
include, but not limited to:
|
● |
Reduced disclosure about the emerging growth company’s executive compensation arrangements in our periodic reports, proxy statements and registration statements; and |
|
● |
an exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002. |
We will remain an “emerging growth company”
until the earliest to occur of (i) the last day of the fiscal year (a) following the fifth anniversary of the closing of the
Business Combination, (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which we are
deemed to be a large accelerated filer, which means the market value of equity securities held by our non-affiliates exceeds $700 million
as of the last business day of our prior second fiscal quarter, and (ii) the date on which we have issued more than $1.0 billion
in non-convertible debt during the prior three-year period.
Implication of Being a Foreign Private Issuer
We are a foreign private issuer within the meaning
of the rules under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As such, we are exempt from certain
provisions applicable to United States domestic public companies. For example:
|
● |
we are not required to provide as many Exchange Act reports or provide periodic and current reports as frequently, as a domestic public company; |
|
● |
for interim reporting, we are permitted to comply solely with our home country requirements, which are less rigorous than the rules that apply to domestic public companies; |
|
● |
we are not required to provide the same level of disclosure on certain issues, such as executive compensation; |
|
● |
we are exempt from provisions of Regulation FD aimed at preventing issuers from making selective disclosures of material information; |
|
● |
we are not required to comply with the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; and |
|
● |
we are not required to comply with Section 16 of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and establishing insider liability for profits realized from any “short-swing” trading transaction. |
Implication of Holding Foreign Companies Accountable
Act
U.S. laws and regulations, including the
Holding Foreign Companies Accountable Act, or HFCAA, may restrict or eliminate our ability to complete a business combination with certain
companies, particularly those acquisition candidates with substantial operations in China.
On March 24, 2021, the SEC adopted interim
final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. An identified issuer
will be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to
be subsequently established by the SEC. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies
Accountable Act, and on December 29, 2022, legislation entitled “Consolidated Appropriations Act, 2023” (the “Consolidated
Appropriations Act”) was signed into law by President Biden, which contained, among other things, an identical provision to the
Accelerating Holding Foreign Companies Accountable Act and amended the HFCAA by requiring the SEC to prohibit an issuer’s securities
from trading on any U.S stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three,
thus reducing the time period for triggering the prohibition on trading. On September 22, 2021, the PCAOB adopted a final rule implementing
the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether the PCAOB is unable
to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken
by one or more authorities in that jurisdiction.
On December 2, 2021, the SEC issued amendments
to finalize rules implementing the submission and disclosure requirements in the HFCAA. The rules apply to registrants that the SEC
identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign
jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions.
On December 16, 2021, the PCAOB issued a report on its determinations that it is unable to inspect or investigate completely PCAOB-registered
public accounting firms headquartered in mainland China and in Hong Kong, because of positions taken by PRC authorities in those
jurisdictions. On August 26, 2022, the PCAOB announced that it had signed a Statement of Protocol (the “SOP”) with the
China Securities Regulatory Commission and the Ministry of Finance of China. The SOP, together with two protocol agreements governing
inspections and investigations (together, the “SOP Agreement”), establishes a specific, accountable framework to make possible
complete inspections and investigations by the PCAOB of audit firms based in mainland China and Hong Kong, as required under U.S. law.
On December 15, 2022, the PCAOB announced that it was able to secure complete access to inspect and investigate PCAOB-registered
public accounting firms headquartered in mainland China and Hong Kong completely in 2022. The PCAOB Board vacated its previous 2021
determinations that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in mainland
China and Hong Kong. However, whether the PCAOB will continue to be able to satisfactorily conduct inspections of PCAOB-registered
public accounting firms headquartered in mainland China and Hong Kong is subject to uncertainties and depends on a number of factors
out of our and our auditor’s control. The PCAOB continues to demand complete access in mainland China and Hong Kong moving
forward and is making plans to resume regular inspections in early 2023 and beyond, as well as to continue pursuing ongoing investigations
and initiate new investigations as needed. The PCAOB has also indicated that it will act immediately to consider the need to issue new
determinations with the HFCAA if needed.
Our auditor, Enrome LLP, the independent registered
public accounting firm, as an auditor of companies that are traded publicly in the United States and a firm registered with the PCAOB,
is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess Enrome LLP’s compliance
with applicable professional standards. Enrome LLP is headquartered in Singapore. As of the date of this annual report, Enrome LLP is
not included in the list of PCAOB Identified Firms in the PCAOB Determination Report issued in December 2021. Our auditors, B&V for
the fiscal year ended December 31, 2020 and TPS Thayer for the fiscal year ended December 31, 2021 and 2022, are both based in the U.S.
B&V withdrew its registration from the PCAOB in January 2022. TPS Thayer is headquartered in Sugar Land, Texas, and its registration
with the PCAOB took effect in September 2020 and it is currently subject to PCAOB inspections.
However, we cannot assure you whether Nasdaq or
regulatory authorities would apply additional and more stringent criteria to us after considering the effectiveness of our auditor’s
audit procedures and quality control procedures, adequacy of personnel and training, or sufficiency of resources, geographic reach or
experience as it relates to the audit of our financial statements. See “Risk Factors — Risks Related to Doing Business
in China — The recent joint statement by the SEC and PCAOB, proposed rule changes submitted by Nasdaq, and the Holding
Foreign Companies Accountable Act all call for additional and more stringent criteria to be applied to emerging market companies upon
assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB. These developments
could add uncertainties to our offering” on page 29.
Transfers of Cash to and from Our Subsidiaries
We
currently have not maintained any cash management policies that dictate the purpose, amount and procedure of cash transfers between the
Company, our subsidiaries, or investors. Rather, the funds can be transferred in accordance with the applicable PRC laws and regulations.
To the extent cash or assets in the business is in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may not be available
to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations
on the ability of us or our subsidiaries by the PRC government to transfer cash or assets.
Under
existing PRC foreign exchange regulations, payment of current account items, such as profit distributions and trade and service-related
foreign exchange transactions, can be made in foreign currencies without prior approval from the State Administration of Foreign Exchange,
or the SAFE, by complying with certain procedural requirements. Therefore, our PRC subsidiaries are able to pay dividends in foreign currencies
to us without prior approval from SAFE, subject to the condition that the remittance of such dividends outside of the PRC complies with
certain procedures under PRC foreign exchange regulations, such as the overseas investment registrations by our shareholders or the ultimate
shareholders of our corporate shareholders who are PRC residents. Approval from, or registration with, appropriate government authorities
is, however, required where the RMB is to be converted into foreign currency and remitted out of China to pay capital expenses such as
the repayment of loans denominated in foreign currencies. The PRC government may also at its discretion restrict access in the future
to foreign currencies for current account transactions. Current PRC regulations permit our PRC subsidiaries to pay dividends to the Company
only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. As of the date
of this prospectus, there are no restrictions or limitations imposed by the Hong Kong government on the transfer of capital within, into
and out of Hong Kong (including funds from Hong Kong to the PRC), except for transfer of funds involving money laundering and criminal
activities. Cayman Islands law prescribes that a company may only pay dividends out of its profits. Other than that, there is no restrictions
on Lichen China Limited’s ability to transfer cash to investors. See “Risk Factors - Risks Related to Doing Business in China
- To the extent cash or assets in the business is in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may not be
available to fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions
and limitations on the ability of us or our subsidiaries by the PRC government to transfer cash or assets,” “Risk Factors
- Risks Related to Doing Business in China - We rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund
any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could
have a material adverse effect on our ability to conduct our business,” and “Risk Factors - Risks Related to Doing Business
in China - Our PRC subsidiaries are subject to restrictions on paying dividends or making other payments to us, which may have a material
adverse effect on our ability to conduct our business.”
As
a holding company, we may rely on dividends and other distributions on equity paid by our subsidiaries, including those based in the PRC,
for our cash and financing requirements. If any of our PRC subsidiaries incurs debt on its own behalf in the future, the instruments governing
such debt may restrict their ability to pay dividends to us. Lichen China Limited is permitted under the laws of the Cayman Islands to
provide funding to our subsidiaries incorporated in the British Virgin Islands and Hong Kong through loans or capital contributions
without restrictions on the amount of the funds. Our subsidiaries are permitted under the respective laws of the British Virgin Islands
and Hong Kong to provide funding to Lichen China Limited through dividend distribution without restrictions on the amount of the funds.
There are no restrictions on dividends transfers from HK to BVI and BVI to the Cayman Islands. Current PRC regulations permit our WFOE to
pay dividends to the Company only out of its accumulated profits, if any, determined in accordance with Chinese accounting standards and
regulations.
The
PRC has currency and capital transfer regulations that require us to comply with certain requirements for the movement of capital. The
Company is able to transfer cash (US Dollars) to its PRC subsidiaries through an investment (by increasing the Company’s registered
capital in a PRC subsidiary). The Company’s subsidiaries within China can transfer funds to each other when necessary through the
way of current lending. The transfer of funds among companies are subject to the Provisions on Private Lending Cases, which was implemented
on August 20, 2020 to regulate the financing activities between natural persons, legal persons and unincorporated organizations. As advised
by our PRC counsel, Tianyuan Law Firm, the Provisions on Private Lending Cases does not prohibit using cash generated from one subsidiary
to fund another subsidiary’s operations. We have not been notified of any other restriction which could limit our PRC subsidiaries’
ability to transfer cash between PRC subsidiaries. The Company’s subsidiaries in the PRC have not transferred any earnings or cash
to the Company to date. As of the date of this prospectus, there has not been any assets or cash transfer between the holding company
and its subsidiaries. As of the date of this prospectus, there has not been any dividends or distributions made to US investors. The Company’s
business is primarily conducted through its subsidiaries. The Company is a holding company and its material assets consist solely of the
ownership interests held in its PRC subsidiaries. The Company relies on dividends paid by its subsidiaries for its working capital and
cash needs, including the funds necessary: (i) to pay dividends or cash distributions to its shareholders, (ii) to service any debt obligations
and (iii) to pay operating expenses. As a result of PRC laws and regulations (noted below) that require annual appropriations of 10% of
after-tax income to be set aside in a general reserve fund prior to payment of dividends, the Company’s PRC subsidiaries are restricted
in that respect, as well as in other respects noted below, in their ability to transfer a portion of their net assets to the Company as
a dividend.
With
respect to transferring cash from the Company to its subsidiaries, increasing the Company’s registered capital in a PRC subsidiary
requires the filing of the local commerce department, while a shareholder loan requires a filing with the State Administration of Foreign
Exchange or its local bureau. Aside from the declaration to the State Administration of Foreign Exchange, there is no restriction or limitations
on such cash transfer or earnings distribution.
With
respect to the payment of dividends, we note the following:
|
1. |
PRC regulations currently permit the payment of dividends only out of accumulated profits, as determined in accordance with accounting standards and PRC regulations (an in-depth description of the PRC regulations is set forth below); |
|
2. |
Our PRC subsidiaries are required to set aside, at a minimum, 10% of their net income after taxes, based on PRC accounting standards, each year as statutory surplus reserves until the cumulative amount of such reserves reaches 50% of their registered capital; |
|
3. |
Such reserves may not be distributed as cash dividends; |
|
4. |
Our PRC subsidiaries may also allocate a portion of their after-tax profits to fund their staff welfare and bonus funds; except in the event of a liquidation, these funds may also not be distributed to shareholders; the Company does not participate in a Common Welfare Fund; and |
|
5. |
The incurrence of debt, specifically the instruments governing such debt, may restrict a subsidiary’s ability to pay shareholder dividends or make other cash distributions. |
If,
for the reasons noted above, our subsidiaries are unable to pay shareholder dividends and/or make other cash payments to the Company when
needed, the Company’s ability to conduct operations, make investments, engage in acquisitions, or undertake other activities requiring
working capital may be materially and adversely affected. However, our operations and business, including investment and/or acquisitions
by our subsidiaries within China, will not be affected as long as the capital is not transferred in or out of the PRC.
During
the fiscal years ended December 31, 2020, Lichen Zixun made dividend payments of RMB30 million (approximately $4.3 million) to the then
eventual shareholders of Lichen Zixun, who are PRC individuals. The Company made no such dividend, distribution or transfer during the
fiscal year ended December 31, 2021. As of the date of this prospectus, the Company or its subsidiaries have made no other transfers,
dividends, or distributions to investors and no investors have made transfers, dividends, or distributions to the Company or its subsidiaries.
As
of the date of this prospectus, no dividends, distributions or transfers has been made between Lichen China Limited and any of its subsidiaries.
For the foreseeable future, the Company intends to use the earnings for research and development, to develop new products and to expand
its production capacity. As a result, we do not expect to pay any cash dividends in the foreseeable future. Also, as of the date
of this prospectus, no cash generated from one subsidiary is used to fund another subsidiary’s operations and we do not anticipate
any difficulties or limitations on our ability to transfer cash between subsidiaries.
PRC Regulations
In
accordance with PRC regulations, a domestic company is required to maintain a surplus reserve of at least 10% of its annual after-tax
profit until such reserve has reached 50% of its respective registered capital based on the enterprise’s PRC statutory accounts.
The aforementioned reserves can only be used for specific purposes and may not be distributed as cash dividends. Lichen Zixun and Lichen
Education were established as domestic companies; therefore, each is subject to the above-mentioned restrictions on distributable profits.
As a result of PRC laws
and regulations that require annual appropriations of 10% of after-tax income to be set aside, prior to payment of dividends, in a general
reserve fund, the Company’s PRC subsidiaries are restricted in their ability to transfer a portion of their net assets to the Company
as a dividend or otherwise.
Regulatory Permissions
Our Subsidiaries currently
have obtained all material permissions and approvals required for our operations in compliance with the relevant PRC laws and regulations
in the PRC, including the business license and agency bookkeeping license. The business license is a permit issued by Market Supervision
and Administration that allows the company to conduct specific business within the government’s geographical jurisdiction. The agency
bookkeeping license is issued by the financial department to enterprises, allowing enterprises to accept entrusted bookkeeping business.
The business license and agency bookkeeping license are the only two permissions and approvals that our PRC subsidiaries are required
to obtain to conduct our business in China. In addition, Lichen China Limited, Legend Consulting BVI and Legend Consulting HK are not
required to obtain any permissions or approvals from any Chinese authorities to operate our business as of the date of this prospectus.
However, applicable laws and regulations may be tightened, and new laws or regulations may be introduced to impose additional government
approval, license and permit requirements. If we or our Subsidiaries inadvertently conclude that such permissions and approvals relating
to the operations of our business are not required, fail to obtain and maintain such approvals, licenses or permits required for our business,
or fail to respond to changes in the applicable laws, regulations, interpretations and regulatory environment, we or our subsidiaries
could be subject to liabilities, monetary penalties and even operational disruption, which may materially and adversely affect our business,
operating results, financial condition and the value of our Class A Ordinary Shares, significantly limit or completely hinder our ability
to offer or continue to offer securities to investors, or cause such securities to significantly decline in value or become worthless.
As confirmed by our PRC counsel,
Tianyuan Law Firm, we and our Subsidiaries are not subject to cybersecurity review with the Cyberspace Administration of China, or the
“CAC,” after the Cybersecurity Review Measures became effective on February 15, 2022, since we currently do not have over
one million users’ personal information and do not anticipate that we will be collecting over one million users’ personal
information in the foreseeable future, which we understand might otherwise subject us to the Cybersecurity Review Measures; we are also
not subject to network data security review by the CAC if the Draft Regulations on the Network Data Security Administration are enacted
as proposed, since we currently do not have over one million users’ personal information and do not collect data that affects or
may affect national security and we do not anticipate that we will be collecting over one million users’ personal information or
data that affects or may affect national security in the foreseeable future, which we understand might otherwise subject us to the Network
Data Security Administration Draft. However, the changing applicable laws, regulations or interpretations may require us to do so in the
future. Accordingly, any future failure to obtain prior approval of the CSRC, CAC, or any other Chinese authorities for the listing and
trading of our Class A Ordinary Shares on a foreign stock exchange could have a material adverse effect upon our business. If we or our
subsidiaries inadvertently conclude that such approval or permission is not required, fail to obtain and maintain such approval or permission
required, we or our subsidiaries may face sanctions by the CSRC, CAC or other PRC regulatory agencies for failure to seek CSRC, CAC approval.
These sanctions may include fines and penalties on our operations in China, limitations on our operations in China, delays in or restrictions
on the repatriation of the proceeds from this offering into the PRC, restrictions on or prohibition of the payments or remittance of dividends
by our subsidiaries in China, or other actions that could have a material adverse effect on our business, financial condition, results
of operations, reputation, prospects, the trading price of our Class A Ordinary Shares, and the ability to offer the securities being
registered to foreign investors.
On August 8, 2006, six PRC regulatory agencies
jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&A Rules, which
came into effect on September 8, 2006 and were amended on June 22, 2009. The M&A Rules requires that an offshore special
purpose vehicle formed for overseas listing purposes and controlled directly or indirectly by the PRC Citizens shall obtain the approval
of the CSRC prior to overseas listing and trading of such special purpose vehicle’s securities on an overseas stock exchange. Based
on our understanding of the Chinese laws and regulations in effect at the time of this prospectus, we will not be required to submit an
application to the CSRC for its approval of this offering and the listing and trading of our ordinary shares on the Nasdaq under the M&A
Rules. However, there remains some uncertainty as to how the M&A Rules will be interpreted or implemented, and the opinions of our
PRC counsel summarized above are subject to any new laws, rules and regulations or detailed implementations and interpretations in any
form relating to the M&A Rules. We cannot assure you that relevant Chinese government agencies, including the CSRC, would reach the
same conclusion.
Recently, the General Office of the Central Committee
of the Communist Party of China and the General Office of the State Council jointly issued the Opinions on Strictly Cracking Down on Illegal
Securities Activities, which were made available to the public on July 6, 2021. The Opinions on Strictly Cracking Down on Illegal
Securities Activities emphasized the need to strengthen the administration over illegal securities activities, and the need to strengthen
the supervision over overseas listings by Chinese companies. Effective measures, such as promoting the construction of relevant regulatory
systems will be taken to deal with the risks and incidents of China-based overseas listed companies, and cybersecurity and data privacy
protection requirements and similar matters. It is still uncertain how PRC governmental authorities will regulate overseas listing in
general and whether we are required to obtain any specific regulatory approvals. Furthermore, if the CSRC or other regulatory agencies
later promulgate new rules or explanations requiring that we obtain their approvals for this offering and any follow-on offering, we may
be unable to obtain such approvals which could significantly limit or completely hinder our ability to offer or continue to offer securities
to our investors. On December 24, 2021, the CSRC, together with other relevant government authorities in China issued the Provisions
of the State Council on the Administration of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments), and
the Measures for the Filing of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments) (“Draft Overseas
Listing Regulations”). The Draft Overseas Listing Regulations requires that a PRC domestic enterprise seeking to issue and list
its shares overseas (“Overseas Issuance and Listing”) shall complete the filing procedures of and submit the relevant information
to CSRC. The Overseas Issuance and Listing includes direct and indirect issuance and listing. Where an enterprise whose principal
business activities are conducted in PRC seeks to issue and list its shares in the name of an overseas enterprise (“Overseas Issuer”)
on the basis of the equity, assets, income or other similar rights and interests of the relevant PRC domestic enterprise, such activities
shall be deemed an indirect overseas issuance and listing (“Indirect Overseas Issuance and Listing”) under the Draft Overseas
Listing Regulations. Therefore, the proposed offering would be deemed an Indirect Overseas Issuance and Listing under the Draft Overseas
Listing Regulations. As such, the Company would be required to complete the filing procedures of and submit the relevant information to
CSRC after the Draft Overseas Listing Regulations become effective.
On December 28, 2021, the Cyberspace Administration
of China jointly with the relevant authorities formally published Measures for Cybersecurity Review (2021) which took effect on February 15,
2022 and replace the former Measures for Cybersecurity Review (2020). Measures for Cybersecurity Review (2021) stipulates that operators
of critical information infrastructure purchasing network products and services, and online platform operator (together with the operators
of critical information infrastructure, the “Operators”) carrying out data processing activities that affect or may affect
national security, shall conduct a cybersecurity review, any online platform operator who controls more than one million users’
personal information must go through a cybersecurity review by the cybersecurity review office if it seeks to be listed in a foreign country.
Since we are not an Operator, nor do we control more than one million users’ personal information, we would not be required to apply
for a cybersecurity review under the Measures for Cybersecurity Review (2021).
On February 17, 2023, the China Securities
Regulatory Commission, or the CSRC, announced the Circular on the Administrative Arrangements for Filing of Securities Offering and Listing
by Domestic Companies, or the Circular, and released a set of new regulations which consists of the Trial Administrative Measures of Overseas
Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines. On the same date, the CSRC
also released the Notice on the Arrangements for the Filing Management of Overseas Listing of Domestic Companies, or the Notice. The Trial
Measures came into effect on March 31, 2023. The Trial Measures refine the regulatory system by subjecting both direct and indirect
overseas offering and listing activities to the CSRC filing-based administration. Requirements for filing entities, time points and procedures
are specified. A PRC domestic company that seeks to offer and list securities in overseas markets shall fulfill the filing procedure with
the CSRC per the requirements of the Trial Measures. Where a PRC domestic company seeks to indirectly offer and list securities in overseas
markets, the issuer shall designate a major domestic operating entity, which shall, as the domestic responsible entity, file with the
CSRC. The Trial Measures also lay out requirements for the reporting of material events. Breaches of the Trial Measures, such as
offering and listing securities overseas without fulfilling the filing procedures, shall bear legal liabilities, including a fine between
RMB 1.0 million (approximately $150,000) and RMB 10.0 million (approximately $1.5 million), and the Trial Measures increase
the cost for offenders by enforcing accountability with administrative penalties and incorporating the compliance status of relevant market
participants into the Securities Market Integrity Archives.
According to the Circular, since the date of effectiveness
of the Trial Measures on March 31, 2023, PRC domestic enterprises falling within the scope of filing that have been listed overseas
or met the following circumstances are “existing enterprises”: before the effectiveness of the Trial Measures on March 31,
2023, the application for indirect overseas issuance and listing has been approved by the overseas regulators or overseas stock exchanges
(such as the registration statement has become effective on the U.S. market), it is not required to perform issuance and listing
supervision procedures of the overseas regulators or overseas stock exchanges, and the overseas issuance and listing will be completed
by September 30, 2023. Existing enterprises are not required to file with the CSRC immediately, and filings with the CSRC should
be made as required if they involve refinancings and other filing matters. PRC domestic enterprises that have submitted valid applications
for overseas issuance and listing but have not been approved by overseas regulatory authorities or overseas stock exchanges at the date
of effectiveness of the Trial Measures on March 31, 2023 can reasonably arrange the timing of filing applications with the CSRC and
shall complete the filing with the CSRC before the overseas issuance and listing.
In addition, an overseas-listed company must also
submit the filing with respect to its follow-on offerings, issuance of convertible corporate bonds and exchangeable bonds, and other equivalent
offering activities, within the time frame specified by the Trial Measures. As a result, we will be required to file with the CSRC within
three business days after the completion of the offerings in connection with this registration statement. We will begin the process
of preparing a report and other required materials in connection with the CSRC filing, which will be submitted to the CSRC in due course.
However, if we do not maintain the permissions and approvals of the filing procedure in a timely manner under PRC laws and regulations,
we may be subject to investigations by competent regulators, fines or penalties, ordered to suspend our relevant operations and rectify
any non-compliance, prohibited from engaging in relevant business or conducting any offering, and these risks could result in a material
adverse change in our operations, limit our ability to offer or continue to offer securities to investors, or cause such securities to
significantly decline in value or become worthless. As the Circular and Trial Measures were newly published, there exists uncertainty
with respect to the filing requirements and their implementation. Any failure or perceived failure of us to fully comply with such new
regulatory requirements could significantly limit or completely hinder our ability to offer or continue to offer securities to investors,
cause significant disruption to our business operations, and severely damage our reputation, which could materially and adversely affect
our financial condition and results of operations and could cause the value of our securities to significantly decline or be worthless.
See “Risk Factors — Risks Related to Doing Business in China — The filing, approval or other administration
requirements of the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required
in connection with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be
able to complete the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable” on page 14.
As
of the date of this prospectus, according to our PRC counsel, Tianyuan Law Firm,
although we are required to complete the filing procedure in connection with our offerings under the Trial Measures, no relevant PRC laws
or regulations in effect require that we obtain permission from any PRC authorities to issue securities to foreign investors, and we have
not received any inquiry, notice, warning, sanction, or any regulatory objection to this offering from the CSRC, the CAC, or any other
PRC authorities that have jurisdiction over our operations.
However, there remains some uncertainty as to
how the M&A Rules will be interpreted or implemented in the context of an overseas offering and the opinions summarized above are
subject to any new laws, rules and regulations or detailed implementations and interpretations in any form relating to the M&A Rules.
We cannot assure you that relevant PRC government agencies, including the CSRC, would reach the same conclusion as our PRC counsel does,
and hence we may face regulatory actions or other sanctions from the CSRC or other PRC regulatory agencies. These regulatory agencies
may impose fines and penalties on our operations in China, limit our operating privileges in China, delay or restrict the repatriation
of the proceeds from this offering into China, restrict or prohibit the payments or remittance of dividends by our PRC subsidiaries or
take other actions that could have a material adverse effect on our business, financial condition, results of operations, reputation and
prospects, as well as the trading price of the shares. It is uncertain when and whether the Company will be required to obtain permission
from the PRC government to list on U.S. exchanges in the future, and even when such permission is obtained, whether it will be denied
or rescinded.
The PRC government may intervene or influence
our operations at any time, which could result in a material change in our operations. For example, the PRC government has recently published
new policies that significantly affected certain industries such as the education and internet industries, and we cannot rule out the
possibility that it will in the future release regulations or policies regarding any industry that could adversely affect the business,
financial condition and results of operations of our company. Recently, the PRC government initiated a series of regulatory actions and
statements to regulate business operations in China with little advance notice, including cracking down on illegal activities in the securities
market, enhancing supervision over China-based companies listed overseas using variable interest entity structure, adopting new measures
to extend the scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. As confirmed by our PRC counsel,
we currently are not subject to cybersecurity review with the CAC, to conduct business operations in China, given that: (i) we do
not possess a large amount of personal information in our business operations; and (ii) data processed in our business does not have
a bearing on national security and thus may not be classified as core or important data by the authorities. In addition, as confirmed
by our PRC counsel, we are not subject to merger control review by China’s anti-monopoly enforcement agency due to the level of
our revenues which provided from us and audited by our auditor, and the fact that we currently do not expect to propose or implement any
acquisition of control of, or decisive influence over, any company with revenues within China of more than RMB 400 million.
The Chinese government has exercised and
continues to exercise substantial control over virtually every sector of the Chinese economy through regulation and state ownership.
Our ability to operate in China may be harmed by changes in its laws and regulations, including those relating to taxation,
environmental regulations, land use rights, property and other matters. The central or local governments of these jurisdictions may
impose new, stricter regulations or interpretations of existing regulations that would require additional expenditures and efforts
on our part to ensure our compliance with such regulations or interpretations. Accordingly, government actions in the future,
including any decision not to continue to support recent economic reforms and to return to a more centrally planned economy or
regional or local variations in the implementation of economic policies, could have a significant effect on economic conditions in
China or particular regions thereof, and could require us to divest ourselves of any interest we then hold in Chinese properties.
See “Risk Factors — Risks Related to Doing Business in China — Uncertainties with respect to
the PRC legal system, including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in laws and
regulations in China with little advance notice could adversely affect us and limit the legal protections available to you and
us” on page 13, “Any actions by the Chinese government to exert more oversight and control over offerings that are
conducted overseas and foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer
or continue to offer our Class A ordinary shares to investors and cause the value of our Class A ordinary shares to significantly
decline or be worthless. The M&A Rules and certain other PRC regulations establish complex procedures for some acquisitions of
Chinese companies by foreign investors, which could make it more difficult for us to pursue growth through acquisitions in
China” on page 16, and “We may lose the ability to offer or continue to offer securities to investors and cause the
value of such securities to significantly decline or be worthless if the Chinese government may exert more oversight and control
over offerings that are conducted overseas and/or foreign investment in China-based issuers” on page 20.
Although we have not received any denial to continue
to list on the U.S. exchange or conduct our daily business operation, it is highly uncertain how soon legislative or administrative
regulation making bodies will respond and what existing or new laws or regulations or detailed implementations and interpretations will
be modified or promulgated, if any, and the potential impact such modified or new laws and regulations will have on our daily business
operation, the ability to accept foreign investments and list our securities on an U.S. or other foreign exchange. For more detailed
information, see “Risk Factors — Risks Related to Doing Business in China — The approval of the
China Securities Regulatory Commission may be required in connection with this offering, and, if required, we cannot predict whether we
will be able to obtain such approval” on page 31 and “We may become subject to a variety of laws and regulations in the PRC
regarding privacy, data security, cybersecurity, and data protection. We may be liable for improper use or appropriation of personal information
provided by our customers” on page 25.
Corporate Information
Our principal executive office is located 15th
Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013. The telephone number of our principal
executive offices is +86-592-5586999. Our registered office provider in Cayman Islands is Ocorian Trust (Cayman) Limited. Our registered
office in Cayman Islands is at Windward 3, Regatta Office Park, PO Box 1350, Grand Cayman KY1-1108, Cayman Islands. Our registered agent
in the United States is Cogency Global Inc., 122 E 42nd St 18th Fl, New York, NY 10168. We maintain a corporate website at http://www.lichenzx.com.
We do not incorporate the information on our website into this prospectus and you should not consider any information on, or that can
be accessed through, our website as part of this prospectus.
The SEC maintains an internet site at http://www.sec.gov
that contains reports, information statements, and other information regarding issuers that file electronically with the SEC.
RISK FACTORS
Investing in our securities involves a high degree
of risk. You should carefully review the risks and uncertainties described in this section and under the heading “Risk Factors”
contained in any applicable prospectus supplement and under similar headings in our most recent annual report on Form 20-F as updated
by our subsequent filings, some of which are incorporated by reference into this prospectus, before deciding whether to purchase any of
the securities being registered pursuant to the registration statement of which this prospectus forms a part. Each of the risk factors
could adversely affect our business, results of operations, financial condition and cash flows, as well as adversely affect the value
of an investment in our securities, and the occurrence of any of these risks might cause you to lose all or part of your investment. Additional
risks not presently known to us or that we currently believe are immaterial may also significantly impair our business operations. For
more information, see “Where You Can Find Additional Information” and “Incorporation of Documents by Reference.”
Risks Related to Doing Business in China
Uncertainties with respect to the PRC legal
system, including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in laws and regulations in China with
little advance notice could adversely affect us and limit the legal protections available to you and us.
There are substantial uncertainties regarding
the interpretation and application of PRC laws and regulations including, but not limited to, the laws and regulations governing our business
and the enforcement and performance of our arrangements with customers in certain circumstances. The laws and regulations are sometimes
vague and may be subject to future changes, and their official interpretation and enforcement could be unpredictable, with little advance
notice. The effectiveness and interpretation of newly enacted laws or regulations, including amendments to existing laws and regulations,
may be delayed, and our business may be affected if we rely on laws and regulations which are subsequently adopted or interpreted in a
manner different from our current understanding of these laws and regulations. New laws and regulations that affect existing and proposed
future businesses may also be applied retroactively. We cannot predict what effect the interpretation of existing or new PRC laws or regulations
may have on our business.
The PRC legal system is a civil law system based
on written statutes. Unlike the common law system, prior court decisions under the civil law system may be cited for reference but have
limited precedential value. In addition, any new or changes in PRC laws and regulations related to foreign investment in China could affect
the business environment and our ability to operate our business in China.
From time to time, we may have to resort to administrative
and court proceedings to enforce our legal rights. Any administrative and court proceedings in China may be protracted, resulting in substantial
costs and diversion of resources and management attention. Since PRC administrative and court authorities have significant discretion
in interpreting and implementing statutory provisions and contractual terms, it may be more difficult to evaluate the outcome of administrative
and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These uncertainties may impede
our ability to enforce the contracts we have entered into and could materially and adversely affect our business and results of operations.
Furthermore, the PRC legal system is based in
part on government policies and internal rules, some of which are not published on a timely basis or at all and may have retroactive effect.
As a result, we may not be aware of our violation of any of these policies and rules until sometime after the violation. Such unpredictability
towards our contractual, property and procedural rights could adversely affect our business and impede our ability to continue our operations.
The financial and taxation solution services industry
in China is subject to extensive regulation. Related laws and regulations are relatively new and evolving. The interpretation and application
of existing PRC laws, regulations and policies and possible new laws, regulations or policies relating to the financial and taxation solution
services industry have created substantial uncertainties regarding the legality of existing and future foreign investments in, and the
businesses and activities of, financial and taxation solution services businesses in China, including our business. We cannot assure you
that we will be able to maintain our existing licenses or obtain new ones. If our operations do not comply with these new regulations
at the time they become effective, or if we fail to obtain any licenses required under these new laws and regulations, we could be subject
to penalties.
The PRC government has significant oversight and
discretion over the conduct of our business and may intervene or influence our operations as the government deems appropriate to further
regulatory, political and societal goals. The PRC government has recently published new policies that significantly affected certain industries,
such as the education and internet industries, and we cannot rule out the possibility that it will in the future release regulations or
policies regarding our industry that could adversely affect our business, financial condition and results of operations. Furthermore,
the PRC government has recently indicated an intent to exert more oversight and control over securities offerings and other capital markets
activities that are conducted overseas and foreign investment in China-based companies like us. Any such action, once taken by the PRC
government, could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause
the value of such securities to significantly decline or in extreme cases, become worthless.
The filing, approval or other administration
requirements of the Chinese Securities Regulatory Commission (the “CSRC”) or other PRC government authorities may be required
in connection with our future offshore offering under PRC law, and, if required, we cannot predict whether or for how long we will be
able to complete the filing procedure with the CSRC and obtain such approval or complete such filing, as applicable.
The Regulations on Mergers and Acquisitions of
Domestic Companies by Foreign Investors (the “M&A Rules”), adopted by six PRC regulatory agencies in 2006 and amended
in 2009, include, among other things, provisions that purport to require that an offshore special purpose vehicle, formed for the purpose
of an overseas listing of securities through acquisitions of domestic enterprises in China or assets and controlled by enterprises or
individuals in China, to obtain the approval of the CSRC prior to the listing and trading of such special purpose vehicle’s securities
on an overseas stock exchange. On September 21, 2006, pursuant to the M&A Rules and other PRC laws, the CSRC published on its
official website relevant guidance regarding its approval of the listing and trading of special purpose vehicles’ securities on
overseas stock exchanges, including a list of application materials. However, substantial uncertainty remains regarding the scope and
applicability of the M&A Rules to offshore special purpose vehicles.
On July 6, 2021, the relevant PRC government
authorities issued Opinions on Strictly Cracking Down Illegal Securities Activities in accordance with the Law. These opinions emphasized
the need to strengthen the administration over illegal securities activities and the supervision on overseas listings by China-based companies
and proposed to take effective measures, such as promoting the construction of relevant regulatory systems to deal with the risks and
incidents faced by China-based overseas-listed companies. These opinions and any related implementation rules to be enacted may subject
us to additional compliance requirement in the future. As of the date hereof, no official guidance or related implementation rules have
been issued. As a result, the Opinions on Strictly Cracking Down on Illegal Securities Activities remain unclear on how they will be interpreted,
amended and implemented by the relevant PRC governmental authorities. We cannot assure that we will remain fully compliant with all new
regulatory requirements of these opinions or any future implementation rules on a timely basis, or at all.
Pursuant to Cybersecurity Review Measures which
were issued on December 28, 2021 and became effective on February 15, 2022, network platform operators holding over one million
users’ personal information must apply with the Cybersecurity Review Office for a cybersecurity review before any public offering
at a foreign stock exchange. However, given the Cybersecurity Review Measures were relatively new, there are substantial uncertainties
as to the interpretation, application and enforcement of the Cybersecurity Review Measures. It remains uncertain whether we should apply
for cybersecurity review prior to any offshore offering and that we would be able to complete the applicable cybersecurity review procedures
in a timely manner, or at all, if we are required to do so. In addition, on November 14, 2021, the Cyberspace Administration of China
(the “CAC”) published the Administration Regulations on Network Data Security (Draft for Comments), or the Draft Measures
for Network Data Security, which provides that data processors conducting the following activities shall apply for cybersecurity review:
(i) merger, reorganization or separation of Internet platform operators that have acquired a large number of data resources related
to national security, economic development or public interests affects or may affect national security; (ii) overseas listing of
data processors processing over one million users’ personal information; (iii) listing in Hong Kong which affects or may
affect national security; (iv) other data processing activities that affect or may affect national security. In addition, the Draft
Measures for Network Data Security also require Internet platform operators to establish platform rules, privacy policies and algorithm
strategies related to data, and solicit public comments on their official websites and personal information protection related sections
for no less than 30 working days when they formulate platform rules or privacy policies or makes any amendments that may have significant
impacts on users’ rights and interests. The CAC solicited comments on this draft, but there is no timetable as to when it will be
enacted.
On February 17, 2023, the China Securities
Regulatory Commission, or the CSRC, announced the Circular on the Administrative Arrangements for Filing of Securities Offering and Listing
by Domestic Companies, or the Circular, and released a set of new regulations which consists of the Trial Administrative Measures of Overseas
Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines. On the same date, the CSRC
also released the Notice on the Arrangements for the Filing Management of Overseas Listing of Domestic Companies, or the Notice. The Trial
Measures came into effect on March 31, 2023. The Trial Measures refine the regulatory system by subjecting both direct and indirect
overseas offering and listing activities to the CSRC filing-based administration. Requirements for filing entities, time points and procedures
are specified. A PRC domestic company that seeks to offer and list securities in overseas markets shall fulfill the filing procedure with
the CSRC per the requirements of the Trial Measures. Where a PRC domestic company seeks to indirectly offer and list securities in overseas
markets, the issuer shall designate a major domestic operating entity, which shall, as the domestic responsible entity, file with the
CSRC. The Trial Measures also lay out requirements for the reporting of material events. Breaches of the Trial Measures, such as
offering and listing securities overseas without fulfilling the filing procedures, shall bear legal liabilities, including a fine between
RMB 1.0 million (approximately $150,000) and RMB 10.0 million (approximately $1.5 million), and the Trial Measures heighten
the cost for offenders by enforcing accountability with administrative penalties and incorporating the compliance status of relevant market
participants into the Securities Market Integrity Archives.
According to the Circular, since the date of effectiveness
of the Trial Measures on March 31, 2023, PRC domestic enterprises falling within the scope of filing that have been listed overseas
or met the following circumstances are “existing enterprises”: before the effectiveness of the Trial Measures on March 31,
2023, the application for indirect overseas issuance and listing has been approved by the overseas regulators or overseas stock exchanges
(such as the registration statement has become effective on the U.S. market), it is not required to perform issuance and listing
supervision procedures of the overseas regulators or overseas stock exchanges, and the overseas issuance and listing will be completed
by September 30, 2023. Existing enterprises are not required to file with the CSRC immediately, and filings with the CSRC should
be made as required if they involve refinancings and other filing matters. PRC domestic enterprises that have submitted valid applications
for overseas issuance and listing but have not been approved by overseas regulatory authorities or overseas stock exchanges at the date
of effectiveness of the Trial Measures on March 31, 2023 can reasonably arrange the timing of filing applications with the CSRC and
shall complete the filing with the CSRC before the overseas issuance and listing. According to the Circular, we can reasonably arrange
the timing for submitting the filing application with the CSRC, and shall complete the filing with the CSRC in accordance with the Trial
Measures before this offering. In sum, we are subject to the filing requirements of the CSRC for this offering under the Trial Measures.
In addition, an overseas-listed company must also
submit the filing with respect to its follow-on offerings, issuance of convertible corporate bonds and exchangeable bonds, and other equivalent
offering activities, within the time frame specified by the Trial Measures. As a result, we will be required to file with the CSRC within
three business days after the completion of this offering. We begin the process of preparing a report and other required materials
in connection with the CSRC filing, which will be submitted to the CSRC in due course after this offering. However, if we do not maintain
the permissions and approvals of the filing procedure in a timely manner under PRC laws and regulations, we may be subject to investigations
by competent regulators, fines or penalties, ordered to suspend our relevant operations and rectify any non-compliance, prohibited from
engaging in relevant business or conducting any offering, and these risks could result in a material adverse change in our operations,
limit our ability to offer or continue to offer securities to investors, or cause such securities to significantly decline in value or
become worthless. As the Circular and Trial Measures were newly published, there exists uncertainty with respect to the filing requirements
and their implementation. Any failure or perceived failure of us to fully comply with such new regulatory requirements could significantly
limit or completely hinder our ability to offer or continue to offer securities to investors, cause significant disruption to our business
operations, and severely damage our reputation, which could materially and adversely affect our financial condition and results of operations
and could cause the value of our securities to significantly decline or be worthless.
As of the date of this prospectus, according to
our PRC counsel, Tianyuan Law Firm, although we are required to complete the filing procedure in connection with our offering under the
Trial Measures, no relevant PRC laws or regulations in effect require that we obtain permission from any PRC authorities to issue securities
to foreign investors, and we have not received any inquiry, notice, warning, sanction, or any regulatory objection to this offering from
the CSRC, the CAC, or any other PRC authorities that have jurisdiction over our operations. If it is determined that we are subject to
filing requirements imposed by the CSRC under the Overseas Listing Regulations or approvals from other PRC regulatory authorities or other
procedures, including the cybersecurity review under the revised Cybersecurity Review Measures, for our future offshore offerings, it
would be uncertain whether we can or how long it will take us to complete such procedures or obtain such approval and any such approval
could be rescinded. Any failure to obtain or delay in completing such procedures or obtaining such approval for our offshore offerings,
or a rescission of any such approval if obtained by us, would subject us to sanctions by the CSRC or other PRC regulatory authorities
for failure to file with the CSRC or failure to seek approval from other government authorization for our offshore offerings. These regulatory
authorities may impose fines and penalties on our operations in China, limit our ability to pay dividends outside of China, limit our
operating privileges in China, delay or restrict the repatriation of the proceeds from our offshore offerings into China or take other
actions that could materially and adversely affect our business, financial condition, results of operations, and prospects, as well as
the trading price of our Class A ordinary shares. The CSRC or other PRC regulatory authorities also may take actions requiring us, or
making it advisable for us, to halt our offshore offerings before settlement and delivery of the securities offered. Consequently, if
investors engage in market trading or other activities in anticipation of and prior to settlement and delivery, they do so at the risk
that settlement and delivery may not occur. In addition, if the CSRC or other regulatory authorities later promulgate new rules or explanations
requiring that we obtain their approvals or accomplish the required filing or other regulatory procedures for our prior offshore offerings,
we may be unable to obtain a waiver of such approval requirements, if and when procedures are established to obtain such a waiver. Any
uncertainties or negative publicity regarding such approval requirement could materially and adversely affect our business, prospects,
financial condition, reputation, and the trading price of our Class A ordinary shares.
Any actions by the Chinese government to
exert more oversight and control over offerings that are conducted overseas and foreign investment in China-based issuers could significantly
limit or completely hinder our ability to offer or continue to offer our Class A ordinary shares to investors and cause the value of our
Class A ordinary shares to significantly decline or be worthless. The M&A Rules and certain other PRC regulations establish complex
procedures for some acquisitions of Chinese companies by foreign investors, which could make it more difficult for us to pursue growth
through acquisitions in China.
The Regulations on Mergers and Acquisitions of
Domestic Companies by Foreign Investors, or the M&A Rules, adopted by six PRC regulatory agencies in August 2006 and amended
in 2009, and some other regulations and rules concerning mergers and acquisitions established additional procedures and requirements that
could make merger and acquisition activities by foreign investors more time consuming and complex, including requirements in some instances
that the MOC be notified in advance of any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise.
For example, the M&A Rules require that MOFCOM be notified in advance of any change-of-control transaction in which a foreign investor
takes control of a PRC domestic enterprise, if (i) any important industry is concerned, (ii) such transaction involves factors
that impact or may impact national economic security, or (iii) such transaction will lead to a change in control of a domestic enterprise
which holds a famous trademark or PRC time-honored brand. Moreover, the Anti-Monopoly Law promulgated by the SCNPC effective in 2008 requires
that transactions which are deemed concentrations and involve parties with specified turnover thresholds (i.e., during the previous fiscal
year, (i) the total global turnover of all operators participating in the transaction exceeds RMB10 billion and at least two
of these operators each had a turnover of more than RMB400 million within China, or (ii) the total turnover within China of
all the operators participating in the concentration exceeded RMB 2 billion, and at least two of these operators each had a turnover
of more than RMB 400 million within China) must be cleared by MOFCOM before they can be completed.
Moreover, the Anti-Monopoly Law requires that
the MOC shall be notified in advance of any concentration of undertaking if certain thresholds are triggered. In addition, the security
review rules issued by the MOC that became effective in September 2011 specify that mergers and acquisitions by foreign investors
that raise “national defense and security” concerns and mergers and acquisitions through which foreign investors may acquire
de facto control over domestic enterprises that raise “national security” concerns are subject to strict review by the MOC,
and the rules prohibit any activities attempting to bypass a security review, including by structuring the transaction through a proxy
or contractual control arrangement. In the future, we may grow our business by acquiring complementary businesses. Complying with the
requirements of the above-mentioned regulations and other relevant rules to complete such transactions could be time consuming, and any
required approval processes, including obtaining approval from the MOC or its local counterparts may delay or inhibit our ability to complete
such transactions, which could affect our ability to expand our business or maintain our market share.
There are significant legal and other obstacles
to obtaining information needed for shareholder investigations or litigation outside China or otherwise with respect to foreign entities.
We conduct substantially all of our business operations
in China, and a majority of our directors and senior management are based in China, which is an emerging market. The SEC, U.S. Department
of Justice and other authorities often have substantial difficulties in bringing and enforcing actions against non-U.S. companies
and non-U.S. persons, including company directors and officers, in certain emerging markets, including China. Additionally, our public
shareholders may have limited rights and few practical remedies in emerging markets where we operate, as shareholder claims that are common
in the United States, including class action securities law and fraud claims, generally are difficult to pursue as a matter of law
or practicality in many emerging markets, including China. For example, in China, there are significant legal and other obstacles to obtaining
information needed for shareholder investigations or litigation outside China or otherwise with respect to foreign entities. Although
the local authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another
country or region to implement cross-border supervision and administration, the regulatory cooperation with the securities regulatory
authorities in the Unities States has not been efficient in the absence of a mutual and practical cooperation mechanism. According to
Article 177 of the PRC Securities Law which became effective in March 2020, no foreign securities regulator is allowed to directly
conduct investigation or evidence collection activities within the territory of the PRC. Accordingly, without the consent of the
competent PRC securities regulators and relevant authorities, no organization or individual may provide the documents and materials relating
to securities business activities to foreign securities regulators.
As a result, our public shareholders may have
more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling
shareholders than they would as public shareholders of a company incorporated in the United States.
PRC regulation of loans to, and direct investments
in, PRC entities by offshore holding companies may delay or prevent us from using proceeds from this offering and/or future financing
activities to make loans or additional capital contributions to our PRC operating subsidiaries.
In July 2014, SAFE promulgated the Circular
on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents’ Offshore Investment and Financing and Roundtrip Investment
through Special Purpose Vehicles, or SAFE Circular 37, which replaces the previous SAFE Circular 75. SAFE Circular 37 requires PRC residents,
including PRC individuals and PRC corporate entities, to register with SAFE or its local branches in connection with their direct or indirect
offshore investment activities. SAFE Circular 37 is applicable to our shareholders who are PRC residents and may be applicable to any
offshore acquisitions that we may make in the future.
Under SAFE Circular 37, PRC residents who make,
or have prior to the implementation of SAFE Circular 37 made, direct or indirect investments in offshore special purpose vehicles, or
SPVs, are required to register such investments with SAFE or its local branches. In addition, any PRC resident who is a direct or indirect
shareholder of an SPV, is required to update its registration with the local branch of SAFE with respect to that SPV, to reflect any material
change. Moreover, any subsidiary of such SPV in China is required to urge the PRC resident shareholders to update their registration with
the local branch of SAFE to reflect any material change. If any PRC resident shareholder of such SPV fails to make the required registration
or to update the registration, the subsidiary of such SPV in China may be prohibited from distributing its profits or the proceeds from
any capital reduction, share transfer or liquidation to the SPV, and the SPV may also be prohibited from making additional capital contributions
into its subsidiaries in China. In February, 2015, SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration
Policy on Direct Investment, or SAFE Notice 13. Under SAFE Notice 13, applications for foreign exchange registration of inbound foreign
direct investments and outbound direct investments, including those required under SAFE Circular 37, must be filed with qualified banks
instead of SAFE. Qualified banks should examine the applications and accept registrations under the supervision of SAFE. We
have used our best efforts to notify PRC residents or entities who directly or indirectly hold shares in our Cayman Islands holding company
and who are known to us as being PRC residents to complete the foreign exchange registrations. However, we may not be informed of the
identities of all the PRC residents or entities holding direct or indirect interest in our company, nor can we compel our beneficial owners
to comply with SAFE registration requirements. We cannot assure you that all other shareholders or beneficial owners of ours who are PRC
residents or entities have complied with, and will in the future make, obtain or update any applicable registrations or approvals required
by, SAFE regulations. Failure by such shareholders or beneficial owners to comply with SAFE regulations, or failure by us to amend the
foreign exchange registrations of our PRC subsidiaries, could subject us to fines or legal sanctions, restrict our overseas or cross-border
investment activities, and limit our PRC subsidiaries’ ability to make distributions or pay dividends to us or affect our ownership
structure, which could adversely affect our business and prospects.
Furthermore, as these foreign exchange and outbound
investment related regulations are relatively new and their interpretation and implementation has been constantly evolving, it is unclear
how these regulations, and any future regulation concerning offshore or cross-border investments and transactions, will be interpreted,
amended and implemented by the relevant government authorities. For example, we may be subject to a more stringent review and approval
process with respect to our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings,
which may adversely affect our financial condition and results of operations. We cannot assure you that we have complied or will be able
to comply with all applicable foreign exchange and outbound investment related regulations. In addition, if we decide to acquire a PRC
domestic company, we cannot assure you that we or the owners of such company, as the case may be, will be able to obtain the necessary
approvals or complete the necessary filings and registrations required by the foreign exchange regulations. This may restrict our ability
to implement our acquisition strategy and could adversely affect our business and prospects.
As an offshore holding company with PRC subsidiaries,
we may transfer funds to our operating entity or finance our operating entity by means of loans or capital contributions. Any capital
contributions or loans that we, as an offshore entity, make to our Company’s PRC subsidiaries, including from the proceeds of this
offering, are subject to the above PRC regulations. We may not be able to obtain necessary government registrations or approvals on a
timely basis, if at all. If we fail to obtain such approvals or make such registration, our ability to make equity contributions or provide
loans to our Company’s PRC subsidiaries or to fund their operations may be negatively affected, which may adversely affect their
liquidity and ability to fund their working capital and expansion projects and meet their obligations and commitments. As a result, our
liquidity and our ability to fund and expand our business may be negatively affected.
We must remit the offering proceeds to China
before they may be used to benefit our business in China, and this process may take several months to complete.
The process for sending the proceeds from this
offering back to China may take as long as six months after the closing of this offering.
Any loans to the PRC subsidiaries are subject
to PRC regulations. For example, loans by us to our subsidiaries in China, which are foreign-invested enterprises, to finance their activities
cannot exceed statutory limits and must be registered with SAFE.
To remit the proceeds of the offering, we must
take the following steps:
| ● | First, we will open a special foreign exchange account for
capital account transactions. To open this account, we must submit to SAFE certain application forms, identity documents, transaction
documents, form of foreign exchange registration of overseas investments of the domestic residents, and foreign exchange registration
certificate of the invested company. As of the date of this prospectus, we have already opened a special foreign exchange account for
capital account transactions. |
| ● | Second, we will remit the offering proceeds into this special
foreign exchange account. |
| ● | Third, we will apply for settlement of the foreign exchange.
In order to do so, we must submit to SAFE certain application forms, identity documents, payment order to a designated person, and a
tax certificate. |
The timing of the process is difficult to estimate
because the efficiencies of different SAFE branches can vary significantly. Ordinarily the process takes several months but is required
by law to be accomplished within 180 days of application.
We may also decide to finance our subsidiaries
by means of capital contributions. These capital contributions must be approved by MOFCOM or its local counterpart. We cannot assure you
that we will be able to obtain these government approvals on a timely basis, if at all, with respect to future capital contributions by
us to our subsidiaries. If we fail to receive such approvals, our ability to use the proceeds of this offering and to capitalize our Chinese
operations may be negatively affected, which could adversely affect our liquidity and our ability to fund and expand our business. If
we fail to receive such approvals, our ability to use the proceeds of this offering and to capitalize our Chinese operations may be negatively
affected, which could adversely affect our liquidity and our ability to fund and expand our business.
PRC regulation of loans to and direct investment
in PRC entities by offshore holding companies to PRC entities may delay or prevent us from making loans or additional capital contributions
to our PRC operating subsidiaries.
As an offshore holding company of our PRC subsidiaries,
we may make loans to our PRC subsidiaries or may make additional capital contributions to our PRC subsidiaries, subject to satisfaction
of applicable governmental registration and approval requirements.
Any loans we extend to our PRC subsidiaries cannot
exceed the statutory limit and must be registered with the local counterpart of the SAFE.
We may also decide to finance our PRC subsidiaries
by means of capital contributions. According to the relevant PRC regulations on foreign-invested enterprises in China, these capital contributions
are subject to registration with or approval by the MOFCOM or its local counterparts. In addition, the PRC government also restricts the
convertibility of foreign currencies into Renminbi and use of the proceeds. On March 30, 2015, SAFE promulgated Circular 19, which
took effect and replaced certain previous SAFE regulations from June 1, 2015. SAFE further promulgated Circular 16, effective on
June 9, 2016, which, among other things, amend certain provisions of Circular 19. According to SAFE Circular 19 and SAFE Circular
16, the flow and use of the Renminbi capital converted from foreign currency denominated registered capital of a foreign-invested company
is regulated such that Renminbi capital may not be used for business beyond its business scope or to provide loans to persons other than
affiliates unless otherwise permitted under its business scope. Violations of the applicable circulars and rules may result in severe
penalties, including substantial fines as set forth in the Foreign Exchange Administration Regulations. SAFE Circular 19 and SAFE Circular
16 may significantly limit our ability to use Renminbi converted from the net proceeds of this offering to fund our PRC operating subsidiaries,
to invest in or acquire any other PRC companies through our PRC Subsidiaries, which may adversely affect our business, financial condition
and results of operations.
Adverse changes in political and economic
policies of the PRC government could have a material adverse effect on the overall economic growth of China, which could reduce the demand
for our products and services and materially and adversely affect our competitive position.
Substantially all of our business operations are
conducted in China. Accordingly, our business, results of operations, financial condition and prospects are subject to economic, political
and legal developments in China. Although the Chinese economy is no longer a planned economy, the PRC government continues to exercise
significant control over China’s economic growth through direct allocation of resources, monetary and tax policies, and a host of
other government policies such as those that encourage or restrict investment in certain industries by foreign investors, control the
exchange between RMB and foreign currencies, and regulate the growth of the general or specific market.
From time to time, we may have to resort to administrative
and court proceedings to enforce our legal rights. Any administrative and court proceedings in China may be protracted, resulting in substantial
costs and diversion of resources and management attention. Since PRC administrative and court authorities have significant discretion
in interpreting and implementing statutory provisions and contractual terms, it may be more difficult to evaluate the outcome of administrative
and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These uncertainties may impede
our ability to enforce the contracts we have entered into and could materially and adversely affect our business and results of operations.
Furthermore, the PRC legal system is based in
part on government policies and internal rules, some of which are not published on a timely basis or at all and may have retroactive effect.
As a result, we may not be aware of our violation of any of these policies and rules until sometime after the violation. Such unpredictability
towards our contractual, property (including intellectual property) and procedural rights could adversely affect our business and impede
our ability to continue our operations.
These government involvements have been instrumental
in China’s significant growth in the past 30 years. In response to the recent global and Chinese economic downturn, the PRC
government has adopted policy measures aimed at stimulating the economic growth in China. If the PRC government’s current or future
policies fail to help the Chinese economy achieve further growth or if any aspect of the PRC government’s policies limits the growth
of our industry or otherwise negatively affects our business, our growth rate or strategy, our results of operations could be adversely
affected as a result.
Changes in China’s economic, political
or social conditions or government policies could have a material adverse effect on our business and results of operations.
All of our operations are located in China. Accordingly,
our business, prospects, financial condition and results of operations may be influenced to a significant degree by political, economic
and social conditions in China generally and by continued economic growth in China as a whole.
The Chinese economy differs from the economies
of most developed countries in many respects, including the amount of government involvement, level of development, growth rate, control
of foreign exchange and allocation of resources. Although the Chinese government has implemented measures emphasizing the utilization
of market forces for economic reform, the reduction of state ownership of productive assets and the establishment of improved corporate
governance in business enterprises, a substantial portion of productive assets in China is still owned by the government. In addition,
the Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese
government also exercises significant control over China’s economic growth through allocating resources, controlling payment of
foreign currency-denominated obligations, setting monetary policy, and providing preferential treatment to particular industries or companies.
While the Chinese economy has experienced significant
growth over the past decades, growth has been uneven, both geographically and among various sectors of the economy. The Chinese government
has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures may benefit
the overall Chinese economy, but may have a negative effect on us. For example, our financial condition and results of operations may
be adversely affected by government control over capital investments or changes in tax regulations. In addition, in the past the Chinese
government has implemented certain measures, including interest rate increases, to control the pace of economic growth. These measures
may cause decreased economic activity in China, and since 2012, China’s economic growth has slowed down. Any prolonged slowdown
in the Chinese economy may reduce the demand for our products and services and materially and adversely affect our business and results
of operations.
The Chinese government may intervene or
influence our operations at any time, which could result in a material change in our operations and/or the value of our ordinary shares.
Our business is subject to governmental supervision
and regulation by the relevant PRC governmental authorities, including but not limited to the State Administration for Market Regulation
and the State Administration for Industry and Commerce. Together, these governmental authorities promulgate and enforce regulations that
cover many aspects of our day-to-day operations. If we are deemed to be not in compliance with these requirements, we may be subject
to fines and other administrative penalties from the relevant PRC government authorities. In case of our failure to rectify our noncompliance
within required period by the relevant PRC government authorities, we may be forced to suspend our operation.
Existing and new laws and regulations may be enforced
from time to time and substantial uncertainties exist regarding the interpretation and implementation of current and any future PRC laws
and regulations applicable to us. If the PRC government promulgates new laws and regulations that impose additional restrictions on our
operations, or tightens enforcements of existing or new laws or regulations, it has the authority, among other things, to levy fines,
confiscate income, revoke business licenses, and require us to discontinue our relevant business or impose restrictions on the affected
portion of our business. Any of these actions by the PRC government may have a material and adverse effect on our results of operations.
As a result, our business, reputation, value of our Class A ordinary shares, financial condition and results of operations may be materially
and adversely affected.
We may lose the ability to offer or continue
to offer securities to investors and cause the value of such securities to significantly decline or be worthless if the Chinese government
may exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers.
The recently issued Opinions on Strictly Cracking
Down on Illegal Securities Activities emphasized the need to strengthen the administration over illegal securities activities and the
supervision on listings by China-based companies in foreign countries, and proposed to take effective measures, such as promoting the
construction of relevant regulatory systems to deal with the risks and incidents faced by China-based companies listed in foreign countries,
and provided that the special provisions of the State Council on offering and listing by those companies in foreign countries limited
by shares will be revised and therefore the duties of domestic industry competent authorities and regulatory agencies will be clarified.
As these opinions were newly issued and there are no further explanations or detailed rules and regulations with respect to such opinions,
there are still uncertainties regarding the interpretation and implementation of such opinions. And new rules or regulations promulgated
in future could impose additional requirements on us.
In addition, on July 10, 2021, the Cyberspace
Administration of China issued a revised draft of the Cybersecurity Review Measures for public comments, according to which, among others,
an “operator of critical information infrastructure” or a “data processor”, who has personal information of more
than one million users and is going to list in foreign countries, must report to the relevant cybersecurity review office for a cybersecurity
review. On December 28, 2021, the Cyberspace Administration of China jointly with the relevant authorities formally published Measures
for Cybersecurity Review (2021) which took effect on February 15, 2022 and replace the former Measures for Cybersecurity Review
(2020). Measures for Cybersecurity Review (2021) stipulates that operators of critical information infrastructure purchasing network
products and services, and online platform operator (together with the operators of critical information infrastructure, the “Operators”)
carrying out data processing activities that affect or may affect national security, shall conduct a cybersecurity review, any online
platform operator who controls more than one million users’ personal information must go through a cybersecurity review by the cybersecurity
review office if it seeks to be listed in a foreign country. Since we are not an Operator, nor do we control more than one million users’
personal information, we would not be required to apply for a cybersecurity review under the Measures for Cybersecurity Review (2021).
However, if the CSRC or other relevant PRC regulatory
agencies subsequently determine that prior approval is required, failure of obtaining such approval may lead us face regulatory actions
or other sanctions from the CSRC or other PRC regulatory agencies. These regulatory agencies may impose fines and penalties on our operations
in China, limit our ability to pay dividends outside of China, limit our operations in China, delay or restrict the repatriation of the
proceeds from this Offering into China or take other actions that could have a material adverse effect on our business, financial condition,
results of operations and prospects, as well as the Offering of the Shares.
Under the PRC Enterprise Income Tax Law,
we may be classified as a “Resident Enterprise” of China. Such classification will likely result in unfavorable tax consequences
to us and our non-PRC shareholders.
China passed the PRC Enterprise Income Tax Law,
or the EIT Law, and its implementing rules, both of which became effective on January 1, 2008, and as amended in December 2018.
Under the EIT Law, an enterprise established outside of China with “de facto management bodies” within China is considered
a “resident enterprise,” meaning that it can be treated in a manner similar to a Chinese enterprise for enterprise income
tax purposes. The implementing rules of the EIT Law define de facto management as “substantial and overall management and control
over the production and operations, personnel, accounting, and properties” of the enterprise.
On April 22, 2009, the State Administration
of Taxation of China issued the Notice Concerning Relevant Issues Regarding Cognizance of Chinese Investment Controlled Enterprises Incorporated
Offshore as Resident Enterprises pursuant to Criteria of de facto Management Bodies, or the Notice, further interpreting the application
of the EIT Law and its implementation to offshore entities controlled by a Chinese enterprise or group. Pursuant to the Notice, an enterprise
incorporated in an offshore jurisdiction and controlled by a Chinese enterprise or group will be classified as a “non-domestically
incorporated resident enterprise” if (i) its senior management in charge of daily operations reside or perform their duties
mainly in China; (ii) its financial or personnel decisions are made or approved by bodies or persons in China; (iii) its substantial
assets and properties, accounting books, corporate stamps, board and shareholder minutes are kept in China; and (iv) all of its directors
with voting rights or senior management reside in China. A resident enterprise would be subject to an enterprise income tax rate of 25%
on its worldwide income and must pay a withholding tax at a rate of 10% when paying dividends to its non-PRC shareholders. Because substantially
all of our operations and senior management are located within the PRC and are expected to remain so for the foreseeable future, we may
be considered a PRC resident enterprise for enterprise income tax purposes and therefore subject to the PRC enterprise income tax at the
rate of 25% on its worldwide income. However, it remains unclear as to whether the Notice is applicable to an offshore enterprise controlled
by a Chinese natural person. Therefore, it is unclear how tax authorities will determine tax residency based on the facts of each case.
If the PRC tax authorities determine that we are
a “resident enterprise” for PRC enterprise income tax purposes, a number of unfavorable PRC tax consequences could follow.
First, we may be subject to the enterprise income tax at a rate of 25% on our worldwide taxable income as well as PRC enterprise income
tax reporting obligations. In our case, this would mean that income such as non-China source income would be subject to PRC enterprise
income tax at a rate of 25%. Currently, we do not have any non-China source income, as we conduct our sales in China. However, under the
EIT Law and its implementing rules, dividends paid to us from our PRC subsidiary would be deemed as “qualified investment income
between resident enterprises” and therefore qualify as “tax-exempt income” pursuant to clause 26 of the EIT Law. Second,
it is possible that future guidance issued with respect to the new “resident enterprise” classification could result in a
situation in which the dividends we pay with respect to our ordinary shares, or the gain our non-PRC shareholders may realize from the
transfer of our ordinary shares, may be treated as PRC-sourced income and may therefore be subject to a 10% PRC withholding tax. The EIT
Law and its implementing regulations are, however, relatively new and ambiguities exist with respect to the interpretation and identification
of PRC-sourced income, and the application and assessment of withholding taxes. If we are required under the EIT Law and its implementing
regulations to withhold PRC income tax on dividends payable to our non-PRC shareholders, or if non-PRC shareholders are required to pay
PRC income tax on gains on the transfer of their ordinary shares, our business could be negatively impacted and the value of your investment
may be materially reduced. Further, if we were treated as a “resident enterprise” by PRC tax authorities, we would be subject
to taxation in both China and such countries in which we have taxable income, and our PRC tax may not be creditable against such other
taxes.
We may be exposed to liabilities under the
Foreign Corrupt Practices Act and Chinese anti-corruption law.
In connection with this offering, we will become
subject to the U.S. Foreign Corrupt Practices Act (the “FCPA”), and other laws that prohibit improper payments or offers
of payments to foreign governments and their officials and political parties by U.S. persons and issuers as defined by the statute
for the purpose of obtaining or retaining business. We are also subject to Chinese anti-corruption laws, which strictly prohibit the payment
of bribes to government officials. We have operations agreements with third parties, and make sales in China, which may experience corruption.
Our activities in China create the risk of unauthorized payments.
Although we believe, to date, we have complied
in all material respects with the provisions of the FCPA and Chinese anti-corruption law, our existing safeguards and any future improvements
may prove to be less than effective, and the employees, consultants, or distributors may engage in conduct for which we might be held
responsible. Violations of the FCPA or Chinese anti-corruption law may result in severe criminal or civil sanctions, and we may be subject
to other liabilities, which could negatively affect our business, operating results and financial condition. In addition, the government
may seek to hold our Company liable for successor liability FCPA violations committed by companies in which we invest or that we acquire.
Uncertainties with respect to the PRC legal
system and changes in laws and regulations in China could adversely affect us.
We conduct all of our business through our PRC
subsidiaries. Our operations in China are governed by PRC laws and regulations. The PRC subsidiaries are generally subject to laws and
regulations applicable to foreign investments in China and, in particular, laws and regulations applicable to wholly foreign-owned enterprises.
The PRC legal system is based on statutes. Prior court decisions may be cited for reference but have limited precedential value.
Since 1979, PRC legislation and regulations have
significantly enhanced the protections afforded to various forms of foreign investments in China. However, China has not developed a fully
integrated legal system and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in China.
In particular, because these laws and regulations are relatively new, and because of the limited volume of published decisions and their
nonbinding nature, the interpretation and enforcement of these laws and regulations involve uncertainties. In addition, the PRC legal
system is based in part on government policies and internal rules (some of which are not published on a timely basis or at all) that may
have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules until sometime after the violation.
In addition, any litigation in China may be protracted and result in substantial costs and diversion of resources and management attention.
PRC regulation of loans and direct investment
by offshore holding companies to PRC entities may delay or prevent us from using the proceeds of this offering to make loans or additional
capital contributions to the PRC subsidiaries, which could materially and adversely affect our liquidity and our ability to fund and expand
our business.
In utilizing the proceeds of this offering
in the manner described in “Use of Proceeds” on page 33 of this prospectus, as an offshore holding company of our PRC
operating subsidiaries, we may make loans to our PRC subsidiaries, or we may make additional capital contributions to our PRC
subsidiaries.
Any loans to our PRC subsidiaries are subject
to PRC regulations. For example, loans by us to our subsidiaries in China, which are foreign invested entities (“FIEs”), to
finance their activities cannot exceed statutory limits and must be registered with SAFE. On March 30, 2015, SAFE promulgated
Hui Fa 2015 No.19, a notice regulating the conversion by a foreign-invested company of foreign currency into RMB. The foreign exchange
capital, for which the monetary contribution has been confirmed by the foreign exchange authorities (or for which the monetary contribution
has been registered for account entry) in the capital account of a foreign-invested enterprise may be settled at a bank as required by
the enterprise’s actual management needs. Foreign-invested enterprises with investment as their main business (including foreign-oriented
companies, foreign-invested venture capital enterprises and foreign-invested equity investment enterprises) are allowed to, under the
premise of authenticity and compliance of their domestic investment projects, carry out based on their actual investment scales direct
settlement of foreign exchange capital or transfer the RMB funds in the foreign exchange settlement account for pending payment to the
invested enterprises’ accounts.
On May 10, 2013, SAFE released Circular 21,
which came into effect on May 13, 2013. According to Circular 21, SAFE has simplified the foreign exchange administration procedures
with respect to the registration, account openings and conversions, settlements of FDI-related foreign exchange, as well as fund remittances.
Circular 21 may significantly limit our ability
to convert, transfer and use the net proceeds from this offering and any offering of additional equity securities in China, which may
adversely affect our liquidity and our ability to fund and expand our business in the PRC.
We may also decide to finance our subsidiaries
by means of capital contributions. These capital contributions must be approved by MOFCOM or its local counterpart, which usually takes
no more than 30 working days to complete. We may not be able to obtain these government approvals on a timely basis, if at all, with
respect to future capital contributions by us to our PRC subsidiaries. If we fail to receive such approvals, we will not be able to capitalize
our PRC operations, which could adversely affect our liquidity and our ability to fund and expand our business.
Governmental control of currency conversion
may affect the value of your investment.
The PRC government imposes controls on the convertibility
of the RMB into foreign currencies and, in certain cases, the remittance of currency out of China. We receive substantially all of our
revenues in RMB. Under our current corporate structure, our income is primarily derived from dividend payments from our PRC subsidiaries.
Shortages in the availability of foreign currency may restrict the ability of our PRC subsidiaries to remit sufficient foreign currency
to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated obligations. Under existing PRC foreign
exchange regulations, payments of current account items, including profit distributions, interest payments and expenditures from trade-related
transactions can be made in foreign currencies without prior approval from SAFE by complying with certain procedural requirements. However,
approval from appropriate government authorities is required where RMB is to be converted into foreign currency and remitted out of China
to pay capital expenses such as the repayment of loans denominated in foreign currencies. The PRC government may also at its discretion
restrict access in the future to foreign currencies for current account transactions. If the foreign exchange control system prevents
us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay dividends in foreign currencies
to our security-holders.
We are a holding company and we rely on
our subsidiaries for funding dividend payments, which are subject to restrictions under PRC laws.
We are a holding company incorporated in the Cayman
Islands, and we operate our core businesses through our PRC subsidiaries. Therefore, the availability of funds for us to pay dividends
to our shareholders and to service our indebtedness depends upon dividends received from the PRC subsidiaries. If the PRC subsidiaries
incur debt or losses, their ability to pay dividends or other distributions to us may be impaired. As a result, our ability to pay dividends
and to repay our indebtedness will be restricted. PRC laws require that dividends be paid only out of the after-tax profit of our subsidiaries
in the PRC calculated according to PRC accounting principles, which differ in many aspects from generally accepted accounting principles
in other jurisdictions. PRC laws also require enterprises established in the PRC to set aside part of their after-tax profits as statutory
reserves. These statutory reserves are not available for distribution as cash dividends. In addition, restrictive covenants in bank credit
facilities or other agreements that we or our subsidiaries may enter into in the future may also restrict the ability of our subsidiaries
to pay dividends to us. These restrictions on the availability of our funding may impact our ability to pay dividends to our shareholders
and to service our indebtedness.
To the extent cash or assets in the business
is in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may not be available to fund operations or for
other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations on the ability
of us or our subsidiaries by the PRC government to transfer cash or assets.
The transfer of funds and assets among Lichen
China Limited, its Hong Kong and PRC subsidiaries is subject to restrictions. The PRC government imposes controls on the conversion
of the RMB into foreign currencies and the remittance of currencies out of the PRC. See “Risk Factors — Governmental
control of currency conversion may affect the value of your investment.” In addition, the PRC Enterprise Income Tax Law and its
implementation rules provide that a withholding tax at a rate of 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident
enterprises, unless reduced under treaties or arrangements between the PRC central government and the governments of other countries or
regions where the non-PRC resident enterprises are tax resident. See “Risk Factors — Our PRC subsidiaries are subject
to restrictions on paying dividends or making other payments to us, which may have a material adverse effect on our ability to conduct
our business.”
As of the date of this prospectus, there are no
restrictions or limitations imposed by the Hong Kong government on the transfer of capital within, into and out of Hong Kong
(including funds from Hong Kong to the PRC), except for the transfer of funds involving money laundering and criminal activities.
However, there is no guarantee that the Hong Kong government will not promulgate new laws or regulations that may impose such restrictions
in the future.
As a result of the above, to the extent cash or
assets in the business is in the PRC or Hong Kong or a PRC or Hong Kong entity, the funds or assets may not be available to
fund operations or for other use outside of the PRC or Hong Kong due to interventions in or the imposition of restrictions and limitations
on the ability of us or our subsidiaries by the PRC government to transfer cash or assets.
Our PRC subsidiaries are subject to restrictions
on paying dividends or making other payments to us, which may have a material adverse effect on our ability to conduct our business.
We are a holding company incorporated in the Cayman
Islands. We may need dividends and other distributions on equity from our PRC subsidiaries to satisfy our liquidity requirements, including
the funds necessary to pay dividends and other cash distributions to our shareholders and service any debt we may incur. If our PRC subsidiaries
incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends or make other
distributions to us.
Current PRC regulations permit our PRC subsidiaries
to pay dividends to us only out of their accumulated profits, if any, determined in accordance with PRC accounting standards and regulations.
In addition, our PRC subsidiaries are required to set aside at least 10% of their respective accumulated profits each year, if any, to
fund certain reserve funds until the total amount set aside reaches 50% of their respective registered capital. Our PRC subsidiaries may
also allocate a portion of their respective after-tax profits based on PRC accounting standards to employee welfare and bonus funds at
their discretion. These reserves are not distributable as cash dividends. These limitation on the ability of our PRC subsidiaries to pay
dividends or make other distributions to us could materially and adversely limit our ability to grow, make investments, or acquisitions
that could be beneficial to our business, pay dividends, or otherwise fund and conduct our business.
Our business may be materially and adversely
affected if any of our PRC subsidiary declare bankruptcy or become subject to a dissolution or liquidation proceeding.
The Enterprise Bankruptcy Law of the PRC, or the
Bankruptcy Law, came into effect on June 1, 2007. The Bankruptcy Law provides that an enterprise will be liquidated if the enterprise
fails to settle its debts as and when they fall due and if the enterprise’s assets are, or are demonstrably, insufficient to clear
such debts.
Our PRC subsidiaries hold certain assets that
are important to our business operations. If our PRC subsidiaries undergo a voluntary or involuntary liquidation proceeding, unrelated
third-party creditors may claim rights to some or all of these assets, thereby hindering our ability to operate our business, which could
materially and adversely affect our business, financial condition and results of operations.
Fluctuations in exchange rates could adversely
affect our business and the value of our securities.
Changes in the value of the RMB against the U.S. dollar,
Euro and other foreign currencies are affected by, among other things, changes in China’s political and economic conditions. Any
significant revaluation of the RMB may have a material adverse effect on our revenues and financial condition, and the value of, and any
dividends payable on our shares in U.S. dollar terms. For example, to the extent that we need to convert U.S. dollars we receive
from our initial public offering into RMB for our operations, appreciation of the RMB against the U.S. dollar would have an adverse
effect on RMB amount we would receive from the conversion. Conversely, if we decide to convert our RMB into U.S. dollars for the
purpose of paying dividends on our Class A ordinary shares or for other business purposes, appreciation of the U.S. dollar against
the RMB would have a negative effect on the U.S. dollar amount available to us. In addition, fluctuations of the RMB against other
currencies may increase or decrease the cost of imports and exports, and thus affect the price-competitiveness of our products against
products of foreign manufacturers or products relying on foreign inputs.
Since July 2005, the RMB is no longer pegged
to the U.S. dollar. Although the People’s Bank of China regularly intervenes in the foreign exchange market to prevent significant
short-term fluctuations in the exchange rate, the RMB may appreciate or depreciate significantly in value against the U.S. dollar
in the medium to long term. Moreover, it is possible that in the future PRC authorities may lift restrictions on fluctuations in the RMB
exchange rate and lessen intervention in the foreign exchange market.
Increases in labor costs in the PRC may
adversely affect our business and results of operations.
The currently effective PRC Labor Contract
Law, or the Labor Contract Law was first adopted on June 29, 2007 and later amended on December 28, 2012. The PRC Labor
Contract Law has reinforced the protection of employees who, under the Labor Contract Law, have the right, among others, to have written
employment contracts, to enter into employment contracts with no fixed term under certain circumstances, to receive overtime wages and
to terminate or alter terms in labor contracts. Furthermore, the Labor Contract Law sets forth additional restrictions and increases the
costs involved with dismissing employees. To the extent that we need to significantly reduce our workforce, the Labor Contract Law could
adversely affect our ability to do so in a timely and cost-effective manner, and our results of operations could be adversely affected.
In addition, for employees whose employment contracts include noncompetition terms, the Labor Contract Law requires us to pay monthly
compensation after such employment is terminated, which will increase our operating expenses.
We expect that our labor costs, including wages
and employee benefits, will continue to increase. Unless we are able to pass on these increased labor costs to our buyers by increasing
the prices of our products and services, our financial condition and results of operations would be materially and adversely affected.
We may become subject to a variety of laws
and regulations in the PRC regarding privacy, data security, cybersecurity, and data protection. We may be liable for improper use or
appropriation of personal information provided by our customers.
We may become subject to a variety of laws and
regulations in the PRC regarding privacy, data security, cybersecurity, and data protection. These laws and regulations are continuously
evolving and developing. The scope and interpretation of the laws that are or may be applicable to us are often uncertain and may be conflicting,
particularly with respect to foreign laws. In particular, there are numerous laws and regulations regarding privacy and the collection,
sharing, use, processing, disclosure, and protection of personal information and other user data. Such laws and regulations often vary
in scope, may be subject to differing interpretations, and may be inconsistent among different jurisdictions.
We expect to obtain information about various
aspects of our operations as well as regarding our employees and third parties. We also maintain information about various aspects of
our operations as well as regarding our employees. The integrity and protection of our customer, employee and company data is critical
to our business. Our customers and employees expect that we will adequately protect their personal information. We are required by applicable
laws to keep strictly confidential the personal information that we collect, and to take adequate security measures to safeguard such
information.
The PRC Criminal Law, as amended by its Amendment
7 (effective on February 28, 2009) and Amendment 9 (effective on November 1, 2015), prohibits institutions, companies and their
employees from selling or otherwise illegally disclosing a citizen’s personal information obtained during the course of performing
duties or providing services or obtaining such information through theft or other illegal ways. On November 7, 2016, the Standing
Committee of the PRC National People’s Congress issued the Cyber Security Law of the PRC, or Cyber Security Law, which became effective
on June 1, 2017.
Pursuant to the Cyber Security Law, network operators
must not, without users’ consent, collect their personal information, and may only collect users’ personal information necessary
to provide their services. Providers are also obliged to provide security maintenance for their products and services and shall comply
with provisions regarding the protection of personal information as stipulated under the relevant laws and regulations.
The Civil Code of the PRC (issued by the PRC National
People’s Congress on May 28, 2020 and effective from January 1, 2021) provides main legal basis for privacy and personal
information infringement claims under the Chinese civil laws. PRC regulators, including the Cyberspace Administration of China, MIIT,
and the Ministry of Public Security have been increasingly focused on regulation in the areas of data security and data protection.
The PRC regulatory requirements regarding cybersecurity
are constantly evolving. For instance, various regulatory bodies in China, including the Cyberspace Administration of China, the Ministry
of Public Security and the SAMR, have enforced data privacy and protection laws and regulations with varying and evolving standards and
interpretations. In April 2020, the Chinese government promulgated Cybersecurity Review Measures, which came into effect on June 1,
2020. According to the Cybersecurity Review Measures, operators of critical information infrastructure must pass a cybersecurity review
when purchasing network products and services which do or may affect national security.
In November 2016, the Standing Committee
of China’s National People’s Congress passed China’s first Cybersecurity Law (“CSL”), which became effective
in June 2017. The CSL is the first PRC law that systematically lays out the regulatory requirements on cybersecurity and data protection,
subjecting many previously under-regulated or unregulated activities in cyberspace to government scrutiny. The legal consequences of violation
of the CSL include penalties of warning, confiscation of illegal income, suspension of related business, winding up for rectification,
shutting down the websites, and revocation of business license or relevant permits. In April 2020, the Cyberspace Administration
of China and certain other PRC regulatory authorities promulgated the Cybersecurity Review Measures, which became effective in June 2020.
Pursuant to the Cybersecurity Review Measures, operators of critical information infrastructure must pass a cybersecurity review when
purchasing network products and services which do or may affect national security. On July 10, 2021, the Cyberspace Administration
of China issued a revised draft of the Measures for Cybersecurity Review for public comments (“Draft Measures”), which required
that, in addition to “operator of critical information infrastructure,” any “data processor” carrying out data
processing activities that affect or may affect national security should also be subject to cybersecurity review, and further elaborated
the factors to be considered when assessing the national security risks of the relevant activities, including, among others, (i) the
risk of core data, important data or a large amount of personal information being stolen, leaked, destroyed, and illegally used or exited
the country; and (ii) the risk of critical information infrastructure, core data, important data or a large amount of personal information
being affected, controlled, or maliciously used by foreign governments after listing abroad. The Cyberspace Administration of China has
said that under the proposed rules companies holding data on more than 1,000,000 users must now apply for cybersecurity approval when
seeking listings in other nations because of the risk that such data and personal information could be “affected, controlled, and
maliciously exploited by foreign governments,” The cybersecurity review will also investigate the potential national security risks
from overseas IPOs. We do not know what regulations will be adopted or how such regulations will affect us and our listing on Nasdaq.
In the event that the Cyberspace Administration of China determines that we are subject to these regulations, we may be required to delist
from Nasdaq and we may be subject to fines and penalties. On June 10, 2021, the Standing Committee of the NPC promulgated the PRC
Data Security Law, which took effect on September 1, 2021. The Data Security Law also sets forth the data security protection obligations
for entities and individuals handling personal data, including that no entity or individual may acquire such data by stealing or other
illegal means, and the collection and use of such data should not exceed the necessary limits The costs of compliance with, and other
burdens imposed by, CSL and any other cybersecurity and related laws may limit the use and adoption of our products and services and could
have an adverse impact on our business. Further, if the enacted version of the Measures for Cybersecurity Review mandates clearance of
cybersecurity review and other specific actions to be completed by companies like us, we face uncertainties as to whether such clearance
can be timely obtained, or at all.
On July 10, 2021, the Cyberspace Administration
of China issued a revised draft of the Measures for Cybersecurity Review for public comments (the “Review Measures”), and
on December 28, 2021, the Cyberspace Administration of China jointly with the relevant authorities published Measures for Cybersecurity
Review (2021) which took effect on February 15, 2022 and replace the Review Measures, which required that, operators of critical
information infrastructure purchasing network products and services, and data processors (together with the operators of critical information
infrastructure, the “Operators”) carrying out data processing activities that affect or may affect national security, shall
conduct a cybersecurity review, any operator who controls more than one million users’ personal information must go through a cybersecurity
review by the cybersecurity review office if it seeks to be listed in a foreign country.
Under the Data Security Law enacted on September 1,
2021 and the Measures for Cybersecurity Review (2021) implemented on February 15, 2022, since we are not an Operator, nor do
we control more than one million users’ personal information, we would not be required to apply for a cybersecurity review by the
CAC. However, if the CSRC, CAC or other regulatory agencies later promulgate new rules or explanations requiring that we obtain their
approvals for this offering and any follow-on offering, we may be unable to obtain such approvals and we may face sanctions by the CSRC,
CAC or other PRC regulatory agencies for failure to seek their approval which could significantly limit or completely hinder our ability
to offer or continue to offer securities to our investors and the securities currently being offered may substantially decline in value
and be worthless.
On August 17, 2021, the State Council promulgated
the Regulations on the Protection of the Security of Critical Information Infrastructure, or the Regulations, which took effect on September 1,
2021. The Regulations supplement and specify the provisions on the security of critical information infrastructure as stated in the Cybersecurity
Review Measures. The Regulations provide, among others, that protection department of certain industry or sector shall notify the operator
of the critical information infrastructure in time after the identification of certain critical information infrastructure.
On August 20, 2021, the Standing Committee
of the NPC approved the Personal Information Protection Law (“PIPL”), which became effective on November 1, 2021. The
PIPL regulates collection of personal identifiable information and seeks to address the issue of algorithmic discrimination. Companies
in violation of the PIPL may be subject to warnings and admonishments, forced corrections, confiscation of corresponding income, suspension
of related services, and fines. We had not collected identifiable or sensitive personal information of individual end-users, such as ID
card numbers and real names, which means our potential access or exposure to customers’ personal information is limited. However,
in the event we inadvertently access or become exposed to customers’ personal identifiable information, then we may face heightened
exposure to the PIPL.
We cannot assure you that PRC regulatory agencies,
including the CAC, would take the same view as we do, and there is no assurance that we can fully or timely comply with such laws. In
the event that we are subject to any mandatory cybersecurity review and other specific actions required by the CAC, we face uncertainty
as to whether any clearance or other required actions can be timely completed, or at all. Given such uncertainty, we may be further required
to suspend our relevant business, shut down our website, or face other penalties, which could materially and adversely affect our business,
financial condition, and results of operations.
If we become directly subject to the recent
scrutiny, criticism and negative publicity involving U.S.-listed Chinese companies, we may have to expend significant resources to investigate
and resolve the matter which could harm our business operations, this offering and our reputation and could result in a loss of your investment
in our ordinary shares, especially if such matter cannot be addressed and resolved favorably.
Recently, U.S. public companies that have
substantially all of their operations in China, have been the subject of intense scrutiny, criticism and negative publicity by investors,
financial commentators and regulatory agencies, such as the SEC. Much of the scrutiny, criticism and negative publicity has centered
around financial and accounting irregularities, a lack of effective internal controls over financial accounting, inadequate corporate
governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. As a result of the scrutiny, criticism and
negative publicity, the publicly traded stock of many U.S. listed Chinese companies has sharply decreased in value and, in some cases,
has become virtually worthless. Many of these companies are now subject to shareholder lawsuits and SEC enforcement actions and are conducting
internal and external investigations into the allegations. It is not clear what effect this sector-wide scrutiny, criticism and negative
publicity will have on our Company, our business and this offering. If we become the subject of any unfavorable allegations, whether such
allegations are proven to be true or untrue, we will have to expend significant resources to investigate such allegations and/or defend
the Company. This situation may be a major distraction to our management. If such allegations are not proven to be groundless, our Company
and business operations will be severely hampered and your investment in our ordinary shares could be rendered worthless.
You may experience difficulties in effecting
service of legal process, enforcing foreign judgments, or bringing actions in China against us or our management named in the prospectus.
It may also be difficult for you or overseas regulators to conduct investigations or collect evidence within China.
We are a company incorporated under the laws of
the Cayman Islands, and we conduct most of our operations in China and most of our assets are located in China. In addition, substantially
all our senior executive officers reside within China, are physically there for a significant portion of each year, and are PRC nationals.
As a result, it may be difficult for you to effect service of process upon us or those persons inside mainland China. In addition, there
is uncertainty as to whether the courts of the Cayman Islands or the PRC would recognize or enforce judgments of U.S. courts against
us or such persons predicated upon the civil liability provisions of U.S. securities laws or those of any U.S. state.
The recognition and enforcement of foreign judgments
are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements
of the PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made or on principles of
reciprocity between jurisdictions. China does not have any treaties or other forms of written arrangement with the U.S. that provide
for the reciprocal recognition and enforcement of foreign judgments. In addition, according to the PRC Civil Procedures Law, the
PRC courts will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the
basic principles of PRC laws or national sovereignty, security, or public interest. As a result, it is uncertain whether and on what basis
a PRC court would enforce a judgment rendered by a court in the U.S. See “Enforceability of Civil Liabilities” on page 56.
It may also be difficult for you or overseas regulators
to conduct investigations or collect evidence within China. For example, in China, there are significant legal and other obstacles to
obtaining information needed for shareholder investigations or litigation outside China or otherwise with respect to foreign entities.
Although the authorities in China may establish a regulatory cooperation mechanism with its counterparts of another country or region
to monitor and oversee cross-border securities activities, such regulatory cooperation with the securities regulatory authorities in the
U.S. may not be efficient in the absence of a practical cooperation mechanism. Furthermore, according to Article 177 of the
PRC Securities Law, or “Article 177,” which became effective in March 2020, no overseas securities regulator is
allowed to directly conduct investigations or evidence collection activities within the territory of the PRC. Article 177 further
provides that Chinese entities and individuals are not allowed to provide documents or materials related to securities business activities
to foreign agencies without prior consent from the securities regulatory authority of the PRC State Council and the competent departments
of the PRC State Council. While the detailed interpretation of or implementing of rules under Article 177 have to be promulgated,
the inability of an overseas securities regulator to directly conduct investigation or evidence collection activities within China may
further increase the difficulties faced by you in protecting your interests.
You may face difficulties in protecting
your interests and exercising your rights as a shareholder since we conduct substantially all of our operations in China, and all of our
officers and directors reside outside the U.S.
Although we are incorporated in the Cayman Islands,
we conduct substantially all of our operations in China. All of our current officers and all of our directors reside outside the U.S. and
substantially all of the assets of those persons are located outside of the U.S. It may be difficult for you to conduct due diligence
on the Company or such directors in your election of the directors and attend shareholders meeting if the meeting is held in China. We
plan to have one shareholder meeting each year at a location to be determined, potentially in China. As a result of all of the above,
our public shareholders may have more difficulty in protecting their interests through actions against our management, directors or major
shareholders than would shareholders of a corporation doing business entirely or predominantly within the U.S.
Our financial and operating performance
may be adversely affected by general economic conditions, natural catastrophic events, epidemics, and public health crises that impact
the metaverse industry.
Our operating results will be subject to fluctuations
based on general economic conditions, in particular those conditions that impact the metaverse industry. Deterioration in economic conditions
could cause decreases in both volume and reduce and/or negatively impact our short-term ability to grow our revenues. Further, any decreased
collectability of accounts receivable or early termination of agreements due to deterioration in economic conditions could negatively
impact our results of operations.
Our business is subject to the impact of natural
catastrophic events such as earthquakes, floods or power outages, political crises such as terrorism or war, and public health crises,
such as disease outbreaks, epidemics, or pandemics in the U.S. and global economies, our markets and business locations. Currently, the
rapid spread of coronavirus (COVID-19) globally has resulted in increased travel restrictions and disruption and shutdown of
businesses. Our buyers may experience financial distress, file for bankruptcy protection, go out of business, or suffer disruptions in
their business due to the coronavirus outbreak; as a result, our revenues may be impacted. The extent to which the coronavirus impacts
our results will depend on future developments, which are highly uncertain and will include emerging information concerning the severity
of the coronavirus and the actions taken by governments and private businesses to attempt to contain the coronavirus, but is likely to
result in a material adverse impact on our business, results of operations and financial condition at least for the near term.
Similarly, natural disasters, wars (including
the potential of war), terrorist activity (including threats of terrorist activity), social unrest and heightened travel security measures
instituted in response, and travel-related accidents, as well as geopolitical uncertainty and international conflict, will affect travel
volume and may in turn have a material adverse effect on our business and results of operations. In addition, we may not be adequately
prepared in contingency planning or recovery capability in relation to a major incident or crisis, and as a result, our operational continuity
may be adversely and materially affected, which in turn may harm our reputation.
The recent joint statement by the SEC and
PCAOB, proposed rule changes submitted by Nasdaq, and the Holding Foreign Companies Accountable Act all call for additional and more stringent
criteria to be applied to emerging market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors
who are not inspected by the PCAOB. These developments could add uncertainties to our offering.
On April 21, 2020, SEC Chairman Jay Clayton
and PCAOB Chairman William D. Duhnke III, along with other senior SEC staff, released a joint statement highlighting the risks
associated with investing in companies based in or have substantial operations in emerging markets including China. The joint statement
emphasized the risks associated with lack of access for the PCAOB to inspect auditors and audit work papers in China and higher risks
of fraud in emerging markets.
On May 18, 2020, Nasdaq filed three proposals
with the SEC to (i) apply minimum offering size requirement for companies primarily operating in “Restrictive Market”,
(ii) adopt a new requirement relating to the qualification of management or board of director for Restrictive Market companies, and
(iii) apply additional and more stringent criteria to an applicant or listed company based on the qualifications of the company’s
auditors.
On May 20, 2020, the U.S. Senate passed
the Holding Foreign Companies Accountable Act requiring a foreign company to certify it is not owned or controlled by a foreign government
if the PCAOB is unable to audit specified reports because the company uses a foreign auditor not subject to PCAOB inspection. If the PCAOB
is unable to inspect the company’s auditors for three consecutive years, the issuer’s securities are prohibited to trade
on a national securities exchange or in the over the counter trading market in the U.S. On December 2, 2020, the U.S. House
of Representatives approved the Holding Foreign Companies Accountable Act. On December 18, 2020, the Holding Foreign Companies Accountable
Act was signed into law.
On March 24, 2021, the SEC announced that
it had adopted interim final amendments to implement congressionally mandated submission and disclosure requirements of the Act. The interim
final amendments will apply to registrants that the SEC identifies as having filed an annual report on Forms 10-K, 20-F, 40-F or N-CSR
with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined
it is unable to inspect or investigate completely because of a position taken by an authority in that jurisdiction. The SEC will implement
a process for identifying such a registrant and any such identified registrant will be required to submit documentation to the SEC establishing
that it is not owned or controlled by a governmental entity in that foreign jurisdiction, and will also require disclosure in the registrant’s
annual report regarding the audit arrangements of, and governmental influence on, such a registrant.
On June 22, 2021, the U.S. Senate passed
the Accelerating Holding Foreign Companies Accountable Act, and on December 29, 2022, legislation entitled “Consolidated Appropriations
Act, 2023” (the “Consolidated Appropriations Act”) was signed into law by President Biden, which contained, among other
things, an identical provision to the Accelerating Holding Foreign Companies Accountable Act and amended the HFCAA by requiring the SEC
to prohibit an issuer’s securities from trading on any U.S stock exchanges if its auditor is not subject to PCAOB inspections for
two consecutive years instead of three, thus reducing the time period for triggering the prohibition on trading.
On September 22, 2021, the PCAOB adopted
a final rule implementing the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA,
whether the PCAOB is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction
because of a position taken by one or more authorities in that jurisdiction.
On December 2, 2021, the SEC issued amendments
to finalize rules implementing the submission and disclosure requirements in the HFCAA. The rules apply to registrants that the SEC
identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign
jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions.
On December 16, 2021, the PCAOB issued a
report on its determinations that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered
in mainland China and in Hong Kong, because of positions taken by PRC authorities in those jurisdictions.
On August 26, 2022, the PCAOB announced that
it had signed a Statement of Protocol (the “SOP”) with the China Securities Regulatory Commission and the Ministry of Finance
of China. The SOP, together with two protocol agreements governing inspections and investigations (together, the “SOP Agreement”),
establishes a specific, accountable framework to make possible complete inspections and investigations by the PCAOB of audit firms based
in mainland China and Hong Kong, as required under U.S. law. On December 15, 2022, the PCAOB announced that it was able
to secure complete access to inspect and investigate PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong
completely in 2022. The PCAOB Board vacated its previous 2021 determinations that the PCAOB was unable to inspect or investigate completely
registered public accounting firms headquartered in mainland China and Hong Kong. However, whether the PCAOB will continue to be
able to satisfactorily conduct inspections of PCAOB-registered public accounting firms headquartered in mainland China and Hong Kong
is subject to uncertainties and depends on a number of factors out of our and our auditor’s control. The PCAOB continues to demand
complete access in mainland China and Hong Kong moving forward and is making plans to resume regular inspections in early 2023 and
beyond, as well as to continue pursuing ongoing investigations and initiate new investigations as needed. The PCAOB has also indicated
that it will act immediately to consider the need to issue new determinations with the HFCAA if needed.
Our auditor, Enrome LLP, the independent
registered public accounting firm, as an auditor of companies that are traded publicly in the United States and a firm registered
with the PCAOB, is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess Enrome
LLP’s compliance with applicable professional standards. Enrome LLP is headquartered in Singapore. As of the date of this
annual report, Enrome LLP is not included in the list of PCAOB Identified Firms in the PCAOB Determination Report issued in December
2021. Our auditors, B&V for the fiscal year ended December 31, 2020 and TPS Thayer for the fiscal year ended December 31, 2021
and 2022, are both based in the U.S. B&V withdrew its registration from the PCAOB in January 2022. TPS Thayer is headquartered
in Sugar Land, Texas, and its registration with the PCAOB took effect in September 2020 and it is currently subject to PCAOB
inspections.
We cannot assure you whether Nasdaq or
regulatory authorities would apply additional and more stringent criteria to us after considering the effectiveness of our auditor’s
audit procedures and quality control procedures, adequacy of personnel and training, or sufficiency of resources, geographic reach or
experience as it relates to the audit of our financial statements.
Trading in our securities may be prohibited
under the HFCAA and as a result an exchange may determine to delist our securities if it is later determined that the PCAOB is unable
to inspect or investigate completely our auditor because of a position taken by an authority in a foreign jurisdiction.
The HFCAA, was enacted on December 18, 2020.
The HFCAA states if the SEC determines that a company has filed audit reports issued by a registered public accounting firm that has not
been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit such shares from being
traded on a national securities exchange or in the over-the-counter trading market in the U.S.
On March 24, 2021, the SEC adopted interim
final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. A company will be required
to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to be subsequently established
by the SEC. The SEC is assessing how to implement other requirements of the HFCAA, including the listing and trading prohibition
requirements described above.
Despite that we have a U.S.-based auditor that
is registered with the PCAOB and subject to PCAOB inspection, there are still risks to the company and investors if it is later determined
that the PCAOB is unable to inspect or investigate completely our auditor because of a position taken by an authority in a foreign jurisdiction.
Such risks include, but are not limited to that trading in our securities may be prohibited under the HFCAA and as a result an exchange
may determine to delist our securities.
The approval of the China Securities Regulatory
Commission may be required in connection with this offering, and, if required, we cannot predict whether we will be able to obtain such
approval.
The Regulations on Mergers and Acquisitions of
Domestic Companies by Foreign Investors, or the M&A Rules, adopted by six PRC regulatory agencies requires an overseas special purpose
vehicle formed for listing purposes through acquisitions of PRC domestic companies and controlled by PRC companies or individuals to obtain
the approval of the China Securities Regulatory Commission, or the CSRC, prior to the listing and trading of such special purpose vehicle’s
securities on an overseas stock exchange.
We believe that the CSRC’s approval is not
required for the listing and trading of our Class A ordinary shares on Nasdaq in the context of this offering, given that: (i) our
PRC subsidiary was incorporated as a wholly foreign-owned enterprise by means of direct investment rather than by merger or acquisition
of equity interest or assets of a PRC domestic company owned by PRC companies or individuals as defined under the M&A Rules that are
our beneficial owners; (ii) the CSRC currently has not issued any definitive rule or interpretation concerning whether offerings
like ours under this prospectus are subject to the M&A Rules; and (iii) no provision in the M&A Rules clearly classifies
contractual arrangements as a type of transaction subject to the M&A Rules.
However, there remains some uncertainties as to
how the M&A Rules will be interpreted or implemented in the context of an overseas offering and its opinions summarized above are
subject to any new laws, rules and regulations or detailed implementations and interpretations in any form relating to the M&A Rules.
We cannot assure you that relevant PRC government agencies, including the CSRC, would reach the same conclusion as we do. If it is determined
that CSRC approval is required for this offering, we may face sanctions by the CSRC or other PRC regulatory agencies for failure to seek
CSRC approval for this offering. These sanctions may include fines and penalties on our operations in the PRC, limitations on our operating
privileges in the PRC, delays in or restrictions on the repatriation of the proceeds from this offering into the PRC, restrictions on
or prohibition of the payments or remittance of dividends by our PRC subsidiary, or other actions that could have a material and adverse
effect on our business, financial condition, results of operations, reputation and prospects, as well as the trading price of our Class
A ordinary shares. Furthermore, the CSRC or other PRC regulatory agencies may also take actions requiring us, or making it advisable for
us, to halt this offering before the settlement and delivery of the Class A ordinary shares that we are offering. Consequently, if you
engage in market trading or other activities in anticipation of and prior to the settlement and delivery of the Class A ordinary shares
we are offering, you would be doing so at the risk that the settlement and delivery may not occur.
CAPITALIZATION AND INDEBTNESS
Our capitalization will
be set forth in the applicable prospectus supplement or in a report on Form 6-K subsequently furnished to the SEC and specifically
incorporated by reference into this prospectus.
DILUTION
If required, we will
set forth in a prospectus supplement the following information regarding any material dilution of the equity interests of investors purchasing
securities in an offering under this prospectus:
|
● |
the net tangible book value per share of our equity securities before and after the offering; |
|
● |
the amount of the increase in such net tangible book value per share attributable to the cash payments made by purchasers in the offering; and |
|
● |
the amount of the immediate dilution from the public offering price which will be absorbed by such purchasers. |
USE OF PROCEEDS
We intend
to use the net proceeds from the sale of securities we offer as indicated in the applicable prospectus supplement, information incorporated
by reference, or free writing prospectus.
DESCRIPTION OF ORDINARY SHARES
Lichen China Limited is
an exempted company incorporated under the Companies Act (Revised) of the Cayman Islands, as amended (the “Cayman Islands
Companies Act”). Pursuant to our amended and restated memorandum and amended and restated articles of association, the authorized
share capital of our company is US$50,000, divided into 1,000,000,000 Class A ordinary shares of a par value of US$0.00004 each, and 250,000,000
Class B ordinary shares of a par value of US$0.00004 each. As of the date of this prospectus, 17,500,000 Class A ordinary shares and 9,000,000
Class B ordinary shares are issued and outstanding.
The following are summaries of the material provisions
of our amended and restated memorandum and articles of association and the Cayman Islands Companies Act, insofar as they relate to the
material terms of our ordinary shares. Copies of our amended and restated memorandum and articles of association are filed as exhibits
to the most recent annual report on Form 20-F, which is incorporated by reference in this prospectus.
General
As of the date of this prospectus, under our amended
and restated memorandum of association, we are authorized to issue 1,000,000,000 Class A ordinary shares of a par value of US$0.00004
each, and 250,000,000 Class B ordinary shares of a par value of US$0.00004 each. As of the date of this prospectus, 17,500,000 Class A
ordinary shares and 9,000,000 Class B ordinary shares are issued and outstanding.
Holders of Class A ordinary shares and Class B
ordinary shares will have the same rights except for voting and conversion rights. All of our issued Class A ordinary shares and Class
B ordinary shares are fully paid and non-assessable. Certificates representing the ordinary shares are issued in registered form.
Dividends
The holders of our ordinary shares are entitled
to such dividends as may be declared by our Board of Directors subject to the Cayman Islands Companies Act. The Directors may from time
to time declare dividends (including interim dividends) and distributions on the issued and outstanding shares of the Company and authorize
payment of the same out of the funds of the Company lawfully available therefor. Dividends may also be declared or paid out of share premium
account or otherwise permitted by the Cayman Islands Companies Act, provided that in no circumstances may we pay a dividend if this would
result in our company being unable to pay its debts as they fall due in the ordinary course of business.
Voting rights
At each general meeting of our company, on a poll
or a show of hands, each shareholder who is present in person or by proxy (or, in the case of a shareholder being a corporation, by its
duly authorized representative) shall have one (1) vote for each Class A ordinary share and ten (10) votes for each Class B ordinary share
which such shareholder holds. The holders of Class A ordinary shares and Class B ordinary shares shall at all times vote together as one
class on all resolutions of the shareholders. At any general meeting the chairman is responsible for deciding in such manner as he considers
appropriate whether any resolution proposed has been carried or not and the result of his decision shall be announced to the meeting and
recorded in the minutes of the meeting. At any general meeting, a resolution put to the vote at the meeting shall be decided on a poll
unless a show of hand is, before or on the declaration of the result of the poll, demanded by the chairman of such meeting or by one or
more shareholders present in person or by proxy.
Election of directors
Directors may be appointed by an ordinary resolution
of our shareholders. Directors may also be appointed by a resolution of the directors of the Company, provided that the total number of
directors (exclusive of alternate directors) shall not at any time exceed the number fixed in accordance with the amended and restated
articles of association.
Meetings of shareholders
Any of our directors may convene general meetings
of shareholders at such times and in such manner and places within or outside the Cayman Islands as the director considers necessary or
desirable. The director convening a general meeting shall give at least five days’ notice of the general meeting to those shareholders
whose names on the date the notice is given appear as members in the register of members of the Company and are entitled to vote at the
meeting, and each of the Company’s directors. Our Board of Directors must convene a general meeting upon the written request of
one or more shareholders holding no less than 10% of the Company’s paid-up capital as at the date of the deposit of the requisition
carries the right of voting at general meetings of the Company.
No business may be transacted at any general
meeting unless a quorum is present at the time the meeting proceeds to business. The quorum shall be (i) two or more shareholders
present in person or by proxy; or (ii) for so long as any shares are listed on the Nasdaq Capital Market (and any other
stock exchange on which the Company’s shares are listed for trading), one or more shareholders holding shares that represent
not less than one-third of the outstanding issued shares carrying the right to vote at such general meeting. If, within half an hour
from the time appointed for the meeting, a quorum is not present, the meeting, if convened upon the requisition of shareholders,
shall be dissolved. In any other case, it shall stand adjourned to the same day in the next week at the same time and place or to
such other time or such other place as the directors may determine, and if at the adjourned meeting a quorum is not present within
half an hour from the time appointed for the meeting, the shareholders present shall be a quorum and may transact the business for
which the meeting was called. The chairman, if any, of our Board of Directors shall preside as chairman at every general meeting of
the Company, or if there is no such chairman, or if he shall not be present within fifteen minutes after the time appointed for the
holding of the general meeting, or is unwilling to act, the directors present shall elect one of their number to be chairman of the
general meeting.
Meetings of directors
Subject to the Cayman Islands Companies Act and
the amended and restated articles of association of our company, the management of our company is entrusted to our Board of Directors,
who will make decisions by voting on resolutions of directors. At any meeting of directors, a quorum will be present if two directors
are present, unless otherwise fixed by the directors. If there is a sole director, that director shall be a quorum. A director and his
appointed alternate director shall be considered as only one person for the purpose of calculating quorum. An alternate director or proxy
appointed by a director shall be counted in a quorum at a meeting at which the director appointing him is not present. An action that
may be taken by the directors at a meeting may also be taken by a resolution of directors consented to in writing by all of the directors.
Pre-emptive rights
There are no pre-emptive rights applicable to
the issue by us of Class A ordinary shares under either Cayman Islands law or our amended and restated memorandum and articles of
association.
Conversion
Each Class B ordinary share is convertible into
one Class A ordinary share at any time at the option of the holder thereof. Class A ordinary shares are not convertible into Class B ordinary
shares under any circumstances.
Transfer of Ordinary Shares
Subject to the restrictions in our amended and
restated memorandum and articles of association and applicable securities laws, any of our shareholders may transfer all or any of his
or her Class A ordinary shares or Class B ordinary shares by written instrument of transfer signed by the transferor and containing the
name and address of the transferee. Our Board of Directors may resolve by resolution to refuse or delay the registration of the transfer
of any Class A ordinary shares or Class B ordinary shares without giving any reason.
Winding Up
On a return of capital on winding up or otherwise
(other than on conversion, redemption or purchase of shares), assets available for distribution among the holders of ordinary shares shall
be distributed among the holders of our shares in proportion to the capital paid up. If our assets available for distribution are insufficient
to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by our shareholders in proportion to
the capital paid up.
Calls on Ordinary Shares and forfeiture of
Ordinary Shares
Our Board of Directors may from time to time make
calls upon shareholders for any amounts unpaid on their ordinary shares in a notice served to such shareholders at least 14 days prior
to the specified time of payment provided that no call shall be payable at less than one month from the date fixed for the payment of
the last preceding call. The ordinary shares that have been called upon and remain unpaid are subject to forfeiture if the call remains
unpaid after a second notice by the directors in accordance with the amended and restated articles of association.
Repurchase of Shares
The Cayman Islands Companies Act and our amended
and restated memorandum and articles of association permit us to purchase our own shares, subject to certain restrictions and requirements.
Our directors may only exercise this power on our behalf, subject to the Cayman Islands Companies Act, our amended and restated memorandum
and articles of association and to any applicable requirements imposed from time to time by the Nasdaq, the Securities and Exchange Commission,
or by any other recognized stock exchange on which our securities are listed.
Provided the necessary shareholders and board
approval have been obtained, we may issue shares on terms that are subject to redemption, at our option or at the option of the holders
of these shares, on such terms and in such manner, provided the requirements under the Cayman Islands Companies Act have been satisfied.
Under the Cayman Islands Companies Act, the repurchase of any share may be paid out of our company’s profits, out of the share premium
account or out of the proceeds of a fresh issue of shares made for the purpose of such repurchase, or out of capital. If the repurchase
proceeds are paid out of our Company’s capital, our Company must, immediately following the date of such payment, be able to pay
its debts as they fall due in the ordinary course of business. In addition, under the Cayman Islands Companies Act, no such share may
be repurchased (1) unless it is fully paid up, (2) if such repurchase would result in there being no shares outstanding, and (3) unless
the manner of purchase (if not so authorized under the amended and restated memorandum and articles of association) has first been authorized
by a resolution of our shareholders. In addition, under the Cayman Islands Companies Act, our Company may accept the surrender of any
fully paid share for no consideration unless, as a result of the surrender, the surrender would result in there being no shares outstanding
(other than shares held as treasury shares).
Variation of Rights of Shares
The rights attached to any class or series of
shares (unless otherwise provided by the terms of issue of the shares of that class or series), whether or not our company is being wound-up,
may be varied with the consent in writing of the holders of three-fourths of the issued shares of that class or series or with the sanction
of a special resolution passed at a separate meeting of the holders of the shares of the class or series. The rights conferred upon the
holders of the shares of any class issued shall not, unless otherwise expressly provided by the terms of issue of the shares of that class,
be deemed to be varied by the creation or issue of further shares ranking pari passu with such existing class of shares.
Changes in the number of shares we are authorized
to issue and those in issue
We may from time to time by resolution of shareholders
in the requisite majorities:
| ● | amend
our amended and restated memorandum of association to increase the authorized share capital of our Company or cancel any shares which
at the date of the passing of the resolution have not been taken or agreed to be taken by any person; |
| ● | subdivide
our authorized and issued shares into a larger number of shares; and |
| ● | consolidate
our authorized and issued shares into a smaller number of shares. |
Inspection of books and records
Holders of our ordinary shares will have no general
right under Cayman Islands law to inspect or obtain copies of our register of members or our corporate records. However, we will provide
our shareholders with annual audited financial statements. See “Where You Can Find Additional Information.”
Rights of non-resident or foreign shareholders
There are no limitations imposed by our amended
and restated memorandum and articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights
on our shares. In addition, there are no provisions in our amended and restated memorandum and articles of association governing the ownership
threshold above which shareholder ownership must be disclosed.
Issuance of additional Ordinary Shares
Our amended and restated memorandum and articles
of association authorizes our Board of Directors to issue additional ordinary shares from time to time as our Board of Directors shall
determine, to the extent that there are sufficient authorized but unissued shares.
Exempted Company
We are an exempted company with limited liability
under the Cayman Islands Companies Act. The Cayman Islands Companies Act distinguishes between ordinary resident companies and exempted
companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to
be registered as an exempted company. An exempted company shall not trade in the Cayman Islands with any person, firm or corporation except
in furtherance of the business of the exempted company carried on outside the Cayman Islands:
| ● | does
not have to file an annual return of its shareholders with the Registrar of Companies; |
| ● | is
not required to open its register of members for inspection; |
| ● | does
not have to hold an annual general meeting; |
| ● | is
prohibited from making any invitation to the public in the Cayman Islands to subscribe for any of its securities if it is not listed
on the Cayman Islands Stock Exchange; |
| ● | may
issue bearer shares or shares with no par value; |
| ● | may
obtain an undertaking against the imposition of any future taxation (for a period of up to 30 years); |
| ● | may
register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; |
| ● | may
register as an exempted limited duration company; and |
| ● | may
register as a segregated portfolio company. |
“Limited liability” means that the
liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company.
Differences in Corporate Law
The Cayman Islands Companies Act is modeled after
that of English law but does not follow recent English statutory enactments. In addition, the Cayman Islands Companies Act differs from
laws applicable to United States corporations and their shareholders. Set forth below is a summary of the significant differences between
the provisions of the Cayman Islands Companies Act applicable to us and the laws applicable to companies incorporated in the State of
Delaware.
Mergers and Similar Arrangements
The Cayman Islands Companies Act permits mergers
and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes,
a “merger” means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities
in one of such companies as the surviving company, and a “consolidation” means the combination of two or more constituent
companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated
company.
In order to effect such a merger or consolidation,
the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by a special
resolution of the shareholders of each constituent company, and such other authorization, if any, as may be specified in such constituent
company’s articles of association.
The plan of merger or consolidation must be filed
with the Registrar of Companies of the Cayman Islands together with the requisite declarations and undertakings required under the Cayman
Islands Companies Act, including a declaration as to the solvency of the consolidated or surviving company, a list of the assets and liabilities
of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members
and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands
Gazette. Dissenting shareholders have the right to be paid the fair value of their shares if they follow the required procedures, under
the Cayman Islands Companies Act subject to certain exceptions. The fair value of the shares will be determined by the Cayman Islands
court if it cannot be agreed among the parties. Court approval is not required for a merger or consolidation effected in compliance with
these statutory procedures.
In addition, there are statutory provisions that
facilitate the reconstruction of companies, provided that the arrangement is approved by a majority in number of each class of shareholders
and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of
shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened
for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands.
The Cayman Islands Companies Act provides that
shareholders of companies incorporated in Cayman Islands have rights of dissent and appraisal and are entitled to be paid the fair value
of their shares upon dissenting to a merger or consolidation.
A company that has received any notice of dissent
must, within specified time periods, make a written offer to each dissenting shareholder to purchase its shares at a price that the company
determines to be the fair value, and if agreed by the shareholder, monies must be paid to the dissenting shareholder within thirty days
of the offer being made. If no price is agreed upon, the company must file a petition with the Grand Court of the Cayman Islands for a
determination of the fair value of the shares of all dissenting shareholders and any dissenting shareholders is permitted to be involved
in those proceedings.
If the arrangement and reconstruction is thus
sanctioned by the Grand Court of the Cayman Islands, the dissenting shareholder would have no rights comparable to appraisal rights, which
would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash
for the judicially determined value of the shares.
The Cayman Islands Companies Act also contains
a statutory power of compulsory acquisition which may facilitate the “squeeze out” of dissentient minority shareholders upon
a tender offer. When a tender offer is made and accepted by holders of not less than 90% of the shares which are subject to the offer
within four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders
of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands.
Shareholders’ Suits and Protection of
Minority Shareholders
In principle, we will normally be the proper plaintiff
to sue for a wrong done to us as a company and as a general rule a derivative action may not be brought by a minority shareholder. However,
based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Grand Court can be expected
to apply and follow the common law principles (namely the rule derived from the seminal English case of Foss v. Harbottle, and
the exceptions thereto, which limits the circumstances in which a shareholder may bring a derivative action on behalf of the company or
a personal action to claim loss which is reflective of loss suffered by the company) which permit a minority shareholder to commence a
class action against, or derivative actions in the name of the company to challenge the following acts in the following circumstances:
| ● | a
company acts or proposes to act illegally or ultra vires; |
| ● | an
irregularity in the passing of a resolution which requires a special majority; and |
| ● | an
act which constitutes a fraud on the minority where the wrongdoers are themselves in control of the company, so that they will not cause
the company to bring an action. |
In the case of a company (not being
a bank) having its share capital divided into shares, the Grand Court may, on the application of members holding not less than one fifth
of the shares of the company in issue, appoint an inspector to examine the affairs of the company and to report thereon in such manner
as the Grand Court shall direct.
Indemnification of Directors and Executive
Officers and Limitation of Liability
The Cayman Islands Companies Act does not limit
the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors,
except to the extent any such indemnification may be held by the Cayman Islands courts to be contrary to public policy, such as to provide
indemnification against civil fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association
permit indemnification of officers and directors for losses, damages, costs and expenses incurred in their capacities as such unless such
losses or damages shall incur or sustain by or through their own wilful neglect or default respectively. This standard of conduct is generally
the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have
been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is
therefore unenforceable.
Directors’ Fiduciary Duties
Under Delaware corporate law, a director of a
Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and
the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would
exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information
reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably
believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty
prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over
any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions
of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in
the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties.
Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction,
and that the transaction was of fair value to the corporation.
As a matter of Cayman Islands law, a
director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that
he or she owes the following duties to the company - a duty to act in good faith in the best interests of the company,
a duty not to make a personal profit based on his or her position as director (unless the company permits him or her to do so), a duty
not to put himself or herself in a position where the interests of the company conflict with his or her personal interest or his or her
duty to a third party and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands
company owes to the company a duty to act with skill and care. English and Commonwealth courts have moved towards an objective standard
with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands.
Shareholder Action by Written Consent
Under the Delaware corporate law, a corporation
may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. Our articles of association
provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder
who would have been entitled to vote on such matter at a general meeting without a meeting being held.
Shareholder Proposals
Under the Delaware corporate law, a shareholder
has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing
documents. A special meeting may be called by the Board of Directors or any other person authorized to do so in the governing documents,
but shareholders may be precluded from calling special meetings. The Cayman Islands Companies Act does not provide shareholders of a Cayman
exempted company with any rights to requisition a general meeting nor any right to put any proposal before a general meeting. However,
these rights may be provided in articles of association. Our articles of association allow our shareholders holding 10% or more of the
paid-up capital of the Company to requisition a general meeting. Other than this right to requisition a general meeting, our articles
of association do not provide our shareholders other right to put a proposal before a meeting. As an exempted Cayman Islands company,
we are not obliged by law to call shareholders’ annual general meetings unless expressly provided under the articles of association.
Cumulative Voting
Under the Delaware corporate law, cumulative voting
for elections of directors is not permitted unless the corporation’s certificate of incorporation specifically provides for it.
Cumulative voting potentially facilitates the representation of minority shareholders on a Board of Directors since it permits the minority
shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder’s voting
power with respect to electing such director. There are no prohibitions in relation to cumulative voting under the Cayman Islands Companies
Act but our articles of association do not provide for cumulative voting.
Removal of Directors
Under the Delaware corporate law, a director of
a corporation may be removed with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation
provides otherwise. Under our articles of association, directors may be removed with or without cause, by an ordinary resolution of our
shareholders.
Transactions with Interested Shareholders
The Delaware corporate law contains a business
combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by
such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an
“interested shareholder” for three years following the date that such person becomes an interested shareholder. An interested
shareholder generally is a person or a group who or which owns or owned 15% or more of the target’s outstanding voting share within
the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which
all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder
becomes an interested shareholder, the Board of Directors approves either the business combination or the transaction which resulted in
the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms
of any acquisition transaction with the target’s Board of Directors. The Cayman Islands Companies Act has no comparable statute.
As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although
Cayman Islands law does not regulate transactions between a company and its significant shareholders, as mentioned above the directors
have certain fiduciary duties including a duty to act bona fide in the best interests of the company. Our articles of association require
directors to disclose the nature of their interest in any contract or transaction at or prior to the Board of Directors’ consideration
of such contract or transaction and any vote thereon.
Dissolution; Winding up
Under the Delaware corporate law, unless the Board
of Directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of
the corporation. Only if the dissolution is initiated by the Board of Directors may it be approved by a simple majority of the corporation’s
outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement
in connection with dissolutions initiated by the board. Under the Cayman Islands Companies Act, a company may be wound up by either an
order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they
fall due, by an ordinary resolution of its shareholders. The court has authority to order winding up in a number of specified circumstances,
including where it is, in the opinion of the court, just and equitable to do so. Under the Cayman Islands Companies Act and our articles
of association, our company may be dissolved, liquidated or wound up by a special resolution of our shareholders.
Variation of Rights of Shares
Under the Delaware corporate law, a corporation
may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate
of incorporation provides otherwise. Under our articles of association, if our share capital is divided into more than one class of shares,
we may vary the rights attached to any class with the written consent of the holders of three-fourths of the issued shares of that class
or with the sanction of a special resolution passed at a separate general meeting of the holders of the shares of that class.
Amendment of Governing Documents
Under the Delaware corporate law, a corporation’s
governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate
of incorporation provides otherwise. As permitted by the Cayman Islands Companies Act, our memorandum and articles of association may
only be amended with a special resolution of our shareholders.
Listing
We have our Class A ordinary shares listed on
the Nasdaq Capital Market under the symbol “LICN.”
Transfer Agent and Registrar
The transfer agent and registrar for the Class
A ordinary shares is Vstock Transfer, LLC.
DESCRIPTION OF WARRANTS
The following description, together with the additional
information we may include in any applicable prospectus supplements, summarizes the material terms and provisions of the warrants that
we may offer under this prospectus and the related warrant agreements and warrant certificates. While the terms summarized below will
apply generally to any warrants that we may offer under this prospectus, we will describe the particular terms of any series of warrants
that we may offer in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the terms of any
warrants offered under that prospectus supplement may differ from the terms described below. However, no prospectus supplement shall fundamentally
change the terms that are set forth in this prospectus or offer a security that is not registered and described in this prospectus at
the time of its effectiveness. Specific warrant agreements will contain additional important terms and provisions and will be incorporated
by reference as an exhibit to the registration statement that includes this prospectus or as an exhibit to a report filed under the Exchange
Act.
General
We may issue warrants that entitle the holder
to purchase ordinary shares, debt securities or any combination thereof. We may issue warrants independently or together with ordinary
shares, debt securities or any combination thereof, and the warrants may be attached to or separate from these securities.
We will describe in the applicable prospectus
supplement the terms of the series of warrants, including:
|
● |
the offering price and aggregate number of warrants offered; |
|
● |
the currency for which the warrants may be purchased, if not United States dollars; |
|
● |
if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
|
● |
if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
|
● |
in the case of warrants to purchase ordinary shares, the number of ordinary shares purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |
|
|
|
|
● |
in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency, if not United States dollars, in which, this principal amount of debt securities may be purchased upon such exercise; |
|
● |
the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants; |
|
|
|
|
● |
the term of any rights to redeem or call the warrants; |
|
|
|
|
● |
any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
|
● |
the dates on which the right to exercise the warrants will commence and expire; |
|
● |
the manner in which the warrant agreement and warrants may be modified; |
|
● |
federal income tax consequences of holding or exercising the warrants; |
|
● |
the terms of the securities issuable upon exercise of the warrants; and |
|
● |
any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |
Before exercising their warrants, holders of warrants
will not have any of the rights of holders of the securities purchasable upon such exercise, including:
|
● |
in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture; or |
|
● |
in the case of warrants to purchase our ordinary shares, the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any. |
Exercise of Warrants
Each warrant will entitle the holder to purchase
the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in the applicable prospectus
supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at
any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of
business on the expiration date, unexercised warrants will become void.
Holders of the warrants may exercise the warrants
by delivering the warrant certificate representing the warrants to be exercised together with specified information, and paying the required
amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement. We will set forth on
the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the holder of the warrant
will be required to deliver to the warrant agent.
Upon receipt of the required payment and the warrant
certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the
applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If fewer than all of the warrants
represented by the warrant certificate are exercised, then we will issue a new warrant certificate for the remaining amount of warrants.
If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise
price for warrants.
Enforceability of Rights by Holders of Warrants
Each warrant agent will act solely as our agent
under the applicable warrant agreement and will not assume any obligation or relationship of agency or trust with any holder of any warrant.
A single bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility
in case of any default by us under the applicable warrant agreement or warrant, including any duty or responsibility to initiate any proceedings
at law or otherwise, or to make any demand upon us. Any holder of a warrant may, without the consent of the related warrant agent or the
holder of any other warrant, enforce by appropriate legal action its right to exercise, and receive the securities purchasable upon exercise
of, its warrants.
Warrant Agreement Will Not Be Qualified Under
Trust Indenture Act
No warrant agreement will be qualified as an indenture,
and no warrant agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore, holders of warrants issued under
a warrant agreement will not have the protection of the Trust Indenture Act with respect to their warrants.
Modification of the Warrant Agreement
The warrant agreements may permit us and the warrant
agent, if any, without the consent of the warrant holders, to supplement or amend the agreement in the following circumstances:
|
● |
to correct or supplement any provision which may be defective or inconsistent with any other provisions; or |
|
● |
to add new provisions regarding matters or questions that we and the warrant agent may deem necessary or desirable and which do not adversely affect the interests of the warrant holders. |
DESCRIPTION OF DEBT SECURITIES
As used in this prospectus, debt securities mean
the debentures, notes, bonds and other evidences of indebtedness, which may or may not be converted into our ordinary shares, that we
may issue from time to time. The debt securities may be either secured or unsecured and will either be senior debt securities or subordinated
debt securities. The debt securities may be issued under one or more separate indentures between us and a trustee to be specified in an
accompanying prospectus supplement. Senior debt securities will be issued under a new senior indenture. Subordinated debt securities will
be issued under a subordinated indenture. Together, the senior indentures and the subordinated indentures are sometimes referred to in
this prospectus as the indentures. This prospectus, together with the applicable prospectus supplement, will describe the terms of a particular
series of debt securities.
The statements and descriptions in this prospectus
or in any prospectus supplement regarding provisions of the indentures and debt securities are summaries thereof, do not purport to be
complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the indentures (and any amendments
or supplements we may enter into from time to time which are permitted under each indenture) and the debt securities, including the definitions
therein of certain terms.
General
Unless otherwise specified in a prospectus supplement,
the debt securities will be direct unsecured obligations of Lichen China Limited. The senior debt securities will rank equally with any
of our other senior and unsubordinated debt. The subordinated debt securities will be subordinate and junior in right of payment to any
senior indebtedness.
Unless otherwise specified in a prospectus supplement,
the indentures do not limit the aggregate principal amount of debt securities that we may issue and provide that we may issue debt securities
from time to time at par or at a discount, and in the case of the new indentures, if any, in one or more series, with the same or various
maturities. Unless indicated in a prospectus supplement, we may issue additional debt securities of a particular series without the consent
of the holders of the debt securities of such series outstanding at the time of the issuance. Any such additional debt securities, together
with all other outstanding debt securities of that series, will constitute a single series of debt securities under the applicable indenture.
Each prospectus supplement will describe the terms
relating to the specific series of debt securities being offered. These terms will include some or all of the following:
|
● |
the title of the debt securities and whether they are subordinated debt securities or senior debt securities; |
|
● |
any limit on the aggregate principal amount of the debt securities; |
|
● |
the ability to issue additional debt securities of the same series; |
|
● |
the price or prices at which we will sell the debt securities; |
|
● |
the maturity date or dates of the debt securities on which principal will be payable; |
|
● |
the rate or rates of interest, if any, which may be fixed or variable, at which the debt securities will bear interest, or the method of determining such rate or rates, if any; |
|
● |
the date or dates from which any interest will accrue or the method by which such date or dates will be determined; |
|
● |
the conversion price at which the debt securities may be converted; |
|
● |
the date on which the right to convert the debt securities will commence and the date on which the right will expire; |
|
● |
if applicable, the minimum or maximum amount of debt securities that may be converted at any one time; |
|
● |
the right, if any, to extend the interest payment periods and the duration of any such deferral period, including the maximum consecutive period during which interest payment periods may be extended; |
|
● |
whether the amount of payments of principal of (and premium, if any) or interest on the debt securities may be determined with reference to any index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner of determining the amount of such payments; |
|
● |
the dates on which we will pay interest on the debt securities and the regular record date for determining who is entitled to the interest payable on any interest payment date; |
|
● |
the place or places where the principal of (and premium, if any) and interest on the debt securities will be payable, where any securities may be surrendered for registration of transfer, exchange or conversion, as applicable, and notices and demands may be delivered to or upon us pursuant to the indenture; |
|
● |
if we possess the option to do so, the periods within which and the prices at which we may redeem the debt securities, in whole or in part, pursuant to optional redemption provisions, and the other terms and conditions of any such provisions; |
|
● |
our obligation, if any, to redeem, repay or purchase debt securities by making periodic payments to a sinking fund or through an analogous provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices at which we will redeem, repay or purchase the debt securities, in whole or in part, pursuant to such obligation, and the other terms and conditions of such obligation; |
|
● |
the denominations in which the debt securities will be issued, if other than denominations of $1,000 and integral multiples of $1,000; |
|
● |
the portion, or methods of determining the portion, of the principal amount of the debt securities which we must pay upon the acceleration of the maturity of the debt securities in connection with an event of default (as described below), if other than the full principal amount; |
|
● |
the currency, currencies or currency unit in which we will pay the principal of (and premium, if any) or interest, if any, on the debt securities, if not United States dollars; |
|
● |
provisions, if any, granting special rights to holders of the debt securities upon the occurrence of specified events; |
|
● |
any deletions from, modifications of or additions to the events of default or our covenants with respect to the applicable series of debt securities, and whether or not such events of default or covenants are consistent with those contained in the applicable indenture; |
|
● |
any limitation on our ability to incur debt, redeem shares, sell our assets or other restrictions; |
|
● |
the application, if any, of the terms of the indenture relating to defeasance and covenant defeasance (which terms are described below) to the debt securities; |
|
● |
whether the subordination provisions summarized below or different subordination provisions will apply to the debt securities; |
|
● |
the terms, if any, upon which the holders may convert or exchange the debt securities into or for our ordinary shares or other securities or property; |
|
● |
whether any of the debt securities will be issued in global form and, if so, the terms and conditions upon which global debt securities may be exchanged for certificated debt securities; |
|
● |
any change in the right of the trustee or the requisite holders of debt securities to declare the principal amount thereof due and payable because of an event of default; |
|
● |
the depository for global or certificated debt securities; |
|
● |
any special tax implications of the debt securities; |
|
● |
any foreign tax consequences applicable to the debt securities, including any debt securities denominated and made payable, as described in the prospectus supplements, in foreign currencies, or units based on or related to foreign currencies; |
|
● |
any trustees, authenticating or paying agents, transfer agents or registrars, or other agents with respect to the debt securities; |
|
● |
any other terms of the debt securities not inconsistent with the provisions of the indentures, as amended or supplemented; |
|
● |
to whom any interest on any debt security shall be payable, if other than the person in whose name the security is registered, on the record date for such interest, the extent to which, or the manner in which, any interest payable on a temporary global debt security will be paid if other than in the manner provided in the applicable indenture; |
|
● |
if the principal of or any premium or interest on any debt securities of the series is to be payable in one or more currencies or currency units other than as stated, the currency, currencies or currency units in which it shall be paid and the periods within and terms and conditions upon which such election is to be made and the amounts payable (or the manner in which such amount shall be determined); |
|
● |
the portion of the principal amount of any securities of the series which shall be payable upon declaration of acceleration of the maturity of the debt securities pursuant to the applicable indenture if other than the entire principal amount; and |
|
● |
if the principal amount payable at the stated maturity of any debt security of the series will not be determinable as of any one or more dates prior to the stated maturity, the amount which shall be deemed to be the principal amount of such securities as of any such date for any purpose, including the principal amount thereof which shall be due and payable upon any maturity other than the stated maturity or which shall be deemed to be outstanding as of any date prior to the stated maturity (or, in any such case, the manner in which such amount deemed to be the principal amount shall be determined). |
Unless otherwise specified in the applicable prospectus
supplement, the debt securities will not be listed on any securities exchange and will be issued in fully-registered form without coupons.
Debt securities may be sold at a substantial discount
below their stated principal amount, bearing no interest or interest at a rate which at the time of issuance is below market rates. The
applicable prospectus supplement will describe the federal income tax consequences and special considerations applicable to any such debt
securities. The debt securities may also be issued as indexed securities or securities denominated in foreign currencies, currency units
or composite currencies, as described in more detail in the prospectus supplement relating to any of the particular debt securities. The
prospectus supplement relating to specific debt securities will also describe any special considerations and certain additional tax considerations
applicable to such debt securities.
Conversion of Debt Securities
The debt securities may entitle the holder to
purchase, in exchange for the extinguishment of debt, an amount of securities at a conversion price that will be stated in the debt securities.
If such debt securities are convertible, unless otherwise specified in a prospectus supplement, the debt securities will be convertible
at any time up to the close of business on the expiration date set forth in the terms of such debt securities. After the close of business
on the expiration date, the debt securities not converted will be paid in accordance with their terms.
Subordination
The prospectus supplement relating to any offering
of subordinated debt securities will describe the specific subordination provisions. However, unless otherwise noted in the prospectus
supplement, subordinated debt securities will be subordinate and junior in right of payment to any existing senior indebtedness.
Unless otherwise specified in the applicable prospectus
supplement, under the subordinated indenture, “senior indebtedness” means all amounts due on obligations in connection with
any of the following, whether outstanding at the date of execution of the subordinated indenture, or thereafter incurred or created:
|
● |
the principal of (and premium, if any) and interest due on our indebtedness for borrowed money and indebtedness evidenced by bonds, notes, debentures or similar instruments or letters of credit (or reimbursement agreements in respect thereof); |
|
● |
all of our capital lease obligations or attributable debt (as defined in the indentures) in respect of sale and leaseback transactions; |
|
● |
all obligations representing the balance deferred and unpaid of the purchase price of any property or services, which purchase price is due more than six months after the date of placing such property in service or taking delivery and title thereto, except any such balance that constitutes an accrued expense or trade payable or any similar obligation to trade creditors; |
|
● |
all of our obligations in respect of interest rate swap agreements (whether from fixed to floating or from floating to fixed), interest rate cap agreements and interest rate collar agreements; other agreements or arrangements designed to manage interest rates or interest rate risk; and other agreements or arrangements designed to protect against fluctuations in currency exchange rates or commodity prices; |
|
● |
all obligations of the types referred to above of other persons for the payment of which we are responsible or liable as obligor, guarantor or otherwise; and |
|
● |
all obligations of the types referred to above of other persons secured by any lien on any property or asset of ours (whether or not such obligation is assumed by us). |
However, senior indebtedness does not include:
|
● |
any indebtedness which expressly provides that such indebtedness shall not be senior in right of payment to the subordinated debt securities, or that such indebtedness shall be subordinated to any other of our indebtedness, unless such indebtedness expressly provides that such indebtedness shall be senior in right of payment to the subordinated debt securities; |
|
● |
any of our obligations to our subsidiaries or of a subsidiary guarantor to us or any other of our other subsidiaries; |
|
● |
any liability for federal, state, local or other taxes owed or owing by us or any subsidiary guarantor, |
|
● |
any accounts payable or other liability to trade creditors arising in the ordinary course of business (including guarantees thereof or instruments evidencing such liabilities); |
|
● |
any obligations with respect to any capital stock; |
|
● |
any indebtedness incurred in violation of the indenture, provided that indebtedness under our credit facilities will not cease to be senior indebtedness under this bullet point if the lenders of such indebtedness obtained an officer’s certificate as of the date of incurrence of such indebtedness to the effect that such indebtedness was permitted to be incurred by the indenture; and |
|
● |
any of our indebtedness in respect of the subordinated debt securities. |
Senior indebtedness shall continue to be senior
indebtedness and be entitled to the benefits of the subordination provisions irrespective of any amendment, modification or waiver of
any term of such senior indebtedness.
Unless otherwise noted in an accompanying prospectus
supplement, if we default in the payment of any principal of (or premium, if any) or interest on any senior indebtedness when it becomes
due and payable, whether at maturity or at a date fixed for prepayment or by declaration or otherwise, then, unless and until such default
is cured or waived or ceases to exist, we will make no direct or indirect payment (in cash, property, securities, by set-off or otherwise)
in respect of the principal of or interest on the subordinated debt securities or in respect of any redemption, retirement, purchase or
other requisition of any of the subordinated debt securities.
In the event of the acceleration of the maturity
of any subordinated debt securities, the holders of all senior debt securities outstanding at the time of such acceleration, subject to
any security interest, will first be entitled to receive payment in full of all amounts due on the senior debt securities before the holders
of the subordinated debt securities will be entitled to receive any payment of principal (and premium, if any) or interest on the subordinated
debt securities.
If any of the following events occurs, we will
pay in full all senior indebtedness before we make any payment or distribution under the subordinated debt securities, whether in cash,
securities or other property, to any holder of subordinated debt securities:
|
● |
any dissolution or winding-up or liquidation or reorganization of Lichen China Limited, whether voluntary or involuntary or in bankruptcy, |
|
● |
insolvency or receivership; |
|
● |
any general assignment by us for the benefit of creditors; or |
|
● |
any other marshaling of our assets or liabilities. |
In such event, any payment or distribution under
the subordinated debt securities, whether in cash, securities or other property, which would otherwise (but for the subordination provisions)
be payable or deliverable in respect of the subordinated debt securities, will be paid or delivered directly to the holders of senior
indebtedness in accordance with the priorities then existing among such holders until all senior indebtedness has been paid in full. If
any payment or distribution under the subordinated debt securities is received by the trustee of any subordinated debt securities in contravention
of any of the terms of the subordinated indenture and before all the senior indebtedness has been paid in full, such payment or distribution
will be received in trust for the benefit of, and paid over or delivered and transferred to, the holders of the senior indebtedness at
the time outstanding in accordance with the priorities then existing among such holders for application to the payment of all senior indebtedness
remaining unpaid to the extent necessary to pay all such senior indebtedness in full.
The subordinated indenture does not limit the
issuance of additional senior indebtedness.
Events of Default, Notice and Waiver
Unless an accompanying prospectus supplement states
otherwise, the following shall constitute “events of default” under the indentures with respect to each series of debt securities:
|
● |
we default for 30 consecutive days in the payment when due of interest on the debt securities; |
|
● |
we default in the payment when due (at maturity, upon redemption or otherwise) of the principal of, or premium, if any, on the debt securities; |
|
● |
our failure to observe or perform any other of our covenants or agreements with respect to such debt securities for 60 days after we receive notice of such failure; |
|
● |
certain events of bankruptcy, insolvency or reorganization Lichen China Limited; or |
|
● |
any other event of default provided with respect to securities of that series. |
Unless an accompanying prospectus supplement states
otherwise, if an event of default with respect to any debt securities of any series outstanding under either of the indentures shall occur
and be continuing, the trustee under such indenture or the holders of at least 25% (or at least 10%, in respect of a remedy (other than
acceleration) for certain events of default relating to the payment of dividends) in aggregate principal amount of the debt securities
of that series outstanding may declare, by notice as provided in the applicable indenture, the principal amount (or such lesser amount
as may be provided for in the debt securities of that series) of all the debt securities of that series outstanding to be due and payable
immediately; provided that, in the case of an event of default involving certain events in bankruptcy, insolvency or reorganization, acceleration
is automatic; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders
of a majority in aggregate principal amount of the outstanding debt securities of that series may, under certain circumstances, rescind
and annul such acceleration if all events of default, other than the nonpayment of accelerated principal, have been cured or waived. Upon
the acceleration of the maturity of original issue discount securities, an amount less than the principal amount thereof will become due
and payable. Reference is made to the prospectus supplement relating to any original issue discount securities for the particular provisions
relating to acceleration of maturity thereof.
Any past default under either indenture with respect
to debt securities of any series, and any event of default arising therefrom, may be waived by the holders of a majority in principal
amount of all debt securities of such series outstanding under such indenture, except in the case of (1) default in the payment of the
principal of (or premium, if any) or interest on any debt securities of such series or (2) certain events of default relating to the payment
of dividends.
The trustee is required within 90 days after the
occurrence of a default (which is known to the trustee and is continuing), with respect to the debt securities of any series (without
regard to any grace period or notice requirements), to give to the holders of the debt securities of such series notice of such default.
The trustee, subject to its duties during default
to act with the required standard of care, may require indemnification by the holders of the debt securities of any series with respect
to which a default has occurred before proceeding to exercise any right or power under the indentures at the request of the holders of
the debt securities of such series. Subject to such right of indemnification and to certain other limitations, the holders of a majority
in principal amount of the outstanding debt securities of any series under either indenture may direct the time, method and place of conducting
any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee with respect to the
debt securities of such series, provided that such direction shall not be in conflict with any rule of law or with the applicable indenture
and the trustee may take any other action deemed proper by the trustee which is not inconsistent with such direction.
No holder of a debt security of any series may
institute any action against us under either of the indentures (except actions for payment of overdue principal of (and premium, if any)
or interest on such debt security or for the conversion or exchange of such debt security in accordance with its terms) unless (1) the
holder has given to the trustee written notice of an event of default and of the continuance thereof with respect to the debt securities
of such series specifying an event of default, as required under the applicable indenture, (2) the holders of at least 25% in aggregate
principal amount of the debt securities of that series then outstanding under such indenture shall have requested the trustee to institute
such action and offered to the trustee indemnity reasonably satisfactory to it against the costs, expenses and liabilities to be incurred
in compliance with such request; (3) the trustee shall not have instituted such action within 60 days of such request and (4) no direction
inconsistent with such written request has been given to the trustee during such 60-day period by the holders of a majority in principal
amount of the debt securities of that series. We are required to furnish annually to the trustee statements as to our compliance with
all conditions and covenants under each indenture.
Discharge, Defeasance and Covenant Defeasance
We may discharge or defease our obligations under
the indenture as set forth below, unless otherwise indicated in the applicable prospectus supplement.
We may discharge certain obligations to holders
of any series of debt securities issued under either the senior indenture or the subordinated indenture which have not already been delivered
to the trustee for cancellation by irrevocably depositing with the trustee money in an amount sufficient to pay and discharge the entire
indebtedness on such debt securities not previously delivered to the trustee for cancellation, for principal and any premium and interest
to the date of such deposit (in the case of debt securities which have become due and payable) or to the stated maturity or redemption
date, as the case may be, and we or, if applicable, any guarantor, have paid all other sums payable under the applicable indenture.
If indicated in the applicable prospectus supplement,
we may elect either (1) to defease and be discharged from any and all obligations with respect to the debt securities of or within any
series (except in all cases as otherwise provided in the relevant indenture) (“legal defeasance”) or (2) to be released from
our obligations with respect to certain covenants applicable to the debt securities of or within any series (“covenant defeasance”),
upon the deposit with the relevant indenture trustee, in trust for such purpose, of money and/or government obligations which through
the payment of principal and interest in accordance with their terms will provide money in an amount sufficient to pay the principal of
(and premium, if any) or interest on such debt securities to maturity or redemption, as the case may be, and any mandatory sinking fund
or analogous payments thereon. As a condition to legal defeasance or covenant defeasance, we must deliver to the trustee an opinion of
counsel to the effect that the holders of such debt securities will not recognize income, gain or loss for federal income tax purposes
as a result of such legal defeasance or covenant defeasance and will be subject to federal income tax on the same amounts and in the same
manner and at the same times as would have been the case if such legal defeasance or covenant defeasance had not occurred. Such opinion
of counsel, in the case of legal defeasance under clause (i) above, must refer to and be based upon a ruling of the Internal Revenue Service
or a change in applicable federal income tax law occurring after the date of the relevant indenture. In addition, in the case of either
legal defeasance or covenant defeasance, we shall have delivered to the trustee (1) if applicable, an officer’s certificate to the
effect that the relevant debt securities exchange(s) have informed us that neither such debt securities nor any other debt securities
of the same series, if then listed on any securities exchange, will be delisted as a result of such deposit and (2) an officer’s
certificate and an opinion of counsel, each stating that all conditions precedent with respect to such legal defeasance or covenant defeasance
have been complied with.
We may exercise our defeasance option with respect
to such debt securities notwithstanding our prior exercise of our covenant defeasance option.
Modification and Waiver
Under the indentures, unless an accompanying prospectus
supplement states otherwise, we and the applicable trustee may supplement the indentures for certain purposes which would not materially
adversely affect the interests or rights of the holders of debt securities of a series without the consent of those holders. We and the
applicable trustee may also modify the indentures or any supplemental indenture in a manner that affects the interests or rights of the
holders of debt securities with the consent of the holders of at least a majority in aggregate principal amount of the outstanding debt
securities of each affected series issued under the indenture. However, the indentures require the consent of each holder of debt securities
that would be affected by any modification which would:
|
● |
reduce the principal amount of debt securities whose holders must consent to an amendment, supplement or waiver; |
|
● |
reduce the principal of or change the fixed maturity of any debt security or, except as provided in any prospectus supplement, alter or waive any of the provisions with respect to the redemption of the debt securities; |
|
● |
reduce the rate of or change the time for payment of interest, including default interest, on any debt security; |
|
● |
waive a default or event of default in the payment of principal of or interest or premium, if any, on, the debt securities (except a rescission of acceleration of the debt securities by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities and a waiver of the payment default that resulted from such acceleration); |
|
● |
make any debt security payable in money other than that stated in the debt securities; |
|
● |
make any change in the provisions of the applicable indenture relating to waivers of past defaults or the rights of holders of the debt securities to receive payments of principal of, or interest or premium, if any, on, the debt securities; |
|
● |
waive a redemption payment with respect to any debt security (except as otherwise provided in the applicable prospectus supplement); |
|
● |
except in connection with an offer by us to purchase all debt securities, (1) waive certain events of default relating to the payment of dividends or (2) amend certain covenants relating to the payment of dividends and the purchase or redemption of certain equity interests; |
|
● |
make any change to the subordination or ranking provisions of the indenture or the related definitions that adversely affect the rights of any holder; or |
|
● |
make any change in the preceding amendment and waiver provisions. |
The indentures permit the holders of at least
a majority in aggregate principal amount of the outstanding debt securities of any series issued under the indenture which is affected
by the modification or amendment to waive our compliance with certain covenants contained in the indentures.
Payment and Paying Agents
Unless otherwise indicated in the applicable prospectus
supplement, payment of interest on a debt security on any interest payment date will be made to the person in whose name a debt security
is registered at the close of business on the record date for the interest.
Unless otherwise indicated in the applicable prospectus
supplement, principal, interest and premium on the debt securities of a particular series will be payable at the office of such paying
agent or paying agents as we may designate for such purpose from time to time. Notwithstanding the foregoing, at our option, payment of
any interest may be made by check mailed to the address of the person entitled thereto as such address appears in the security register.
Unless otherwise indicated in the applicable prospectus
supplement, a paying agent designated by us will act as paying agent for payments with respect to debt securities of each series. All
paying agents initially designated by us for the debt securities of a particular series will be named in the applicable prospectus supplement.
We may at any time designate additional paying agents or rescind the designation of any paying agent or approve a change in the office
through which any paying agent acts, except that we will be required to maintain a paying agent in each place of payment for the debt
securities of a particular series.
All moneys paid by us to a paying agent for the
payment of the principal, interest or premium on any debt security which remain unclaimed at the end of two years after such principal,
interest or premium has become due and payable will be repaid to us upon request, and the holder of such debt security thereafter may
look only to us for payment thereof.
Denominations, Registrations and Transfer
Unless an accompanying prospectus supplement states
otherwise, debt securities will be represented by one or more global certificates registered in the name of a nominee for The Depository
Trust Company, or DTC. In such case, each holder’s beneficial interest in the global securities will be shown on the records of
DTC and transfers of beneficial interests will only be effected through DTC’s records.
A holder of debt securities may only exchange
a beneficial interest in a global security for certificated securities registered in the holder’s name if:
|
● |
we deliver to the trustee notice from DTC that it is unwilling or unable to continue to act as depository or that it is no longer a clearing agency registered under the Exchange Act and, in either case, a successor depositary is not appointed by us within 120 days after the date of such notice from DTC; |
|
● |
we in our sole discretion determine that the debt securities (in whole but not in part) should be exchanged for definitive debt securities and deliver a written notice to such effect to the trustee; or |
|
● |
there has occurred and is continuing a default or event of default with respect to the debt securities. |
If debt securities are issued in certificated
form, they will only be issued in the minimum denomination specified in the accompanying prospectus supplement and integral multiples
of such denomination. Transfers and exchanges of such debt securities will only be permitted in such minimum denomination. Transfers of
debt securities in certificated form may be registered at the trustee’s corporate office or at the offices of any paying agent or
trustee appointed by us under the indentures. Exchanges of debt securities for an equal aggregate principal amount of debt securities
in different denominations may also be made at such locations.
Governing Law
The indentures and debt securities will be governed
by, and construed in accordance with, the laws of the State of New York, without regard to its principles of conflicts of laws, except
to the extent the Trust Indenture Act is applicable or as otherwise agreed to by the parties thereto.
Trustee
The trustee or trustees under the indentures will
be named in any applicable prospectus supplement.
Conversion or Exchange Rights
The prospectus supplement will describe the terms,
if any, on which a series of debt securities may be convertible into or exchangeable for our ordinary shares or other debt securities.
These terms will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. These
provisions may allow or require the number of shares of our ordinary shares or other securities to be received by the holders of such
series of debt securities to be adjusted. Any such conversion or exchange will comply with applicable Cayman Islands law and our amended
and restated memorandum and articles of association.
DESCRIPTION OF UNITS
We may issue units comprising one or more of the
other securities described in this prospectus in any combination. Each unit will be issued so that the holder of the unit is also the
holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included
security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred
separately, at any time or at any time before a specified date or occurrence.
The applicable prospectus supplement may describe:
|
● |
the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; |
|
● |
any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and |
|
● |
whether the units will be issued in fully registered or global form. |
The applicable prospectus supplement will describe
the terms of any units. The preceding description and any description of units in the applicable prospectus supplement does not purport
to be complete and is subject to and is qualified in its entirety by reference to the unit agreement and, if applicable, collateral arrangements
and depository arrangements relating to such units.
DESCRIPTION OF SHARE PURCHASE CONTRACTS AND
SHARE PURCHASE UNITS
We may issue share purchase contracts, including
contracts obligating holders to purchase from us, and obligating us to sell to the holders, a specified number of ordinary shares or other
securities registered hereunder at a future date or dates, which we refer to in this prospectus as “share purchase contracts.”
The price per share of the securities and the number of shares of the securities may be fixed at the time the share purchase contracts
are issued or may be determined by reference to a specific formula set forth in the share purchase contracts.
The share purchase contracts may be issued separately
or as part of units consisting of a share purchase contract and debt securities, warrants, other securities registered hereunder, which
we refer to herein as “share purchase units.” The share purchase contracts may require holders to secure their obligations
under the share purchase contracts in a specified manner. The share purchase contracts also may require us to make periodic payments to
the holders of the share purchase units or vice versa, and those payments may be unsecured or refunded on some basis.
The share purchase contracts, and, if applicable,
collateral or depositary arrangements, relating to the share purchase contracts or share purchase units, will be filed with the SEC in
connection with the offering of share purchase contracts or share purchase units. The prospectus supplement relating to a particular issue
of share purchase contracts or share purchase units will describe the terms of those share purchase contracts or share purchase units,
including the following:
|
● |
if applicable, a discussion of material tax considerations; and |
|
● |
any other information we think is important about the share purchase contracts or the share purchase units. |
DESCRIPTION OF RIGHTS
We may issue rights to purchase ordinary shares
that we may offer to our securityholders. The rights may or may not be transferable by the persons purchasing or receiving the rights.
In connection with any rights offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or
other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after
such rights offering. Each series of rights will be issued under a separate rights agent agreement to be entered into between us and a
bank or trust company, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act solely as
our agent in connection with the rights and will not assume any obligation or relationship of agency or trust for or with any holders
of rights certificates or beneficial owners of rights.
The prospectus supplement relating to any rights
that we offer will include specific terms relating to the offering, including, among other matters:
|
● |
the date of determining the securityholders entitled to the rights distribution; |
|
● |
the aggregate number of rights issued and the aggregate number of ordinary shares purchasable upon exercise of the rights; |
|
● |
the conditions to completion of the rights offering; |
|
● |
the date on which the right to exercise the rights will commence and the date on which the rights will expire; and |
|
● |
applicable tax considerations. |
Each right would entitle the holder of the rights
to purchase for cash the principal amount of debt securities or ordinary shares at the exercise price set forth in the applicable prospectus
supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable
prospectus supplement. After the close of business on the expiration date, all unexercised rights will become void.
If less than all of the rights issued in any rights
offering are exercised, we may offer any unsubscribed securities directly to persons other than our security holders, to or through agents,
underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable
prospectus supplement.
PLAN OF DISTRIBUTION
We may sell the securities described in this prospectus
through underwriters or dealers, through agents, directly to one or more purchasers, “at-the-market” offerings, negotiated
transactions, block trades or through a combination of these methods. The applicable prospectus supplement will describe the terms
of the offering of the securities, including:
|
● |
the name or names of any underwriters, if any, and if required, any dealers or agents, and the amount of securities underwritten or purchased by each of them, if any; |
|
● |
the public offering price or purchase price of the securities from us and the net proceeds to us from the sale of the securities; |
|
● |
any underwriting discounts and other items constituting underwriters’ compensation; |
|
● |
any discounts or concessions allowed or re-allowed or paid to dealers; and |
|
● |
any securities exchange or market on which the securities may be listed. |
We may distribute the securities from time to
time in one or more transactions at:
|
● |
a fixed price or prices, which may be changed; |
|
● |
market prices prevailing at the time of sale; |
|
● |
varying prices determined at the time of sale related to such prevailing market prices; or |
Only underwriters named in the prospectus supplement
will be underwriters of the securities offered by the prospectus supplement.
If we use underwriters in the sale, the underwriters
will either acquire the securities for their own account and may resell the securities from time to time in one or more transactions at
a fixed public offering price or at varying prices determined at the time of sale, or sell the Shares on a “best efforts, minimum/maximum
basis” when the underwriters agree to do their best to sell the securities to the public. We may offer the securities to the public
through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Any public offering price
and any discounts or concessions allowed or re-allowed or paid to dealers may change from time to time.
If we use a dealer in the sale of the securities
being offered pursuant to this prospectus or any prospectus supplement, the securities will be sold directly to the dealer, as principal.
The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.
Our ordinary shares are listed on the Nasdaq Capital
Market. Unless otherwise specified in the related prospectus supplement, all securities we offer, other than ordinary shares, will be
new issues of securities with no established trading market. Any underwriter may make a market in these securities, but will not be obligated
to do so and may discontinue any market making at any time without notice. We may apply to list any series of warrants or other securities
that we offer on an exchange, but we are not obligated to do so. Therefore, there may not be liquidity or a trading market for any series
of securities.
We may sell the securities directly or through
agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any
commissions we may pay the agent in the applicable prospectus supplement.
We may authorize agents or underwriters to solicit
offers by institutional investors to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant
to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to
these contracts and the commissions we must pay for solicitation of these contracts in the applicable prospectus supplement.
In connection with the sale of the securities,
underwriters, dealers or agents may receive compensation from us or from purchasers of the securities for whom they act as agents in the
form of discounts, concessions or commissions. Underwriters may sell the securities to or through dealers, and those dealers may receive
compensation in the form of discounts, concessions or commissions from the underwriters or commissions from the purchasers for whom they
may act as agents. Underwriters, dealers and agents that participate in the distribution of the securities, and any institutional investors
or others that purchase securities directly and then resell the securities, may be deemed to be underwriters, and any discounts or commissions
received by them from us and any profit on the resale of the securities by them may be deemed to be underwriting discounts and commissions
under the Securities Act.
TAXATION
Cayman Islands Taxation
The Cayman Islands government currently imposes
no taxes on companies or individuals relating to profits, income or dividends, capital gains, death or succession. There are no other
taxes likely to be material to us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments
executed in, or after execution brought within the jurisdiction of the Cayman Islands. The Cayman Islands is a party to a double tax arrangement
entered with the United Kingdom in 2010, but otherwise is not party to any double tax treaties that are applicable to any payments made
to or by our company. There are no exchange control regulations or currency restrictions in the Cayman Islands.
As an exempted company incorporated in the Cayman
Islands, the Company is required to pay an annual government fee (“Government Fee”), which is determined on a sliding scale
by reference to the level of its authorized share capital. The Government Fee is payable at the end of January in every year and is based
on the level of the authorized share capital at the time when the fee is due.
Payments of dividends and capital in respect of
our Class A Ordinary Shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of
a dividend or capital to any holder of our Class A Ordinary Shares, nor will gains derived from the disposal of our Class A Ordinary Shares
be subject to Cayman Islands income or corporation tax.
No stamp duty is payable in the Cayman Islands in respect of the issue
of the shares or on an instrument of transfer in respect of a share of a Cayman company, except those which hold interests in land in
the Cayman Islands and that stamp duty will be payable on an instrument of transfer if it is executed in or brought to the Cayman Islands,
or produced before a Cayman Islands court.
United States Federal Income Tax Considerations
Information regarding United States Federal Income
Tax Considerations is set forth under the heading “10.E. Taxation - United States Federal Income Tax Considerations” in our
most recent annual report on Form 20-F, which is incorporated in this prospectus by reference, as updated by our subsequent filings under
the Exchange Act.
EXPENSES
The following table sets forth the estimated costs
and expenses, other than underwriting discounts and commissions, payable by us in connection with the offering of the securities being
registered. All the amounts shown are estimates, except for the SEC registration fee.
SEC registration fee | |
$ | 14,760 | |
Financial Industry Regulatory Authority fee | |
$ | * | |
Legal fees and expenses | |
$ | * | |
Accounting fees and expenses | |
$ | * | |
Miscellaneous | |
$ | * | |
Total | |
$ | * | |
* |
To be provided by a prospectus supplement or as an exhibit to a report of foreign private issuer on Form 6-K that is incorporated by reference into this registration statement. Estimated solely for this item. Actual expenses may vary. |
MATERIAL CONTRACTS
Our material contracts are described in the documents
incorporated by reference into this prospectus. See “Incorporation of Documents by Reference” below.
MATERIAL CHANGES
Except as otherwise described in our most recent
annual report on Form 20-F, in our Reports on Form 6-K furnished under the Exchange Act and incorporated by reference herein and as disclosed
in this prospectus, no reportable material changes have occurred since June 30, 2023.
LEGAL MATTERS
We are being represented by Ortoli Rosenstadt
LLP with respect to certain legal matters as to United States federal securities and New York State law. The legality and validity
of the securities offered from time to time under this prospectus under the laws of the Cayman Islands was passed upon by Appleby. Ortoli
Rosenstadt LLP may rely upon Appleby with respect to
matters governed by Cayman Islands law.
If legal
matters in connection with offerings made pursuant to this prospectus are passed upon by counsel to underwriters, dealers, or agents,
such counsel will be named in the applicable prospectus supplement relating to any such offering.
EXPERTS
The consolidated financial statements for the
years ended December 31, 2022 and 2021, incorporated by reference in this prospectus have been so included in reliance on the report of
TPS Thayer, an independent registered public accounting firm, given on their authority as experts in accounting and auditing. The office
of TPS Thayer is located at 1600 Hwy 6 Suite 100, Sugar Land, TX 77478. The consolidated financial statements of the Company for the year
ended December 31, 2020, as incorporated by reference herein and elsewhere in the registration statement have been so included in reliance
on the report of Briggs & Veselka Co., an independent registered public accounting firm, given on their authority as experts in accounting
and auditing. The office of Briggs & Veselka Co. is located at 9 Greenway Plaza #1700, Houston, TX 77046.
INTERESTS OF EXPERTS AND COUNSEL
No named expert of or counselor to us was employed
on a contingent basis, or owns an amount of our shares (or those of our subsidiaries) which is material to that person, or has a material,
direct or indirect economic interest in us or that depends on the success of the offering.
ENFORCEABILITY OF CIVIL LIABILITIES
We are incorporated under the laws of the Cayman
Islands as an exempted company with limited liability. We are incorporated in the Cayman Islands because of certain benefits associated
with being a Cayman Islands entity, such as political and economic stability, an effective judicial system, a favorable tax system, the
absence of exchange control or currency restrictions and the availability of professional and support services. However, the Cayman Islands
has a less developed body of securities laws as compared to the United States and provides protections for investors to a lesser extent.
In addition, Cayman Islands companies may not have standing to sue before the federal courts of the United States.
Substantially all of our assets are located outside
the United States. In addition, a majority of our directors and officers are nationals and/or residents of countries other than the United
States, and all or a substantial portion of such persons’ assets are located outside the United States. As a result, it may be difficult
for investors to effect service of process within the United States upon these persons or to enforce against us or them, judgments obtained
in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States
or any state thereof.
Lichen China Limited has appointed Cogency Global
Inc. as the agent to receive service of process with respect to any action brought against us under the securities laws of the United
States. Cogency Global Inc. will be engaged by the officers and directors who are residents
of a foreign country to accept service for any action under the civil liability provisions of the U.S. federal securities
laws against such officers and directors.
We have been advised by our counsel as to Cayman
Islands law that there is uncertainty as to whether the courts of the Cayman Islands would (1) recognize or enforce judgments of United
States courts obtained against the Company or its directors or officers predicated upon the civil liability provisions of the securities
laws of the United States or any state in the United States, or (2) entertain original actions brought in the Cayman Islands against the
Company or its directors or officers predicated upon the securities laws of the United States or any state in the United States. Furthermore,
our counsel as to Cayman Islands law has advised us that, as of the date of this prospectus, no treaty or other form of reciprocity exists
between the Cayman Islands and United States governing the recognition and enforcement of judgments.
Our counsel as to Cayman Islands law has informed
us that the uncertainty with regard to Cayman Islands law relates to whether a judgment obtained from the United States courts under civil
liability provisions of the securities laws will be determined by the courts of the Cayman Islands as penal or punitive in nature. If
such a determination is made, the courts of the Cayman Islands will not recognize or enforce the judgment against a Cayman company. As
the courts of the Cayman Islands have yet to rule on whether such judgments are penal or punitive in nature, it is uncertain whether they
would be enforceable in the Cayman Islands.
Our counsel as to Cayman Islands law has further advised us that although
there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, a judgment obtained in the United
States will be recognized and enforced in the courts of the Cayman Islands at common law, without any re-examination of the merits of
the underlying dispute, by an action commenced on the foreign judgment debt in the Grand Court of the Cayman Islands, provided such judgment
(1) is given by a foreign court of competent jurisdiction, (2) imposes on the judgment debtor a liability to pay a liquidated sum for
which the judgment has been given, (3) is final, (4) is not in respect of taxes, a fine or a penalty and (5) was not obtained in a manner
and is not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands.
INCORPORATION OF DOCUMENTS BY REFERENCE
The SEC allows us to “incorporate by reference”
into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring
you to these documents. The information that we incorporate by reference into this prospectus forms a part of this prospectus. When we
update the information contained in documents that have been incorporated by reference by making future filings with the SEC, the information
incorporated by reference in this prospectus is considered to be automatically updated and superseded. In other words, in the case of
a conflict or inconsistency between information contained in this prospectus and information incorporated by reference into this prospectus,
you should rely on the information contained in the document that was filed later.
We incorporate by reference into this prospectus
the documents listed below:
|
● |
our
Annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on May 1, 2023; |
|
|
|
|
● |
our
report of foreign private issuer on Form 6-K, furnished to the SEC on October 13, 2023 and February 6, 2024; |
|
|
|
|
● |
the
description of our Class A ordinary shares contained in our registration statement on Form 8-A, filed with the SEC on September
7, 2022, and any amendment or report filed for the purpose of updating such description; |
|
|
|
|
● |
any
future annual reports on Form 20-F filed with the SEC after the date of this prospectus and prior to the termination of the offering
of the securities offered by this prospectus; and |
|
|
|
|
● |
any
future reports of foreign private issuer on Form 6-K that we furnish to the SEC after the date of this prospectus that are identified
in such reports as being incorporated by reference into the registration statement of which this prospectus forms a part. |
Any statement contained in a document that is
incorporated by reference into this prospectus will be deemed to be modified or superseded for the purposes of this prospectus to the
extent that a statement contained in this prospectus, or in any other subsequently filed document which also is or is deemed to be incorporated
by reference into this prospectus, modifies or supersedes that statement. The modifying or superseding statement does not need to state
that it has modified or superseded a prior statement or include any other information set forth in the document that it modifies or supersedes.
Unless expressly incorporated by reference, nothing
in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC. Copies of all documents
incorporated by reference in this prospectus, other than exhibits to those document unless such exhibits are specially incorporated by
reference in this prospectus, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this
prospectus on the written or oral request of that person made to:
15th Floor, Xingang Square, Hubin North Road,
Siming District, Xiamen City,
Fujian Province, China, 361013
+86-592-5586999
You should rely only on the information that we
incorporate by reference or provide in this prospectus. We have not authorized anyone to provide you with different information. We are
not making any offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that
the information contained or incorporated in this prospectus by reference is accurate as of any date other than the date of the document
containing the information.
WHERE YOU CAN FIND ADDITIONAL INFORMATION
As permitted by SEC rules, this prospectus omits
certain information and exhibits that are included in the registration statement of which this prospectus forms a part. Since this prospectus
may not contain all of the information that you may find important, you should review the full text of these documents. If we have filed
a contract, agreement, or other document as an exhibit to the registration statement of which this prospectus forms a part, you should
read the exhibit for a more complete understanding of the document or matter involved. Each statement in this prospectus, including statements
incorporated by reference as discussed above, regarding a contract, agreement, or other document is qualified in its entirety by reference
to the actual document.
We are subject to periodic reporting and other
informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file
reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC can be inspected
over the Internet at the SEC’s website at www.sec.gov and copied at the public reference facilities maintained by the SEC at 100
F Street, N.E., Washington, D.C. 20549. You can request copies of these documents, upon payment of a duplicating fee, by writing to the
SEC.
As a foreign private issuer, we are exempt under
the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our executive
officers, directors, and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in
Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic or current reports
and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange
Act.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 8. Indemnification of Directors and Officers
Cayman Islands law does not limit the extent to
which a company’s amended and restated memorandum and articles of association may provide for indemnification of officers and directors,
except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association provide
for indemnification of officers and directors for losses, damages, costs and expenses incurred in their capacities as such unless such
losses or damages arise from their own willful neglect or default.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have
been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is
therefore unenforceable as a matter of United States law.
Any underwriting agreement entered into in connection
with an offering of securities will also provide for indemnification of us and our officers and directors in certain cases.
Item 9. Exhibits
The following exhibits are attached hereto:
+ |
Filed herewith |
|
|
* |
To be filed, if necessary, after effectiveness of this registration statement by an amendment to the registration statement or incorporated by reference to a Current Report on Form 6-K filed in connection with an underwritten offering of the shares offered hereunder. |
|
|
** |
To be filed in accordance with the requirements of Section 305(b)(2) of the Trust Indenture Act of 1939, as amended. |
Item 10. Undertakings
The undersigned Registrant hereby undertakes:
|
(1) |
To file, during any period in which offers or sales of securities are being made, a post-effective amendment to this registration statement: |
|
(i) |
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
|
(ii) |
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
|
(iii) |
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
|
(2) |
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
(3) |
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
|
(4) |
To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the Registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Rule 3-19 of Regulation S-X if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3. |
|
(5) |
That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
|
(i) |
If the registrant is relying on Rule 430B: |
|
(a) |
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
|
(b) |
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or |
|
(ii) |
If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
|
(6) |
That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
|
(i) |
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
|
(ii) |
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
|
(iii) |
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
|
(iv) |
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
|
(b) |
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
|
(h) |
If any provision or arrangement exists whereby the Registrant may indemnify a director, officer or controlling person of the registrant against liabilities arising under the Securities Act, or the underwriting agreement contains a provision whereby the Registrant indemnifies the underwriter or controlling persons of the underwriter against such liabilities and a director, officer or controlling person of the registrant is such an underwriter or controlling person thereof or a member of any firm which is such an underwriter, and the benefits of such indemnification are not waived by such persons, insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. |
|
(i) |
Not applicable. |
|
|
|
|
(j) |
The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act (“Act”) in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act. |
|
|
|
|
(k) |
Not applicable. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Xiamen City, People’s Republic
of China, on February 21, 2024.
|
Lichen China Limited |
|
|
|
|
By: |
/s/ Ya Li |
|
|
Ya Li |
|
|
Chief Executive Officer and
Chairman of the Board |
Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Capacity |
|
Date |
|
|
|
|
|
/s/ Ya Li |
|
Chief Executive Officer and Chairman of the Board |
|
February 21, 2024 |
Ya Li |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Zhixiang Fang |
|
Chief Financial Officer |
|
February 21, 2024 |
Zhixiang Fang |
|
(Principal Financial Officer) |
|
|
|
|
|
|
|
/s/ Yi Deng |
|
Director |
|
February 21, 2024 |
Yi Deng |
|
|
|
|
|
|
|
|
|
/s/ Zhihuang Deng |
|
Director |
|
February 21, 2024 |
Zhihuang Deng |
|
|
|
|
|
|
|
|
|
/s/ Lourdes Felix |
|
Director |
|
February 21, 2024 |
Lourdes Felix |
|
|
|
|
|
|
|
|
|
/s/ Kipton Cariaga |
|
Director |
|
February 21, 2024 |
Kipton Cariaga |
|
|
|
|
SIGNATURE OF AUTHORIZED UNITED STATES REPRESENTATIVE
OF THE REGISTRANT
Pursuant to the requirements of the Securities
Act of 1933, the Registrant’s duly authorized representative has signed this registration statement on Form F-3, in the City of
New York, New York, on February 21, 2024.
|
COGENCY GLOBAL INC. |
|
|
|
|
By: |
/s/ Colleen A. De Vries |
|
|
Name: |
Colleen A. De Vries |
|
|
Title: |
Senior Vice-President on behalf of Cogency Global Inc. |
II-5
Exhibit 4.2
Lichen China Limited
FORM OF
SENIOR INDENTURE
Dated as of [ ],
20[ ]
[ ]
Trustee
TABLE OF CONTENTS
|
|
PAGE |
ARTICLE I DEFINITIONS AND INCORPORATION
BY REFERENCE |
1 |
SECTION 1.01. |
Definitions. |
1 |
SECTION 1.02. |
Other Definitions. |
4 |
SECTION 1.03. |
Incorporation by Reference of Trust Indenture Act. |
4 |
SECTION 1.04. |
Rules of Construction. |
5 |
|
|
|
ARTICLE II THE
SECURITIES |
5 |
SECTION 2.01. |
Issuable in Series. |
5 |
SECTION 2.02. |
Establishment of Terms of Series of Securities. |
5 |
SECTION 2.03. |
Execution and Authentication. |
6 |
SECTION 2.04. |
Registrar and Paying Agent. |
7 |
SECTION 2.05. |
Paying Agent to Hold Money in Trust. |
8 |
SECTION 2.06. |
Securityholder Lists. |
8 |
SECTION 2.07. |
Transfer and Exchange. |
8 |
SECTION 2.08. |
Mutilated, Destroyed, Lost and Stolen Securities. |
8 |
SECTION 2.09. |
Outstanding Securities. |
9 |
SECTION 2.10. |
Treasury Securities. |
9 |
SECTION 2.11. |
Temporary Securities. |
9 |
SECTION 2.12. |
Cancellation. |
10 |
SECTION 2.13. |
Defaulted Interest. |
10 |
SECTION 2.14. |
Global Securities. |
10 |
SECTION 2.15. |
CUSIP Numbers. |
11 |
|
|
|
ARTICLE III REDEMPTION |
12 |
SECTION 3.01. |
Notice to Trustee. |
12 |
SECTION 3.02. |
Selection of Securities to be Redeemed. |
12 |
SECTION 3.03. |
Notice of Redemption. |
12 |
SECTION 3.04. |
Effect of Notice of Redemption. |
12 |
SECTION 3.05. |
Deposit of Redemption Price. |
13 |
SECTION 3.06. |
Securities Redeemed in Part. |
13 |
|
|
|
ARTICLE IV COVENANTS |
13 |
SECTION 4.01. |
Payment of Principal and Interest. |
13 |
SECTION 4.02. |
SEC Reports. |
13 |
SECTION 4.03. |
Compliance Certificate. |
14 |
SECTION 4.04. |
Stay, Extension and Usury Laws. |
14 |
SECTION 4.05. |
Corporate Existence. |
14 |
SECTION 4.06. |
Taxes. |
14 |
SECTION 4.07. |
Additional Interest Notice. |
14 |
SECTION 4.08. |
Further Instruments and Acts. |
15 |
|
|
|
ARTICLE V SUCCESSORS |
15 |
SECTION 5.01. |
When Company May Merge, Etc. |
15 |
SECTION 5.02. |
Successor Corporation Substituted. |
15 |
|
|
|
ARTICLE VI DEFAULTS AND REMEDIES |
15 |
SECTION 6.01. |
Events of Default. |
15 |
SECTION 6.02. |
Acceleration of Maturity; Rescission and Annulment. |
17 |
SECTION 6.03. |
Collection of Indebtedness and Suits for Enforcement by Trustee. |
17 |
SECTION 6.04. |
Trustee May File Proofs of Claim. |
18 |
SECTION 6.05. |
Trustee May Enforce Claims Without Possession of Securities. |
18 |
SECTION 6.06. |
Application of Money Collected. |
18 |
SECTION 6.07. |
Limitation on Suits. |
19 |
SECTION 6.08. |
Unconditional Right of Holders to Receive Principal and Interest. |
19 |
SECTION 6.09. |
Restoration of Rights and Remedies. |
19 |
SECTION 6.10. |
Rights and Remedies Cumulative. |
19 |
SECTION 6.11. |
Delay or Omission Not Waiver. |
19 |
SECTION 6.12. |
Control by Holders. |
20 |
SECTION 6.13. |
Waiver of Past Defaults. |
20 |
SECTION 6.14. |
Undertaking for Costs. |
20 |
|
|
|
ARTICLE VII TRUSTEE |
20 |
SECTION 7.01. |
Duties of Trustee. |
20 |
SECTION 7.02. |
Rights of Trustee. |
21 |
SECTION 7.03. |
Individual Rights of Trustee. |
22 |
SECTION 7.04. |
Trustee’s Disclaimer. |
22 |
SECTION 7.05. |
Notice of Defaults. |
22 |
SECTION 7.06. |
Reports by Trustee to Holders. |
22 |
SECTION 7.07. |
Compensation and Indemnity. |
22 |
SECTION 7.08. |
Replacement of Trustee. |
23 |
SECTION 7.09. |
Successor Trustee by Merger, etc. |
23 |
SECTION 7.10. |
Eligibility; Disqualification. |
24 |
SECTION 7.11. |
Preferential Collection of Claims Against Company. |
24 |
|
|
|
ARTICLE VIII SATISFACTION AND DISCHARGE; DEFEASANCE |
24 |
SECTION 8.01. |
Satisfaction and Discharge of Indenture. |
24 |
SECTION 8.02. |
Application of Trust Funds; Indemnification. |
25 |
SECTION 8.03. |
Legal Defeasance of Securities of any Series. |
25 |
SECTION 8.04. |
Covenant Defeasance. |
26 |
SECTION 8.05. |
Repayment to Company. |
27 |
|
|
|
ARTICLE IX AMENDMENTS AND WAIVERS |
27 |
SECTION 9.01. |
Without Consent of Holders. |
27 |
SECTION 9.02. |
With Consent of Holders. |
28 |
SECTION 9.03. |
Limitations. |
28 |
SECTION 9.04. |
Compliance with Trust Indenture Act. |
29 |
SECTION 9.05. |
Revocation and Effect of Consents. |
29 |
SECTION 9.06. |
Notation on or Exchange of Securities. |
29 |
SECTION 9.07. |
Trustee Protected. |
29 |
SECTION 9.08. |
Effect of Supplemental Indenture. |
29 |
|
|
|
ARTICLE X MISCELLANEOUS |
30 |
SECTION 10.01. |
Trust Indenture Act Controls. |
30 |
SECTION 10.02. |
Notices. |
30 |
SECTION 10.03. |
Communication by Holders with Other Holders. |
31 |
SECTION 10.04. |
Certificate and Opinion as to Conditions Precedent. |
31 |
SECTION 10.05. |
Statements Required in Certificate or Opinion. |
31 |
SECTION 10.06. |
Record Date for Vote or Consent of Holders. |
31 |
SECTION 10.07. |
Rules by Trustee and Agents. |
31 |
SECTION 10.08. |
Legal Holidays. |
32 |
SECTION 10.09. |
No Recourse Against Others. |
32 |
SECTION 10.10. |
Counterparts. |
32 |
SECTION 10.11. |
Governing Laws and Submission to Jurisdiction. |
32 |
SECTION 10.12. |
No Adverse Interpretation of Other Agreements. |
32 |
SECTION 10.13. |
Successors. |
32 |
SECTION 10.14. |
Severability. |
32 |
SECTION 10.15. |
Table of Contents, Headings, Etc. |
32 |
SECTION 10.16. |
Securities in a Foreign Currency or in ECU. |
33 |
SECTION 10.17. |
Judgment Currency. |
33 |
SECTION 10.18. |
Compliance with Applicable Anti-Terrorism and Money Laundering Regulations. |
33 |
|
|
|
ARTICLE XI SINKING FUNDS |
34 |
SECTION 11.01. |
Applicability of Article. |
34 |
SECTION 11.02. |
Satisfaction of Sinking Fund Payments with Securities. |
34 |
SECTION 11.03. |
Redemption of Securities for Sinking Fund. |
34 |
Reconciliation and tie between Trust Indenture
Act of 1939 and Indenture,
Dated as of [ ],
20[ ]
Section 310(a)(1) |
7.10 |
(a)(2) |
7.10 |
(a)(3) |
Not Applicable |
(a)(4) |
Not Applicable |
(a)(5) |
7.10 |
(b) |
7.10 |
(c) |
Not Applicable |
Section 311(a) |
7.11 |
(b) |
7.11 |
(c) |
Not Applicable |
Section 312(a) |
2.06 |
(b) |
10.03 |
(c) |
10.03 |
Section 313(a) |
7.06 |
(b)(1) |
7.06 |
(b)(2) |
7.06 |
(c)(1) |
7.06 |
(d) |
7.06 |
Section 314(a) |
4.02, 10.05 |
(b) |
Not Applicable |
(c)(1) |
10.04 |
(c)(2) |
10.04 |
(c)(3) |
Not Applicable |
(d) |
Not Applicable |
(e) |
10.05 |
(f) |
Not Applicable |
Section 315(a) |
7.01 |
(b) |
7.05 |
(c) |
7.01 |
(d) |
7.01 |
(e) |
6.14 |
Section 316(a)(1)(A) |
6.12 |
(a)(1)(B) |
6.13 |
(a)(2) |
Not Applicable |
(b) |
6.13 |
(c) |
10.06 |
Section 317(a)(1) |
6.03 |
(a)(2) |
6.04 |
(b) |
2.05 |
Section 318(a) |
10.01 |
Note: This reconciliation and tie shall not, for any purpose,
be deemed to be part of the Indenture.
Indenture dated as of [ ],
20[ ] between Lichen China Limited, a company organized under the laws of the Cayman Islands (the “Company”) and [
] (the “Trustee”).
Each party agrees as follows
for the benefit of the other party and for the equal and ratable benefit of the Holders of the Securities issued under this Indenture.
ARTICLE I
DEFINITIONS AND INCORPORATION BY REFERENCE
SECTION 1.01. Definitions.
“Additional Amounts”
means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid
by the Company in respect of certain taxes imposed on Holders specified therein and which are owing to such Holders.
“Affiliate”
of any specified person means any other person directly or indirectly controlling or controlled by or under direct or indirect common
control with such specified person. For the purposes of this definition, “control” (including, with correlative meanings,
the terms “controlled by” and “under common control with”), as used with respect to any person, shall mean the possession,
directly or indirectly, of the power to direct or cause the direction of the management or policies of such person, whether through the
ownership of voting securities or by agreement or otherwise.
“Agent” means
any Registrar or Paying Agent.
“Bankruptcy Law”
means Title 11 of the United States Code (or any successor thereto) or any similar federal or state law for the relief of debtors.
“Board of Directors”
means the board of directors of the Company or any duly authorized committee thereof.
“Board Resolution”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been adopted by the Board of
Directors or pursuant to authorization by the Board of Directors and to be in full force and effect on the date of the certificate and
delivered to the Trustee.
“Business Day”
means any day other than a (x) Saturday, (y) Sunday or (z) day on which state or federally chartered banking institutions in New York,
New York are not required to be open.
“Capital Stock”
of any Person means any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests
in (however designated) equity of such Person, but excluding any debt securities convertible into such equity.
“Certificated Securities”
means Securities in the form of physical, certificated Securities in registered form.
“Company”
means the party named as such above until a successor replaces it in accordance with the terms of this Indenture and thereafter means
the successor.
“Company Order”
means a written order signed in the name of the Company by two Officers, one of whom must be the Company’s principal executive officer,
principal financial officer or principal accounting officer.
“Company Request”
means a written request signed in the name of the Company by its Chairman of the Board, a President or a Vice President, and by its Chief
Financial Officer, its Secretary or an Assistant Secretary, and delivered to the Trustee.
“Corporate Trust Office”
means the office of the Trustee at which at any particular time its corporate trust business shall be principally administered which office
at the date of the execution of this Indenture is [ ], Attention: [ ], or at such other address as the Trustee may designate from time to
time.
“Custodian”
means any receiver, trustee, assignee, liquidator, sequestrator or similar official under any Bankruptcy Law.
“Default”
or “default” means any event which is, or after notice or passage of time or both would be, an Event of Default.
“Default Rate”
means the default rate of interest specified in the Securities.
“Depository”
means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities,
the person designated as Depository for such Series by the Company, which Depository shall be a clearing agency registered under the Exchange
Act; and if at any time there is more than one such person, “Depository” as used with respect to the Securities of any Series
shall mean the Depository with respect to the Securities of such Series.
“Discount Security”
means any Security that provides for an amount less than the stated principal amount thereof to be due and payable upon declaration of
acceleration of the maturity thereof pursuant to Section 6.02.
“Dollars”
means the currency of The United States of America.
“ECU” means
the European Currency Unit as determined by the Commission of the European Union.
“Exchange Act”
means the Securities Exchange Act of 1934, as amended.
“Foreign Currency”
means any currency or currency unit issued by a government other than the government of The United States of America.
“Foreign Government
Obligations” means with respect to Securities of any Series that are denominated in a Foreign Currency, (i) direct obligations
of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged
or (ii) obligations of a person controlled or supervised by or acting as an agency or instrumentality of such government the timely payment
of which is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i)
or (ii), are not callable or redeemable at the option of the issuer thereof.
“Global Security”
or “Global Securities” means a Security or Securities, as the case may be, in the form established pursuant to Section
2.02 evidencing all or part of a Series of Securities, issued to the Depository for such Series or its nominee, and registered in the
name of such Depository or nominee.
“Holder”
or “Securityholder” means a person in whose name a Security is registered.
“Indenture”
means this Indenture as amended and supplemented from time to time and shall include the form and terms of particular Series of Securities
established as contemplated hereunder.
“Interest,”
in respect of the Securities, unless the context otherwise requires, refers to interest payable on the Securities, including any additional
interest that may become payable pursuant to Section 6.02(b).
“Maturity,”
when used with respect to any Security or installment of principal thereof, means the date on which the principal of such Security or
such installment of principal becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration
of acceleration, call for redemption, notice of option to elect repayment or otherwise.
“Officer”
means the Chairman of the Board, the President, any Vice-President, the Treasurer, the Secretary, any Assistant Treasurer or any Assistant
Secretary of the Company.
“Officers’ Certificate”
means a certificate signed by two Officers, one of whom must be the Company’s principal executive officer, principal financial officer
or principal accounting officer.
“Opinion of Counsel”
means a written opinion of legal counsel who is, and which opinion is, acceptable to the Trustee and its counsel. Such legal counsel
may be an employee of or counsel to the Company or the Trustee.
“Person”
means any individual, corporation, partnership, joint venture, association, limited liability company, joint-stock company, trust, unincorporated
organization or government or any agency or political subdivision thereof.
“Principal”
or “principal” of a Security means the principal of the Security plus, when appropriate, the premium, if any, on, and
any Additional Amounts in respect of, the Security.
“Responsible Officer”
means any officer of the Trustee in its Corporate Trust Office and also means, any vice president, managing director, director, associate,
assistant vice president, or any other officer of the Trustee customarily performing functions similar to those performed by any of the
above designated officers and also, with respect to a particular corporate trust matter, any other officer to whom any corporate trust
matter is referred because of his or her knowledge of and familiarity with a particular subject.
“SEC” means
the Securities and Exchange Commission.
“Security”
or “Securities” means the debentures, notes or other debt instruments of the Company of any Series authenticated and
delivered under this Indenture.
“Series”
or “Series of Securities” means each series of debentures, notes or other debt instruments of the Company created pursuant
to Sections 2.01 and 2.02 hereof.
“Stated Maturity”
when used with respect to any Security or any installment of principal thereof or interest thereon, means the date specified in such Security
as the fixed date on which the principal of such Security or such installment of principal or interest is due and payable.
“Subordinated Indebtedness”
means any indebtedness which is expressly subordinated to the indebtedness evidenced by Securities.
“Subsidiary”
means, in respect of any Person, any corporation, association, partnership or other business entity of which more than 50% of the total
voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence
of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled,
directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries
of such Person.
“TIA” means
the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb) as in effect on the date of this Indenture; provided, however, that
in the event the Trust Indenture Act of 1939 is amended after such date, “TIA” means, to the extent required by any such amendment,
the Trust Indenture Act as so amended.
“Trustee”
means the person named as the “Trustee” in the first paragraph of this instrument until a successor Trustee shall have become
such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each person who
is then a Trustee hereunder, and if at any time there is more than one such person, “Trustee” as used with respect to the Securities
of any Series shall mean the Trustee with respect to Securities of that Series.
“U.S. Government Obligations”
means securities which are (i) direct obligations of The United States of America for the payment of which its full faith and credit is
pledged or (ii) obligations of a person controlled or supervised by and acting as an agency or instrumentality of The United States of
America the payment of which is unconditionally guaranteed as a full faith and credit obligation by The United States of America, and
which in the case of (i) and (ii) are not callable or redeemable at the option of the issuer thereof, and shall also include a depository
receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific payment of interest
on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depository receipt, provided
that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such
depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation evidenced by such depository
receipt.
SECTION 1.02. Other
Definitions.
TERM |
|
DEFINED IN SECTION |
“Applicable Law” |
|
10.18 |
“Event of Default” |
|
6.01 |
“Instrument” |
|
6.01 |
“Journal” |
|
10.16 |
“Judgment Currency” |
|
10.17 |
“Legal Holiday” |
|
10.08 |
“mandatory sinking fund payment” |
|
11.01 |
“Market Exchange Rate” |
|
10.16 |
“New York Banking Day” |
|
10.17 |
“optional sinking fund payment” |
|
11.01 |
“Paying Agent” |
|
2.04 |
“Registrar” |
|
2.04 |
“Required Currency” |
|
10.17 |
“successor person” |
|
5.01 |
“Temporary Securities” |
|
2.11 |
SECTION 1.03. Incorporation
by Reference of Trust Indenture Act.
Whenever this Indenture refers
to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. This Indenture shall
also include those provisions of the TIA required to be included herein by the provisions of the Trust Indenture Reform Act of 1990.
The following TIA terms used in this Indenture have the following meanings:
“indenture securities”
means the Securities.
“indenture security
holder” means a Securityholder.
“indenture to be qualified”
means this Indenture.
“indenture trustee”
or “institutional trustee” means the Trustee.
“obligor”
on the indenture securities means the Company and any successor obligor upon the Securities.
All other terms used in this
Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA and not otherwise
defined herein are used herein as so defined.
SECTION 1.04. Rules
of Construction.
Unless the context otherwise
requires:
(a) a
term has the meaning assigned to it;
(b) an
accounting term not otherwise defined has the meaning assigned to it in accordance with generally accepted accounting principles;
(c) references
to “generally accepted accounting principles” shall mean generally accepted accounting principles in effect as of the time when
and for the period as to which such accounting principles are to be applied;
(d) “or”
is not exclusive;
(e) words
in the singular include the plural, and in the plural include the singular;
(f) provisions
apply to successive events and transactions;
(g) references
to agreements and other instruments include subsequent amendments thereto;
(h) the
term “merger” includes a statutory share exchange, and the term “merged” has a correlative meaning; and
(i) “herein,”
“hereof” and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or
other subdivision.
ARTICLE II
THE SECURITIES
SECTION 2.01. Issuable
in Series.
The aggregate principal amount
of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or
more Series. All Securities of a Series shall be identical except as may be set forth in a Board Resolution, a supplemental indenture
or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the authority granted under a Board Resolution.
In the case of Securities of a Series to be issued from time to time, the Board Resolution, Officers’ Certificate or supplemental indenture
may provide for the method by which specified terms (such as interest rate, maturity date, record date or date from which interest shall
accrue) are to be determined. Securities may differ between Series in respect of any matters, provided that all Series of Securities
shall be equally and ratably entitled to the benefits of the Indenture.
SECTION 2.02. Establishment
of Terms of Series of Securities.
At or prior to the issuance
of any Securities within a Series, the following shall be established (as to the Series generally, in the case of Subsection (a), and
either as to such Securities within the Series or as to the Series generally in the case of Subsections (b) through (t) by a Board Resolution,
a supplemental indenture or an Officers’ Certificate pursuant to authority granted under a Board Resolution:
(a) the
title, designation, aggregate principal amount and authorized denominations of the Securities of the Series;
(b) the
price or prices, (expressed as a percentage of the aggregate principal amount thereof) at which the Securities of the Series will be issued;
(c) the
date or dates on which the principal of the Securities of the Series is payable;
(d) the
rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including,
but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall
bear interest, if any, the date or dates from which such interest, if any, shall commence and be payable and any regular record date for
the interest payable on any interest payment date;
(e) any
optional or mandatory sinking fund provisions or conversion or exchangeability provisions upon which Securities of the Series shall be
redeemed, purchased, converted or exchanged;
(f) the
date, if any, after which and the price or prices at which the Securities of the Series may be optionally redeemed or must be mandatorily
redeemed and any other terms and provisions of optional or mandatory provisions;
(g) if
other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities of the Series shall be
issuable;
(h) if
other than the full principal amount, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration
of acceleration pursuant to Section 6.02 or provable in bankruptcy;
(i) any
addition to or change in the Events of Default which applies to any Securities of the Series and any change in the right of the Trustee
or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.02;
(j) the
currency or currencies, including composite currencies, in which payments of principal of, premium or interest, if any, on the Securities
of the Series will be payable, if other than the currency of the United States of America;
(k) if
payments of principal of, premium or interest, if any, on the Securities of the Series will be payable, at the Company’s election or at
the election of any Holder, in a currency other than that in which the Securities of the Series are stated to be payable, the period or
periods within which, and the terms and conditions upon which, the election may be made;
(l) if
payments of interest, if any, on the Securities of the Series will be payable, at the Company’s election or at the election of any Holder,
in cash or additional securities, and the terms and conditions upon which the election may be made;
(m) if
denominated in a currency or currencies other than the currency of the United States of America, the equivalent price of the Securities
of the Series in the currency of the United States of America for purposes of determining the voting rights of Holders of the Securities
of the Series;
(n) if
the amount of payments of principal, premium or interest may be determined with reference to an index, formula or other method based on
a coin or currency other than that in which the Securities of the Series are stated to be payable, the manner in which the amounts will
be determined;
(o) any
restrictive covenants or other material terms relating to the Securities of the Series;
(p) whether
the Securities of the Series will be issued in the form of global securities or certificates in registered form;
(q) any
terms with respect to subordination;
(r) any
listing on any securities exchange or quotation system;
(s) additional
provisions, if any, related to defeasance and discharge of the offered debt securities; and
(t) the
applicability of any guarantees, which would be governed by New York law.
All Securities of any one
Series need not be issued at the same time and may be issued from time to time, consistent with the terms of this Indenture, if so provided
by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, and the authorized principal
amount of any Series may not be increased to provide for issuance of additional Securities of such Series, unless otherwise provided in
such Board Resolution, supplemental Indenture or Officers’ Certificate.
SECTION 2.03. Execution
and Authentication.
Two Officers shall sign the
Securities for the Company by manual or facsimile signature.
If an Officer whose signature
is on a Security no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid.
A Security shall not be valid
until authenticated by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence
that the Security has been authenticated under this Indenture.
The Trustee shall at any time,
and from time to time, authenticate Securities for original issue in the principal amount provided in the Board Resolution, supplemental
indenture hereto or Officers’ Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication
and delivery pursuant to oral or electronic instructions from the Company or its duly authorized agent or agents, which oral instructions
shall be promptly confirmed in writing. Each Security shall be dated the date of its authentication unless otherwise provided by
a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate.
The aggregate principal amount
of Securities of any Series outstanding at any time may not exceed any limit upon the maximum principal amount for such Series set forth
in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.02, except as provided
in Section 2.08.
Prior to the issuance of Securities
of any Series, the Trustee shall have received and (subject to Section 7.02) shall be fully protected in relying on: (a) the Board Resolution,
supplemental indenture hereto or Officers Certificate establishing the form of the Securities of that Series or of Securities within that
Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers’ Certificate complying with
Section 10.04, and (c) an Opinion of Counsel complying with Section 10.04.
The Trustee shall have the
right to decline to authenticate and deliver any Securities of such Series: (a) if the Trustee, being advised by counsel, determines that
such action may not lawfully be taken; or (b) if a Responsible Officer of the Trustee in good faith shall determine that such action would
expose the Trustee to personal liability to Holders of any then outstanding Series of Securities.
The Trustee may appoint an
authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever
the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent.
An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate.
If any successor that has
replaced the Company in accordance with Article 5 has executed an indenture supplemental hereto with the Trustee pursuant to Section 5.01,
any of the Securities authenticated or delivered prior to such transaction may, from time to time, at the request of such successor, be
exchanged for other Securities executed in the name of the such successor with such changes in phraseology and form as may be appropriate,
but otherwise identical to the Securities surrendered for such exchange and of like principal amount; and the Trustee, upon receipt of
a Company Order of such successor, shall authenticate and deliver Securities as specified in such order for the purpose of such exchange.
If Securities shall at any time be authenticated and delivered in any new name of such successor pursuant to this provision of Section
2.03 in exchange or substitution for or upon registration of transfer of any Securities, such successor, at the option of the Holders
but without expense to them, shall provide for the exchange of all Securities then outstanding for Securities authenticated and delivered
in such new name.
SECTION 2.04. Registrar
and Paying Agent.
The Company shall maintain,
with respect to each Series of Securities, at the place or places specified with respect to such Series pursuant to Section 2.02, an office
or agency where Securities of such Series may be presented or surrendered for payment (“Paying Agent”) and where Securities
of such Series may be surrendered for registration of transfer or exchange (“Registrar”). The Registrar shall keep a register
with respect to each Series of Securities and to their transfer and exchange. The Company will give prompt written notice to the
Trustee of the name and address, and any change in the name or address, of each Registrar and Paying Agent. If at any time the Company
shall fail to maintain any such required Registrar or Paying Agent or shall fail to furnish the Trustee with the name and address thereof,
such presentations and surrenders may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints
the Trustee as its agent to receive all such presentations and surrenders.
The Company may also from
time to time designate one or more co-registrars or additional paying agents and may from time to time rescind such designations; provided,
however, that no such designation or rescission shall in any manner relieve the Company of its obligations to maintain a Registrar or
Paying Agent in each place so specified pursuant to Section 2.02 for Securities of any Series for such purposes. The Company will
give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of any such co-registrar
or additional paying agent. The term “Registrar” includes any co-registrar; and the term “Paying Agent” includes
any additional paying agent.
The Company hereby appoints
[ ]
as the initial Registrar and Paying Agent for each Series unless another Registrar or Paying Agent as the case may be, is appointed prior
to the time Securities of that Series are first issued. Each Registrar and Paying Agent shall be entitled to all of the rights,
protections, exculpations and indemnities afforded to the Trustee in connection with its roles as Registrar and Paying Agent.
SECTION 2.05. Paying
Agent to Hold Money in Trust.
The Company shall require
each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust, for the benefit of Securityholders
of any Series of Securities, or the Trustee, all money held by the Paying Agent for the payment of principal of or interest on the Series
of Securities, and will notify the Trustee of any default by the Company in making any such payment. While any such default continues,
the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying
Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company
or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate
and hold in a separate trust fund for the benefit of Securityholders of any Series of Securities all money held by it as Paying Agent.
SECTION 2.06. Securityholder
Lists.
The Trustee shall preserve
in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders of
each Series of Securities and shall otherwise comply with TIA Section 312(a). If the Trustee is not the Registrar, the Company shall
furnish to the Trustee at least [ ] days before each interest payment date and at such other times as the Trustee may request in
writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of Securityholders
of each Series of Securities.
SECTION 2.07. Transfer
and Exchange.
Where Securities of a Series
are presented to the Registrar or a co-registrar with a request to register a transfer or to exchange them for an equal principal amount
of Securities of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions
are met. To permit registrations of transfers and exchanges, the Trustee shall authenticate Securities at the Registrar’s request.
Any exchange or transfer shall be without charge, except that the Company or the Registrar may require payment of a sum sufficient to
cover any tax or other governmental charge required by law; provided that this sentence shall not apply to any exchange pursuant to Section
2.11, 2.08, 3.06 or 9.06.
Neither the Company nor the
Registrar shall be required (a) to issue, register the transfer of, or exchange Securities of any Series for the period beginning at the
opening of business [ ] days immediately preceding the mailing of a notice of redemption of Securities of that Series selected for
redemption and ending at the close of business on the day of such mailing, or (b) to register the transfer of or exchange Securities of
any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Securities selected, called
or being called for redemption in part.
All Securities issued upon
any transfer or exchange of Securities shall be valid obligations of the Company, evidencing the same debt and entitled to the same benefits
under this Indenture, as the Securities surrendered upon such transfer or exchange. Any Registrar appointed pursuant to Section
2.04 shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar
of Securities upon transfer or exchange of Securities. Each Holder of a Security agrees to indemnify the Company and the Trustee
against any liability that may result from the transfer, exchange or assignment of such Holder’s Security in violation of any provision
of this Indenture and/or applicable U.S. federal or state securities law.
SECTION 2.08. Mutilated,
Destroyed, Lost and Stolen Securities.
If any mutilated Security
is surrendered to the Registrar, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a new Security
of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.
If there shall be delivered
to the Company and the Registrar (i) evidence to their satisfaction of the destruction, loss or theft of any Security and (ii) such security
or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice
to the Company or the Registrar that such Security has been acquired by a bona fide purchaser, the Company shall execute and upon its
request the Trustee shall authenticate and make available for delivery, in lieu of any such destroyed, lost or stolen Security, a new
Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.
In case any such mutilated,
destroyed, lost or stolen Security has become or is about to become due and payable, the Company in its discretion may, instead of issuing
a new Security, pay such Security.
Upon the issuance of any new
Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that
may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.
Every new Security of any
series issued pursuant to this Section in lieu of any destroyed, lost or stolen Security shall constitute an original additional contractual
obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall
be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that Series duly issued
hereunder.
The provisions of this Section
are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated,
destroyed, lost or stolen Securities.
SECTION 2.09. Outstanding
Securities.
The Securities outstanding
at any time are all the Securities authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation,
those reductions in the interest on a Global Security effected by the Trustee in accordance with the provisions hereof and those described
in this Section as not outstanding.
If a Security is replaced
pursuant to Section 2.08, it ceases to be outstanding until the Trustee receives proof satisfactory to it that the replaced Security is
held by a bona fide purchaser.
If the Paying Agent (other
than the Company, a Subsidiary or an Affiliate of any thereof) holds on the Maturity of Securities of a Series money sufficient to pay
such Securities payable on that date, then on and after that date such Securities of the Series cease to be outstanding and interest on
them ceases to accrue.
A Security does not cease
to be outstanding because the Company or an Affiliate holds the Security.
In determining whether the
Holders of the requisite principal amount of outstanding Securities have given any request, demand, authorization, direction, notice,
consent or waiver hereunder, the principal amount of a Discount Security that shall be deemed to be outstanding for such purposes shall
be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration
of the Maturity thereof pursuant to Section 6.02.
SECTION 2.10. Treasury
Securities.
In determining whether the
Holders of the required principal amount of Securities of a Series have concurred in any request, demand, authorization, direction, notice,
consent or waiver Securities of a Series owned by the Company or an Affiliate shall be disregarded, except that for the purposes of determining
whether the Trustee shall be protected in relying on any such request, demand, authorization, direction, notice, consent or waiver only
Securities of a Series that a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded.
SECTION 2.11. Temporary
Securities.
Until definitive Securities
are ready for delivery, the Company may prepare and the Trustee shall authenticate temporary securities upon a Company Order (“Temporary
Securities”). Temporary Securities shall be substantially in the form of definitive Securities but may have variations that
the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and the Trustee
upon written request shall authenticate definitive Securities of the same Series and date of maturity in exchange for temporary Securities.
Until so exchanged, temporary securities shall have the same rights under this Indenture as the definitive Securities.
SECTION 2.12. Cancellation.
The Company at any time may
deliver Securities to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee or its agent
any Securities surrendered to them for transfer, exchange, payment or conversion. The Trustee and no one else shall cancel, in accordance
with its standard procedures, all Securities surrendered for transfer, exchange, payment, conversion or cancellation and shall deliver
the cancelled Securities to the Company. No Security shall be authenticated in exchange for any Security cancelled pursuant to this
Section 2.12.
The Company may, to the extent
permitted by law, purchase Securities in the open market or by tender offer at any price or by private agreement. Any Securities
purchased or otherwise acquired by the Company or any of its Subsidiaries prior to the final maturity of such Securities may, to the extent
permitted by law, be reissued or resold or may, at the option of the Company, be surrendered to the Trustee for cancellation. Any
Securities surrendered for cancellation may not be reissued or resold and shall be promptly cancelled by the Trustee, and the Company
may not hold or resell such Securities or issue any new Securities to replace any such Securities.
SECTION 2.13. Defaulted
Interest.
If the Company defaults in
a payment of interest on a Series of Securities, it shall pay defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest at the Default Rate, to the persons who are Security holders of the Series on a subsequent special record date.
The Company shall fix the record date and payment date. At least [ ] days before the record date, the Company shall mail to
the Trustee and the Paying Agent and to each Securityholder of the Series a notice that states the record date, the payment date and the
amount of interest to be paid. The Company may pay defaulted interest in any other lawful manner.
SECTION 2.14. Global
Securities.
(a) A
Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall establish whether the Securities of a Series shall
be issued in whole or in part in the form of one or more Global Securities and the Depository for such Global Security or Securities.
(b) (i) Notwithstanding
any provisions to the contrary contained in Section 2.07 of the Indenture and in addition thereto, any Global Security shall be exchangeable
pursuant to Section 2.07 of the Indenture for Securities registered in the names of Holders other than the Depository for such Security
or its nominee only if (A) such Depository notifies the Company that it is unwilling or unable to continue as Depository for such Global
Security or if at any time such Depository ceases to be a clearing agency registered under the Exchange Act, and, in either case, the
Company fails to appoint a successor Depository within 90 days of such event, (B) the Company executes and delivers to the Trustee an
Officers’ Certificate to the effect that such Global Security shall be so exchangeable or (C) an Event of Default with respect to the
Securities represented by such Global Security shall have happened and be continuing.
(ii) Except
as provided in this Section 2.14(b), a Global Security may not be transferred except as a whole by the Depository with respect to such
Global Security to a nominee of such Depository, by a nominee of such Depository to such Depository or another nominee of such Depository
or by the Depository or any such nominee to a successor Depository or a nominee of such a successor Depository.
(iii) Securities
issued in exchange for a Global Security or any portion thereof shall be issued in definitive, fully registered form, without interest
coupons, shall have an aggregate principal amount equal to that of such Global Security or portion thereof to be so exchanged, shall be
registered in such names and be in such authorized denominations as the Depository shall designate and shall bear the applicable legends
provided for herein. Any Global Security to be exchanged in whole shall be surrendered by the Depository to the Trustee, as Registrar.
With regard to any Global Security to be exchanged in part, either such Global Security shall be so surrendered for exchange or, if the
Registrar is acting as custodian for the Depository or its nominee with respect to such Global Security, the principal amount thereof
shall be reduced by an amount equal to the portion thereof to be so exchanged, by means of an appropriate adjustment made on the records
of the Trustee. Upon any such surrender or adjustment, the Trustee shall authenticate and deliver the Security issuable on such
exchange to or upon the order of the Depository or an authorized representative thereof.
(iv) The
registered Holder may grant proxies and otherwise authorize any Person, including participants in the Depository and persons that may
hold interests through participants in the Depository, to take any action which a Holder is entitled to take under this Indenture or the
Securities.
(v) In
the event of the occurrence of any of the events specified in 2.14(b)(i), the Company will promptly make available to the Trustee a reasonable
supply of Certificated Securities in definitive, fully registered form, without interest coupons. If (A) an event described in Section
2.14(b)(i)(A) or (B) occurs and definitive Certificated Securities are not issued promptly to all beneficial owners or (B) the Registrar
receives from a beneficial owner instructions to obtain definitive Certificated Securities due to an event described in Section 2.14(b)(i)(C)
and definitive Certificated Securities are not issued promptly to any such beneficial owner, the Company expressly acknowledges, with
respect to the right of any Holder to pursue a remedy pursuant to Section 6.07 hereof, the right of any beneficial owner of Securities
to pursue such remedy with respect to the portion of the Global Security that represents such beneficial owner’s Securities as if such
definitive certificated Securities had been issued.
(vi) Notwithstanding
any provision to the contrary in this Indenture, so long as a Global Security remains outstanding and is held by or on behalf of the Depository,
transfers of a Global Security, in whole or in part, or of any beneficial interest therein, shall only be made in accordance with Section
2.07, this Section 2.14(b) and the rules and procedures of the Depository for such Global Security to the extent applicable to such transaction
and as in effect from time to time.
(c) Any
Global Security issued hereunder shall bear a legend in substantially the following form:
“This Security is a Global
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee of the
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture, and may not be transferred except as a whole by the Depository to a nominee
of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such
nominee to a successor Depository or a nominee of such a successor Depository.”
(d) The
Depository, as a Holder, may appoint agents and otherwise authorize participants to give or take any request, demand, authorization, direction,
notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture.
(e) Notwithstanding
the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.02, payment of the principal of and interest,
if any, on any Global Security shall be made to the Holder thereof at their registered office.
(f) At
all times the Securities are held in book-entry form with a Depository, (i) the Trustee may deal with such Depository as the authorized
representative of the Holders, (ii) the rights of the Holders shall be exercised only through the Depository and shall be limited to those
established by law and agreement between the Holders and the Depository and/or direct participants of the Depository, (iii) the Depository
will make book-entry transfers among the direct participants of the Depository and will receive and transmit distributions of principal
and interest on the Securities to such direct participants; and (iv) the direct participants of the Depository shall have no rights under
this Indenture, or any supplement hereto, under or with respect to any of the Securities held on their behalf by the Depository, and the
Depository may be treated by the Trustee and its agents, employees, officers and directors as the absolute owner of the Securities for
all purposes whatsoever.
SECTION 2.15. CUSIP
Numbers.
The Company in issuing the
Securities may use “CUSIP”, “ISIN” or other identification numbers (if then generally in use), and, if so, the Trustee
shall use “CUSIP”, “ISIN” or such other identification numbers in notices of redemption as a convenience to Holders;
provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the
Securities or as contained in any notice of a redemption and that reliance may be placed only on the other elements of identification
printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers.
ARTICLE III
REDEMPTION
SECTION 3.01. Notice
to Trustee.
The Company may, with respect
to any series of Securities, reserve the right to redeem and pay the Series of Securities or may covenant to redeem and pay the Series
of Securities or any part thereof prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities.
If a Series of Securities is redeemable and the Company wants or is obligated to redeem prior to the Stated Maturity thereof all or part
of the Series of Securities pursuant to the terms of such Securities, it shall notify the Trustee and Registrar in writing of the redemption
date and the principal amount of Series of Securities to be redeemed. The Company shall give the notice at least [ ] days
before the redemption date (or such shorter notice as may be acceptable to the Trustee and Registrar).
SECTION 3.02. Selection
of Securities to be Redeemed.
Unless otherwise indicated
for a particular Series by a Board Resolution, a supplemental indenture or an Officers’ Certificate, if less than all the Securities of
a Series are to be redeemed, the Registrar shall select the Securities of the Series to be redeemed in accordance with its customary procedures.
The Registrar shall make the selection from Securities of the Series outstanding not previously called for redemption. The Registrar
may select for redemption portions of the principal of Securities of the Series that have denominations larger than $1,000. Securities
of the Series and portions of them it selects shall be in amounts of $1,000 or whole multiples of $1,000 or, with respect to Securities
of any Series issuable in other denominations pursuant to Section 2.02(g), the minimum principal denomination for each Series and integral
multiples thereof. Provisions of this Indenture that apply to Securities of a Series called for redemption also apply to portions
of Securities of that Series called for redemption.
SECTION 3.03. Notice
of Redemption.
Unless otherwise indicated
for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least [ ] days but
not more than [ ] days before a redemption date, the Company shall mail a notice of redemption by first-class mail to each Holder
whose Securities are to be redeemed.
The notice shall identify
the Securities of the Series to be redeemed and shall state:
(a) the
redemption date;
(b) the
redemption price;
(c) the
name and address of the Paying Agent;
(d) that
Securities of the Series called for redemption must be surrendered to the Paying Agent to collect the redemption price;
(e) that
interest on Securities of the Series called for redemption ceases to accrue on and after the redemption date; and
(f) any
other information as may be required by the terms of the particular Series or the Securities of a Series being redeemed.
At the Company’s written request,
the Trustee shall distribute the notice of redemption prepared by the Company in the Company’s name and at its expense.
SECTION 3.04. Effect
of Notice of Redemption.
Once notice of redemption
is mailed or published as provided in Section 3.03, Securities of a Series called for redemption become due and payable on the redemption
date and at the redemption price. A notice of redemption may not be conditional. Upon surrender to the Paying Agent, such
Securities shall be paid at the redemption price plus accrued interest to the redemption date.
SECTION 3.05. Deposit
of Redemption Price.
On or before the redemption
date, the Company shall deposit with the Paying Agent money sufficient to pay the redemption price of and accrued interest, if any, on
all Securities to be redeemed on that date.
SECTION 3.06. Securities
Redeemed in Part.
Upon surrender of a Security
that is redeemed in part, the Trustee shall authenticate for the Holder a new Security of the same Series and the same maturity equal
in principal amount to the unredeemed portion of the Security surrendered.
ARTICLE IV
COVENANTS
SECTION 4.01. Payment
of Principal and Interest.
The Company covenants and
agrees for the benefit of the Holders of each Series of Securities that it will duly and punctually pay the principal of and interest,
if any, on the Securities of that Series in accordance with the terms of such Securities and this Indenture.
Unless otherwise provided
under the terms of a particular Series of Securities:
(a) an
installment of principal or interest shall be considered paid on the date it is due if the Paying Agent (other than the Company) holds
by [ ] [a].m., New York City time, on that date money, deposited by the Company or an Affiliate thereof, sufficient to pay
such installment. The Company shall (in immediately available funds), to the fullest extent permitted by law, pay interest on overdue
principal and overdue installments of interest at the rate borne by the Securities per annum; and
(b) payment
of the principal of and interest on the Securities shall be made at the office or agency of the Company maintained for that purpose in
[ ] (which shall initially be [ ], the Paying Agent) in such coin or currency of the United States of America as
at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the
Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address appears in the register; provided,
further, that a Holder with an aggregate principal amount in excess of $[ ] will be paid by wire transfer in immediately available
funds at the election of such Holder if such Holder has provided wire transfer instructions to the Company at least [ ] Business
Days prior to the payment date.
SECTION 4.02. SEC
Reports.
So long as any Securities
are outstanding, the Company shall (i) file with the SEC within the time periods prescribed by its rules and regulations and (ii) furnish
to the Trustee and the Holders of the Securities within [ ] days after the date on which the Company would be required to file the
same with the SEC pursuant to its rules and regulations (giving effect to any grace period provided by Rule 12b-25 under the Exchange
Act), all quarterly and annual financial information required to be furnished or filed with the SEC pursuant to Section 13 and Section
15(d) of the Exchange Act and, with respect to the annual consolidated financial statements only, a report thereon by the Company’s independent
auditors. The Company also shall comply with the other provisions of TIA Section 314(a).
Delivery of such reports,
information and documents to the Trustee is for informational purposes only, and the Trustee’s receipt of such shall not constitute constructive
notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with
any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates). The Company
shall not be required to file any report or other information with the SEC if the SEC does not permit such filing, although such reports
shall be furnished to the Trustee. Documents filed by the Company with the SEC via the SEC’s EDGAR system (or any successor thereto)
will be deemed furnished to the Trustee and the Holders of the Securities as of the time such documents are filed via EDGAR (or such successor).
SECTION 4.03. Compliance
Certificate.
The Company shall deliver
to the Trustee, within [ ] days after the end of each fiscal year of the Company, an officers certificate signed by two of
the Company’s officers stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has
been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed and
fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best
of his knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and is not
in default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default
shall have occurred, describing all such Defaults or Events of Default of which he may have knowledge in reasonable detail and the efforts
to remedy the same). For purposes of this Section 4.03, compliance shall be determined without regard to any grace period or requirement
of notice provided pursuant to the terms of this Indenture.
The Company shall deliver
to the Trustee, within [ ] days after the occurrence thereof, written notice in the form of an Officers’ Certificate of any Event
of Default described in Section 6.01(e), (f), (g) or (h) and any event of which it becomes aware that with the giving of notice or the
lapse of time would become such an Event of Default, its status and what action the Company is taking or proposes to take with respect
thereto. For the avoidance of doubt, a breach of a covenant under an Instrument that is not a payment default and that has not given
rise to a right of acceleration under such Instrument shall not trigger the requirement to provide notice under this paragraph.
SECTION 4.04. Stay,
Extension and Usury Laws.
The Company covenants (to
the extent that it may lawfully do so) that it will not at any time insist upon, plead, or in any manner whatsoever claim or take the
benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, which may affect the
covenants or the performance of this Indenture or the Securities; and the Company (to the extent it may lawfully do so) hereby expressly
waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the
execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law
has been enacted.
SECTION 4.05. Corporate
Existence.
Subject to Article V, the
Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and the
corporate, partnership or other existence of each Subsidiary in accordance with the respective organizational documents of each Subsidiary
and the rights (charter and statutory), licenses and franchises of the Company and its Subsidiaries; provided, however, that the Company
shall not be required to preserve any such right, license or franchise, or the corporate, partnership or other existence of any Subsidiary,
if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company
and its Subsidiaries taken as a whole and that the loss thereof is not adverse in any material respect to the Holders.
SECTION 4.06. Taxes.
The Company shall, and shall
cause each of its Subsidiaries to, pay prior to delinquency all taxes, assessments and governmental levies, except as contested in good
faith and by appropriate proceedings.
SECTION 4.07. Additional
Interest Notice.
In the event that the Company
is required to pay additional interest to Holders of Securities pursuant to Section 6.02(b) hereof, the Company shall provide a direction
or order in the form of a written notice to the Trustee (and if the Trustee is not the Paying Agent, the Paying Agent) of the Company’s
obligation to pay such additional interest no later than [ ] Business Days prior to date on which any such additional interest
is scheduled to be paid. Such notice shall set forth the amount of additional interest to be paid by the Company on such payment
date and direct the Trustee (or, if the Trustee is not the Paying Agent, the Paying Agent) to make payment to the extent it receives funds
from the Company to do so. The Trustee shall not at any time be under any duty or responsibility to any Holder to determine whether
additional interest is payable, or with respect to the nature, extent, or calculation of the amount of additional interest owed, or with
respect to the method employed in such calculation of additional interest.
SECTION 4.08. Further
Instruments and Acts.
The Company will execute and
deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purposes
of this Indenture.
ARTICLE V
SUCCESSORS
SECTION 5.01. When
Company May Merge, Etc.
The Company shall not consolidate
with, enter into a binding share exchange, or merge into any other Person in a transaction in which it is not the surviving entity, or
sell, assign, convey, transfer or lease or otherwise dispose of all or substantially all of its properties and assets to any Person (a
“successor person”), unless:
(a) the
successor person (if any) is a corporation, partnership, trust or other entity organized and validly existing under the laws of the Cayman
Islands and expressly assumes by a supplemental indenture executed and delivered to the Trustee, in form satisfactory to the Trustee,
the due and punctual payment of the principal of, and any interest on, all Securities and the performance or observance of every covenant
of this Indenture on the part of the Company to be performed or observed;
(b) immediately
after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing; and
(c) the
Company shall have delivered to the Trustee, prior to the consummation of the proposed transaction, an Officers’ Certificate to the foregoing
effect and an Opinion of Counsel stating that the proposed transaction and such supplemental indenture comply with this Indenture.
SECTION 5.02. Successor
Corporation Substituted.
Upon any consolidation or
merger, or any sale, lease, conveyance or other disposition of all or substantially all of the assets of the Company in accordance with
Section 5.01, the successor person formed by such consolidation or into or with which the Company is merged or to which such sale, lease,
conveyance or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company
under this Indenture with the same effect as if such successor person has been named as the Company herein; provided, however, that the
predecessor company in the case of a sale, lease, conveyance or other disposition of all or substantially all of the assets of the Company
shall not be released from the obligation to pay the principal of and interest, if any, on the Securities.
ARTICLE VI
DEFAULTS AND REMEDIES
SECTION 6.01. Events
of Default.
“Event of Default,”
wherever used herein with respect to securities of any Series, means any one of the following events, unless in the establishing Board
Resolution, supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said Event
of Default:
(a) default
in the payment of any interest on any Security of that Series when it becomes due and payable, and continuance of such default for a period
of 30 days (unless the entire amount of such payment is deposited by the Company with the Trustee or with a Paying Agent prior to the
expiration of such period of 30 days); or
(b) default
in the payment of any principal of any Security of that Series at its Maturity; or
(c) default
in the deposit of any sinking fund payment, when and as due in respect of any Security of that Series; or
(d) the
Company fails to perform or comply with any of its other covenants or agreements contained in the Securities or in this Indenture (other
than a covenant or agreement a default in whose performance or whose breach is specifically dealt with in clauses (a), (b) or (c) of this
Section 6.01) and the default continues for 60 days after notice is given as specified below;
(e) any
indebtedness under any bond, debenture, note or other evidence of indebtedness for money borrowed by the Company or any Subsidiary or
under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any indebtedness
for money borrowed by, or any other payment obligation of, the Company or any Subsidiary (an “Instrument”) with a principal
amount then, individually or in the aggregate, outstanding in excess of $[ ], whether such indebtedness now exists or shall hereafter be
created, is not paid at Maturity or when otherwise due or is accelerated, and such indebtedness is not discharged, or such default in
payment or acceleration is not cured or rescinded, within a period of 30 days after there shall have been given, by registered or certified
mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least [ ]% in aggregate principal amount
of the outstanding Securities of that Series a written notice specifying such default and requiring the Company to cause such indebtedness
to be discharged or cause such default to be cured or waived or such acceleration to be rescinded or annulled and stating that such notice
is a “Notice of Default” hereunder. A payment obligation (other than indebtedness under any bond, debenture, note or other
evidence of indebtedness for money borrowed by the Company or any Subsidiary or under any mortgage, indenture or instrument under which
there may be issued or by which there may be secured or evidenced any indebtedness for money borrowed by the Company or any Subsidiary)
shall not be deemed to have matured, come due, or been accelerated to the extent that it is being disputed by the relevant obligor or
obligors in good faith. For the avoidance of doubt, the Maturity of an Instrument is the Maturity as set forth in that Instrument,
as it may be amended from time to time in accordance with the terms of that Instrument;
(f) the
Company or any Subsidiary fails to pay one or more final and non-appealable judgments entered by a court or courts of competent jurisdiction,
the aggregate uninsured or unbonded portion of which is in excess of $[ ], if the judgments are not paid, discharged, waived or stayed
within [ ] days;
(g) the
Company or any Subsidiary of the Company, pursuant to or within the meaning of any Bankruptcy Law:
(i) commences
a voluntary case or proceeding;
(ii) consents
to the entry of an order for relief against it in an involuntary case or proceeding;
(iii) consents
to the appointment of a Custodian of it or for all or substantially all of its property; or
(iv) makes
a general assignment for the benefit of its creditors; or
(v) or
generally is unable to pay its debts as the same become due; or
(h) a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:
(i) is
for relief against the Company or any of its Subsidiaries in an involuntary case or proceeding;
(ii) appoints
a Custodian of the Company or any of its Subsidiaries for all or substantially all of the property of the Company or any such Subsidiary;
or
(iii) orders
the liquidation of the Company or any of its Subsidiaries;
and the case of
each of clause (i), (ii) and (iii), the order or decree remains unstayed and in effect for [ ] consecutive days; or
(i) any
other Event of Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture
hereto or an Officers’ Certificate, in accordance with Section 2.02(i).
A default under clause (d)
above is not an Event of Default until the Trustee notifies the Company, or the Holders of at least [ ]% in aggregate principal
amount of the Securities then outstanding notify the Company and the Trustee, in writing of the default, and the Company does not cure
the default within 60 days after receipt of such notice. The notice given pursuant to this Section 6.01 must specify the default,
demand that it be remedied and state that the notice is a “Notice of Default.” When any default under this Section 6.01
is cured, it ceases.
The Trustee shall not be charged
with knowledge of any Event of Default unless written notice thereof shall have been given to a Trust Officer at the Corporate Trust Office
of the Trustee by the Company, a Paying Agent, any Holder or any agent of any Holder.
SECTION 6.02. Acceleration
of Maturity; Rescission and Annulment.
(a) If
an Event of Default (other than an Event of Default specified in clause (g) or (h) of Section 6.01) occurs and is continuing with respect
to any Securities of any Series, then in every such case, the Trustee may, by notice to the Company, or the Holders of at least 25% in
aggregate principal amount of the Securities of that Series (or, if any Securities of that Series are Discount Securities, such portion
of the principal amount as may be specified in the terms of such Securities) then outstanding may, by notice to the Company and the Trustee,
declare all unpaid principal of, and accrued and unpaid interest on to the date of acceleration, the Securities of that Series then outstanding
(if not then due and payable) to be due and payable upon any such declaration, and the same shall become and be immediately due and payable.
If an Event of Default specified in clause (g) or (h) of Section 6.01 occurs, all unpaid principal of the Securities then outstanding,
and all accrued and unpaid interest thereon to the date of acceleration, shall ipso facto become and be immediately due and payable without
any declaration or other act on the part of the Trustee or any Holder. The Holders of a majority in aggregate principal amount of
the Securities of that Series then outstanding by notice to the Trustee may rescind an acceleration of such Securities of that Series
and its consequences if (a) all existing Events of Default, other than the nonpayment of the principal of the Securities which has become
due solely by such declaration of acceleration, have been cured or waived; (b) to the extent the payment of such interest is lawful, interest
(calculated at the Default Rate) on overdue installments of interest and overdue principal, which has become due otherwise than by such
declaration of acceleration, has been paid; (c) the rescission would not conflict with any judgment or decree of a court of competent
jurisdiction; and (d) all payments due to the Trustee and any predecessor Trustee under Section 7.07 have been made. No such rescission
shall affect any subsequent default or impair any right consequent thereto.
(b) Notwithstanding
any of provision of this Article 6, at the election of the Company in its sole discretion, the sole remedy under this Indenture for an
Event of Default relating to the failure to comply with Section 4.02, and for any failure to comply with the requirements of Section 314(a)(1)
of the TIA, will consist, for the 180 days after the occurrence of such an Event of Default, exclusively of the right to receive additional
interest on the Securities at a rate equal to 0.50% per annum of the aggregate principal amount of the Securities then outstanding up
to, but not including, the 181st day thereafter (or, if applicable, the earlier date on which the Event of Default relating to Section
4.02 is cured or waived). Any such additional interest will be payable in the same manner and on the same dates as the stated interest
payable on the Securities. In no event shall additional interest accrue under the terms of this Indenture at a rate in excess of
0.50% per annum, in the aggregate, for any violation or default caused by the failure of the Company to be current in respect of its Exchange
Act reporting obligations. If the Event of Default is continuing on the 181st day after an Event of Default relating to a failure
to comply with Section 4.02, the Securities will be subject to acceleration as provided in this Section 6.02. The provisions of
this Section 6.02(b) will not affect the rights of Holders in the event of the occurrence of any other Events of Default.
In order to elect to pay additional
interest as the sole remedy during the first 180 days after the occurrence of an Event of Default relating to the failure to comply with
Section 4.02 in accordance with the immediately preceding paragraph, the Company shall notify all Holders and the Trustee and Paying Agent
of such election on or before the close of business on the fifth Business Day after the date on which such Event of Default otherwise
would occur. Upon a failure by the Company to timely give such notice or pay additional interest, the Securities will be immediately
subject to acceleration as otherwise provided in this Section 6.02.
SECTION 6.03. Collection
of Indebtedness and Suits for Enforcement by Trustee.
If an Event of Default with
respect to any Securities of any Series occurs and is continuing, the Trustee may in its discretion proceed to protect and enforce its
rights and the rights of the Holders of Securities of such Series by such appropriate judicial proceedings as the Trustee shall deem most
effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture
or in aid of the exercise of any power granted herein, or to enforce any other proper remedy.
If an Event of Default in
the payment of principal, interest, if any, specified in clause (a) or (b) of Section 6.01 occurs and is continuing, the Trustee may recover
judgment in its own name and as trustee of an express trust against the Company or another obligor on the Securities for the whole amount
of principal, and accrued interest remaining unpaid, if any, together with, to the extent that payment of such interest is lawful, interest
on overdue principal, on overdue installments of interest, if any, in each case at the Default Rate, and such further amount as shall
be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances
of the Trustee, its agents and counsel.
SECTION 6.04. Trustee
May File Proofs of Claim.
In case of the pendency of
any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding
relative to the Company or any other obligor upon the Securities or the property of the Company or of such other obligor or their creditors,
the Trustee (irrespective of whether the principal of the Securities shall then be due and payable as therein expressed or by declaration
or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue principal or
interest) shall be entitled and empowered, by intervention in such proceeding or otherwise,
(a) to
file and prove a claim for the whole amount of principal and interest owing and unpaid in respect of the Securities and to file such other
papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial
proceeding, and
(b) to
collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same, and any custodian,
receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by
each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly
to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel, and any other amounts due the Trustee under Section 7.07.
Nothing herein contained shall
be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement,
adjustment or composition affecting the Securities or the rights of any Holder thereof or to authorize the Trustee to vote in respect
of the claim of any Holder in any such proceeding.
SECTION 6.05. Trustee
May Enforce Claims Without Possession of Securities.
All rights of action and claims
under this Indenture or the Securities may be prosecuted and enforced by the Trustee without the possession of any of the Securities or
the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own
name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Securities
in respect of which such judgment has been recovered.
SECTION 6.06. Application
of Money Collected.
Any money collected by the
Trustee pursuant to this Article shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the
distribution of such money on account of principal or interest, upon presentation of the Securities and the notation thereon of the payment
if only partially paid and upon surrender thereof if fully paid: and
First: To the payment
of all amounts due the Trustee under Section 7.07;
Second: To the payment
of the amounts then due and unpaid for principal of and interest on the Securities in respect of which or for the benefit of which such
money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities
for principal and interest, respectively; and
Third: To the Company.
SECTION 6.07. Limitation
on Suits.
No Holder of any Security
of any Series shall have any right to institute any proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment
of a receiver or trustee, or for any other remedy hereunder (except actions for payment of overdue principal and interest), unless:
(a) such
Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that Series;
(b) the
Holders of not less than [ ]% in principal amount of the outstanding Securities of that Series shall have made written request to
the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder;
(c) such
Holder or Holders have offered to the Trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred
in compliance with such request;
(d) the
Trustee for [ ] days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding;
and
(e) no
direction inconsistent with such written request has been given to the Trustee during such [ ]-day period by the Holders of a majority
in principal amount of the outstanding Securities of that Series; it being understood and intended that no one or more of such Holders
shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or prejudice
the rights of any other of such Holders, or to obtain or to seek to obtain priority or preference over any other of such Holders or to
enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders.
SECTION 6.08. Unconditional
Right of Holders to Receive Principal and Interest.
Notwithstanding any other
provision in this Indenture, the Holder of any Security shall have the right, which is absolute and unconditional, to receive payment
of the principal of and interest, if any, on such Security on the Stated Maturity or Stated Maturities expressed in such Security (or,
in the case of redemption, on the redemption date) and to institute suit for the enforcement of any such payment, and such rights shall
not be impaired without the consent of such Holder.
SECTION 6.09. Restoration
of Rights and Remedies.
If the Trustee or any Holder
has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned
for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination
in such proceeding, the Company, the Trustee and the Holders shall be restored severally and respectively to their former positions hereunder
and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted.
SECTION 6.10. Rights
and Remedies Cumulative.
Except as otherwise provided
with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities in Section 2.08, no right or remedy herein
conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right
and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now
or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise,
shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.
SECTION 6.11. Delay
or Omission Not Waiver.
No delay or omission of the
Trustee or of any Holder of any Securities to exercise any right or remedy accruing upon any Event of Default shall impair any such right
or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article
or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed expedient, by the Trustee
or by the Holders, as the case may be.
SECTION 6.12. Control
by Holders.
The Holders of a majority
in principal amount of the outstanding Securities of any Series shall have the right to direct the time, method and place of conducting
any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the
Securities of such Series, provided that
(a) such
direction shall not be in conflict with any rule of law or with this Indenture,
(b) the
Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction; and
(c) subject
to the provisions of Section 6.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith
shall, by a Responsible Officer of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability
or would be unduly prejudicial to the rights of another Holder or the Trustee.
SECTION 6.13. Waiver
of Past Defaults.
Subject to Section 9.02, the
Holders of not less than a majority in principal amount of the outstanding Securities of any Series may on behalf of the Holders of all
the Securities of such Series waive any past Default hereunder with respect to such Series and its consequences, except a Default in the
payment of the principal of or interest on any Security of such Series (provided, however, that the Holders of a majority in principal
amount of the outstanding Securities of any Series may rescind an acceleration and its consequences, including any related payment default
that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising
therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or
other Default or impair any right consequent thereon.
SECTION 6.14. Undertaking
for Costs.
All parties to this Indenture
agree, and each Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court may in its discretion
require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action
taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such
suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any party litigant
in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions
of this Section shall not apply to any suit instituted by the Company, to any suit instituted by the Trustee, to any suit instituted by
any Holder, or group of Holders, holding in the aggregate more than [ ]% in principal amount of the outstanding Securities of any
Series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest on any Security on
or after the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of redemption, on the redemption date).
ARTICLE VII
TRUSTEE
SECTION 7.01. Duties
of Trustee.
(a) If
an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and
use the same degree of care and skill in their exercise as a prudent person would exercise or use under the circumstances in the conduct
of his own affairs.
(b) Except
during the continuance of an Event of Default:
(i) The
Trustee need perform only those duties that are specifically set forth in this Indenture and no implied duties, covenants or obligations
shall be deemed to be imposed upon the Trustee.
(ii) in
the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the
opinions expressed therein, upon Officers’ Certificates or Opinions of Counsel furnished to the Trustee and conforming to the requirements
of this Indenture; however, in the case of any such Officers’ Certificates or Opinions of Counsel which by any provisions hereof are specifically
required to be furnished to the Trustee, the Trustee shall examine such Officers’ Certificates and Opinions of Counsel to determine whether
or not they conform on their face to the requirements of this Indenture.
(c) The
Trustee may not be relieved from liability for its own its own negligent action, its own negligent failure to act or willful misconduct,
except that:
(i) This
paragraph does not limit the effect of paragraph (b) of Section 7.01 herein.
(ii) The
Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer.
(iii) The
Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it with respect to Securities of any
Series in good faith in accordance with the direction of the Holders of a majority in principal amount of the outstanding Securities of
such Series relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such Series.
(d) Every
provision of this Indenture that in any way relates to the Trustee is subject to paragraph (a), (b) and (c) of this Section.
(e) The
Trustee may refuse to perform any duty or exercise any right or power unless it receives an indemnity satisfactory to it against any loss,
liability or expense.
(f) The
Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company.
Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.
(g) No
provision of this Indenture shall require the Trustee to risk or expend its own funds or otherwise incur liability, financial or otherwise,
in the performance of any of its duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing
that repayment of such funds or indemnity satisfactory to it against such risk is not reasonably assured to it.
(h) The
Paying Agent, the Registrar and any authenticating agent shall be entitled to the same rights, indemnities, protections and immunities
afforded to the Trustee.
(i) The
Trustee shall have no duty to monitor the performance or compliance of the Company with its obligations hereunder or any under supplement
hereto, nor shall it have any liability in connection with the malfeasance or nonfeasance by the Company. The Trustee shall have
no liability in connection with compliance by the Company with statutory or regulatory requirements related to this Indenture, any supplement
or any Securities issued pursuant hereto or thereto.
SECTION 7.02. Rights
of Trustee.
(a) The
Trustee may conclusively rely on and shall be fully protected in acting or refraining from acting as a result of its reasonable belief
that any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, direction, approval or other
paper or document was genuine and had been signed or presented by the proper person. The Trustee need not investigate any fact or
matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters
as it sees fit.
(b) Before
the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel or both. The Trustee
shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel.
(c) The
Trustee may act through agents and shall not be responsible for the misconduct or negligence of, or for the supervision of, any agent
appointed with due care. No Depository shall be deemed an agent of the Trustee and the Trustee shall not be responsible for any
act or omission by any Depository.
(d) The
Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights
or powers.
(e) The
Trustee may consult with counsel of its selection and the advice of such counsel or any Opinion of Counsel shall be full and complete
authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.
(f) The
Trustee shall be under no obligation to exercise any of the rights or powers vested in it by or pursuant to this Indenture at the request,
order or direction of any of the Holders of Securities, unless such Holders shall have offered to the Trustee reasonable security or indemnity
satisfactory to it against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.
SECTION 7.03. Individual
Rights of Trustee.
The Trustee, in its individual
or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with the Company or an Affiliate with the
same rights it would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee is also subject
to Sections 7.10 and 7.11.
SECTION 7.04. Trustee’s
Disclaimer.
The Trustee makes no representation
as to the validity or adequacy of this Indenture or the Securities and the recitals contained herein and in the Securities shall be taken
as statements of the Company and not of the Trustee, and the Trustee has no responsibility for such recitals. The Trustee shall not be
accountable for the Company’s use or application of the proceeds from the Securities or for monies paid over to the Company pursuant to
this Indenture, and it shall not be responsible for any statement in the Securities other than its authentication.
SECTION 7.05. Notice
of Defaults.
If a Default or Event of Default
occurs and is continuing with respect to the Securities of any Series and if a Responsible Officer of the Trustee has knowledge or receives
written notice of such event, the Trustee shall mail to each Securityholder of the Securities of that Series, notice of a Default or Event
of Default within [ ] days after it occurs or, if later, after a Responsible Officer of the Trustee has actual knowledge of such
Default or Event of Default. Except in the case of a Default or Event of Default in payment of principal of or interest on any Security
of any Series, including any additional interest that may become payable pursuant to Section 6.02(b), the Trustee may withhold the notice
so long as the Trustee in good faith determines that withholding the notice is in the interests of Securityholders of that Series.
SECTION 7.06. Reports
by Trustee to Holders.
Within [ ] days after
[ ]
in each year, the Trustee shall transmit by mail to all Securityholders, as their names and addresses appear on the register kept by the
Registrar, a brief report dated as of such [ ], in accordance with, and to the extent required under, TIA Section 313.
A copy of each report at the
time of its mailing to Securityholders of any Series shall be filed with the SEC and each stock exchange on which the Securities of that
Series are listed. The Company shall promptly notify the Trustee when Securities of any Series are listed on any stock exchange.
SECTION 7.07. Compensation
and Indemnity.
The Company shall pay to the
Trustee from time to time such compensation for its services as shall be agreed upon in writing. The Trustee’s compensation shall
not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request
for all reasonable out-of-pocket expenses, disbursements and advances incurred by it. Such expenses shall include the reasonable
compensation and expenses of the Trustee’s agents, counsel and other persons not regularly in its employ.
The Company shall indemnify,
defend and hold harmless the Trustee and its officers, directors, employees, representatives and agents, from and against and reimburse
the Trustee for any and all claims, expenses, obligations, liabilities, losses, damages, injuries (to person, property, or natural resources),
penalties, stamp or other similar taxes, actions, suits, judgments, reasonable costs and expenses (including reasonable attorney’s and
agent’s fees and expenses) of whatever kind or nature regardless of their merit, demanded, asserted or claimed against the Trustee directly
or indirectly relating to, or arising from, claims against the Trustee by reason of its participation in the transactions contemplated
hereby, including without limitation all reasonable costs required to be associated with claims for damages to persons or property, and
reasonable attorneys’ and consultants’ fees and expenses and court costs except to the extent caused by the Trustee’s negligence or willful
misconduct. The provisions of this Section 7.07 shall survive the termination of this Agreement or the earlier resignation or removal
of the Trustee. The Company shall defend any claim and the Trustee shall cooperate in the defense. The Trustee may have separate
counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement
made without its consent, which consent shall not be unreasonably withheld or delayed. This indemnification shall apply to officers,
directors, employees, shareholders and agents of the Trustee.
The Company need not reimburse
any expense or indemnify against any loss liability incurred by the Trustee or by any officer, director, employee, shareholder or agent
of the Trustee through negligence or bad faith.
To secure the Company’s payment
obligations in this Section, the Trustee shall have a lien prior to the Securities of any Series on all money or property held or collected
by the Trustee, except that held in trust to pay principal and interest on particular Securities of that Series.
When the Trustee incurs expenses
or renders services after an Event of Default specified in Section 6.01(f) or (g) occurs, the expenses and the compensation for the services
are intended to constitute expenses of administration under any Bankruptcy Law.
SECTION 7.08. Replacement
of Trustee.
A resignation or removal of
the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s acceptance of appointment
as provided in this Section.
The Trustee may resign with
respect to the Securities of one or more Series by so notifying the Company. The Holders of a majority in principal amount of the
Securities of any Series may remove the Trustee with respect to that Series by so notifying the Trustee and the Company. The Company
may remove the Trustee with respect to Securities of one or more Series if:
(a) the
Trustee fails to comply with Section 7.10;
(b) the
Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;
(c) a
Custodian or public officer takes charge of the Trustee or its property; or
(d) the
Trustee becomes incapable of acting.
If the Trustee resigns or
is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee.
Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities
may appoint a successor Trustee to replace the successor Trustee appointed by the Company.
If a successor Trustee with
respect to the Securities of any one or more Series does not take office within [ ] days after the retiring Trustee resigns or is
removed, the retiring Trustee, the Company or the Holders of at least [ ]% in principal amount of the Securities of the applicable
Series may petition any court of competent jurisdiction for the appointment of a successor Trustee.
A successor Trustee shall
deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately after that, the retiring
Trustee shall transfer all property held by it as Trustee to the successor Trustee subject to the lien provided for in Section 7.07, and
subject to the payment of any and all amounts then due and owing to the retiring Trustee, the resignation or removal of the retiring Trustee
shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series
of Securities for which it is acting as Trustee under this Indenture. A successor Trustee shall mail a notice of its succession
to each Securityholder of each such Series. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company’s
obligations under Section 7.07 hereof shall continue for the benefit of the retiring trustee with respect to expenses and liabilities
incurred by it prior to such replacement.
SECTION 7.09. Successor
Trustee by Merger, etc.
If the Trustee consolidates
with, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor
corporation without any further act shall be the successor Trustee with the same effect as if the successor Trustee had been named as
the Trustee herein.
SECTION 7.10. Eligibility;
Disqualification.
This Indenture shall always
have a Trustee who satisfies the requirements of TIA Section 310(a)(1), (2) and (5). The Trustee shall always have a combined capital
and surplus of at least $[ ] as set forth in its most recent published annual report of condition. The Trustee shall comply with
TIA Section 310(b).
SECTION 7.11. Preferential
Collection of Claims Against Company.
The Trustee is subject to
TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed
shall be subject to TTA Section 311(a) to the extent indicated.
ARTICLE VIII
SATISFACTION AND DISCHARGE; DEFEASANCE
SECTION 8.01. Satisfaction
and Discharge of Indenture.
This Indenture shall upon Company
Order cease to be of further effect (except as hereinafter provided in this Section 8.01), and the Trustee, on the demand of and at the
expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when
(a) either
(i)
all Securities theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and
that have been replaced or paid) have been delivered to the Trustee for cancellation; or
(ii) all
such Securities not theretofore delivered to the Trustee for cancellation have become due and payable, or
(1) have
become due and payable, or
(2) will
become due and payable at their Stated Maturity within [ ], or
(3) are
to be called for redemption within [ ] under arrangements satisfactory to the Trustee for the giving of notice of redemption
by the Trustee in the name, and at the expense, of the Company, or
(4) are
deemed paid and discharged pursuant to section 8.03, as applicable; and the Company, in the case of (1), (2) or (3) above, has deposited
or caused to be deposited with the Trustee as trust funds in trust an amount sufficient for the purpose of paying and discharging the
entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, for principal and interest to the date
of such deposit (in the case of Securities which have become due and payable on or prior to the date of such deposit) or to the Stated
Maturity or redemption date, as the case may be;
(b) the
Company has paid or caused to be paid all other sums payable hereunder by the Company; and
(c) the
Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each meeting the applicable requirements of Sections
10.04 and 10.05 and each stating that all conditions precedent herein relating to the satisfaction and discharge of this Indenture have
been complied with and the Trustee receives written demand from the Company to discharge.
Notwithstanding the satisfaction
and discharge of this Indenture, the obligations of the Company to the Trustee under Section 7.07, and, if money shall have been deposited
with the Trustee pursuant to clause (a) of this Section, the provisions of Sections 2.04, 2.07, 2.08, 8.01 8.02 and 8.05 shall survive.
SECTION 8.02. Application
of Trust Funds; Indemnification.
(a) Subject
to the provisions of Section 8.05, all money deposited with the Trustee pursuant to Section 8.01, all money and U.S. Government Obligations
or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.03 or 8.04 and all money received by the Trustee in
respect of U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.03 or 8.04,
shall be held in trust and applied by it, in accordance with the provisions of the Securities and this Indenture, to the payment, either
directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the persons
entitled thereto, of the principal and interest for whose payment such money has been deposited with or received by the Trustee or to
make mandatory sinking fund payments or analogous payments as contemplated by Sections 8.03 or 8.04.
(b) The
Company shall pay and shall indemnify the Trustee and the Agents against any tax, fee or other charge imposed on or assessed against U.S.
Government Obligations or Foreign Government Obligations deposited pursuant to Sections 8.03 or 8.04 or the interest and principal received
in respect of such obligations other than any payable by or on behalf of Holders.
(c) The
Trustee shall, in accordance with the terms of this Indenture, deliver or pay to the Company from time to time, upon Company Request and
at the expense of the Company any U.S. Government Obligations or Foreign Government Obligations or money held by it pursuant to this Indenture
as provided in Sections 8.03 or 8.04 which, in the opinion of a nationally recognized firm of independent certified public accountants,
expressed in a written certification thereof and delivered to the Trustee together with such Company Request, are then in excess of the
amount thereof which then would have been required to be deposited for the purpose for which such U.S. Government Obligations or Foreign
Government Obligations or money were deposited or received. This provision shall not authorize the sale by the Trustee of any U.S.
Government Obligations or Foreign Government Obligations held under this Indenture.
SECTION 8.03. Legal
Defeasance of Securities of any Series.
Unless this Section 8.03 is
otherwise specified, pursuant to Section 2.02(s), to be inapplicable to Securities of any Series, the Company shall be deemed to have
paid and discharged the entire indebtedness on all the outstanding Securities of such Series on the [ ] day after the date
of the deposit referred to in subparagraph (d) hereof, and the provisions of this Indenture, as it relates to such outstanding Securities
of such Series, shall no longer be in effect (and the Trustee, at the expense of the company, shall, at Company Request, execute proper
instruments acknowledging the same), except as to:
(a) the
rights of Holders of Securities of such Series to receive, from the trust funds described in subparagraph (d) hereof, (i) payment of the
principal of and each installment of principal of and interest on the outstanding Securities of such Series on the Stated Maturity of
such principal or installment of principal or interest and (ii) the benefit of any mandatory sinking fund payments applicable to the Securities
of such Series on the day on which such payments are due and payable in accordance with the terms of this Indenture and the Securities
of such Series;
(b) the
provisions of Sections 2.04, 2.07, 2.08, 2.14, 8.02, 8.03 and 8.05; and
(c) the
rights, powers, trust and immunities of the Trustee hereunder; provided that, the following conditions shall have been satisfied:
(d) the
Company shall have deposited or caused to be deposited irrevocably with the Paying Agent as trust funds in trust for the purpose of making
the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of such Securities in
the case of Securities of such Series denominated in Dollars, cash in Dollars (or such other money or currencies as shall then be legal
tender in the United States) and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign
Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal
in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed
on such Paying Agent), not later than [ ] day before the due date of any payment of money, an amount in cash, sufficient,
in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered
to the Trustee and the Paying Agent, to pay and discharge each installment of principal (including mandatory sinking fund or analogous
payments) of and interest, if any, on all the Securities of such Series on the dates such installments of interest or principal are due;
(e) such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument
to which the Company is a party or by which it is bound;
(f) no
Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit
or during the period ending on the [ ] day after such date;
(g) the
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel to the effect that (i) the Company has
received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of execution of this Indenture,
there has been a change in the applicable Federal income tax law, in either case to the effect that, and based thereon such Opinion of
Counsel shall confirm that, the Holders of the Securities of such Series will not recognize income, gain or loss for Federal income tax
purposes as a result of such deposit, defeasance and discharge and will be subject to Federal income tax on the same amount and in the
same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred;
(h) the
Company shall have delivered to the Trustee an Officers’ Certificate stating that the deposit was not made by the Company with the intent
of preferring the Holders of the Securities of such Series over any other creditors of the company or with the intent of defeating, hindering,
delaying or defrauding any other creditors of the Company;
(i) such
deposit shall not result in the trust arising from such deposit constituting an investment company (as defined in the Investment Company
Act of 1940, as amended), or such trust shall be qualified under such Act or exempt from regulation thereunder; and
(j) the
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent
provided for relating to the defeasance contemplated by this Section have been complied with.
SECTION 8.04. Covenant
Defeasance.
Unless this Section 8.04 is
otherwise specified pursuant to Section 2.02(s) to be inapplicable to Securities of any Series, on and after the [ ] day
after the date of the deposit referred to in subparagraph (a) hereof, the Company may omit to comply with any term, provision or condition
set forth under Sections 4.02, 4.03, 4.04, 4.05, 4.06, and 5.01 as well as any additional covenants contained in a supplemental indenture
hereto for a particular Series of Securities or a Board Resolution or an Officers’ Certificate delivered pursuant to Section 2.02(s) (and
the failure to comply with any such covenants shall not constitute a Default or Event of Default under Section 6.01) and the occurrence
of any event described in clause (e) of Section 6.01 shall not constitute a Default or Event of Default hereunder, with respect to the
Securities of such Series, provided that the following conditions shall have been satisfied:
(a) With
reference to this Section 8.04, the Company has deposited or caused to be irrevocably deposited (except as provided in Section 8.02(c))
with the Paying Agent as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders
of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars (or such other money or currencies
as shall then be legal tender in the United States) and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series
denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment
of interest and principal in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax
liability will be imposed on such Paying Agent), not later than [ ] day before the due date of any payment of money, an amount
in cash, sufficient, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written
certification thereof delivered to the Paying Agent, to pay principal and interest, if any, on and any mandatory sinking fund in respect
of the Securities of such Series on the dates such installments of interest or principal are due;
(b) Such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument
to which the Company is a party or by which it is bound;
(c) No
Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit
or during the period ending on the [ ] day after such date;
(d) the
company shall have delivered to the Trustee an Opinion of Counsel confirming that Holders of the Securities of such Series will not recognize
income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income
tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred;
(e) the
Company shall have delivered to the Trustee an Officers’ Certificate stating the deposit was not made by the Company with the intent of
preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering,
delaying or defrauding any other creditors of the Company; and
(f) The
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent
herein provided for relating to the defeasance contemplated by this Section have been complied with.
SECTION 8.05. Repayment
to Company.
The Paying Agent shall pay
to the Company upon request any money held by them for the payment of principal and interest that remains unclaimed for two years.
After that, Securityholders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned
property law designates another person and all liability of the Paying Agent with respect to that money shall cease.
ARTICLE IX
AMENDMENTS AND WAIVERS
SECTION 9.01. Without
Consent of Holders.
The Company and the Trustee
may amend or supplement this Indenture or the Securities of one or more Series without the consent of any Securityholder:
(a) to
cure any ambiguity, defect or inconsistency;
(b) to
comply with Article V;
(c) to
provide for uncertificated Securities in addition to or in place of certificated Securities;
(d) to
make any change that does not adversely affect the rights of any Securityholder;
(e) to
provide for the issuance of and establish the form and terms and conditions of Securities of any Series as permitted by this Indenture;
(f) to
evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more
Series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration
of the trusts hereunder by more than one Trustee;
(g) to
comply with requirements of the TIA and any rules promulgated under the TIA; and
(h) to
add to the covenants of the Company for the equal and ratable benefit of the Holders or to surrender any right, power or option conferred
upon the Company.
Any amendment or supplement
made solely to conform the provisions of this Indenture or the Securities of any Series to the description thereof contained in the final
prospectus relating to such Series will be deemed not to adversely affect the rights of any Holder.
SECTION 9.02. With
Consent of Holders.
The Company and the Trustee
may enter into a supplemental indenture with the written consent of the Holders of at least a majority in principal amount of the outstanding
Securities of all Series affected by such supplemental indenture, taken together as one class (including consents obtained in connection
with a tender offer or exchange offer for the Securities of such Series), for the purpose of adding any provisions to or changing in any
manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights
of the Securityholders of each such Series. Except as provided in Section 6.13, the Holders of at least a majority in principal
amount of the outstanding Securities of all Series affected by such waiver by notice to the Trustee, taken together as one class (including
consents obtained in connection with a tender offer or exchange offer for the Securities of such Series) may waive compliance by the Company
with any provision of this Indenture or the Securities with respect to such Series.
It shall not be necessary
for the consent of the Holders of Securities under this Section 9.02 to approve the particular form of any proposed supplemental indenture
or waiver, but it shall be sufficient if such consent approves the substance thereof. After a supplemental indenture or waiver under
this section becomes effective, the Company shall mail to the Holders of Securities affected thereby a notice briefly describing the supplemental
indenture or waiver. Any failure by the Company to mail or publish such notice, or any defect therein, shall not, however, in any
way impair or affect the validity of any such supplemental indenture or waiver.
SECTION 9.03. Limitations.
Without the consent of each
Securityholder affected, an amendment or waiver may not:
(a) change
the amount of Securities whose Holders must consent to an amendment, supplement or waiver, except to increase any such amount or to provide
that certain provisions of this Indenture cannot be modified, amended or waived without the consent of the Holder of each outstanding
Security affected thereby;
(b) reduce
the amount of interest, or change the interest payment time, on any Security;
(c) waive
a redemption payment or alter the redemption provisions (other than any alteration that would not materially adversely affect the legal
rights of any Holder under this Indenture) or the price at which the Company is required to offer to purchase the Securities;
(d) reduce
the principal or change the Stated Maturity of any Security or reduce the amount of, or postpone the date fixed for, the payment of any
sinking fund or analogous obligation;
(e) reduce
the principal amount payable of any Security upon Maturity;
(f) waive
a Default or Event of Default in the payment of the principal of or interest, if any, on any Security (except a rescission of acceleration
of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series
and a waiver of the payment default that resulted from such acceleration);
(g) change
the place or currency of payment of principal of or interest, if any, on any Security other than that stated in the Security;
(h) impair
the right of any Holder to receive payment of principal or, or interest on, the Securities of such Holder on or after the due dates therefor;
(i) impair
the right to institute suit for the enforcement of any payment on, or with respect to, any Security;
(j) make
any change in Sections 10.15 or 10.16;
(k) change
the ranking of the Securities; or
(l) make
any other change which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate as a limitation
under this Section.
For the avoidance of doubt,
any amendment or waiver shall always be subject to the consent of the Company.
SECTION 9.04. Compliance
with Trust Indenture Act.
Every amendment to this Indenture
or the Securities of one or more Series shall be set forth in a supplemental indenture hereto that complies with the TIA as then in effect.
SECTION 9.05. Revocation
and Effect of Consents.
Until an amendment or waiver
becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder and every subsequent Holder of a Security
or portion of a Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent is not made
on any Security. However, any such Holder or subsequent Holder may revoke the consent as to his Security or portion of a Security
if the Trustee receives the notice of revocation before the date the amendment or waiver becomes effective.
Any amendment or waiver once
effective shall bind every Securityholder of each Series affected by such amendment or waiver unless it is of the type described in any
of clauses (a) through (g) of Section 9.03 in that case, the amendment or waiver shall bind each Holder of a Security who has consented
to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security.
SECTION 9.06. Notation
on or Exchange of Securities.
If an amendment, supplement
or waiver changes the terms of a Security, the Trustee may require the Holder of the Security to deliver it to the Trustee and the Trustee
may place an appropriate notation on the Security about the changed terms and return it to the Holder. Alternatively, if the Company
or the Trustee so determines, the Company shall issue and the Trustee shall authenticate upon request new Securities of that Series that
reflect the changed terms.
SECTION 9.07. Trustee
Protected.
In executing, or accepting
the additional trusts created by, any supplemental indenture permitted by this Article or the modifications thereby of the trusts created
by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an
Opinion of Counsel or an Officer’s Certificate, or both stating that the execution of such supplemental indenture is authorized or permitted
by this Indenture. The Trustee shall sign all supplemental indentures, except that the Trustee need not sign any supplemental indenture
that adversely affects its rights, duties or indemnities.
SECTION 9.08. Effect
of Supplemental Indenture.
Upon the execution of any
supplemental indenture under this Article, this Indenture shall be modified in accordance therewith, and each such supplemental indenture
shall form part of this Indenture for all purposes with respect to the relevant Series; and every Holder of Securities of the relevant
Series theretofore or thereafter authenticated and delivered hereunder shall be bound thereby.
ARTICLE X
MISCELLANEOUS
SECTION 10.01. Trust
Indenture Act Controls.
If any provision of this Indenture
limits, qualifies, or conflicts with another provision which is required or deemed to be included in this Indenture by the TIA, such required
or deemed provision shall control.
SECTION 10.02. Notices.
Any notice or communication
by the Company, the Trustee, the Paying Agent or the Registrar to another is duly given if in writing and delivered in person or mailed
by first-class mail:
if to the Company:
[
]
Attn: [
]
Fax: [
]
if to the Trustee:
if to the Registrar or Paying
Agent:
[ ]
Attn: [ ]
Fax: [
]
with copy to:
[ ]
Attn: [
]
Fax: [
]
The Company, the Trustee and
each Agent by notice to each other may designate additional or different addresses for subsequent notices or communications.
Any notice or communication
to a Securityholder shall be mailed by first-class mail to his address shown on the register kept by the Registrar. Failure to mail
a notice or communication to a Securityholder of any Series or any defect in it shall not affect its sufficiency with respect to other
Securityholders of that or any other Series.
If a notice or communication
is mailed or published in the manner provided above, within the time prescribed, it is duly given, whether or not the Securityholder receives
it.
If the company mails a notice
or communication to Securityholders, it will mail a copy to the Trustee and each Agent at the same time.
Whenever a notice is required
to be given by the Company, such notice may be given by the Trustee or Registrar on the Company’s behalf (and the Company will make any
notice it is required to give to Holders available on its website).
SECTION 10.03. Communication
by Holders with Other Holders.
Securityholders of any Series
may communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or any other Series with respect to their rights
under this Indenture or the Securities of that Series or all Series. The Company, the Trustee, the Registrar and anyone else shall
have the protection of TIA Section 312(c).
SECTION 10.04. Certificate
and Opinion as to Conditions Precedent.
Upon any request or application
by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:
(a) an
Officers’ Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating
to the proposed action have been complied with; and
(b) an
Opinion of Counsel stating that, in the opinion of counsel, all such conditions precedent (including any covenants, compliance with which
constitutes a condition precedent) have been complied with.
SECTION 10.05. Statements
Required in Certificate or Opinion.
Each certificate or opinion
with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to
TIA Section 314(a)(4)) shall comply with the provisions of TIA Section 314(e) and shall include:
(a) a
statement that the person making such certificate or opinion has read such covenant or condition;
(b) a
brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained
in such certificate or opinion are based;
(c) a
statement that, in the opinion of such person, he has made such examination or investigation as is necessary to enable him to express
an informed opinion as to whether or not such covenant or condition has been complied with; and
(d) a
statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.
provided, however, that with respect to
matters of fact an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials.
SECTION 10.06. Record
Date for Vote or Consent of Holders.
The Company (or, in the event
deposits have been made pursuant to Section 11.02, the Trustee) may set a record date for purposes of determining the identity of Holders
entitled to vote or consent to any action by vote or consent authorized or permitted under this Indenture, which record date shall not
be more than [ ] days prior to the date of the commencement of solicitation of such action. Notwithstanding the provisions
of Section 9.05, if a record date is fixed, those persons who were Holders of Securities at the close of business on such record date
(or their duly designated proxies), and only those persons, shall be entitled to take such action by vote or consent or to revoke any
vote or consent previously given, whether or not such persons continue to be Holders after such record date.
SECTION 10.07. Rules
by Trustee and Agents.
The Trustee may make reasonable
rules for action by or a meeting of Securityholders of one or more Series. Any Agent may make reasonable rules and set reasonable
requirements for its functions.
SECTION 10.08. Legal
Holidays.
Unless otherwise provided
by Board Resolution, Officers’ Certificate or supplemental indenture for a particular Series, a “Legal Holiday” is any day that
is not a Business Day. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next
succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period.
SECTION 10.09. No
Recourse Against Others.
A director, officer, employee
or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture
or for any claim based on, in respect of or by reason of such obligations or their creation. Each Securityholder by accepting a
Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities.
SECTION 10.10. Counterparts.
This Indenture may be executed
in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be
an original and all of which taken together shall constitute one and the same agreement.
SECTION 10.11. Governing
Laws and Submission to Jurisdiction.
THIS INDENTURE AND THE SECURITIES
SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK EXCLUDING ANY RULE OF LAW THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION
OTHER THAN THE STATE OF NEW YORK.
The Company agrees that any
legal suit, action or proceeding arising out of or based upon this Indenture may be instituted in any federal or state court sitting in
New York City, and, to the fullest extent permitted by law, waives any objection which it may now or hereafter have to the laying of venue
of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such court in any suit, action or proceeding.
The Company, as long as any Securities remain outstanding or the parties hereto have any obligation under this Indenture, shall have an
authorized agent in the United States upon whom process may be served in any such legal action or proceeding. Service of process upon
such agent and written notice of such service mailed or delivered to it shall to the extent permitted by law be deemed in every respect
effective service of process upon it in any such legal action or proceeding and, if it fails to maintain such agent, any such process
or summons may be served by mailing a copy thereof by registered mail, or a form of mail substantially equivalent thereto, addressed to
it at its address as provided for notices hereunder. The Company hereby appoints Seward & Kissel LLP, One Battery Park Plaza, New
York, NY, 10004, as its agent for such purposes, and covenants and agrees that service of process in any legal action or proceeding
may be made upon it at such office of such agent.
SECTION 10.12. No
Adverse Interpretation of Other Agreements.
This Indenture may not be
used to interpret another indenture, loan or debt agreement of the Company or a Subsidiary. Any such indenture, loan or debt agreement
may not be used to interpret this Indenture.
SECTION 10.13. Successors.
All agreements of the Company
in this Indenture and the Securities shall bind its successor. All agreements of the Trustee in this Indenture shall bind its successor.
SECTION 10.14. Severability.
In case any provision in this
Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby.
SECTION 10.15. Table
of Contents, Headings, Etc.
The Table of Contents, Cross
Reference Table, and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are
not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.
SECTION 10.16. Securities
in a Foreign Currency or in ECU.
Unless otherwise specified
in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to Section 2.02 of this Indenture
with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a
specified percentage in aggregate principal amount of Securities of all Series or all Series affected by a particular action at the time
outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars
(including ECUs), then the principal amount of Securities of such Series which shall be deemed to be outstanding for the purpose of taking
such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For
purposes of this Section 10.16, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for cable transfers
of that currency as published by the Federal Reserve Bank of New York; provided, however, in the case of ECUs, Market Exchange Rate shall
mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal
of the European Union (such publication or any successor publication, the “Journal”). If such Market Exchange Rate is
not available for any reason with respect to such currency, the Trustee shall use, without liability on its part, such quotation of the
Federal Reserve Bank of New York or, in the case of ECUs, the rate of exchange as published in the Journal, as of the most recent available
date, or quotations or, in the case of ECUs, rates of exchange from one or more major banks in The City of New York or in the country
of issue of the currency in question or, in the case of ECUs, in Luxembourg or such other quotations or, in the case of ECUs, rates of
exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall apply
in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection
with any action taken by Holders of Securities pursuant to the terms of this Indenture.
All decisions and determinations
of the Trustee regarding the Market Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in
its sole discretion and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all purposes and irrevocably
binding upon the Company and all Holders.
SECTION 10.17. Judgment
Currency.
The Company agrees, to the
fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is
necessary to convert the sum due in respect of the principal of or interest or other amount on the Securities of any Series (the “Required
Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall
be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency
with the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a New York Banking Day,
then, the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in
The City of New York the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which final unappealable
judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged
or satisfied by any tender, any recovery pursuant to any judgment (whether or not entered in accordance with subsection (a)), in any currency
other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee,
of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative
or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt
shall fall short of the full amount of the Required Currency so expressed to be payable, and (iii) shall not be affected by judgment being
obtained for any other sum due under this Indenture. For purposes of the foregoing, “New York Banking Day” means any day
except a Saturday, Sunday or a legal holiday in The City of New York on which banking institutions are authorized or required by law,
regulation or executive order to close.
SECTION 10.18. Compliance with Applicable Anti-Terrorism and Money Laundering Regulations.
In order to comply with the
laws, rules, regulations and executive orders in effect from time to time applicable to banking institutions, including those relating
to the funding of terrorist activities and money laundering (“Applicable Law”), the Trustee is required to obtain, verify and
record certain information relating to individuals and entities which maintain a business relationship with the Trustee. Accordingly,
each of the parties agree to provide to the Trustee, upon its request from time to time such identifying information and documentation
as may be available for such party in order to enable the Trustee to comply with the Applicable Law.
ARTICLE XI
SINKING FUNDS
SECTION 11.01. Applicability
of Article.
The provisions of this Article
shall be applicable to any sinking fund for the retirement of the Securities of a Series, except as otherwise permitted or required by
any form of Security of such Series issued pursuant to this Indenture.
The minimum amount of any
sinking fund payment provided for by the terms of the Securities of any Series is herein referred to as a “mandatory sinking fund
payment” and any other amount provided for by the terms of Securities of such Series is herein referred to as an “optional sinking
fund payment.” If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment may be subject
to reduction as provided in Section 11.02. Each sinking fund payment shall be applied to the redemption of Securities of any Series
as provided for by the terms of the securities of such Series.
SECTION 11.02. Satisfaction
of Sinking Fund Payments with Securities.
The Company may, in satisfaction
of all or any part of any sinking fund payment with respect to the Securities of any Series to be made pursuant to the terms of such Securities
(1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities
previously called for mandatory sinking fund redemption) and (2) apply as credit Securities of such Series to which such sinking fund
payment is applicable and which have been redeemed either at the election of the Company pursuant to the terms of such Series of Securities
(except pursuant to any mandatory sinking fund) or through the application of permitted optional sinking fund payments or other optional
redemptions pursuant to the terms of such Securities, provided that such Securities have not been previously so credited. Such Securities
shall be received by the Registrar, together with an Officers’ Certificate with respect thereto, not later than [ ] days prior to
the date on which the Registrar begins the process of selecting Securities for redemption, and shall be credited for such purpose by the
Registrar at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking
fund payment shall be reduced accordingly. If as a result of the delivery or credit of Securities in lieu of cash payments pursuant
to this Section 11.02, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment
shall be less than $[ ], the Registrar need not call Securities of such Series for redemption, except upon receipt of a Company Order that
such action be taken, and such cash payment shall be held by the Paying Agent and applied to the next succeeding sinking fund payment,
provided, however, that the Paying Agent shall from time to time upon receipt of a Company Order pay over and deliver to the Company any
cash payment so being held by the Paying Agent upon delivery by the Company to the Registrar of Securities of that Series purchased by
the Company having an unpaid principal amount equal to the cash payment required to be released to the Company.
SECTION 11.03. Redemption
of Securities for Sinking Fund.
Not less than [ ] days
(unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers’ Certificate in respect of a particular
Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee and
the Paying Agent an Officers’ Certificate specifying the amount of the next ensuing mandatory sinking fund payment for that Series pursuant
to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any,
which is to be satisfied by delivering and crediting of Securities of that Series pursuant to Section 11.02., and the optional amount,
if any, to be added in cash to the next ensuing mandatory sinking fund payment, and the Company shall thereupon be obligated to pay the
amount therein specified. Not less than [ ] days (unless otherwise indicated in the Board Resolution, Officers’ Certificate
or supplemental indenture in respect of a particular Series of Securities) before each such sinking fund payment date the Trustee shall
select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 and cause notice of the
redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.03. Such notice
having been duly given, the redemption of such Securities shall stated in Sections 3.04, 3.05 and 3.06.
[The remainder of this page is intentionally
left blank]
IN WITNESS WHEREOF, the parties
hereto have caused this Indenture to be duly executed as of the day and year first above written.
LICHEN CHINA LIMITED |
|
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
[ ] |
|
as Trustee |
|
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
[ ] |
|
as Registrar and Paying Agent |
|
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
35
Exhibit 4.3
Lichen China Limited
FORM OF
SUBORDINATED INDENTURE
Dated as of [
], 20[ ]
[
]
Trustee
TABLE OF CONTENTS
|
PAGE |
ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE |
1 |
SECTION 1.01. |
Definitions. |
1 |
SECTION 1.02. |
Other Definitions. |
4 |
SECTION 1.03. |
Incorporation by Reference of Trust Indenture Act. |
4 |
SECTION 1.04. |
Rules of Construction. |
4 |
|
|
ARTICLE II THE SECURITIES |
5 |
SECTION 2.01. |
Issuable in Series. |
5 |
SECTION 2.02. |
Establishment of Terms of Series of Securities. |
5 |
SECTION 2.03. |
Execution and Authentication. |
6 |
SECTION 2.04. |
Registrar and Paying Agent. |
7 |
SECTION 2.05. |
Paying Agent to Hold Money in Trust. |
8 |
SECTION 2.06. |
Securityholder Lists. |
8 |
SECTION 2.07. |
Transfer and Exchange. |
8 |
SECTION 2.08. |
Mutilated, Destroyed, Lost and Stolen Securities. |
8 |
SECTION 2.09. |
Outstanding Securities. |
9 |
SECTION 2.10. |
Treasury Securities. |
9 |
SECTION 2.11. |
Temporary Securities. |
9 |
SECTION 2.12. |
Cancellation. |
10 |
SECTION 2.13. |
Defaulted Interest. |
10 |
SECTION 2.14. |
Global Securities. |
10 |
SECTION 2.15. |
CUSIP Numbers. |
11 |
|
|
ARTICLE III REDEMPTION |
12 |
SECTION 3.01. |
Notice to Trustee. |
12 |
SECTION 3.02. |
Selection of Securities to be Redeemed. |
12 |
SECTION 3.03. |
Notice of Redemption. |
12 |
SECTION 3.04. |
Effect of Notice of Redemption. |
12 |
SECTION 3.05. |
Deposit of Redemption Price. |
13 |
SECTION 3.06. |
Securities Redeemed in Part. |
13 |
|
|
ARTICLE IV COVENANTS |
13 |
SECTION 4.01. |
Payment of Principal and Interest. |
13 |
SECTION 4.02. |
SEC Reports. |
13 |
SECTION 4.03. |
Compliance Certificate. |
14 |
SECTION 4.04. |
Stay, Extension and Usury Laws. |
14 |
SECTION 4.05. |
Corporate Existence. |
14 |
SECTION 4.06. |
Taxes. |
14 |
SECTION 4.07. |
Additional Interest Notice. |
15 |
SECTION 4.08. |
Further Instruments and Acts. |
15 |
|
|
ARTICLE V SUCCESSORS |
15 |
SECTION 5.01. |
When Company May Merge, Etc. |
15 |
SECTION 5.02. |
Successor Corporation Substituted. |
15 |
|
|
ARTICLE VI DEFAULTS AND REMEDIES |
15 |
SECTION 6.01. |
Events of Default. |
15 |
SECTION 6.02. |
Acceleration of Maturity; Rescission and Annulment. |
17 |
SECTION 6.03. |
Collection of Indebtedness and Suits for Enforcement by Trustee. |
18 |
SECTION 6.04. |
Trustee May File Proofs of Claim. |
18 |
SECTION 6.05. |
Trustee May Enforce Claims Without Possession of Securities. |
18 |
SECTION 6.06. |
Application of Money Collected. |
19 |
SECTION 6.07. |
Limitation on Suits. |
19 |
SECTION 6.08. |
Unconditional Right of Holders to Receive Principal and Interest. |
19 |
SECTION 6.09. |
Restoration of Rights and Remedies. |
19 |
SECTION 6.10. |
Rights and Remedies Cumulative. |
19 |
SECTION 6.11. |
Delay or Omission Not Waiver. |
20 |
SECTION 6.12. |
Control by Holders. |
20 |
SECTION 6.13. |
Waiver of Past Defaults. |
20 |
SECTION 6.14. |
Undertaking for Costs. |
20 |
|
|
ARTICLE VII TRUSTEE |
21 |
SECTION 7.01. |
Duties of Trustee. |
21 |
SECTION 7.02. |
Rights of Trustee. |
22 |
SECTION 7.03. |
Individual Rights of Trustee. |
22 |
SECTION 7.04. |
Trustee’s Disclaimer. |
22 |
SECTION 7.05. |
Notice of Defaults. |
22 |
SECTION 7.06. |
Reports by Trustee to Holders. |
22 |
SECTION 7.07. |
Compensation and Indemnity. |
23 |
SECTION 7.08. |
Replacement of Trustee. |
23 |
SECTION 7.09. |
Successor Trustee by Merger, etc. |
24 |
SECTION 7.10. |
Eligibility; Disqualification. |
24 |
SECTION 7.11. |
Preferential Collection of Claims Against Company. |
24 |
ARTICLE VIII SATISFACTION AND DISCHARGE; DEFEASANCE |
24 |
SECTION 8.01. |
Satisfaction and Discharge of Indenture. |
24 |
SECTION 8.02. |
Application of Trust Funds; Indemnification. |
25 |
SECTION 8.03. |
Legal Defeasance of Securities of any Series. |
26 |
SECTION 8.04. |
Covenant Defeasance. |
27 |
SECTION 8.05. |
Repayment to Company. |
27 |
|
|
ARTICLE IX AMENDMENTS AND WAIVERS |
28 |
SECTION 9.01. |
Without Consent of Holders. |
28 |
SECTION 9.02. |
With Consent of Holders. |
28 |
SECTION 9.03. |
Limitations. |
28 |
SECTION 9.04. |
Compliance with Trust Indenture Act. |
29 |
SECTION 9.05. |
Revocation and Effect of Consents. |
29 |
SECTION 9.06. |
Notation on or Exchange of Securities. |
29 |
SECTION 9.07. |
Trustee Protected. |
29 |
SECTION 9.08. |
Effect of Supplemental Indenture. |
30 |
|
|
ARTICLE X MISCELLANEOUS |
30 |
SECTION 10.01. |
Trust Indenture Act Controls. |
30 |
SECTION 10.02. |
Notices. |
30 |
SECTION 10.03. |
Communication by Holders with Other Holders. |
31 |
SECTION 10.04. |
Certificate and Opinion as to Conditions Precedent. |
31 |
SECTION 10.05. |
Statements Required in Certificate or Opinion. |
31 |
SECTION 10.06. |
Record Date for Vote or Consent of Holders. |
31 |
SECTION 10.07. |
Rules by Trustee and Agents. |
32 |
SECTION 10.08. |
Legal Holidays. |
32 |
SECTION 10.09. |
No Recourse Against Others. |
32 |
SECTION 10.10. |
Counterparts. |
32 |
SECTION 10.11. |
Governing Laws and Submission to Jurisdiction. |
32 |
SECTION 10.12. |
No Adverse Interpretation of Other Agreements. |
32 |
SECTION 10.13. |
Successors. |
32 |
SECTION 10.14. |
Severability. |
33 |
SECTION 10.15. |
Table of Contents, Headings, Etc. |
33 |
SECTION 10.16. |
Securities in a Foreign Currency or in ECU. |
33 |
SECTION 10.17. |
Judgment Currency. |
33 |
SECTION 10.18. |
Compliance with Applicable Anti-Terrorism and Money Laundering Regulations. |
34 |
|
|
ARTICLE XI SINKING FUNDS |
34 |
SECTION 11.01. |
Applicability of Article. |
34 |
SECTION 11.02. |
Satisfaction of Sinking Fund Payments with Securities. |
34 |
SECTION 11.03. |
Redemption of Securities for Sinking Fund. |
34 |
Reconciliation and tie between Trust Indenture
Act of 1939 and Indenture,
Dated as of [ ], 20[ ]
Section 310(a)(1) |
7.10 |
(a)(2) |
7.10 |
(a)(3) |
Not Applicable |
(a)(4) |
Not Applicable |
(a)(5) |
7.10 |
(b) |
7.10 |
(c) |
Not Applicable |
Section 311(a) |
7.11 |
(b) |
7.11 |
(c) |
Not Applicable |
Section 312(a) |
2.06 |
(b) |
10.03 |
(c) |
10.03 |
Section 313(a) |
7.06 |
(b)(1) |
7.06 |
(b)(2) |
7.06 |
(c)(1) |
7.06 |
(d) |
7.06 |
Section 314(a) |
4.02, 10.05 |
(b) |
Not Applicable |
(c)(1) |
10.04 |
(c)(2) |
10.04 |
(c)(3) |
Not Applicable |
(d) |
Not Applicable |
(e) |
10.05 |
(f) |
Not Applicable |
Section 315(a) |
7.01 |
(b) |
7.05 |
(c) |
7.01 |
(d) |
7.01 |
(e) |
6.14 |
Section 316(a)(1)(A) |
6.12 |
(a)(1)(B) |
6.13 |
(a)(2) |
Not Applicable |
(b) |
6.13 |
(c) |
10.06 |
Section 317(a)(1) |
6.03 |
(a)(2) |
6.04 |
(b) |
2.05 |
Section 318(a) |
10.01 |
Note: This reconciliation and tie shall not, for any purpose,
be deemed to be part of the Indenture.
Indenture dated as of [
], 20[ ] between Lichen China Limited, a company organized under the laws of the Cayman Islands
(the “Company”) and [ ] (the “Trustee”).
Each party agrees as follows for the benefit of the
other party and for the equal and ratable benefit of the Holders of the Securities issued under this Indenture.
ARTICLE I
DEFINITIONS AND INCORPORATION BY REFERENCE
SECTION 1.01. |
Definitions. |
“Additional Amounts”
means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid
by the Company in respect of certain taxes imposed on Holders specified therein and which are owing to such Holders.
“Affiliate”
of any specified person means any other person directly or indirectly controlling or controlled by or under direct or indirect common
control with such specified person. For the purposes of this definition, “control” (including, with correlative meanings,
the terms “controlled by” and “under common control with”), as used with respect to any person, shall mean the
possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such person, whether
through the ownership of voting securities or by agreement or otherwise.
“Agent”
means any Registrar or Paying Agent.
“Bankruptcy Law”
means Title 11 of the United States Code (or any successor thereto) or any similar federal or state law for the relief of debtors.
“Board of Directors”
means the board of directors of the Company or any duly authorized committee thereof.
“Board Resolution”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been adopted by the Board of
Directors or pursuant to authorization by the Board of Directors and to be in full force and effect on the date of the certificate and
delivered to the Trustee.
“Business Day”
means any day other than a (x) Saturday, (y) Sunday or (z) day on which state or federally chartered banking institutions in New York,
New York are not required to be open.
“Capital Stock”
of any Person means any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests
in (however designated) equity of such Person, but excluding any debt securities convertible into such equity.
“Certificated Securities”
means Securities in the form of physical, certificated Securities in registered form.
“Company”
means the party named as such above until a successor replaces it in accordance with the terms of this Indenture and thereafter means
the successor.
“Company Order”
means a written order signed in the name of the Company by two Officers, one of whom must be the Company’s principal executive officer,
principal financial officer or principal accounting officer.
“Company Request”
means a written request signed in the name of the Company by its Chairman of the Board, a President or a Vice President, and by its Chief
Financial Officer, its Secretary or an Assistant Secretary, and delivered to the Trustee.
“Corporate Trust
Office” means the office of the Trustee at which at any particular time its corporate trust business shall be principally administered
which office at the date of the execution of this Indenture is [
], Attention: [ ], or at such other address as the Trustee may designate
from time to time.
“Custodian”
means any receiver, trustee, assignee, liquidator, sequestrator or similar official under any Bankruptcy Law.
“Default”
or “default” means any event which is, or after notice or passage of time or both would be, an Event of Default.
“Default Rate”
means the default rate of interest specified in the Securities.
“Depository”
means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities,
the person designated as Depository for such Series by the Company, which Depository shall be a clearing agency registered under the Exchange
Act; and if at any time there is more than one such person, “Depository” as used with respect to the Securities of any Series
shall mean the Depository with respect to the Securities of such Series.
“Discount Security”
means any Security that provides for an amount less than the stated principal amount thereof to be due and payable upon declaration of
acceleration of the maturity thereof pursuant to Section 6.02.
“Dollars”
means the currency of The United States of America.
“ECU” means
the European Currency Unit as determined by the Commission of the European Union.
“Exchange Act”
means the Securities Exchange Act of 1934, as amended.
“Foreign Currency”
means any currency or currency unit issued by a government other than the government of The United States of America.
“Foreign Government
Obligations” means with respect to Securities of any Series that are denominated in a Foreign Currency, (i) direct obligations
of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged
or (ii) obligations of a person controlled or supervised by or acting as an agency or instrumentality of such government the timely payment
of which is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i)
or (ii), are not callable or redeemable at the option of the issuer thereof.
“Global Security”
or “Global Securities” means a Security or Securities, as the case may be, in the form established pursuant to Section
2.02 evidencing all or part of a Series of Securities, issued to the Depository for such Series or its nominee, and registered in the
name of such Depository or nominee.
“Holder”
or “Securityholder” means a person in whose name a Security is registered.
“Indenture”
means this Indenture as amended and supplemented from time to time and shall include the form and terms of particular Series of Securities
established as contemplated hereunder.
“Interest,”
in respect of the Securities, unless the context otherwise requires, refers to interest payable on the Securities, including any additional
interest that may become payable pursuant to Section 6.02(b).
“Maturity,”
when used with respect to any Security or installment of principal thereof, means the date on which the principal of such Security or
such installment of principal becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration
of acceleration, call for redemption, notice of option to elect repayment or otherwise.
“Officer”
means the Chairman of the Board, the President, any Vice-President, the Treasurer, the Secretary, any Assistant Treasurer or any Assistant
Secretary of the Company.
“Officers’
Certificate” means a certificate signed by two Officers, one of whom must be the Company’s principal executive officer,
principal financial officer or principal accounting officer.
“Opinion of Counsel”
means a written opinion of legal counsel who is, and which opinion is, acceptable to the Trustee and its counsel. Such legal counsel
may be an employee of or counsel to the Company or the Trustee.
“Person”
means any individual, corporation, partnership, joint venture, association, limited liability company, joint-stock company, trust, unincorporated
organization or government or any agency or political subdivision thereof.
“Principal”
or “principal” of a Security means the principal of the Security plus, when appropriate, the premium, if any, on, and
any Additional Amounts in respect of, the Security.
“Responsible Officer”
means any officer of the Trustee in its Corporate Trust Office and also means, any vice president, managing director, director, associate,
assistant vice president, or any other officer of the Trustee customarily performing functions similar to those performed by any of the
above designated officers and also, with respect to a particular corporate trust matter, any other officer to whom any corporate trust
matter is referred because of his or her knowledge of and familiarity with a particular subject.
“SEC” means
the Securities and Exchange Commission.
“Security”
or “Securities” means the debentures, notes or other debt instruments of the Company of any Series authenticated and
delivered under this Indenture.
“Series”
or “Series of Securities” means each series of debentures, notes or other debt instruments of the Company created pursuant
to Sections 2.01 and 2.02 hereof.
“Stated Maturity”
when used with respect to any Security or any installment of principal thereof or interest thereon, means the date specified in such Security
as the fixed date on which the principal of such Security or such installment of principal or interest is due and payable.
“Subordinated Indebtedness”
means any indebtedness which is expressly subordinated to the indebtedness evidenced by Securities.
“Subsidiary”
means, in respect of any Person, any corporation, association, partnership or other business entity of which more than 50% of the total
voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence
of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled,
directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries
of such Person.
“TIA” means
the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb) as in effect on the date of this Indenture; provided, however, that
in the event the Trust Indenture Act of 1939 is amended after such date, “TIA” means, to the extent required by any such amendment,
the Trust Indenture Act as so amended.
“Trustee”
means the person named as the “Trustee” in the first paragraph of this instrument until a successor Trustee shall have become
such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each person who
is then a Trustee hereunder, and if at any time there is more than one such person, “Trustee” as used with respect to the
Securities of any Series shall mean the Trustee with respect to Securities of that Series.
“U.S. Government
Obligations” means securities which are (i) direct obligations of The United States of America for the payment of which its
full faith and credit is pledged or (ii) obligations of a person controlled or supervised by and acting as an agency or instrumentality
of The United States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by The United
States of America, and which in the case of (i) and (ii) are not callable or redeemable at the option of the issuer thereof, and shall
also include a depository receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or
a specific payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder
of a depository receipt, provided that (except as required by law) such custodian is not authorized to make any deduction from the amount
payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation
evidenced by such depository receipt.
SECTION 1.02. |
Other Definitions. |
TERM |
|
DEFINED IN
SECTION |
“Applicable Law” |
|
10.18 |
“Event of Default” |
|
6.01 |
“Instrument” |
|
6.01 |
“Journal” |
|
10.16 |
“Judgment Currency” |
|
10.17 |
“Legal Holiday” |
|
10.08 |
“mandatory sinking fund payment” |
|
11.01 |
“Market Exchange Rate” |
|
10.16 |
“New York Banking Day” |
|
10.17 |
“optional sinking fund payment” |
|
11.01 |
“Paying Agent” |
|
2.04 |
“Registrar” |
|
2.04 |
“Required Currency” |
|
10.17 |
“successor person” |
|
5.01 |
“Temporary Securities” |
|
2.11 |
SECTION 1.03. |
Incorporation by Reference of Trust Indenture Act. |
Whenever this Indenture refers
to a provision of the TIA, the provision is incorporated by reference in and made a part of this Indenture. This Indenture shall
also include those provisions of the TIA required to be included herein by the provisions of the Trust Indenture Reform Act of 1990.
The following TIA terms used in this Indenture have the following meanings:
“indenture securities”
means the Securities.
“indenture security
holder” means a Securityholder.
“indenture to be
qualified” means this Indenture.
“indenture trustee”
or “institutional trustee” means the Trustee.
“obligor”
on the indenture securities means the Company and any successor obligor upon the Securities.
All other terms used in this
Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule under the TIA and not otherwise
defined herein are used herein as so defined.
SECTION 1.04. |
Rules of
Construction. |
Unless the context otherwise
requires:
(a) a
term has the meaning assigned to it;
(b) an
accounting term not otherwise defined has the meaning assigned to it in accordance with generally accepted accounting principles;
(c) references
to “generally accepted accounting principles” shall mean generally accepted accounting principles in effect as of the time
when and for the period as to which such accounting principles are to be applied;
(d) “or”
is not exclusive;
(e) words
in the singular include the plural, and in the plural include the singular;
(f) provisions
apply to successive events and transactions;
(g) references
to agreements and other instruments include subsequent amendments thereto;
(h) the
term “merger” includes a statutory share exchange, and the term “merged” has a correlative meaning; and
(i)
“herein,” “hereof” and other words of similar import refer to this Indenture as a whole and not to any
particular Article, Section or other subdivision.
ARTICLE II
THE SECURITIES
SECTION 2.01. |
Issuable in Series. |
The aggregate principal amount
of Securities that may be authenticated and delivered under this Indenture is unlimited. The Securities may be issued in one or
more Series. All Securities of a Series shall be identical except as may be set forth in a Board Resolution, a supplemental indenture
or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the authority granted under a Board Resolution.
In the case of Securities of a Series to be issued from time to time, the Board Resolution, Officers’ Certificate or supplemental
indenture may provide for the method by which specified terms (such as interest rate, maturity date, record date or date from which interest
shall accrue) are to be determined. Securities may differ between Series in respect of any matters, provided that all Series of
Securities shall be equally and ratably entitled to the benefits of the Indenture.
SECTION 2.02. |
Establishment of Terms of Series of Securities. |
At or prior to the issuance
of any Securities within a Series, the following shall be established (as to the Series generally, in the case of Subsection (a), and
either as to such Securities within the Series or as to the Series generally in the case of Subsections (b) through (t) by a Board Resolution,
a supplemental indenture or an Officers’ Certificate pursuant to authority granted under a Board Resolution:
(a) the
title, designation, aggregate principal amount and authorized denominations of the Securities of the Series;
(b) the
price or prices, (expressed as a percentage of the aggregate principal amount thereof) at which the Securities of the Series will be issued;
(c) the
date or dates on which the principal of the Securities of the Series is payable;
(d) the
rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such rate or rates (including,
but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall
bear interest, if any, the date or dates from which such interest, if any, shall commence and be payable and any regular record date for
the interest payable on any interest payment date;
(e) any
optional or mandatory sinking fund provisions or conversion or exchangeability provisions upon which Securities of the Series shall be
redeemed, purchased, converted or exchanged;
(f) the
date, if any, after which and the price or prices at which the Securities of the Series may be optionally redeemed or must be mandatorily
redeemed and any other terms and provisions of optional or mandatory provisions;
(g) if
other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities of the Series shall be
issuable;
(h) if
other than the full principal amount, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration
of acceleration pursuant to Section 6.02 or provable in bankruptcy;
(i) any
addition to or change in the Events of Default which applies to any Securities of the Series and any change in the right of the Trustee
or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.02;
(j) the
currency or currencies, including composite currencies, in which payments of principal of, premium or interest, if any, on the Securities
of the Series will be payable, if other than the currency of the United States of America;
(k) if
payments of principal of, premium or interest, if any, on the Securities of the Series will be payable, at the Company’s election
or at the election of any Holder, in a currency other than that in which the Securities of the Series are stated to be payable, the period
or periods within which, and the terms and conditions upon which, the election may be made;
(l) if
payments of interest, if any, on the Securities of the Series will be payable, at the Company’s election or at the election of any
Holder, in cash or additional securities, and the terms and conditions upon which the election may be made;
(m) if
denominated in a currency or currencies other than the currency of the United States of America, the equivalent price of the Securities
of the Series in the currency of the United States of America for purposes of determining the voting rights of Holders of the Securities
of the Series;
(n) if
the amount of payments of principal, premium or interest may be determined with reference to an index, formula or other method based on
a coin or currency other than that in which the Securities of the Series are stated to be payable, the manner in which the amounts will
be determined;
(o) any
restrictive covenants or other material terms relating to the Securities of the Series;
(p) whether
the Securities of the Series will be issued in the form of global securities or certificates in registered form;
(q) any
terms with respect to subordination;
(r) any
listing on any securities exchange or quotation system;
(s) additional
provisions, if any, related to defeasance and discharge of the offered debt securities; and
(t) the
applicability of any guarantees, which would be governed by New York law.
All Securities of any one
Series need not be issued at the same time and may be issued from time to time, consistent with the terms of this Indenture, if so provided
by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, and the authorized principal
amount of any Series may not be increased to provide for issuance of additional Securities of such Series, unless otherwise provided in
such Board Resolution, supplemental Indenture or Officers’ Certificate.
SECTION 2.03. |
Execution and Authentication. |
Two Officers shall sign the
Securities for the Company by manual or facsimile signature.
If an Officer whose signature
is on a Security no longer holds that office at the time the Security is authenticated, the Security shall nevertheless be valid.
A Security shall not be valid
until authenticated by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence
that the Security has been authenticated under this Indenture.
The Trustee shall at any time,
and from time to time, authenticate Securities for original issue in the principal amount provided in the Board Resolution, supplemental
indenture hereto or Officers’ Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize
authentication and delivery pursuant to oral or electronic instructions from the Company or its duly authorized agent or agents, which
oral instructions shall be promptly confirmed in writing. Each Security shall be dated the date of its authentication unless otherwise
provided by a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate.
The aggregate principal amount
of Securities of any Series outstanding at any time may not exceed any limit upon the maximum principal amount for such Series set forth
in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.02, except as provided
in Section 2.08.
Prior to the issuance of Securities
of any Series, the Trustee shall have received and (subject to Section 7.02) shall be fully protected in relying on: (a) the Board Resolution,
supplemental indenture hereto or Officers Certificate establishing the form of the Securities of that Series or of Securities within that
Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers’ Certificate complying
with Section 10.04, and (c) an Opinion of Counsel complying with Section 10.04.
The Trustee shall have the
right to decline to authenticate and deliver any Securities of such Series: (a) if the Trustee, being advised by counsel, determines that
such action may not lawfully be taken; or (b) if a Responsible Officer of the Trustee in good faith shall determine that such action would
expose the Trustee to personal liability to Holders of any then outstanding Series of Securities.
The Trustee may appoint an
authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever
the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent.
An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate.
If any successor that has
replaced the Company in accordance with Article 5 has executed an indenture supplemental hereto with the Trustee pursuant to Section 5.01,
any of the Securities authenticated or delivered prior to such transaction may, from time to time, at the request of such successor, be
exchanged for other Securities executed in the name of the such successor with such changes in phraseology and form as may be appropriate,
but otherwise identical to the Securities surrendered for such exchange and of like principal amount; and the Trustee, upon receipt of
a Company Order of such successor, shall authenticate and deliver Securities as specified in such order for the purpose of such exchange.
If Securities shall at any time be authenticated and delivered in any new name of such successor pursuant to this provision of Section
2.03 in exchange or substitution for or upon registration of transfer of any Securities, such successor, at the option of the Holders
but without expense to them, shall provide for the exchange of all Securities then outstanding for Securities authenticated and delivered
in such new name.
SECTION 2.04. |
Registrar and Paying Agent. |
The Company shall maintain,
with respect to each Series of Securities, at the place or places specified with respect to such Series pursuant to Section 2.02, an office
or agency where Securities of such Series may be presented or surrendered for payment (“Paying Agent”) and where Securities
of such Series may be surrendered for registration of transfer or exchange (“Registrar”). The Registrar shall keep a
register with respect to each Series of Securities and to their transfer and exchange. The Company will give prompt written notice
to the Trustee of the name and address, and any change in the name or address, of each Registrar and Paying Agent. If at any time
the Company shall fail to maintain any such required Registrar or Paying Agent or shall fail to furnish the Trustee with the name and
address thereof, such presentations and surrenders may be made or served at the Corporate Trust Office of the Trustee, and the Company
hereby appoints the Trustee as its agent to receive all such presentations and surrenders.
The Company may also from
time to time designate one or more co-registrars or additional paying agents and may from time to time rescind such designations; provided,
however, that no such designation or rescission shall in any manner relieve the Company of its obligations to maintain a Registrar or
Paying Agent in each place so specified pursuant to Section 2.02 for Securities of any Series for such purposes. The Company will
give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of any such co-registrar
or additional paying agent. The term “Registrar” includes any co-registrar; and the term “Paying Agent”
includes any additional paying agent.
The Company hereby appoints
[ ] as the initial Registrar and Paying Agent for each Series unless another Registrar or Paying Agent
as the case may be, is appointed prior to the time Securities of that Series are first issued. Each Registrar and Paying Agent shall
be entitled to all of the rights, protections, exculpations and indemnities afforded to the Trustee in connection with its roles as Registrar
and Paying Agent.
SECTION 2.05. |
Paying Agent to Hold Money in Trust. |
The Company shall require
each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in trust, for the benefit of Securityholders
of any Series of Securities, or the Trustee, all money held by the Paying Agent for the payment of principal of or interest on the Series
of Securities, and will notify the Trustee of any default by the Company in making any such payment. While any such default continues,
the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying
Agent to pay all money held by it to the Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company
or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate
and hold in a separate trust fund for the benefit of Securityholders of any Series of Securities all money held by it as Paying Agent.
SECTION 2.06. |
Securityholder Lists. |
The Trustee shall preserve
in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders of
each Series of Securities and shall otherwise comply with TIA Section 312(a). If the Trustee is not the Registrar, the Company shall
furnish to the Trustee at least [ ] days before each interest payment date and at such other times as the Trustee may request in
writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of Securityholders
of each Series of Securities.
SECTION 2.07. |
Transfer and Exchange. |
Where Securities of a Series
are presented to the Registrar or a co-registrar with a request to register a transfer or to exchange them for an equal principal amount
of Securities of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions
are met. To permit registrations of transfers and exchanges, the Trustee shall authenticate Securities at the Registrar’s
request. Any exchange or transfer shall be without charge, except that the Company or the Registrar may require payment of a sum
sufficient to cover any tax or other governmental charge required by law; provided that this sentence shall not apply to any exchange
pursuant to Section 2.11, 2.08, 3.06 or 9.06.
Neither the Company nor the
Registrar shall be required (a) to issue, register the transfer of, or exchange Securities of any Series for the period beginning at the
opening of business [ ] days immediately preceding the mailing of a notice of redemption of Securities of that Series selected for
redemption and ending at the close of business on the day of such mailing, or (b) to register the transfer of or exchange Securities of
any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Securities selected, called
or being called for redemption in part.
All Securities issued upon
any transfer or exchange of Securities shall be valid obligations of the Company, evidencing the same debt and entitled to the same benefits
under this Indenture, as the Securities surrendered upon such transfer or exchange. Any Registrar appointed pursuant to Section
2.04 shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar
of Securities upon transfer or exchange of Securities. Each Holder of a Security agrees to indemnify the Company and the Trustee
against any liability that may result from the transfer, exchange or assignment of such Holder’s Security in violation of any provision
of this Indenture and/or applicable U.S. federal or state securities law.
SECTION 2.08. |
Mutilated, Destroyed, Lost and Stolen Securities. |
If any mutilated Security
is surrendered to the Registrar, the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a new Security
of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.
If there shall be delivered
to the Company and the Registrar (i) evidence to their satisfaction of the destruction, loss or theft of any Security and (ii) such security
or indemnity as may be required by them to save each of them and any agent of either of them harmless, then, in the absence of notice
to the Company or the Registrar that such Security has been acquired by a bona fide purchaser, the Company shall execute and upon its
request the Trustee shall authenticate and make available for delivery, in lieu of any such destroyed, lost or stolen Security, a new
Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding.
In case any such mutilated,
destroyed, lost or stolen Security has become or is about to become due and payable, the Company in its discretion may, instead of issuing
a new Security, pay such Security.
Upon the issuance of any new
Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that
may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith.
Every new Security of any
series issued pursuant to this Section in lieu of any destroyed, lost or stolen Security shall constitute an original additional contractual
obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall
be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that Series duly issued
hereunder.
The provisions of this Section
are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated,
destroyed, lost or stolen Securities.
SECTION 2.09. |
Outstanding Securities. |
The Securities outstanding
at any time are all the Securities authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation,
those reductions in the interest on a Global Security effected by the Trustee in accordance with the provisions hereof and those described
in this Section as not outstanding.
If a Security is replaced
pursuant to Section 2.08, it ceases to be outstanding until the Trustee receives proof satisfactory to it that the replaced Security is
held by a bona fide purchaser.
If the Paying Agent (other
than the Company, a Subsidiary or an Affiliate of any thereof) holds on the Maturity of Securities of a Series money sufficient to pay
such Securities payable on that date, then on and after that date such Securities of the Series cease to be outstanding and interest on
them ceases to accrue.
A Security does not cease
to be outstanding because the Company or an Affiliate holds the Security.
In determining whether the
Holders of the requisite principal amount of outstanding Securities have given any request, demand, authorization, direction, notice,
consent or waiver hereunder, the principal amount of a Discount Security that shall be deemed to be outstanding for such purposes shall
be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration
of the Maturity thereof pursuant to Section 6.02.
SECTION 2.10. |
Treasury Securities. |
In determining whether the
Holders of the required principal amount of Securities of a Series have concurred in any request, demand, authorization, direction, notice,
consent or waiver Securities of a Series owned by the Company or an Affiliate shall be disregarded, except that for the purposes of determining
whether the Trustee shall be protected in relying on any such request, demand, authorization, direction, notice, consent or waiver only
Securities of a Series that a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded.
SECTION 2.11. |
Temporary Securities. |
Until definitive Securities
are ready for delivery, the Company may prepare and the Trustee shall authenticate temporary securities upon a Company Order (“Temporary
Securities”). Temporary Securities shall be substantially in the form of definitive Securities but may have variations that
the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall prepare and the Trustee
upon written request shall authenticate definitive Securities of the same Series and date of maturity in exchange for temporary Securities.
Until so exchanged, temporary securities shall have the same rights under this Indenture as the definitive Securities.
SECTION 2.12. |
Cancellation. |
The Company at any time may
deliver Securities to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee or its agent
any Securities surrendered to them for transfer, exchange, payment or conversion. The Trustee and no one else shall cancel, in accordance
with its standard procedures, all Securities surrendered for transfer, exchange, payment, conversion or cancellation and shall deliver
the cancelled Securities to the Company. No Security shall be authenticated in exchange for any Security cancelled pursuant to this
Section 2.12.
The Company may, to the extent
permitted by law, purchase Securities in the open market or by tender offer at any price or by private agreement. Any Securities
purchased or otherwise acquired by the Company or any of its Subsidiaries prior to the final maturity of such Securities may, to the extent
permitted by law, be reissued or resold or may, at the option of the Company, be surrendered to the Trustee for cancellation. Any
Securities surrendered for cancellation may not be reissued or resold and shall be promptly cancelled by the Trustee, and the Company
may not hold or resell such Securities or issue any new Securities to replace any such Securities.
SECTION 2.13. |
Defaulted Interest. |
If the Company defaults in
a payment of interest on a Series of Securities, it shall pay defaulted interest, plus, to the extent permitted by law, any interest payable
on the defaulted interest at the Default Rate, to the persons who are Security holders of the Series on a subsequent special record date.
The Company shall fix the record date and payment date. At least [ ] days before the record date, the Company shall mail to
the Trustee and the Paying Agent and to each Securityholder of the Series a notice that states the record date, the payment date and the
amount of interest to be paid. The Company may pay defaulted interest in any other lawful manner.
SECTION 2.14. |
Global Securities. |
(a) A
Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall establish whether the Securities of a Series
shall be issued in whole or in part in the form of one or more Global Securities and the Depository for such Global Security or Securities.
(b) (i) Notwithstanding
any provisions to the contrary contained in Section 2.07 of the Indenture and in addition thereto, any Global Security shall be exchangeable
pursuant to Section 2.07 of the Indenture for Securities registered in the names of Holders other than the Depository for such Security
or its nominee only if (A) such Depository notifies the Company that it is unwilling or unable to continue as Depository for such Global
Security or if at any time such Depository ceases to be a clearing agency registered under the Exchange Act, and, in either case, the
Company fails to appoint a successor Depository within 90 days of such event, (B) the Company executes and delivers to the Trustee an
Officers’ Certificate to the effect that such Global Security shall be so exchangeable or (C) an Event of Default with respect to
the Securities represented by such Global Security shall have happened and be continuing.
(ii) Except
as provided in this Section 2.14(b), a Global Security may not be transferred except as a whole by the Depository with respect to such
Global Security to a nominee of such Depository, by a nominee of such Depository to such Depository or another nominee of such Depository
or by the Depository or any such nominee to a successor Depository or a nominee of such a successor Depository.
(iii) Securities
issued in exchange for a Global Security or any portion thereof shall be issued in definitive, fully registered form, without interest
coupons, shall have an aggregate principal amount equal to that of such Global Security or portion thereof to be so exchanged, shall be
registered in such names and be in such authorized denominations as the Depository shall designate and shall bear the applicable legends
provided for herein. Any Global Security to be exchanged in whole shall be surrendered by the Depository to the Trustee, as Registrar.
With regard to any Global Security to be exchanged in part, either such Global Security shall be so surrendered for exchange or, if the
Registrar is acting as custodian for the Depository or its nominee with respect to such Global Security, the principal amount thereof
shall be reduced by an amount equal to the portion thereof to be so exchanged, by means of an appropriate adjustment made on the records
of the Trustee. Upon any such surrender or adjustment, the Trustee shall authenticate and deliver the Security issuable on such
exchange to or upon the order of the Depository or an authorized representative thereof.
(iv) The
registered Holder may grant proxies and otherwise authorize any Person, including participants in the Depository and persons that may
hold interests through participants in the Depository, to take any action which a Holder is entitled to take under this Indenture or the
Securities.
(v) In
the event of the occurrence of any of the events specified in 2.14(b)(i), the Company will promptly make available to the Trustee a reasonable
supply of Certificated Securities in definitive, fully registered form, without interest coupons. If (A) an event described in Section
2.14(b)(i)(A) or (B) occurs and definitive Certificated Securities are not issued promptly to all beneficial owners or (B) the Registrar
receives from a beneficial owner instructions to obtain definitive Certificated Securities due to an event described in Section 2.14(b)(i)(C)
and definitive Certificated Securities are not issued promptly to any such beneficial owner, the Company expressly acknowledges, with
respect to the right of any Holder to pursue a remedy pursuant to Section 6.07 hereof, the right of any beneficial owner of Securities
to pursue such remedy with respect to the portion of the Global Security that represents such beneficial owner’s Securities as if
such definitive certificated Securities had been issued.
(vi) Notwithstanding
any provision to the contrary in this Indenture, so long as a Global Security remains outstanding and is held by or on behalf of the Depository,
transfers of a Global Security, in whole or in part, or of any beneficial interest therein, shall only be made in accordance with Section
2.07, this Section 2.14(b) and the rules and procedures of the Depository for such Global Security to the extent applicable to such transaction
and as in effect from time to time.
(c) Any
Global Security issued hereunder shall bear a legend in substantially the following form:
“This Security is a
Global Security within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and may not be transferred except as a whole by the Depository
to a nominee of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository
or any such nominee to a successor Depository or a nominee of such a successor Depository.”
(d) The
Depository, as a Holder, may appoint agents and otherwise authorize participants to give or take any request, demand, authorization, direction,
notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture.
(e) Notwithstanding
the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.02, payment of the principal of and interest,
if any, on any Global Security shall be made to the Holder thereof at their registered office.
(f) At
all times the Securities are held in book-entry form with a Depository, (i) the Trustee may deal with such Depository as the authorized
representative of the Holders, (ii) the rights of the Holders shall be exercised only through the Depository and shall be limited to those
established by law and agreement between the Holders and the Depository and/or direct participants of the Depository, (iii) the Depository
will make book-entry transfers among the direct participants of the Depository and will receive and transmit distributions of principal
and interest on the Securities to such direct participants; and (iv) the direct participants of the Depository shall have no rights under
this Indenture, or any supplement hereto, under or with respect to any of the Securities held on their behalf by the Depository, and the
Depository may be treated by the Trustee and its agents, employees, officers and directors as the absolute owner of the Securities for
all purposes whatsoever.
SECTION 2.15. |
CUSIP Numbers. |
The Company in issuing the
Securities may use “CUSIP”, “ISIN” or other identification numbers (if then generally in use), and, if so, the
Trustee shall use “CUSIP”, “ISIN” or such other identification numbers in notices of redemption as a convenience
to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed
on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other elements of identification
printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers.
ARTICLE III
REDEMPTION
SECTION 3.01. |
Notice to Trustee. |
The Company may, with respect
to any series of Securities, reserve the right to redeem and pay the Series of Securities or may covenant to redeem and pay the Series
of Securities or any part thereof prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities.
If a Series of Securities is redeemable and the Company wants or is obligated to redeem prior to the Stated Maturity thereof all or part
of the Series of Securities pursuant to the terms of such Securities, it shall notify the Trustee and Registrar in writing of the redemption
date and the principal amount of Series of Securities to be redeemed. The Company shall give the notice at least [ ] days
before the redemption date (or such shorter notice as may be acceptable to the Trustee and Registrar).
SECTION 3.02. |
Selection of Securities to be Redeemed. |
Unless otherwise indicated
for a particular Series by a Board Resolution, a supplemental indenture or an Officers’ Certificate, if less than all the Securities
of a Series are to be redeemed, the Registrar shall select the Securities of the Series to be redeemed in accordance with its customary
procedures. The Registrar shall make the selection from Securities of the Series outstanding not previously called for redemption.
The Registrar may select for redemption portions of the principal of Securities of the Series that have denominations larger than $1,000.
Securities of the Series and portions of them it selects shall be in amounts of $1,000 or whole multiples of $1,000 or, with respect to
Securities of any Series issuable in other denominations pursuant to Section 2.02(g), the minimum principal denomination for each Series
and integral multiples thereof. Provisions of this Indenture that apply to Securities of a Series called for redemption also apply
to portions of Securities of that Series called for redemption.
SECTION 3.03. |
Notice of Redemption. |
Unless otherwise indicated
for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least [ ] days
but not more than [ ] days before a redemption date, the Company shall mail a notice of redemption by first-class mail to each Holder
whose Securities are to be redeemed.
The notice shall identify
the Securities of the Series to be redeemed and shall state:
(a) the
redemption date;
(b) the
redemption price;
(c) the
name and address of the Paying Agent;
(d) that
Securities of the Series called for redemption must be surrendered to the Paying Agent to collect the redemption price;
(e) that
interest on Securities of the Series called for redemption ceases to accrue on and after the redemption date; and
(f) any
other information as may be required by the terms of the particular Series or the Securities of a Series being redeemed.
At the Company’s written
request, the Trustee shall distribute the notice of redemption prepared by the Company in the Company’s name and at its expense.
SECTION 3.04. |
Effect of Notice of Redemption. |
Once notice of redemption is mailed or published
as provided in Section 3.03, Securities of a Series called for redemption become due and payable on the redemption date and at the redemption
price. A notice of redemption may not be conditional. Upon surrender to the Paying Agent, such Securities shall be paid at
the redemption price plus accrued interest to the redemption date.
SECTION 3.05. |
Deposit of Redemption Price. |
On or before the redemption date, the Company shall
deposit with the Paying Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed
on that date.
SECTION 3.06. |
Securities Redeemed in Part. |
Upon surrender of a Security that is redeemed in
part, the Trustee shall authenticate for the Holder a new Security of the same Series and the same maturity equal in principal amount
to the unredeemed portion of the Security surrendered.
ARTICLE IV
COVENANTS
SECTION 4.01. |
Payment of Principal and Interest. |
The Company covenants and
agrees for the benefit of the Holders of each Series of Securities that it will duly and punctually pay the principal of and interest,
if any, on the Securities of that Series in accordance with the terms of such Securities and this Indenture.
Unless otherwise provided
under the terms of a particular Series of Securities:
(a) an
installment of principal or interest shall be considered paid on the date it is due if the Paying Agent (other than the Company) holds
by [ ] [a].m., New York City time, on that date money, deposited by the Company or an Affiliate thereof,
sufficient to pay such installment. The Company shall (in immediately available funds), to the fullest extent permitted by law,
pay interest on overdue principal and overdue installments of interest at the rate borne by the Securities per annum; and
(b) payment
of the principal of and interest on the Securities shall be made at the office or agency of the Company maintained for that purpose in
[ ] (which shall initially be [ ], the Paying Agent) in such
coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided,
however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto
as such address appears in the register; provided, further, that a Holder with an aggregate principal amount in excess of
$[ ] will be paid by wire transfer in immediately available funds at the election of such Holder if such Holder has
provided wire transfer instructions to the Company at least [ ] Business Days prior to the payment date.
SECTION 4.02. |
SEC Reports. |
So long as any Securities
are outstanding, the Company shall (i) file with the SEC within the time periods prescribed by its rules and regulations and (ii) furnish
to the Trustee and the Holders of the Securities within [ ] days after the date on which the Company would be required to file the
same with the SEC pursuant to its rules and regulations (giving effect to any grace period provided by Rule 12b-25 under the Exchange
Act), all quarterly and annual financial information required to be furnished or filed with the SEC pursuant to Section 13 and Section
15(d) of the Exchange Act and, with respect to the annual consolidated financial statements only, a report thereon by the Company’s
independent auditors. The Company also shall comply with the other provisions of TIA Section 314(a).
Delivery of such reports,
information and documents to the Trustee is for informational purposes only, and the Trustee’s receipt of such shall not constitute
constructive notice of any information contained therein or determinable from information contained therein, including the Company’s
compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates).
The Company shall not be required to file any report or other information with the SEC if the SEC does not permit such filing, although
such reports shall be furnished to the Trustee. Documents filed by the Company with the SEC via the SEC’s EDGAR system (or
any successor thereto) will be deemed furnished to the Trustee and the Holders of the Securities as of the time such documents are filed
via EDGAR (or such successor).
SECTION 4.03. |
Compliance Certificate. |
The Company shall deliver
to the Trustee, within [ ] days after the end of each fiscal year of the Company, an officers certificate signed by two of
the Company’s officers stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year
has been made under the supervision of the signing Officers with a view to determining whether the Company has kept, observed, performed
and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the
best of his knowledge the Company has kept, observed, performed and fulfilled each and every covenant contained in this Indenture and
is not in default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of
Default shall have occurred, describing all such Defaults or Events of Default of which he may have knowledge in reasonable detail and
the efforts to remedy the same). For purposes of this Section 4.03, compliance shall be determined without regard to any grace period
or requirement of notice provided pursuant to the terms of this Indenture.
The Company shall deliver
to the Trustee, within [ ] days after the occurrence thereof, written notice in the form of an Officers’ Certificate of any
Event of Default described in Section 6.01(e), (f), (g) or (h) and any event of which it becomes aware that with the giving of notice
or the lapse of time would become such an Event of Default, its status and what action the Company is taking or proposes to take with
respect thereto. For the avoidance of doubt, a breach of a covenant under an Instrument that is not a payment default and that has
not given rise to a right of acceleration under such Instrument shall not trigger the requirement to provide notice under this paragraph.
SECTION 4.04. |
Stay, Extension and Usury Laws. |
The Company covenants (to
the extent that it may lawfully do so) that it will not at any time insist upon, plead, or in any manner whatsoever claim or take the
benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, which may affect the
covenants or the performance of this Indenture or the Securities; and the Company (to the extent it may lawfully do so) hereby expressly
waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the
execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law
has been enacted.
SECTION 4.05. |
Corporate Existence. |
Subject to Article V, the
Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and the
corporate, partnership or other existence of each Subsidiary in accordance with the respective organizational documents of each Subsidiary
and the rights (charter and statutory), licenses and franchises of the Company and its Subsidiaries; provided, however, that the Company
shall not be required to preserve any such right, license or franchise, or the corporate, partnership or other existence of any Subsidiary,
if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company
and its Subsidiaries taken as a whole and that the loss thereof is not adverse in any material respect to the Holders.
The Company shall, and shall
cause each of its Subsidiaries to, pay prior to delinquency all taxes, assessments and governmental levies, except as contested in good
faith and by appropriate proceedings.
SECTION 4.07. |
Additional Interest Notice. |
In the event that the Company
is required to pay additional interest to Holders of Securities pursuant to Section 6.02(b) hereof, the Company shall provide a direction
or order in the form of a written notice to the Trustee (and if the Trustee is not the Paying Agent, the Paying Agent) of the Company’s
obligation to pay such additional interest no later than [ ] Business Days prior to date on which any such additional interest
is scheduled to be paid. Such notice shall set forth the amount of additional interest to be paid by the Company on such payment
date and direct the Trustee (or, if the Trustee is not the Paying Agent, the Paying Agent) to make payment to the extent it receives funds
from the Company to do so. The Trustee shall not at any time be under any duty or responsibility to any Holder to determine whether
additional interest is payable, or with respect to the nature, extent, or calculation of the amount of additional interest owed, or with
respect to the method employed in such calculation of additional interest.
SECTION 4.08. |
Further Instruments and Acts. |
The Company will execute and
deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purposes
of this Indenture.
ARTICLE V
SUCCESSORS
SECTION 5.01. |
When Company May Merge, Etc. |
The Company shall not consolidate
with, enter into a binding share exchange, or merge into any other Person in a transaction in which it is not the surviving entity, or
sell, assign, convey, transfer or lease or otherwise dispose of all or substantially all of its properties and assets to any Person (a
“successor person”), unless:
(a) the
successor person (if any) is a corporation, partnership, trust or other entity organized and validly existing under the laws of the Cayman
Islands and expressly assumes by a supplemental indenture executed and delivered to the Trustee, in form satisfactory to the Trustee,
the due and punctual payment of the principal of, and any interest on, all Securities and the performance or observance of every covenant
of this Indenture on the part of the Company to be performed or observed;
(b) immediately
after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing; and
(c) the
Company shall have delivered to the Trustee, prior to the consummation of the proposed transaction, an Officers’ Certificate to
the foregoing effect and an Opinion of Counsel stating that the proposed transaction and such supplemental indenture comply with this
Indenture.
SECTION 5.02. |
Successor Corporation Substituted. |
Upon any consolidation or
merger, or any sale, lease, conveyance or other disposition of all or substantially all of the assets of the Company in accordance with
Section 5.01, the successor person formed by such consolidation or into or with which the Company is merged or to which such sale, lease,
conveyance or other disposition is made shall succeed to, and be substituted for, and may exercise every right and power of, the Company
under this Indenture with the same effect as if such successor person has been named as the Company herein; provided, however, that the
predecessor company in the case of a sale, lease, conveyance or other disposition of all or substantially all of the assets of the Company
shall not be released from the obligation to pay the principal of and interest, if any, on the Securities.
ARTICLE VI
DEFAULTS AND REMEDIES
SECTION 6.01. |
Events of Default. |
“Event of Default,”
wherever used herein with respect to securities of any Series, means any one of the following events, unless in the establishing Board
Resolution, supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said
Event of Default:
(a) default
in the payment of any interest on any Security of that Series when it becomes due and payable, and continuance of such default for a period
of 30 days (unless the entire amount of such payment is deposited by the Company with the Trustee or with a Paying Agent prior to the
expiration of such period of 30 days); or
(b) default
in the payment of any principal of any Security of that Series at its Maturity; or
(c) default
in the deposit of any sinking fund payment, when and as due in respect of any Security of that Series; or
(d) the
Company fails to perform or comply with any of its other covenants or agreements contained in the Securities or in this Indenture (other
than a covenant or agreement a default in whose performance or whose breach is specifically dealt with in clauses (a), (b) or (c) of this
Section 6.01) and the default continues for 60 days after notice is given as specified below;
(e) any
indebtedness under any bond, debenture, note or other evidence of indebtedness for money borrowed by the Company or any Subsidiary or
under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any indebtedness
for money borrowed by, or any other payment obligation of, the Company or any Subsidiary (an “Instrument”) with a principal
amount then, individually or in the aggregate, outstanding in excess of $[ ], whether such indebtedness
now exists or shall hereafter be created, is not paid at Maturity or when otherwise due or is accelerated, and such indebtedness is not
discharged, or such default in payment or acceleration is not cured or rescinded, within a period of 30 days after there shall have been
given, by registered or certified mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least [
]% in aggregate principal amount of the outstanding Securities of that Series a written notice specifying such default and requiring the
Company to cause such indebtedness to be discharged or cause such default to be cured or waived or such acceleration to be rescinded or
annulled and stating that such notice is a “Notice of Default” hereunder. A payment obligation (other than indebtedness
under any bond, debenture, note or other evidence of indebtedness for money borrowed by the Company or any Subsidiary or under any mortgage,
indenture or instrument under which there may be issued or by which there may be secured or evidenced any indebtedness for money borrowed
by the Company or any Subsidiary) shall not be deemed to have matured, come due, or been accelerated to the extent that it is being disputed
by the relevant obligor or obligors in good faith. For the avoidance of doubt, the Maturity of an Instrument is the Maturity as
set forth in that Instrument, as it may be amended from time to time in accordance with the terms of that Instrument;
(f) the
Company or any Subsidiary fails to pay one or more final and non-appealable judgments entered by a court or courts of competent jurisdiction,
the aggregate uninsured or unbonded portion of which is in excess of $[ ], if the judgments are
not paid, discharged, waived or stayed within [ ] days;
(g) the
Company or any Subsidiary of the Company, pursuant to or within the meaning of any Bankruptcy Law:
(i) commences
a voluntary case or proceeding;
(ii) consents
to the entry of an order for relief against it in an involuntary case or proceeding;
(iii) consents
to the appointment of a Custodian of it or for all or substantially all of its property; or
(iv) makes
a general assignment for the benefit of its creditors; or
(v) or
generally is unable to pay its debts as the same become due; or
(h) a
court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:
(i) is
for relief against the Company or any of its Subsidiaries in an involuntary case or proceeding;
(ii) appoints
a Custodian of the Company or any of its Subsidiaries for all or substantially all of the property of the Company or any such Subsidiary;
or
(iii) orders
the liquidation of the Company or any of its Subsidiaries;
and the case of
each of clause (i), (ii) and (iii), the order or decree remains unstayed and in effect for [ ] consecutive days; or
(i) any
other Event of Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture
hereto or an Officers’ Certificate, in accordance with Section 2.02(i).
A default under clause (d)
above is not an Event of Default until the Trustee notifies the Company, or the Holders of at least [ ]% in aggregate principal
amount of the Securities then outstanding notify the Company and the Trustee, in writing of the default, and the Company does not cure
the default within 60 days after receipt of such notice. The notice given pursuant to this Section 6.01 must specify the default,
demand that it be remedied and state that the notice is a “Notice of Default.” When any default under this Section 6.01
is cured, it ceases.
The Trustee shall not be charged
with knowledge of any Event of Default unless written notice thereof shall have been given to a Trust Officer at the Corporate Trust Office
of the Trustee by the Company, a Paying Agent, any Holder or any agent of any Holder.
SECTION 6.02. |
Acceleration of Maturity; Rescission and Annulment. |
(a) If
an Event of Default (other than an Event of Default specified in clause (g) or (h) of Section 6.01) occurs and is continuing with respect
to any Securities of any Series, then in every such case, the Trustee may, by notice to the Company, or the Holders of at least 25% in
aggregate principal amount of the Securities of that Series (or, if any Securities of that Series are Discount Securities, such portion
of the principal amount as may be specified in the terms of such Securities) then outstanding may, by notice to the Company and the Trustee,
declare all unpaid principal of, and accrued and unpaid interest on to the date of acceleration, the Securities of that Series then outstanding
(if not then due and payable) to be due and payable upon any such declaration, and the same shall become and be immediately due and payable.
If an Event of Default specified in clause (g) or (h) of Section 6.01 occurs, all unpaid principal of the Securities then outstanding,
and all accrued and unpaid interest thereon to the date of acceleration, shall ipso facto become and be immediately due and payable without
any declaration or other act on the part of the Trustee or any Holder. The Holders of a majority in aggregate principal amount of
the Securities of that Series then outstanding by notice to the Trustee may rescind an acceleration of such Securities of that Series
and its consequences if (a) all existing Events of Default, other than the nonpayment of the principal of the Securities which has become
due solely by such declaration of acceleration, have been cured or waived; (b) to the extent the payment of such interest is lawful, interest
(calculated at the Default Rate) on overdue installments of interest and overdue principal, which has become due otherwise than by such
declaration of acceleration, has been paid; (c) the rescission would not conflict with any judgment or decree of a court of competent
jurisdiction; and (d) all payments due to the Trustee and any predecessor Trustee under Section 7.07 have been made. No such rescission
shall affect any subsequent default or impair any right consequent thereto.
(b) Notwithstanding
any of provision of this Article 6, at the election of the Company in its sole discretion, the sole remedy under this Indenture for an
Event of Default relating to the failure to comply with Section 4.02, and for any failure to comply with the requirements of Section 314(a)(1)
of the TIA, will consist, for the 180 days after the occurrence of such an Event of Default, exclusively of the right to receive additional
interest on the Securities at a rate equal to 0.50% per annum of the aggregate principal amount of the Securities then outstanding up
to, but not including, the 181st day thereafter (or, if applicable, the earlier date on which the Event of Default relating to Section
4.02 is cured or waived). Any such additional interest will be payable in the same manner and on the same dates as the stated interest
payable on the Securities. In no event shall additional interest accrue under the terms of this Indenture at a rate in excess of
0.50% per annum, in the aggregate, for any violation or default caused by the failure of the Company to be current in respect of its Exchange
Act reporting obligations. If the Event of Default is continuing on the 181st day after an Event of Default relating to a failure
to comply with Section 4.02, the Securities will be subject to acceleration as provided in this Section 6.02. The provisions of
this Section 6.02(b) will not affect the rights of Holders in the event of the occurrence of any other Events of Default.
In order to elect to pay additional
interest as the sole remedy during the first 180 days after the occurrence of an Event of Default relating to the failure to comply with
Section 4.02 in accordance with the immediately preceding paragraph, the Company shall notify all Holders and the Trustee and Paying Agent
of such election on or before the close of business on the fifth Business Day after the date on which such Event of Default otherwise
would occur. Upon a failure by the Company to timely give such notice or pay additional interest, the Securities will be immediately
subject to acceleration as otherwise provided in this Section 6.02.
SECTION 6.03. |
Collection of Indebtedness and Suits for Enforcement by Trustee. |
If an Event of Default with
respect to any Securities of any Series occurs and is continuing, the Trustee may in its discretion proceed to protect and enforce its
rights and the rights of the Holders of Securities of such Series by such appropriate judicial proceedings as the Trustee shall deem most
effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this Indenture
or in aid of the exercise of any power granted herein, or to enforce any other proper remedy.
If an Event of Default in
the payment of principal, interest, if any, specified in clause (a) or (b) of Section 6.01 occurs and is continuing, the Trustee may recover
judgment in its own name and as trustee of an express trust against the Company or another obligor on the Securities for the whole amount
of principal, and accrued interest remaining unpaid, if any, together with, to the extent that payment of such interest is lawful, interest
on overdue principal, on overdue installments of interest, if any, in each case at the Default Rate, and such further amount as shall
be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances
of the Trustee, its agents and counsel.
SECTION 6.04. |
Trustee May File Proofs of Claim. |
In case of the pendency of
any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding
relative to the Company or any other obligor upon the Securities or the property of the Company or of such other obligor or their creditors,
the Trustee (irrespective of whether the principal of the Securities shall then be due and payable as therein expressed or by declaration
or otherwise and irrespective of whether the Trustee shall have made any demand on the Company for the payment of overdue principal or
interest) shall be entitled and empowered, by intervention in such proceeding or otherwise,
(a) to
file and prove a claim for the whole amount of principal and interest owing and unpaid in respect of the Securities and to file such other
papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial
proceeding, and
(b) to
collect and receive any moneys or other property payable or deliverable on any such claims and to distribute the same, and any custodian,
receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by
each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly
to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee,
its agents and counsel, and any other amounts due the Trustee under Section 7.07.
Nothing herein contained shall
be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement,
adjustment or composition affecting the Securities or the rights of any Holder thereof or to authorize the Trustee to vote in respect
of the claim of any Holder in any such proceeding.
SECTION 6.05. |
Trustee May Enforce Claims Without Possession of Securities. |
All rights of action and claims
under this Indenture or the Securities may be prosecuted and enforced by the Trustee without the possession of any of the Securities or
the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own
name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Securities
in respect of which such judgment has been recovered.
SECTION 6.06. |
Application of Money Collected. |
Any money collected by the
Trustee pursuant to this Article shall be applied in the following order, at the date or dates fixed by the Trustee and, in case of the
distribution of such money on account of principal or interest, upon presentation of the Securities and the notation thereon of the payment
if only partially paid and upon surrender thereof if fully paid: and
First: To the payment
of all amounts due the Trustee under Section 7.07;
Second: To the payment
of the amounts then due and unpaid for principal of and interest on the Securities in respect of which or for the benefit of which such
money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities
for principal and interest, respectively; and
Third: To the Company.
SECTION 6.07. |
Limitation on Suits. |
No Holder of any Security
of any Series shall have any right to institute any proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment
of a receiver or trustee, or for any other remedy hereunder (except actions for payment of overdue principal and interest), unless:
(a) such
Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that Series;
(b) the
Holders of not less than [ ]% in principal amount of the outstanding Securities of that Series shall have made written request to
the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder;
(c) such
Holder or Holders have offered to the Trustee indemnity satisfactory to it against the costs, expenses and liabilities to be incurred
in compliance with such request;
(d) the
Trustee for [ ] days after its receipt of such notice, request and offer of indemnity has failed to institute any such proceeding;
and
(e) no
direction inconsistent with such written request has been given to the Trustee during such [ ]-day period by the Holders of a majority
in principal amount of the outstanding Securities of that Series; it being understood and intended that no one or more of such Holders
shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or prejudice
the rights of any other of such Holders, or to obtain or to seek to obtain priority or preference over any other of such Holders or to
enforce any right under this Indenture, except in the manner herein provided and for the equal and ratable benefit of all such Holders.
SECTION 6.08. |
Unconditional Right of Holders to Receive Principal and Interest. |
Notwithstanding any other
provision in this Indenture, the Holder of any Security shall have the right, which is absolute and unconditional, to receive payment
of the principal of and interest, if any, on such Security on the Stated Maturity or Stated Maturities expressed in such Security (or,
in the case of redemption, on the redemption date) and to institute suit for the enforcement of any such payment, and such rights shall
not be impaired without the consent of such Holder.
SECTION 6.09. |
Restoration of Rights and Remedies. |
If the Trustee or any Holder
has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned
for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination
in such proceeding, the Company, the Trustee and the Holders shall be restored severally and respectively to their former positions hereunder
and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding had been instituted.
SECTION 6.10. |
Rights and Remedies Cumulative. |
Except as otherwise provided
with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities in Section 2.08, no right or remedy herein
conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right
and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now
or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise,
shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.
SECTION 6.11. |
Delay or Omission Not Waiver. |
No delay or omission of the
Trustee or of any Holder of any Securities to exercise any right or remedy accruing upon any Event of Default shall impair any such right
or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article
or by law to the Trustee or to the Holders may be exercised from time to time, and as often as may be deemed expedient, by the Trustee
or by the Holders, as the case may be.
SECTION 6.12. |
Control by Holders. |
The Holders of a majority
in principal amount of the outstanding Securities of any Series shall have the right to direct the time, method and place of conducting
any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the
Securities of such Series, provided that
(a) such
direction shall not be in conflict with any rule of law or with this Indenture,
(b) the
Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction; and
(c) subject
to the provisions of Section 6.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith
shall, by a Responsible Officer of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability
or would be unduly prejudicial to the rights of another Holder or the Trustee.
SECTION 6.13. |
Waiver of Past Defaults. |
Subject to Section 9.02, the
Holders of not less than a majority in principal amount of the outstanding Securities of any Series may on behalf of the Holders of all
the Securities of such Series waive any past Default hereunder with respect to such Series and its consequences, except a Default in the
payment of the principal of or interest on any Security of such Series (provided, however, that the Holders of a majority in principal
amount of the outstanding Securities of any Series may rescind an acceleration and its consequences, including any related payment default
that resulted from such acceleration). Upon any such waiver, such Default shall cease to exist, and any Event of Default arising
therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any subsequent or
other Default or impair any right consequent thereon.
SECTION 6.14. |
Undertaking for Costs. |
All parties to this Indenture
agree, and each Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court may in its discretion
require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action
taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such
suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any party
litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions
of this Section shall not apply to any suit instituted by the Company, to any suit instituted by the Trustee, to any suit instituted by
any Holder, or group of Holders, holding in the aggregate more than [ ]% in principal amount of the outstanding Securities of any
Series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest on any Security on
or after the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of redemption, on the redemption date).
ARTICLE VII
TRUSTEE
SECTION 7.01. |
Duties of Trustee. |
(a) If
an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and
use the same degree of care and skill in their exercise as a prudent person would exercise or use under the circumstances in the conduct
of his own affairs.
(b) Except
during the continuance of an Event of Default:
(i) The
Trustee need perform only those duties that are specifically set forth in this Indenture and no implied duties, covenants or obligations
shall be deemed to be imposed upon the Trustee.
(ii) in
the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the
opinions expressed therein, upon Officers’ Certificates or Opinions of Counsel furnished to the Trustee and conforming to the requirements
of this Indenture; however, in the case of any such Officers’ Certificates or Opinions of Counsel which by any provisions hereof
are specifically required to be furnished to the Trustee, the Trustee shall examine such Officers’ Certificates and Opinions of
Counsel to determine whether or not they conform on their face to the requirements of this Indenture.
(c) The
Trustee may not be relieved from liability for its own its own negligent action, its own negligent failure to act or willful misconduct,
except that:
(i) This
paragraph does not limit the effect of paragraph (b) of Section 7.01 herein.
(ii) The
Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer.
(iii) The
Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it with respect to Securities of any
Series in good faith in accordance with the direction of the Holders of a majority in principal amount of the outstanding Securities of
such Series relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such Series.
(d) Every
provision of this Indenture that in any way relates to the Trustee is subject to paragraph (a), (b) and (c) of this Section.
(e) The
Trustee may refuse to perform any duty or exercise any right or power unless it receives an indemnity satisfactory to it against any loss,
liability or expense.
(f) The
Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Company.
Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.
(g) No
provision of this Indenture shall require the Trustee to risk or expend its own funds or otherwise incur liability, financial or otherwise,
in the performance of any of its duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing
that repayment of such funds or indemnity satisfactory to it against such risk is not reasonably assured to it.
(h) The
Paying Agent, the Registrar and any authenticating agent shall be entitled to the same rights, indemnities, protections and immunities
afforded to the Trustee.
(i) The
Trustee shall have no duty to monitor the performance or compliance of the Company with its obligations hereunder or any under supplement
hereto, nor shall it have any liability in connection with the malfeasance or nonfeasance by the Company. The Trustee shall have
no liability in connection with compliance by the Company with statutory or regulatory requirements related to this Indenture, any supplement
or any Securities issued pursuant hereto or thereto.
SECTION 7.02. |
Rights of Trustee. |
(a) The
Trustee may conclusively rely on and shall be fully protected in acting or refraining from acting as a result of its reasonable belief
that any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, direction, approval or other
paper or document was genuine and had been signed or presented by the proper person. The Trustee need not investigate any fact or
matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters
as it sees fit.
(b) Before
the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel or both. The Trustee
shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion
of Counsel.
(c) The
Trustee may act through agents and shall not be responsible for the misconduct or negligence of, or for the supervision of, any agent
appointed with due care. No Depository shall be deemed an agent of the Trustee and the Trustee shall not be responsible for any
act or omission by any Depository.
(d) The
Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights
or powers.
(e) The
Trustee may consult with counsel of its selection and the advice of such counsel or any Opinion of Counsel shall be full and complete
authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.
(f) The
Trustee shall be under no obligation to exercise any of the rights or powers vested in it by or pursuant to this Indenture at the request,
order or direction of any of the Holders of Securities, unless such Holders shall have offered to the Trustee reasonable security or indemnity
satisfactory to it against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction.
SECTION 7.03. |
Individual Rights of Trustee. |
The Trustee, in its individual
or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with the Company or an Affiliate with the
same rights it would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee is also subject
to Sections 7.10 and 7.11.
SECTION 7.04. |
Trustee’s Disclaimer. |
The Trustee makes no representation
as to the validity or adequacy of this Indenture or the Securities and the recitals contained herein and in the Securities shall be taken
as statements of the Company and not of the Trustee, and the Trustee has no responsibility for such recitals. The Trustee shall not be
accountable for the Company’s use or application of the proceeds from the Securities or for monies paid over to the Company pursuant
to this Indenture, and it shall not be responsible for any statement in the Securities other than its authentication.
SECTION 7.05. |
Notice of Defaults. |
If a Default or Event of Default
occurs and is continuing with respect to the Securities of any Series and if a Responsible Officer of the Trustee has knowledge or receives
written notice of such event, the Trustee shall mail to each Securityholder of the Securities of that Series, notice of a Default or Event
of Default within [ ] days after it occurs or, if later, after a Responsible Officer of the Trustee has actual knowledge of such
Default or Event of Default. Except in the case of a Default or Event of Default in payment of principal of or interest on any Security
of any Series, including any additional interest that may become payable pursuant to Section 6.02(b), the Trustee may withhold the notice
so long as the Trustee in good faith determines that withholding the notice is in the interests of Securityholders of that Series.
SECTION 7.06. |
Reports by Trustee to Holders. |
Within [ ] days after
[ ] in each year, the Trustee shall transmit by mail to all Securityholders, as their
names and addresses appear on the register kept by the Registrar, a brief report dated as of such [
], in accordance with, and to the extent required under, TIA Section 313.
A copy of each report at the
time of its mailing to Securityholders of any Series shall be filed with the SEC and each stock exchange on which the Securities of that
Series are listed. The Company shall promptly notify the Trustee when Securities of any Series are listed on any stock exchange.
SECTION 7.07. |
Compensation and Indemnity. |
The Company shall pay to the
Trustee from time to time such compensation for its services as shall be agreed upon in writing. The Trustee’s compensation
shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee upon request
for all reasonable out-of-pocket expenses, disbursements and advances incurred by it. Such expenses shall include the reasonable
compensation and expenses of the Trustee’s agents, counsel and other persons not regularly in its employ.
The Company shall indemnify,
defend and hold harmless the Trustee and its officers, directors, employees, representatives and agents, from and against and reimburse
the Trustee for any and all claims, expenses, obligations, liabilities, losses, damages, injuries (to person, property, or natural resources),
penalties, stamp or other similar taxes, actions, suits, judgments, reasonable costs and expenses (including reasonable attorney’s
and agent’s fees and expenses) of whatever kind or nature regardless of their merit, demanded, asserted or claimed against the Trustee
directly or indirectly relating to, or arising from, claims against the Trustee by reason of its participation in the transactions contemplated
hereby, including without limitation all reasonable costs required to be associated with claims for damages to persons or property, and
reasonable attorneys’ and consultants’ fees and expenses and court costs except to the extent caused by the Trustee’s
negligence or willful misconduct. The provisions of this Section 7.07 shall survive the termination of this Agreement or the earlier
resignation or removal of the Trustee. The Company shall defend any claim and the Trustee shall cooperate in the defense.
The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need
not pay for any settlement made without its consent, which consent shall not be unreasonably withheld or delayed. This indemnification
shall apply to officers, directors, employees, shareholders and agents of the Trustee.
The Company need not reimburse
any expense or indemnify against any loss liability incurred by the Trustee or by any officer, director, employee, shareholder or agent
of the Trustee through negligence or bad faith.
To secure the Company’s
payment obligations in this Section, the Trustee shall have a lien prior to the Securities of any Series on all money or property held
or collected by the Trustee, except that held in trust to pay principal and interest on particular Securities of that Series.
When the Trustee incurs expenses
or renders services after an Event of Default specified in Section 6.01(f) or (g) occurs, the expenses and the compensation for the services
are intended to constitute expenses of administration under any Bankruptcy Law.
SECTION 7.08. |
Replacement of Trustee. |
A resignation or removal of
the Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s acceptance of appointment
as provided in this Section.
The Trustee may resign with
respect to the Securities of one or more Series by so notifying the Company. The Holders of a majority in principal amount of the
Securities of any Series may remove the Trustee with respect to that Series by so notifying the Trustee and the Company. The Company
may remove the Trustee with respect to Securities of one or more Series if:
(a) the
Trustee fails to comply with Section 7.10;
(b) the
Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;
(c) a
Custodian or public officer takes charge of the Trustee or its property; or
(d) the
Trustee becomes incapable of acting.
If the Trustee resigns or
is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor Trustee.
Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities
may appoint a successor Trustee to replace the successor Trustee appointed by the Company.
If a successor Trustee with
respect to the Securities of any one or more Series does not take office within [ ] days after the retiring Trustee resigns or is
removed, the retiring Trustee, the Company or the Holders of at least [ ]% in principal amount of the Securities of the applicable
Series may petition any court of competent jurisdiction for the appointment of a successor Trustee.
A successor Trustee shall
deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately after that, the retiring
Trustee shall transfer all property held by it as Trustee to the successor Trustee subject to the lien provided for in Section 7.07, and
subject to the payment of any and all amounts then due and owing to the retiring Trustee, the resignation or removal of the retiring Trustee
shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series
of Securities for which it is acting as Trustee under this Indenture. A successor Trustee shall mail a notice of its succession
to each Securityholder of each such Series. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company’s
obligations under Section 7.07 hereof shall continue for the benefit of the retiring trustee with respect to expenses and liabilities
incurred by it prior to such replacement.
SECTION 7.09. |
Successor Trustee by Merger, etc. |
If the Trustee consolidates
with, merges or converts into, or transfers all or substantially all of its corporate trust business to, another corporation, the successor
corporation without any further act shall be the successor Trustee with the same effect as if the successor Trustee had been named as
the Trustee herein.
SECTION 7.10. |
Eligibility; Disqualification. |
This Indenture shall always
have a Trustee who satisfies the requirements of TIA Section 310(a)(1), (2) and (5). The Trustee shall always have a combined capital
and surplus of at least $[ ] as set forth in its most recent published annual report of condition. The Trustee shall comply with
TIA Section 310(b).
SECTION 7.11. |
Preferential Collection of Claims Against Company. |
The Trustee is subject to TIA Section 311(a),
excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has resigned or been removed shall be subject to
TTA Section 311(a) to the extent indicated.
ARTICLE VIII
SATISFACTION AND DISCHARGE; DEFEASANCE
SECTION 8.01. |
Satisfaction and Discharge of Indenture. |
This Indenture shall upon
Company Order cease to be of further effect (except as hereinafter provided in this Section 8.01), and the Trustee, on the demand of and
at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when
(a) either
(i) all
Securities theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and that have been
replaced or paid) have been delivered to the Trustee for cancellation; or
(ii) all
such Securities not theretofore delivered to the Trustee for cancellation have become due and payable, or
(1) have
become due and payable, or
(2) will
become due and payable at their Stated Maturity within [ ], or
(3) are
to be called for redemption within [ ] under arrangements satisfactory to the Trustee for the giving
of notice of redemption by the Trustee in the name, and at the expense, of the Company, or
(4) are
deemed paid and discharged pursuant to section 8.03, as applicable; and the Company, in the case of (1), (2) or (3) above, has deposited
or caused to be deposited with the Trustee as trust funds in trust an amount sufficient for the purpose of paying and discharging the
entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, for principal and interest to the date
of such deposit (in the case of Securities which have become due and payable on or prior to the date of such deposit) or to the Stated
Maturity or redemption date, as the case may be;
(b) the
Company has paid or caused to be paid all other sums payable hereunder by the Company; and
(c) the
Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each meeting the applicable requirements
of Sections 10.04 and 10.05 and each stating that all conditions precedent herein relating to the satisfaction and discharge of this Indenture
have been complied with and the Trustee receives written demand from the Company to discharge.
Notwithstanding the satisfaction
and discharge of this Indenture, the obligations of the Company to the Trustee under Section 7.07, and, if money shall have been deposited
with the Trustee pursuant to clause (a) of this Section, the provisions of Sections 2.04, 2.07, 2.08, 8.01 8.02 and 8.05 shall survive.
SECTION 8.02. |
Application of Trust Funds; Indemnification. |
(a) Subject
to the provisions of Section 8.05, all money deposited with the Trustee pursuant to Section 8.01, all money and U.S. Government Obligations
or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.03 or 8.04 and all money received by the Trustee in
respect of U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.03 or 8.04,
shall be held in trust and applied by it, in accordance with the provisions of the Securities and this Indenture, to the payment, either
directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the persons
entitled thereto, of the principal and interest for whose payment such money has been deposited with or received by the Trustee or to
make mandatory sinking fund payments or analogous payments as contemplated by Sections 8.03 or 8.04.
(b) The
Company shall pay and shall indemnify the Trustee and the Agents against any tax, fee or other charge imposed on or assessed against U.S.
Government Obligations or Foreign Government Obligations deposited pursuant to Sections 8.03 or 8.04 or the interest and principal received
in respect of such obligations other than any payable by or on behalf of Holders.
(c) The
Trustee shall, in accordance with the terms of this Indenture, deliver or pay to the Company from time to time, upon Company Request and
at the expense of the Company any U.S. Government Obligations or Foreign Government Obligations or money held by it pursuant to this Indenture
as provided in Sections 8.03 or 8.04 which, in the opinion of a nationally recognized firm of independent certified public accountants,
expressed in a written certification thereof and delivered to the Trustee together with such Company Request, are then in excess of the
amount thereof which then would have been required to be deposited for the purpose for which such U.S. Government Obligations or Foreign
Government Obligations or money were deposited or received. This provision shall not authorize the sale by the Trustee of any U.S.
Government Obligations or Foreign Government Obligations held under this Indenture.
SECTION 8.03. |
Legal Defeasance of Securities of any Series. |
Unless this Section 8.03 is
otherwise specified, pursuant to Section 2.02(s), to be inapplicable to Securities of any Series, the Company shall be deemed to have
paid and discharged the entire indebtedness on all the outstanding Securities of such Series on the [ ] day after the date
of the deposit referred to in subparagraph (d) hereof, and the provisions of this Indenture, as it relates to such outstanding Securities
of such Series, shall no longer be in effect (and the Trustee, at the expense of the company, shall, at Company Request, execute proper
instruments acknowledging the same), except as to:
(a) the
rights of Holders of Securities of such Series to receive, from the trust funds described in subparagraph (d) hereof, (i) payment of the
principal of and each installment of principal of and interest on the outstanding Securities of such Series on the Stated Maturity of
such principal or installment of principal or interest and (ii) the benefit of any mandatory sinking fund payments applicable to the Securities
of such Series on the day on which such payments are due and payable in accordance with the terms of this Indenture and the Securities
of such Series;
(b) the
provisions of Sections 2.04, 2.07, 2.08, 2.14, 8.02, 8.03 and 8.05; and
(c) the
rights, powers, trust and immunities of the Trustee hereunder; provided that, the following conditions shall have been satisfied:
(d) the
Company shall have deposited or caused to be deposited irrevocably with the Paying Agent as trust funds in trust for the purpose of making
the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of such Securities in
the case of Securities of such Series denominated in Dollars, cash in Dollars (or such other money or currencies as shall then be legal
tender in the United States) and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign
Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal
in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed
on such Paying Agent), not later than [ ] day before the due date of any payment of money, an amount in cash, sufficient,
in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered
to the Trustee and the Paying Agent, to pay and discharge each installment of principal (including mandatory sinking fund or analogous
payments) of and interest, if any, on all the Securities of such Series on the dates such installments of interest or principal are due;
(e) such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument
to which the Company is a party or by which it is bound;
(f) no
Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit
or during the period ending on the [ ] day after such date;
(g) the
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel to the effect that (i) the Company
has received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of execution of this
Indenture, there has been a change in the applicable Federal income tax law, in either case to the effect that, and based thereon such
Opinion of Counsel shall confirm that, the Holders of the Securities of such Series will not recognize income, gain or loss for Federal
income tax purposes as a result of such deposit, defeasance and discharge and will be subject to Federal income tax on the same amount
and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred;
(h) the
Company shall have delivered to the Trustee an Officers’ Certificate stating that the deposit was not made by the Company with the
intent of preferring the Holders of the Securities of such Series over any other creditors of the company or with the intent of defeating,
hindering, delaying or defrauding any other creditors of the Company;
(i) such
deposit shall not result in the trust arising from such deposit constituting an investment company (as defined in the Investment Company
Act of 1940, as amended), or such trust shall be qualified under such Act or exempt from regulation thereunder; and
(j) the
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions
precedent provided for relating to the defeasance contemplated by this Section have been complied with.
SECTION 8.04. |
Covenant Defeasance. |
Unless this Section 8.04 is
otherwise specified pursuant to Section 2.02(s) to be inapplicable to Securities of any Series, on and after the [ ] day
after the date of the deposit referred to in subparagraph (a) hereof, the Company may omit to comply with any term, provision or condition
set forth under Sections 4.02, 4.03, 4.04, 4.05, 4.06, and 5.01 as well as any additional covenants contained in a supplemental indenture
hereto for a particular Series of Securities or a Board Resolution or an Officers’ Certificate delivered pursuant to Section 2.02(s)
(and the failure to comply with any such covenants shall not constitute a Default or Event of Default under Section 6.01) and the occurrence
of any event described in clause (e) of Section 6.01 shall not constitute a Default or Event of Default hereunder, with respect to the
Securities of such Series, provided that the following conditions shall have been satisfied:
(a) With
reference to this Section 8.04, the Company has deposited or caused to be irrevocably deposited (except as provided in Section 8.02(c))
with the Paying Agent as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders
of such Securities (i) in the case of Securities of such Series denominated in Dollars, cash in Dollars (or such other money or currencies
as shall then be legal tender in the United States) and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series
denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment
of interest and principal in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax
liability will be imposed on such Paying Agent), not later than [ ] day before the due date of any payment of money, an amount
in cash, sufficient, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written
certification thereof delivered to the Paying Agent, to pay principal and interest, if any, on and any mandatory sinking fund in respect
of the Securities of such Series on the dates such installments of interest or principal are due;
(b) Such
deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other agreement or instrument
to which the Company is a party or by which it is bound;
(c) No
Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit
or during the period ending on the [ ] day after such date;
(d) the
company shall have delivered to the Trustee an Opinion of Counsel confirming that Holders of the Securities of such Series will not recognize
income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income
tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred;
(e) the
Company shall have delivered to the Trustee an Officers’ Certificate stating the deposit was not made by the Company with the intent
of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering,
delaying or defrauding any other creditors of the Company; and
(f) The
Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the defeasance contemplated by this Section have been complied with.
SECTION 8.05. |
Repayment to Company. |
The Paying Agent shall pay
to the Company upon request any money held by them for the payment of principal and interest that remains unclaimed for two years.
After that, Securityholders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned
property law designates another person and all liability of the Paying Agent with respect to that money shall cease.
ARTICLE IX
AMENDMENTS AND WAIVERS
SECTION 9.01. |
Without Consent of Holders. |
The Company and the Trustee
may amend or supplement this Indenture or the Securities of one or more Series without the consent of any Securityholder:
(a) to
cure any ambiguity, defect or inconsistency;
(b) to
comply with Article V;
(c) to
provide for uncertificated Securities in addition to or in place of certificated Securities;
(d) to
make any change that does not adversely affect the rights of any Securityholder;
(e) to
provide for the issuance of and establish the form and terms and conditions of Securities of any Series as permitted by this Indenture;
(f) to
evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the Securities of one or more
Series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration
of the trusts hereunder by more than one Trustee;
(g) to
comply with requirements of the TIA and any rules promulgated under the TIA; and
(h) to
add to the covenants of the Company for the equal and ratable benefit of the Holders or to surrender any right, power or option conferred
upon the Company.
Any amendment or supplement
made solely to conform the provisions of this Indenture or the Securities of any Series to the description thereof contained in the final
prospectus relating to such Series will be deemed not to adversely affect the rights of any Holder.
SECTION 9.02. |
With Consent of Holders. |
The Company and the Trustee
may enter into a supplemental indenture with the written consent of the Holders of at least a majority in principal amount of the outstanding
Securities of all Series affected by such supplemental indenture, taken together as one class (including consents obtained in connection
with a tender offer or exchange offer for the Securities of such Series), for the purpose of adding any provisions to or changing in any
manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights
of the Securityholders of each such Series. Except as provided in Section 6.13, the Holders of at least a majority in principal
amount of the outstanding Securities of all Series affected by such waiver by notice to the Trustee, taken together as one class (including
consents obtained in connection with a tender offer or exchange offer for the Securities of such Series) may waive compliance by the Company
with any provision of this Indenture or the Securities with respect to such Series.
It shall not be necessary
for the consent of the Holders of Securities under this Section 9.02 to approve the particular form of any proposed supplemental indenture
or waiver, but it shall be sufficient if such consent approves the substance thereof. After a supplemental indenture or waiver under
this section becomes effective, the Company shall mail to the Holders of Securities affected thereby a notice briefly describing the supplemental
indenture or waiver. Any failure by the Company to mail or publish such notice, or any defect therein, shall not, however, in any
way impair or affect the validity of any such supplemental indenture or waiver.
SECTION 9.03. |
Limitations. |
Without the consent of each
Securityholder affected, an amendment or waiver may not:
(a) change
the amount of Securities whose Holders must consent to an amendment, supplement or waiver, except to increase any such amount or to provide
that certain provisions of this Indenture cannot be modified, amended or waived without the consent of the Holder of each outstanding
Security affected thereby;
(b) reduce
the amount of interest, or change the interest payment time, on any Security;
(c) waive
a redemption payment or alter the redemption provisions (other than any alteration that would not materially adversely affect the legal
rights of any Holder under this Indenture) or the price at which the Company is required to offer to purchase the Securities;
(d) reduce
the principal or change the Stated Maturity of any Security or reduce the amount of, or postpone the date fixed for, the payment of any
sinking fund or analogous obligation;
(e) reduce
the principal amount payable of any Security upon Maturity;
(f) waive
a Default or Event of Default in the payment of the principal of or interest, if any, on any Security (except a rescission of acceleration
of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series
and a waiver of the payment default that resulted from such acceleration);
(g) change
the place or currency of payment of principal of or interest, if any, on any Security other than that stated in the Security;
(h) impair
the right of any Holder to receive payment of principal or, or interest on, the Securities of such Holder on or after the due dates therefor;
(i) impair
the right to institute suit for the enforcement of any payment on, or with respect to, any Security;
(j) make
any change in Sections 10.15 or 10.16;
(k) change
the ranking of the Securities; or
(l) make
any other change which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate as a limitation
under this Section.
For the avoidance of doubt,
any amendment or waiver shall always be subject to the consent of the Company.
SECTION 9.04. |
Compliance with Trust Indenture Act. |
Every amendment to this Indenture
or the Securities of one or more Series shall be set forth in a supplemental indenture hereto that complies with the TIA as then in effect.
SECTION 9.05. |
Revocation and Effect of Consents. |
Until an amendment or waiver
becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder and every subsequent Holder of a Security
or portion of a Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent is not
made on any Security. However, any such Holder or subsequent Holder may revoke the consent as to his Security or portion of a Security
if the Trustee receives the notice of revocation before the date the amendment or waiver becomes effective.
Any amendment or waiver once
effective shall bind every Securityholder of each Series affected by such amendment or waiver unless it is of the type described in any
of clauses (a) through (g) of Section 9.03 in that case, the amendment or waiver shall bind each Holder of a Security who has consented
to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s
Security.
SECTION 9.06. |
Notation on or Exchange of Securities. |
If an amendment, supplement
or waiver changes the terms of a Security, the Trustee may require the Holder of the Security to deliver it to the Trustee and the Trustee
may place an appropriate notation on the Security about the changed terms and return it to the Holder. Alternatively, if the Company
or the Trustee so determines, the Company shall issue and the Trustee shall authenticate upon request new Securities of that Series that
reflect the changed terms.
SECTION 9.07. |
Trustee Protected. |
In executing, or accepting
the additional trusts created by, any supplemental indenture permitted by this Article or the modifications thereby of the trusts created
by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an
Opinion of Counsel or an Officer’s Certificate, or both stating that the execution of such supplemental indenture is authorized
or permitted by this Indenture. The Trustee shall sign all supplemental indentures, except that the Trustee need not sign any supplemental
indenture that adversely affects its rights, duties or indemnities.
SECTION 9.08. |
Effect of Supplemental Indenture. |
Upon the execution of any
supplemental indenture under this Article, this Indenture shall be modified in accordance therewith, and each such supplemental indenture
shall form part of this Indenture for all purposes with respect to the relevant Series; and every Holder of Securities of the relevant
Series theretofore or thereafter authenticated and delivered hereunder shall be bound thereby.
ARTICLE X
MISCELLANEOUS
SECTION 10.01. |
Trust Indenture Act Controls. |
If any provision of this Indenture
limits, qualifies, or conflicts with another provision which is required or deemed to be included in this Indenture by the TIA, such required
or deemed provision shall control.
Any notice or communication
by the Company, the Trustee, the Paying Agent or the Registrar to another is duly given if in writing and delivered in person or mailed
by first-class mail:
if to the Company:
[ ]
Attn: [ ]
Fax: [ ]
if to the Trustee:
[ ]
Attn: [ ]
Fax: [ ]
if to the Registrar or Paying
Agent:
[
]
Attn: [
]
Fax: [
]
with copy to:
[
]
Attn: [
]
Fax: [
]
The Company, the Trustee and
each Agent by notice to each other may designate additional or different addresses for subsequent notices or communications.
Any notice or communication
to a Securityholder shall be mailed by first-class mail to his address shown on the register kept by the Registrar. Failure to mail
a notice or communication to a Securityholder of any Series or any defect in it shall not affect its sufficiency with respect to other
Securityholders of that or any other Series.
If a notice or communication
is mailed or published in the manner provided above, within the time prescribed, it is duly given, whether or not the Securityholder receives
it.
If the company mails a notice
or communication to Securityholders, it will mail a copy to the Trustee and each Agent at the same time.
Whenever a notice is required
to be given by the Company, such notice may be given by the Trustee or Registrar on the Company’s behalf (and the Company will make
any notice it is required to give to Holders available on its website).
SECTION 10.03. |
Communication by Holders with Other Holders. |
Securityholders of any Series
may communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or any other Series with respect to their rights
under this Indenture or the Securities of that Series or all Series. The Company, the Trustee, the Registrar and anyone else shall
have the protection of TIA Section 312(c).
SECTION 10.04. |
Certificate and Opinion as to Conditions Precedent. |
Upon any request or application
by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee:
(a) an
Officers’ Certificate stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture
relating to the proposed action have been complied with; and
(b) an
Opinion of Counsel stating that, in the opinion of counsel, all such conditions precedent (including any covenants, compliance with which
constitutes a condition precedent) have been complied with.
SECTION 10.05. |
Statements Required in Certificate or Opinion. |
Each certificate or opinion
with respect to compliance with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to
TIA Section 314(a)(4)) shall comply with the provisions of TIA Section 314(e) and shall include:
(a) a
statement that the person making such certificate or opinion has read such covenant or condition;
(b) a
brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained
in such certificate or opinion are based;
(c) a
statement that, in the opinion of such person, he has made such examination or investigation as is necessary to enable him to express
an informed opinion as to whether or not such covenant or condition has been complied with; and
(d) a
statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.
provided, however,
that with respect to matters of fact an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials.
SECTION 10.06. |
Record Date for Vote or Consent of Holders. |
The Company (or, in the event
deposits have been made pursuant to Section 11.02, the Trustee) may set a record date for purposes of determining the identity of Holders
entitled to vote or consent to any action by vote or consent authorized or permitted under this Indenture, which record date shall not
be more than [ ] days prior to the date of the commencement of solicitation of such action. Notwithstanding the provisions
of Section 9.05, if a record date is fixed, those persons who were Holders of Securities at the close of business on such record date
(or their duly designated proxies), and only those persons, shall be entitled to take such action by vote or consent or to revoke any
vote or consent previously given, whether or not such persons continue to be Holders after such record date.
SECTION 10.07. |
Rules by Trustee and Agents. |
The Trustee may make reasonable
rules for action by or a meeting of Securityholders of one or more Series. Any Agent may make reasonable rules and set reasonable
requirements for its functions.
SECTION 10.08. |
Legal Holidays. |
Unless otherwise provided
by Board Resolution, Officers’ Certificate or supplemental indenture for a particular Series, a “Legal Holiday” is any
day that is not a Business Day. If a payment date is a Legal Holiday at a place of payment, payment may be made at that place on
the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period.
SECTION 10.09. |
No Recourse Against Others. |
A director, officer, employee
or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture
or for any claim based on, in respect of or by reason of such obligations or their creation. Each Securityholder by accepting a
Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities.
SECTION 10.10. |
Counterparts. |
This Indenture may be executed
in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be
an original and all of which taken together shall constitute one and the same agreement.
SECTION 10.11. |
Governing Laws and Submission to Jurisdiction. |
THIS INDENTURE AND THE SECURITIES
SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK EXCLUDING ANY RULE OF LAW THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION
OTHER THAN THE STATE OF NEW YORK.
The Company agrees that any
legal suit, action or proceeding arising out of or based upon this Indenture may be instituted in any federal or state court sitting in
New York City, and, to the fullest extent permitted by law, waives any objection which it may now or hereafter have to the laying of venue
of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such court in any suit, action or proceeding.
The Company, as long as any Securities remain outstanding or the parties hereto have any obligation under this Indenture, shall have an
authorized agent in the United States upon whom process may be served in any such legal action or proceeding. Service of process upon
such agent and written notice of such service mailed or delivered to it shall to the extent permitted by law be deemed in every respect
effective service of process upon it in any such legal action or proceeding and, if it fails to maintain such agent, any such process
or summons may be served by mailing a copy thereof by registered mail, or a form of mail substantially equivalent thereto, addressed to
it at its address as provided for notices hereunder. The Company hereby appoints Seward & Kissel LLP, One Battery Park Plaza, New
York, NY, 10004, as its agent for such purposes, and covenants and agrees that service of process in any legal action or proceeding
may be made upon it at such office of such agent.
SECTION 10.12. |
No Adverse Interpretation of Other Agreements. |
This Indenture may not be
used to interpret another indenture, loan or debt agreement of the Company or a Subsidiary. Any such indenture, loan or debt agreement
may not be used to interpret this Indenture.
SECTION 10.13. |
Successors. |
All agreements of the Company
in this Indenture and the Securities shall bind its successor. All agreements of the Trustee in this Indenture shall bind its successor.
SECTION 10.14. |
Severability. |
In case any provision in this
Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby.
SECTION 10.15. |
Table of Contents, Headings, Etc. |
The Table of Contents, Cross
Reference Table, and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are
not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.
SECTION 10.16. |
Securities in a Foreign Currency or in ECU. |
Unless otherwise specified
in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to Section 2.02 of this Indenture
with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a
specified percentage in aggregate principal amount of Securities of all Series or all Series affected by a particular action at the time
outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars
(including ECUs), then the principal amount of Securities of such Series which shall be deemed to be outstanding for the purpose of taking
such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For
purposes of this Section 10.16, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for cable transfers
of that currency as published by the Federal Reserve Bank of New York; provided, however, in the case of ECUs, Market Exchange Rate shall
mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal
of the European Union (such publication or any successor publication, the “Journal”). If such Market Exchange Rate is
not available for any reason with respect to such currency, the Trustee shall use, without liability on its part, such quotation of the
Federal Reserve Bank of New York or, in the case of ECUs, the rate of exchange as published in the Journal, as of the most recent available
date, or quotations or, in the case of ECUs, rates of exchange from one or more major banks in The City of New York or in the country
of issue of the currency in question or, in the case of ECUs, in Luxembourg or such other quotations or, in the case of ECUs, rates of
exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall apply
in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection
with any action taken by Holders of Securities pursuant to the terms of this Indenture.
All decisions and determinations
of the Trustee regarding the Market Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in
its sole discretion and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all purposes and irrevocably
binding upon the Company and all Holders.
SECTION 10.17. |
Judgment Currency. |
The Company agrees, to the
fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is
necessary to convert the sum due in respect of the principal of or interest or other amount on the Securities of any Series (the “Required
Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used
shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required
Currency with the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a New York Banking
Day, then, the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase
in The City of New York the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which final
unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not
be discharged or satisfied by any tender, any recovery pursuant to any judgment (whether or not entered in accordance with subsection
(a)), in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt,
by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable
as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such
actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable, and (iii) shall not be affected
by judgment being obtained for any other sum due under this Indenture. For purposes of the foregoing, “New York Banking Day”
means any day except a Saturday, Sunday or a legal holiday in The City of New York on which banking institutions are authorized or required
by law, regulation or executive order to close.
SECTION 10.18. |
Compliance with Applicable Anti-Terrorism and Money Laundering Regulations. |
In order to comply with the
laws, rules, regulations and executive orders in effect from time to time applicable to banking institutions, including those relating
to the funding of terrorist activities and money laundering (“Applicable Law”), the Trustee is required to obtain, verify
and record certain information relating to individuals and entities which maintain a business relationship with the Trustee. Accordingly,
each of the parties agree to provide to the Trustee, upon its request from time to time such identifying information and documentation
as may be available for such party in order to enable the Trustee to comply with the Applicable Law.
ARTICLE XI
SINKING FUNDS
SECTION 11.01. |
Applicability of Article. |
The provisions of this Article
shall be applicable to any sinking fund for the retirement of the Securities of a Series, except as otherwise permitted or required by
any form of Security of such Series issued pursuant to this Indenture.
The minimum amount of any
sinking fund payment provided for by the terms of the Securities of any Series is herein referred to as a “mandatory sinking fund
payment” and any other amount provided for by the terms of Securities of such Series is herein referred to as an “optional
sinking fund payment.” If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment may
be subject to reduction as provided in Section 11.02. Each sinking fund payment shall be applied to the redemption of Securities
of any Series as provided for by the terms of the securities of such Series.
SECTION 11.02. |
Satisfaction of Sinking Fund Payments with Securities. |
The Company may, in satisfaction
of all or any part of any sinking fund payment with respect to the Securities of any Series to be made pursuant to the terms of such Securities
(1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities
previously called for mandatory sinking fund redemption) and (2) apply as credit Securities of such Series to which such sinking fund
payment is applicable and which have been redeemed either at the election of the Company pursuant to the terms of such Series of Securities
(except pursuant to any mandatory sinking fund) or through the application of permitted optional sinking fund payments or other optional
redemptions pursuant to the terms of such Securities, provided that such Securities have not been previously so credited. Such Securities
shall be received by the Registrar, together with an Officers’ Certificate with respect thereto, not later than [ ] days prior
to the date on which the Registrar begins the process of selecting Securities for redemption, and shall be credited for such purpose by
the Registrar at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking
fund payment shall be reduced accordingly. If as a result of the delivery or credit of Securities in lieu of cash payments pursuant
to this Section 11.02, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment
shall be less than $[ ], the Registrar need not call Securities of such Series for redemption, except
upon receipt of a Company Order that such action be taken, and such cash payment shall be held by the Paying Agent and applied to the
next succeeding sinking fund payment, provided, however, that the Paying Agent shall from time to time upon receipt of a Company Order
pay over and deliver to the Company any cash payment so being held by the Paying Agent upon delivery by the Company to the Registrar of
Securities of that Series purchased by the Company having an unpaid principal amount equal to the cash payment required to be released
to the Company.
SECTION 11.03. |
Redemption of Securities for Sinking Fund. |
Not less than [ ] days
(unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers’ Certificate in respect of a particular
Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee and
the Paying Agent an Officers’ Certificate specifying the amount of the next ensuing mandatory sinking fund payment for that Series
pursuant to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof,
if any, which is to be satisfied by delivering and crediting of Securities of that Series pursuant to Section 11.02., and the optional
amount, if any, to be added in cash to the next ensuing mandatory sinking fund payment, and the Company shall thereupon be obligated to
pay the amount therein specified. Not less than [ ] days (unless otherwise indicated in the Board Resolution, Officers’
Certificate or supplemental indenture in respect of a particular Series of Securities) before each such sinking fund payment date the
Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02 and cause
notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.03.
Such notice having been duly given, the redemption of such Securities shall stated in Sections 3.04, 3.05 and 3.06.
[The remainder of this page is intentionally
left blank]
IN WITNESS WHEREOF, the parties
hereto have caused this Indenture to be duly executed as of the day and year first above written.
Lichen China Limited
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
[
]
as Trustee
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
[ ]
as Registrar and Paying Agent |
|
|
|
By: |
|
|
Name: |
|
|
Its: |
|
|
Exhibit 5.1
|
Lichen China Limited |
Email jlee@applebyglobal.com |
|
Windward 3, Regatta Office Park |
|
|
PO Box 1350, Grand Cayman KY1-1108 |
Direct Dial +852 2905 5737 |
|
Cayman Islands |
|
|
|
Tel +852 2523 8123 |
|
Attention The Board of Directors |
|
|
|
Appleby Ref 437495.0005 |
|
|
|
|
|
21 February 2024 |
Suites 4201 - 03 & 12
42/F, One Island East
Taikoo Place
18 Westlands Road
Quarry Bay
Hong Kong
Tel +852 2523 8123
applebyglobal.com |
|
Lichen China Limited (Company)
INTRODUCTION
This opinion as to Cayman Islands law is addressed to you in connection
with the filing by the Company of a registration statement on Form F-3, on 21 February 2024 (Registration Statement) with the U.S.
Securities and Exchange Commission (SEC) under the U.S. Securities Act of 1933, as amended (Securities Act) relating to
the registration for issue and sale from time to time by the Company of up to US$100,000,000 of securities, such securities to comprise:
|
Managing Partner
David Bulley
Partners
Fiona Chan
Vincent Chan
Chris Cheng
Richard Grasby
Judy Lee
Marc Parrott
Lorinda Peasland
Eliot Simpson |
|
(a)
(b)
(c)
(d) |
series A ordinary shares, par value US$0.00004 each, of the Company
(Ordinary Shares);
warrants to purchase Ordinary Shares, Debt Securities or any combination
thereof (Warrants) that may be issued under warrant agreements to be entered into between the Company and one or more warrant agents
for such Warrants thereunder (the Warrant Agreements);
debt securities of the Company (Debt Securities) that may be
issued under one or more separate indentures between the Company and a trustee to be specified in an accompanying prospectus supplement
(the Indentures);
units comprising one or more of the other securities described in the
Registration Statement in any combination (Units) that may be issued under unit agreements and supplemental agreements to be entered
into between the Company and one or more unit agents or other persons for such Units thereunder (the Unit Agreements); |
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
| (e) | share purchase contracts relating to the Ordinary Shares or other Securities
registered under the Registration Statement (the Share Purchase Contracts); |
| (f) | share purchase units (Share Purchase Units) consisting of Share
Purchase Contract and Debt Securities, Warrants and other securities registered under the Registration Statement (Share Purchase Unit
Agreement); and |
| (g) | rights to purchase Ordinary Shares, (Rights) to be issued under
rights agent agreements to be entered into between the Company and a bank or trust company, as rights agents (the Rights Agreements); |
(together, the Securities).
|
|
OUR REVIEW |
|
|
|
|
|
For the purposes of giving this opinion we have examined and relied (without
further verification) upon the documents listed in Schedule 1 (Documents). We have not examined any other documents, even if they
are referred to in the Documents. |
|
|
|
|
|
We have not made any other enquiries concerning the Company and in particular
we have not investigated or verified any matter of fact or opinion (whether set out in the Documents or elsewhere) other than as expressly
stated in this opinion. |
|
|
|
|
|
Unless otherwise defined herein, capitalised terms have the meanings assigned
to them in Schedule 1. |
|
|
|
|
|
LIMITATIONS |
|
|
|
|
|
Our opinion is limited to, and should be construed in accordance with,
the laws of the Cayman Islands at the date of this opinion. We express no opinion on the laws of any other jurisdiction. |
|
|
|
|
|
This opinion is limited to the matters stated in it and does not extend,
and is not to be extended by implication, to any other matters. We express no opinion on the commercial implications of the Documents
or Securities or whether they give effect to the commercial intentions of the parties. Further, we express no opinion as to any matter
pertaining to the contents of the Documents other than as expressly stated herein with respect to the issue of the Securities. |
|
|
|
|
|
|
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
|
|
This opinion is given solely for the benefit of the addressee in connection with the matters referred to herein and, except with our prior written consent it may not be transmitted or disclosed to or used or relied upon by any other person or be relied upon for any other purpose whatsoever, save as, and to the extent provided, below.
A copy of this opinion may be provided (a) where required by law or
judicial process and (b) for the purpose of information only to the addressee’s affiliates, professional advisers, auditors, insurers
and regulators.
|
|
|
|
|
|
This opinion may be used only in connection with the offer and sale
of the Securities while the Registration Statement is effective. |
|
|
|
|
|
ASSUMPTIONS AND RESERVATIONS |
|
|
|
|
|
We give the following opinions on the basis of the assumptions set
out in Schedule 2 (Assumptions), which we have not verified, and subject to the reservations set out in Schedule 3 (Reservations). |
|
|
|
|
|
OPINIONS |
| 1. | Incorporation and Status: The Company is duly incorporated as an exempted company incorporated
with limited liability and existing under the laws of the Cayman Islands and is a separate legal entity. |
| 2. | Good Standing: The Company is validly existing and in good standing with the Registrar of Companies
of the Cayman Islands. |
| 3. | Ordinary Shares: With respect to
each issue of Ordinary Shares (including any Ordinary Shares duly issued upon the exchange,
exercise or conversion of Securities that are exchangeable or exercisable for, or convertible
into, Ordinary Shares), when (i) the board of directors of the Company (Board) has
taken all necessary corporate action to approve the issue thereof, the terms of the offering
thereof and related matters; (ii) the issue of such Ordinary Shares has been recorded
in the Company’s register of members (shareholders); and (iii) the provisions of the
applicable definitive purchase, underwriting or similar agreement approved by the Board and
any relevant prospectus supplement have been satisfied and the subscription price of such
Ordinary Shares specified therein (being not less than the par value of the Ordinary Shares)
has been fully paid, the Ordinary Shares will be duly authorised, validly issued, fully paid
and non-assessable. As a matter of Cayman Islands law, a share is only issued when it has
been entered in the register of members (shareholders). |
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
| 4. | Warrants: With respect to each issue of Warrants, when (i) the Board has taken all necessary corporate
action to approve the creation and terms of the Warrants and to approve the issue thereof, the terms of the offering thereof and related
matters; (ii) a Warrant Agreement relating to the Warrants shall have been duly authorised and validly executed and delivered by
and on behalf of the Company and all the relevant parties thereunder in accordance with all relevant laws; and (iii) the certificates
representing the Warrants and the Warrants have been duly executed, countersigned, registered, authenticated, issued and delivered (as
and when applicable) in accordance with the Warrant Agreement relating to the Warrants and the applicable definitive purchase, underwriting
or similar agreement approved by the Board and any relevant prospectus supplement, and upon payment of the consideration therefor provided
therein, such Warrants will be duly authorised, issued and delivered. |
| 5. | Debt Securities: With respect to each issue of Debt Securities, when (i) the Board has taken all
necessary corporate action to approve the creation and terms of the Debt Securities and to approve the issue thereof, the terms of the
offering thereof and related matters; (ii) an Indenture relating to the Debt Securities and the Debt Securities shall have been duly
authorised and validly executed and unconditionally delivered by and on behalf of the Company and all the relevant parties thereunder
in accordance with all relevant laws; and (iii) the certificates representing the Debt Securities and the Debt Securities have been
duly executed, countersigned, registered, authenticated, issued and delivered (as and when applicable) in accordance with the Indenture
relating to the Debt Securities, any applicable agreement approved by the Board and any relevant prospectus supplement, and upon payment
of the consideration therefor provided therein, such Debt Securities be duly authorised, issued and delivered. |
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
| 6. | Units: With respect to each issue
of Units, when (i) the Board has taken all necessary corporate action to approve the creation
and terms of the Units and to approve the issue thereof and the Securities comprised in such
Units, the terms of the offering thereof and related matters; (ii) a Unit Agreement
relating to the Units shall have been authorised and duly executed and delivered by and on
behalf of the Company and all the relevant parties thereunder in accordance with all relevant
laws; (iii) in respect of any Ordinary Shares which are components of the Units, the
issue of such Ordinary Shares has been recorded in the Company’s register of members (shareholders);
(iv) in respect of any Warrants which are components of the Units, a Warrant Agreement relating
to the Warrants shall have been duly authorised and validly executed and delivered by and
on behalf of the Company and the warrant agent thereunder in accordance with all relevant
laws; (v) in respect of any Debt Securities which are components of the Units, an Indenture
relating to the Debt Securities and the Debt Securities shall have been duly authorised and
validly executed and unconditionally delivered by and on behalf of the Company and all the
relevant parties thereunder in accordance with all relevant laws (vi) in respect of any Share
Purchase Contracts which are components of the Units, a Share Purchase Contract shall have
been duly authorised and validly executed and delivered by and on behalf of the Company and
all the relevant parties thereunder in accordance with all relevant laws; (vii) in respect
of any Share Purchase Units which are components of the Units, a Share Purchase Unit Agreement
relating to the Share Purchase Units shall have been authorised and duly executed and delivered
by and on behalf of the Company and all the relevant parties thereunder in accordance with
all relevant laws; (viii) in respect of any Rights which are components of the Units, a Rights
Agreement relating to the Rights shall have been duly authorised and validly executed and
delivered by and on behalf of the Company and all the relevant parties thereunder in accordance
with all relevant laws; and (ix) the certificates representing the Units, the Units and any
Securities which are components of the Units shall have been duly executed, countersigned,
registered, authenticated, issued and delivered (in each case, as and when applicable), in
accordance with (A) the applicable Unit Agreement relating to the Units, (B) the applicable
Warrant Agreement relating to any Warrants which are components of the Units, (C) the applicable
Indenture relating to any Debt Securities which are components of the Units, (D) the applicable
Share Purchase Contracts which are components of the Units, (E) the applicable Share Purchase
Unit Agreement relating to any Share Purchase Units which are components of the Units, (F)
the applicable Rights Agreement relating to any Rights which are components of the Units
and (G) the applicable definitive purchase, underwriting or similar agreement approved by
the Board and any relevant prospectus supplement, and upon payment of the consideration therefor
provided therein (being not less than the par value of any Ordinary Shares which are components
of the Units), such Units will be duly authorised, issued and delivered. |
| 7. | Share Purchase Contracts: With
respect to each Share Purchase Contract, when (i) the Board has taken all necessary corporate
action to approve the final terms of the Share Purchase Contract and related matters;
(ii) a Share Purchase Contract shall have been duly authorised and validly executed and delivered
by and on behalf of the Company and all the relevant parties thereunder in accordance with
all relevant laws; and (iii) upon payment of the consideration therefor provided therein,
such Share Purchase Contract will be duly authorised and delivered. |
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
| 8. | Share Purchase Units: With respect
to each issue of the Share Purchase Units, when (i) the Board has taken all necessary corporate
action to approve the creation and terms of the Share Purchase Units and to approve the issue
thereof and the Securities comprised in such Share Purchase Units, the terms of the offering
thereof and related matters; (ii) a Share Purchase Unit Agreement relating to the Share
Purchase Units shall have been authorised and duly executed and delivered by and on behalf
of the Company and all the relevant parties thereunder in accordance with all relevant laws;
(iii) in respect of any Ordinary Shares which are components of the Share Purchase Units,
the issue of such Ordinary Shares has been recorded in the Company’s register of members
(shareholders); (iv) in respect of any Warrants which are components of the Share Purchase
Units, a Warrant Agreement relating to the Warrants shall have been duly authorised and validly
executed and delivered by and on behalf of the Company and the warrant agent thereunder in
accordance with all relevant laws; (v) in respect of any Debt Securities which are components
of the Share Purchase Units, an Indenture relating to the Debt Securities and the Debt Securities
shall have been duly authorised and validly executed and unconditionally delivered by and
on behalf of the Company and all the relevant parties thereunder in accordance with all relevant
laws (vi) in respect of any Share Purchase Contracts which are components of the Share Purchase
Units, a Share Purchase Contract shall have been duly authorised and validly executed and
delivered by and on behalf of the Company and all the relevant parties thereunder in accordance
with all relevant laws; (vii) in respect of any Units which are components of the Share
Purchase Units, a Unit Agreement relating to the Units shall have been authorised and duly
executed and delivered by and on behalf of the Company and all the relevant parties thereunder
in accordance with all relevant laws; (viii) in respect of any Rights which are components
of the Share Purchase Units, a Rights Agreement relating to the Rights shall have been duly
authorised and validly executed and delivered by and on behalf of the Company and all the
relevant parties thereunder in accordance with all relevant laws; and (ix) the certificates
representing the Share Purchase Units, the Share Purchase Units and any Securities which
are components of the Share Purchase Units shall have been duly executed, countersigned,
registered, authenticated, issued and delivered (in each case, as and when applicable), in
accordance with (A) the applicable Share Purchase Unit Agreement relating to the Share Purchase
Units, (B) the applicable Warrant Agreement
relating to any Warrants which are components of the Share Purchase Units, (C) the applicable
Indenture relating to any Debt Securities which are components of the Share Purchase Units,
(D) the applicable Share Purchase Contracts which are components of the Share Purchase Units,
(E) the applicable Unit Agreement relating to any Units which are components of the Share
Purchase Units, (F) the applicable Rights Agreement relating to any Rights which are components
of the Share Purchase Units and (G) the applicable definitive purchase, underwriting or similar
agreement approved by the Board and any relevant prospectus supplement, and upon payment
of the consideration therefor provided therein (being not less than the par value of any
Ordinary Shares which are components of the Share Purchase Units), such Share Purchase Units
will be duly authorised, issued and delivered. |
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
| 9. | Rights: With respect to each issue
of Rights, when (i) the Board has taken all necessary corporate action to approve the creation
and terms of the Rights and to approve the issue thereof, the terms of the offering thereof
and related matters; (ii) a Rights Agreement relating to the Rights shall have been
duly authorised and validly executed and delivered by and on behalf of the Company and all
the relevant parties thereunder in accordance with all relevant laws; and (iii) the
certificates representing the Rights and the Rights have been duly executed, countersigned,
registered, authenticated, issued and delivered (as and when applicable) in accordance with
the Rights Agreement relating to the Rights and the applicable definitive purchase, underwriting
or similar agreement approved by the Board and any relevant prospectus supplement, and upon
payment of the consideration therefor provided therein, such Rights will be duly authorised,
issued and delivered. |
| 10. | Registration Statement: The statements
under the headings “Taxation – Cayman Islands Taxation”, “Enforceability
of Civil Liabilities” and “Description of Ordinary Shares” in the prospectus
forming part of the Registration Statement, to the extent that they constitute statements
of Cayman Islands law, are accurate in all material respects and that such statements constitute
our opinion. |
|
|
We consent to the filing of this
opinion as an exhibit to the Registration Statement and to the reference to our name under the headings “Enforceability of Civil
Liabilities” and “Legal Matters”. In giving this consent, we do not thereby admit that we are within the category of
persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the SEC promulgated thereunder,
or Item 509 of the SEC’s Regulation S-K promulgated under the Securities Act. |
|
|
|
|
|
This opinion may be used only in connection with the offer and sale
of the Securities while the Registration Statement is effective. |
|
|
Yours faithfully |
|
|
|
|
|
/s/ Appleby |
|
|
|
Appleby |
|
|
|
|
|
|
|
|
Bermuda ■ British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■ Isle of Man ■ Jersey ■ Mauritius ■ Seychelles ■ Shanghai |
Schedule
1
Part 1
The Registration Statement
| 1. | A scanned copy of the Registration Statement on Form F-3 dated 21 February
2024. |
Part 2
Other Documents Examined
| 2. | Scanned copies of: (i) the certificate of incorporation of the Company
dated 13 April 2016; (ii) the certificate of incorporation on change of name of the Company dated 11 November 2016; and (iii) the certificate
of incorporation on change of name of the Company dated 7 April 2017 (collectively, Certificate of Incorporation). |
| 3. | Scanned copies of the amended and restated memorandum of association
and articles of association of the Company filed with the Registrar of Companies on 15 June 2022 (collectively, Constitutional Documents). |
| 4. | A scanned copy of the certificate of good standing dated 7 February
2024 issued by the Registrar of Companies in respect of the Company (Certificate of Good Standing). |
| 5. | A scanned copy of the certificate of incumbency dated 8 February 2024
issued by the Company’s registered office provider in respect of the Company (Certificate of Incumbency). |
| 6. | A scanned copy of the unanimous written resolutions of the directors of the Company dated 12
February 2024 (Resolutions). |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
Schedule
2
Assumptions
We have assumed:
| 1. | (i) that the originals of all documents examined in connection with this opinion are authentic, accurate
and complete; and (ii) the authenticity, accuracy, completeness and conformity to original documents of all documents submitted to us
as copies; |
| 2. | that there has been no change to the information contained in the Certificate of Incorporation and that
the Registration Statement and the Constitutional Documents remain in full force and effect and are unamended; |
| 3. | that the signatures, initials and seals on all documents and certificates submitted to us as originals
or copies of executed originals are authentic; |
| 4. | that the Registration Statement does not differ in any material respects from any draft of the same which
we have examined and upon which this opinion is based; |
| 5. | that the Company has not (i) received notice of any stop notice under Order 50 of the Grand Court Rules
in respect of any of its shares or (ii) issued any restrictions notice under the Companies Act in respect of the registration of the beneficial
ownership of any of its shares, which restrictions notice has not been withdrawn by the Company or ceased by court order; |
| 6. | that there is no contractual or other prohibition or restriction
(other than as arising under Cayman Islands law) binding on the Company prohibiting or restricting it from entering into and performing
its obligations under the Registration Statement and a duly authorised, executed and delivered Warrant Agreement, Indenture, Unit Agreement,
Share Purchase Contract, Share Purchase Unit Agreemnent or Rights Agreement; that the Warrant Agreements, the Indentures, the Unit Agreements,
the Share Purchase Contracts, the Share Purchase Unit Agreements and the Rights Agreements will be governed by and construed in accordance
with the laws of New York and will be legal, valid, binding and enforceable against all relevant parties in accordance with their terms
under the laws of the State of New York and all other relevant laws; |
| 7. | that the Warrants, the Debt Securities, the Units, the Share Purchase Contracts,
the Share Purchase Units and the Rights will be governed by and construed in accordance with the laws of New York and will be legal, valid,
binding and enforceable against all relevant parties in accordance with their terms under the laws of the State of New York and all other
relevant laws (other than, with respect to the Company, the laws of the Cayman Islands); |
| 8. | that the choice of the laws of the State of New York as the governing law of the Warrant Agreements and
the Warrants, the Indentures and the Debt Securities, the Unit Agreements and the Units, the Share Purchase Contracts, the Share Purchase
Unit Agreements and the Share Purchase Units and the Rights Agreements and the Rights has and will have, been made in good faith and would
be regarded as a valid and binding selection which will be upheld by the courts of the State of New York and any other relevant jurisdiction
(other than the Cayman Islands) as a matter of the laws of the State of New York and all other relevant laws (other than the laws of the
Cayman Islands); |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
| 9. | the capacity, power, authority and legal right of all parties under all relevant laws and regulations
(other than, with respect to the Company, the laws and regulations of the Cayman Islands) to enter into, execute, unconditionally deliver
and perform their respective obligations under the Warrant Agreements and the Warrants, the Indentures and the Debt Securities, the Unit
Agreements and the Units, the Share Purchase Contracts, the Share Purchase Unit Agreements and the Share Purchase Units and the Rights
Agreements and the Rights; |
| 10. | that all necessary corporate action will be taken by the Board to authorise and approve any issuance of
Securities and the terms of the offering of such Securities thereof and other related matters and that the applicable definitive purchase,
underwriting or similar agreement will be duly approved, executed and delivered by or on behalf of the Company and all other parties thereto; |
| 11. | that no monies paid to or for the account of the Company in respect of the Securities represent or will
represent proceeds of criminal conduct or criminal property or terrorist property (as defined in the Proceeds of Crime Act (As Revised)
and the Terrorism Act (As Revised) respectively); |
| 12. | the truth, accuracy and completeness of all representations and warranties or statements of fact or law
(other than as to the laws of the Cayman Islands in respect of matters upon which we have expressly opined) made in the Registration Statement
and any other documents reviewed by us; |
| 13. | that (i) the Registration Statement is in the form of the document approved in the Resolutions, (ii)
any meeting at which the Resolutions were passed was duly convened and had a duly constituted quorum present and voting throughout and any Resolutions passed in writing were adopted in accordance with the law and the Constitutional Documents,
(iii) all interests of the directors of the Company on the subject matter of the Resolutions, if any, were declared and disclosed in
accordance with the law and Constitutional Documents, (iv) the Resolutions have not been revoked, amended or superseded, in whole or
in part, and remain in full force and effect at the date of this opinion, and will be in full force and effect at any time when the
Securities are issued, offered or sold and that no action will be taken by the Company inconsistent with such Resolutions and (v)
the directors of the Company have concluded that the issue and sale of the Securities and such other transactions approved by the
Resolutions are bona fide in the best interests of the Company and for a proper purpose of the Company; |
| 14. | that the Certificate of Incumbency accurately reflects the names of
all directors and officers of the Company as at the date the Resolutions were passed or adopted, the date the Registration Statement was
issued and/or executed and as at the date of this opinion; |
| 15. | that there is no matter affecting the authority of the directors of
the Company to effect entry by the Company into the Registration Statement and related matters including breach of duty, lack of good
faith, not disclosed by the Constitutional Documents or the Resolutions, which would have any adverse implications in relation to the
opinions expressed in this opinion; |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
| 16. | that there is nothing contained in the minute book or corporate records of the Company (which we have
not inspected) which would or might affect the opinions expressed herein and there are no records of the Company, agreements, documents
or arrangements other than the Constitutional Documents, the Resolutions and the documents expressly referred to herein as having been
examined by us which materially affect, amend or vary the transactions contemplated in the Registration Statement or restrict the powers
and authority of the directors of the Company in any way which would affect opinions expressed in this opinion; |
| 17. | that the Company is not the subject of legal, arbitral, administrative or other proceedings in any jurisdiction
that would have a material adverse effect on the business, properties, financial condition, results of operations or prospects of the
Company; |
| 18. | that the directors or members of the Company have not taken any steps to have the Company struck off or
placed in liquidation, no steps have been taken to wind up the Company and no receiver has been appointed over any of the Company’s
property or assets; |
| 19. | that upon issue of any shares (including the Ordinary Shares) the Company will receive consideration for
the full issue price thereof which shall be equal to at least the par value thereof; |
| 20. | that on the date of allotment (where applicable) and issuance of any Securities the Company is, and after
such allotment and issuance the Company is and will be, able to pay its liabilities as they become due; |
| 21. | that no invitation has been or will be made by or on behalf of the Company to the public in the Cayman
Islands to subscribe for any of the Securities; |
| 22. | that the Registration Statement has been, or will be, declared effective by the SEC prior to the issuance
of the Ordinary Shares; |
| 23. | that on the date of issue of any Ordinary Shares, the Company
shall have sufficient authorised but unissued share capital available; and |
| 24. | that there are no matters of fact or law (excluding matters of Cayman Islands law) which would affect
the opinions expressed herein. |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
Schedule
3
Reservations
Our opinion is subject to the following:
| 1. | Enforcement: The term “enforceable” as used in this opinion means that there is a way
of ensuring that each party performs an agreement or that there are remedies available for breach. The obligations assumed by the Company
under the Warrant Agreements and the Warrants, the Indentures and the Debt Securities, the Unit Agreements and the Units, the Share Purchase
Contracts, the Share Purchase Unit Agreements and the Share Purchase Units and the Rights Agreements and the Rights will not necessarily
be enforceable in all circumstances in accordance with their terms. In particular, but without limitation: |
| (a) | enforcement and priority may be limited by laws relating to bankruptcy, insolvency, reorganisation, liquidation,
court schemes, schemes of arrangements, moratoriums or other laws of general application relating to, or affecting the rights of, creditors
and/or contributories; |
| (b) | enforcement may be limited by the principles of unjust enrichment or by general principles of equity and
we express no opinion as to the availability of equitable remedies or as to any matters which are within the discretion of the courts
of the Cayman Islands, even where such remedies are included in the documents (for example equitable remedies such as the grant of an
injunction or an order for specific performance may not be available where liquidated damages are considered an adequate remedy); |
| (c) | claims may become barred by prescription or may be or become subject to defences of set-off, counterclaim,
estoppel and similar defences; |
| (d) | obligations to be performed outside the Cayman Islands may not be enforceable in the Cayman Islands to
the extent that performance would be illegal or contrary to public policy under the laws of that foreign jurisdiction; |
| (e) | enforcement may be limited to the extent that matters which we have expressly assumed in this opinion
will be done, have not been done; |
| (f) | the enforcement of the obligations of the parties to the documents may be limited by the law applicable
to obligations held to have been frustrated by events happening after their execution; |
| (g) | enforcement of obligations may be invalidated by reason of fraud, duress, mistake, misrepresentation or
undue influence; |
| (h) | where the performance of payment obligations is contrary to the exchange control regulations of any country
in the currency of which such amounts are payable, such obligations may not be enforceable in the Cayman Islands; |
| (i) | matters of procedure on enforcement of the documents and forum conveniens will be governed by and
determined in accordance with the lex fori; |
| (j) | arrangements that constitute penalties will not be enforceable; |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
| (k) | we reserve our opinion as to the enforceability of the relevant provisions of the Warrant Agreements,
the Rights Agreements and the Unit Agreements to the extent that they purport to grant exclusive jurisdiction as there may be circumstances
in which the courts of the Cayman Islands would accept jurisdiction notwithstanding such provisions; |
| (l) | a company cannot, by agreement or in its articles of association, restrict the exercise of a statutory
power and there is doubt as to the enforceability of any provision in the Warrant Agreements, the Rights Agreements and the Unit Agreements
whereby the Company covenants to restrict the exercise of powers specifically given to it under the Companies Act, including, without
limitation, the power to increase its authorised share capital, amend its memorandum and articles of association or present a petition
to a Cayman Islands court for an order to wind up the Company; and |
| (m) | if the Company becomes subject to Part XVIIA of the Companies Act, enforcement or performance of any provision
in the Warrant Agreements, the Rights Agreements and the Unit Agreements which relates, directly or indirectly, to an interest in the
Company constituting shares, voting rights or director appointment rights in the Company may be prohibited or restricted if any such relevant
interest is or becomes subject to a restrictions notice issued under the Companies Act. |
| 2. | Other Obligations: We express no opinion as to whether the acceptance, execution or performance
of the Company’s obligations under the Registration Statement, the Warrant Agreements, the Indentures, the Unit Agreements, the
Share Purchase Contracts, the Share Purchase Unit Agreements and the Rights Agreements will result in the breach of or infringe any other
agreement, deed or document (other than the Constitutional Documents) entered into by or binding on the Company. |
| 3. | Severability: We reserve our opinion as to the extent to which the courts of the Cayman Islands
would, in the event of any relevant illegality or invalidity, sever the relevant provisions of the Warrant Agreements and the Warrants,
the Indentures and the Debt Securities, the Unit Agreements and the Units, the Share Purchase Contracts, the Share Purchase Unit Agreements
and the Share Purchase Units and the Rights Agreements and the Rights and enforce the remainder of the such Warrant Agreements and Warrants,
Indentures and Debt Securities, Unit Agreements and Units, Share Purchase Contracts, Share Purchase Unit Agreements and Share Purchase
Units or Rights Agreements and Rights (as the case may be) or the transaction of which such provisions form a part, notwithstanding any
express provisions in the Warrant Agreements and the Warrants, the Indentures and the Debt Securities, the Unit Agreements and the Units,
the Share Purchase Contracts, the Share Purchase Unit Agreements and the Share Purchase Units and Rights Agreements and the Rights in
this regard. |
| 4. | Non-assessable: In this opinion the phrase “non-assessable” means, with respect to
the Ordinary Shares, that a member of the Company shall not, by virtue of its status as a member (shareholder) of the Company and in absence
of a contractual arrangement, or an obligation pursuant to the memorandum and articles of association, to the contrary, be liable for
additional assessments or calls on the Ordinary Shares by the Company or its creditors (except in exceptional circumstances, such as involving
fraud, the establishment of an agency relationship or an illegal or improper use or other circumstance in which a court may be prepared
to pierce or lift the corporate veil). |
| 5. | Jurisdiction: Where any document provides for the submission to the exclusive or non-exclusive
jurisdiction of the Cayman Islands courts, the court may decline to accept jurisdiction in any matter where (a) it determines that some
other jurisdiction is a more appropriate or convenient forum; (b) another court of competent jurisdiction has made a determination in
respect of the same matter; or (c) litigation is pending in respect of the same matter in another jurisdiction. |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
| 6. | Concurrent Proceedings: Proceedings may be stayed
in the Cayman Islands if concurrent proceedings in respect of the same matter are or have been commenced in another jurisdiction. Notwithstanding
any provision in the documents that all disputes arising under or in connection with the documents should be brought before the competent
court in the jurisdiction specified in the documents, a Cayman Islands court has discretion to refuse to stay proceedings in the Cayman
Islands if it is satisfied that it is just and equitable to do so and may grant leave to serve Cayman Islands proceedings outside of
the Cayman Islands. |
| 7. | Good Standing: Our opinion as to good standing is based solely upon receipt of the Certificate
of Good Standing issued by the Registrar of Companies. The Company shall be deemed to be in good standing under section 200A of the Companies
Act on the date of issue of the certificate if all fees and penalties under the Companies Act have been paid and the Registrar of Companies
has no knowledge that the Company is in default under the Companies Act. |
| 8. | Corporate Documents: The Registry of Companies in the Cayman Islands is not public in the sense
that copies of the Constitutional Documents and information on shareholders is not publicly available and information on directors is
limited. We have therefore obtained copies of the corporate documents specified in Schedule 1 and relied exclusively on such copies for
the verification of such corporate information. |
| 9. | Statements made in Documents: Except as specifically stated herein, we make no comment with respect
to any representations and warranties which may be made by or with respect to the Company in any of the documents or instruments cited
in this opinion or otherwise with respect to the commercial terms of the transactions, which are the subject of this opinion. |
| 10. | Document with an “as of” Date: We express no opinion on the effectiveness of the date
of any document which is dated as of or with effect from a date prior to that on which it is authorised, executed, and delivered by all
parties thereto. |
| 11. | Foreign Laws: We express no opinion as to the meaning, validity or effect of any references to
foreign (i.e. non-Cayman Islands) statutes, rules, regulations, codes, judicial authority or any other promulgations and any references
to them in the Registration Statement, the Warrant Agreements or the Warrants, the Indentures or the Debt Securities, the Unit Agreements
or the Units, the Share Purchase Contracts, the Share Purchase Unit Agreements or the Share Purchase Units or the Rights Agreements or
the Rights. |
| 12. | Documents Reviewed: We have not reviewed any of the Warrant Agreements or the Warrants to be issued
thereunder, the Indentures or the Debt Securities to be issued thereunder, the Unit Agreements or the Units to be issued thereunder, the
Share Purchase Contracts, the Share Purchase Unit Agreements or the Share Purchase Units to be issued thereunder or the Rights Agreements
or the Rights to be issued thereunder and our opinions are qualified accordingly. |
Bermuda ■
British Virgin Islands ■ Cayman Islands ■
Guernsey ■ Hong Kong ■
Isle of Man ■ Jersey ■
Mauritius ■ Seychelles ■
Shanghai
14
Exhibit 5.2
|
366 Madison Avenue
3rd Floor
New York, NY 10017
tel: (212) 588-0022
fax: (212) 826-9307 |
February 21, 2024
Lichen China Limited
15th Floor, Xingang Square, Hubin North Road,
Siming District, Xiamen City,
Fujian Province, China, 361013
Ladies and Gentlemen:
We are acting as United States
counsel Lichen China Limited, a company incorporated in the Cayman Islands (the “Company”), in connection with the registration
statement on Form F-3, File No. [ ] (the “Registration Statement”), including all amendments and supplements thereto, and
accompanying prospectus filed with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as
amended (the “Securities Act”), with respect to the offering by the Company of up to an aggregate of $100,000,000 of securities
which may include Class A ordinary shares (“Class A Ordinary Shares”), share purchase contracts (“Share Purchase Contracts”),
share purchase units (“Share Purchase Units”), warrants (“Warrants”), debt securities (“Debt Securities”),
rights (“Rights”), units (“Units” and, together with the Class A Ordinary Shares, the Share Purchase Contracts,
the Share Purchase Units, the Warrants, the Debt Securities, the Rights, the “Securities”) or any combination of the Securities.
We
have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Registration Statement; (ii) the
prospectus of the Company (the “Prospectus”) included in the Registration Statement; (iii) the form of senior indenture to
be entered into by the Company (the “Senior Indenture”, filed as Exhibit 4.2 to the Registration Statement), (iv) the form
of subordinated indenture to be entered into by the Company (the “Subordinated Indenture”, filed as Exhibit 4.3 to the Registration
Statement, and together with the Senior Indenture, the “Indentures”), (v) the opinion of Appleby dated February 21, 2024 (filed as
Exhibit 5.1 to the Registration Statement), (vi) each document incorporated or deemed to be incorporated by reference into the Registration
Statement and (vii) such corporate documents and records of the Company and such other instruments, certificates and documents as we have
deemed necessary or appropriate as a basis for the opinions hereinafter expressed. In such examinations, we have assumed the authenticity
of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies or drafts
of documents to be executed, the genuineness of all signatures and the legal competence or capacity of persons or entities to complete
the execution of documents. As to various questions of fact which are material to the opinions hereinafter expressed, we have relied upon
statements or certificates of public officials, directors of the Company and others.
We
have further assumed for the purposes of this opinion, without investigation, that (i) the Debt Securities will be governed by, and construed
in accordance with, the laws of the State of New York, (ii) all documents contemplated by the Prospectus to be executed in connection
with the Offering have been duly authorized, executed and delivered by each of the parties thereto other than the Company, and (iii) the
terms of the Offering comply in all respects with the terms, conditions and restrictions set forth in the Prospectus and all of the instruments,
agreements and other documents relating thereto or executed in connection therewith.
Lichen China Limited |
February 21, 2024 |
Subject
to the foregoing and the qualifications set forth in the Registration Statement, we are of the opinion that:
1.
The Debt Securities, when (i) the Debt Securities have been specifically authorized for issuance by the Authorizing Resolutions,
(ii) the applicable Indentures relating to the Debt Securities has been duly authorized, executed and delivered by the Company, (iii) the
terms of the Debt Securities and of their issuance and sale have been duly established in conformity with the applicable Indentures and
authorized by resolutions to be passed by the directors of the Company or an authorized committee thereof authorizing the issue of the
Debt Securities (the “Authorizing Resolutions”), (iv) the Debt Securities have been duly executed by the Company and countersigned
in accordance with the applicable Indentures and Authorizing Resolutions and issued and delivered as contemplated by the Registration
Statement, the Prospectus and the applicable prospectus supplement in accordance with the applicable underwriting or other purchase agreement
against payment therefor, and (v) the Company has received the consideration provided for in the Authorizing Resolutions and the
applicable underwriting agreement or other purchase agreement, will be valid and legally binding obligations of the Company, enforceable
against the Company in accordance with their terms.
2.
The foregoing opinion is subject, in each case, to applicable insolvency, bankruptcy, reorganization, moratorium, fraudulent transfer,
fraudulent conveyance or other similar laws affecting generally the enforceability of creditors’ rights from time to time in effect and
subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, including application of
principles of good faith, fair dealing, commercial reasonableness, materiality, unconscionability and conflict with public policy and
other similar principles.
Our opinion is limited to
the application of the laws of the State of New York, the Securities Act and the rules and regulations of the SEC promulgated thereunder
only and we express no opinion with respect to the applicability of other federal laws, the laws of other countries, the laws of any state
of the United States or any other jurisdiction, or as to any matters of municipal law or the laws of any other local agencies within any
state. No opinion is expressed as to any federal securities laws except as specifically set forth herein. Our opinion represents only
our interpretation of the law and has no binding, legal effect on, without limitation, any court. It is possible that contrary positions
may be asserted and that one or more courts may sustain such contrary positions. Our opinion is expressed as of the date hereof, and we
are under no obligation to supplement or revise this opinion to reflect any changes, including changes which have retroactive effect (i)
in applicable law, or (ii) in any fact, information, document, corporate record, covenant, statement, representation, or assumption stated
herein that becomes untrue, incorrect or incomplete.
This letter is furnished to
you for use in connection with the Registration Statement and is not to be used, circulated, quoted, or otherwise referred to for any
other purpose without our express written permission. We hereby consent to the filing of this opinion as an exhibit to the Registration
Statement and to the use of our name in the Registration Statement wherever it appears. In giving such consent, we do not thereby admit
that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules
and regulations of the SEC thereunder.
|
Very truly yours, |
|
|
|
/s/ Ortoli Rosenstadt LLP |
|
|
|
Ortoli Rosenstadt LLP |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We consent to the reference to our firm
under the caption “Experts” and to the incorporation by reference in this registration statement on form F-3 of Lichen China
Limited of our report dated May 1, 2023, with respect to the consolidated financial statements of Lichen China Limited for the years ended
December 31, 2022 and 2021 which appears in Lichen China Limited form 20-F filed with the Securities and Exchange Commission.
/s/ TPS Thayer LLC
TPS Thayer LLC
Sugar Land, Texas
February 21, 2024
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We hereby consent to the incorporation by reference
in the Registration Statement on Form F-3 of Lichen China Limited and Subsidiaries (the “Company”) of our report dated August
11, 2021, relating to our audit of the consolidated financial statements of the Company for the fiscal year ended December 31, 2020.
We also consent to the reference of our Firm under
the caption “Experts” in this Registration Statement.
/s/ Briggs & Veselka Co.
Briggs & Veselka Co.
Houston, Texas
February 21, 2024
Exhibit 107
Calculation of Filing Fee Tables
Form F-3
(Form Type)
Lichen China Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward
Securities
| |
Security
Type | |
Security
Class Title | |
Fee
Calculation or Carry Forward Rule | | |
Amount
Registered (1) | | |
Proposed
Maximum Offering Price Per Unit (2) | | |
Maximum
Aggregate Offering Price (3) | | |
Fee
Rate | | |
Amount
of Registration Fee | | |
Carry
Forward Form Type | | |
Carry
Forward File Number | | |
Carry
Forward Initial effective date | | |
Filing
Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
Newly
Registered Securities | |
Fees
to Be Paid | |
Equity | |
Class A Ordinary
Shares, par value $0.00004 per share | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Debt | |
Debt Securities | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Other | |
Warrants | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Other | |
Rights | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Other | |
Units | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Unallocated
(Universal) Shelf | |
— | |
| 457 | (o) | |
| | (1) | |
| | (2) | |
$ | 100,000,000 | | |
$ | 0.00014760 | | |
$ | 14,760 | | |
| | | |
| | |
| | | |
| | |
Fees
Previously Paid | |
— | |
— | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| | | |
| | |
Carry
Forward Securities | |
Carry
Forward Securities | |
— | |
— | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| | | |
| — | | |
| — | | |
| — | | |
| — | |
| |
Total Offering
Amounts | | |
| | | |
$ | 100,000,000 | | |
| | | |
$ | 14,760 | | |
| | | |
| | | |
| | | |
| | |
| |
Total Fees
Previously Paid | | |
| | | |
| | | |
| | | |
| — | | |
| | | |
| | | |
| | | |
| | |
| |
Total
Fee Offsets | | |
| | | |
| | | |
| | | |
$ | 14,760 | | |
| | | |
| | | |
| | | |
| | |
| |
Net
Fee Due | | |
| | | |
| | | |
| | | |
$ | 0 | | |
| | | |
| | | |
| | | |
| | |
| (1) | The
registrant is registering an indeterminate number of securities for offer and sale from time to time at indeterminate prices, which shall
have an aggregate offering price not to exceed $100,000,000. In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as
amended, this registration statement shall be deemed to cover any additional number of securities that may be issued from time to time
to prevent dilution as a result of a distribution, split, combination, or similar transaction. Securities registered hereunder may be
sold separately, or together with other securities registered hereunder. Includes consideration to be received by the registrant, if
applicable, for registered securities that are issuable upon exercise, conversion, or exchange of other registered securities. |
| (2) | The
proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection
with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant
to Instructions to the Calculation of Filing Fee Tables and Related Disclosure (2)(A)(iii)(b) of Form F-3 under the Securities Act. |
| (3) | Estimated
solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act. |
Table 2: Fee Offset Claims and Sources
| |
Registrant
or Filer
Name | |
Form
or Filing
Type | |
File
Number | |
Initial
Filing
Date | | |
Filing
Date | | |
Fee
Offset
Claimed | | |
Security Type Associated with Fee
Offset
Claimed | |
Security
Title
Associated
with Fee
Offset
Claimed | | |
Unsold
Securities
Associated
with Fee
Offset
Claimed | | |
Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed | | |
Fee Paid
with Fee
Offset
Source | |
Rule 457(p) | |
Fee Offset Claims | |
Lichen China Limited | |
F-3 | |
333-277106 | |
| February 15, 2024 | | |
| - | | |
$ | 14,760 | | |
Withdrawal
of the Registration Statement | |
| (1 | ) | |
| (1 | ) | |
$ | 100,000,000 | | |
| - | |
Fee Offset Sources | |
Lichen China Limited | |
F-3 | |
333-277106 | |
| - | | |
| February 15, 2024 | | |
| - | | |
- | |
| - | | |
| - | | |
| - | | |
$ | 14,760 | |
(1) | On February 15, 2024, the Registrant filed a registration
statement on Form F-3 (File No. 333-277106) (the “Prior Registration Statement”) with the Securities and Exchange Commission
registering an indeterminate number of securities with a proposed maximum aggregate offering price of $100,000,000. On February 16, 2024,
the Registrant withdrew the Prior Registration Statement. Pursuant to Rule 457(p) under the Securities Act, the Registrant is offsetting
the registration fee due under this registration statement by $14,760, which represents the registration fee previously paid with respect
to $100,000,000 of unsold securities (the “Unsold Offset Securities”) in the Prior Registration Statement. The offering of
the Unsold Offset Securities pursuant to the Prior Registration Statement associated with the claimed fee offset pursuant to Rule 457(p)
have been completed or terminated. |
Lichen China (NASDAQ:LICN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lichen China (NASDAQ:LICN)
Historical Stock Chart
From Apr 2023 to Apr 2024